# www.schott-pharma.com > SCHOTT Pharma designs a drug delivery system for injectable drugs. Explore our website and find a reliable & compatible wide range of offers! ## English ## Products | SCHOTT Pharma’s Products page provides an overview of its drug containment and delivery portfolio, including prefillable glass and polymer syringes, cartridges, vials, and ampoules, all designed for pharmaceutical and biotech manufacturers. - [Glass Ampoules | SCHOTT Pharma](https://www.schott-pharma.com/en/products/glass-ampoules): For exceptional chemical resistance, drug stability and accurate dimensions, explore SCHOTT Pharma’s wide range of pharmaceutical glass ampoules. - [Cartridges | SCHOTT Pharma](https://www.schott-pharma.com/en/products/pharmaceutical-cartridges): From StandardLine and TopLine to cartriQ® and SCHOTT TOPPAC® cartridges, SCHOTT Pharma’s range of glass cartridges dispense drugs in exceptionally accurate doses for any medical situation - [Syringes | SCHOTT Pharma](https://www.schott-pharma.com/en/products/syringes): SCHOTT Pharma glass and polymer prefillable syringes are designed to provide safe and precise drug storage and delivery with reduced errors. - [Vials | SCHOTT Pharma](https://www.schott-pharma.com/en/products/vials): SCHOTT Pharma’s vials enhance fill-and-finish efficiency and boost long-term drug stability with a broad range of advantages. - [Products | SCHOTT Pharma](https://www.schott-pharma.com/en/products): As the leading supplier of pharmaceutical packaging SCHOTT Pharma offers a wide range of glass and polymer syringes, ampoules, cartridges, and vials. ## Syringes | SCHOTT Pharma’s Syringes page showcases its prefillable pharmaceutical syringe solutions made from glass and advanced polymer for secure drug storage and delivery. It highlights syriQ® and SCHOTT TOPPAC® syringes designed to reduce errors, improve safety and support a broad range of applications from vaccines to biologics. - [SCHOTT TOPPAC® unique](https://www.schott-pharma.com/en/products/syringes/schott-toppac-unique): SCHOTT Pharma’s advanced polymer containers offer a range of customizable features and dimensions for individual medical treatments and applications - [syriQ® Prefillable Glass Syringes](https://www.schott-pharma.com/en/products/syringes/syriq): syriQ® ready-to-use prefillable glass syringes for vaccines offer safe storage and delivery of a broad range of inactivated, live-attenuated, conjugate, and mRNA vaccines - [SCHOTT TOPPAC® infuse](https://www.schott-pharma.com/en/products/syringes/schott-toppac-infuse): Advanced syringes for infusion therapy that offer high stability, excellent barrier properties, and an easy-connect Luer Lock system - [syriQ BioPure®](https://www.schott-pharma.com/en/products/syringes/syriq-biopure): SCHOTT Pharma’s prefillable syringes for biologics are engineered to reduce drug-container interaction and ensure safe delivery - [syriQ BioPure® silicone-free](https://www.schott-pharma.com/en/products/syringes/syriq-biopure-silicone-free): Ready-to-use prefillable silicone-free syringes for sensitive biologics, providing high stability and a consistent gliding force. - [SCHOTT TOPPAC® polymer syringes](https://www.schott-pharma.com/en/products/syringes/schott-toppac): Ready-to-use SCHOTT TOPPAC® prefillable polymer syringes offer a versatile primary packaging solution for long-term drug storage. - [SCHOTT TOPPAC® cosmetic](https://www.schott-pharma.com/en/products/syringes/schott-toppac-cosmetic): Learn about SCHOTT TOPPAC® prefillable polymer syringes, which are designed for cosmetic treatments using hyaluronic acid and botulinum toxin (BoNT) - [SCHOTT TOPPAC® freeze](https://www.schott-pharma.com/en/products/syringes/schott-toppac-freeze): SCHOTT Pharma’s prefillable polymer syringes for deep-cold drugs are the ideal storage solution for low-temperature conditions. ## Cartridges | SCHOTT Pharma’s Pharmaceutical Cartridges page outlines its glass and polymer cartridge solutions for precise drug dosing in pens, auto-injectors, and wearable systems. The portfolio includes ready-to-use, double-chamber, and high-durability options designed for injectable therapies and biologics. - [ SCHOTT TOPPAC® cartridge](https://www.schott-pharma.com/en/products/pharmaceutical-cartridges/schott-toppac-cartridge): SCHOTT TOPPAC® polymer cartridges are designed for efficient and reliable drug delivery in clinical and homecare settings - [Cartridges Double Chamber (DC)](https://www.schott-pharma.com/en/products/pharmaceutical-cartridges/cartridges-double-chamber): SCHOTT Pharma’s dual-chamber cartridges provide a secure and efficient solution for handling lyophilized drugs to ensure precise dosage - [cartriQ® Large Volume](https://www.schott-pharma.com/en/products/pharmaceutical-cartridges/cartriq-large-volume): SCHOTT Pharma’s cartriQ® Large Volume cartridges are designed for wearable injection devices and deliver reliable performance and safe, patient-friendly drug delivery - [Core Cartridges](https://www.schott-pharma.com/en/products/pharmaceutical-cartridges/core-cartridges): Chemical-resistant cartridges that offer high chemical resistance and precise tolerances to provide patients with the ability to self-administer drugs. - [Cartridges Break Resistant (BR)](https://www.schott-pharma.com/en/products/pharmaceutical-cartridges/cartridges-break-resistant): Break-resistant cartridges designed to endure the toughest conditions, ensuring the safe storage and delivery of life-saving pharmaceuticals - [cartriQ®](https://www.schott-pharma.com/en/products/pharmaceutical-cartridges/cartriq): SCHOTT Pharma’s ready-to-use cartridges are compatible with a wide range of autoinjectors and pen injectors, and are ideal for hospital and home use ## Vials | SCHOTT Pharma’s Vials page highlights high-quality glass vials engineered for injectable drugs, vaccines, and biologics, offering chemical resistance, dimensional precision, and ready-to-use options to support efficient pharmaceutical fill-and-finish processes. - [EVERIC® freeze](https://www.schott-pharma.com/en/products/vials/everic-freeze): SCHOTT Pharma's EVERIC® freeze vials are designed for stability in deep-cold storage, reducing breakage and optimizing pharmaceutical freeze-drying. - [Core Vials](https://www.schott-pharma.com/en/products/vials/core-vials): Discover SCHOTT Pharma’s Core Vials in TopLine and StandardLine quality for drug stability, production efficiency, and low TCO. - [adaptiQ®](https://www.schott-pharma.com/en/products/vials/adaptiq): The highly standardized pharmaceutical secondary packaging designed to enhance the efficiency, safety, and reliability of injectable drug manufacturing processes - [EVERIC® strong & smooth](https://www.schott-pharma.com/en/products/vials/everic-strong-smooth): SCHOTT Pharma’s break-resistant vial offers increased speed for bulk fill-and-finish lines plus a reduced risk of breakage and lower reject rates - [EVERIC® amber vials](https://www.schott-pharma.com/en/products/vials/everic-amber): EVERIC® amber vials provide superior light protection for antibody-drug conjugates and other sensitive biologics, ensuring stability and efficacy - [EVERIC® pure](https://www.schott-pharma.com/en/products/vials/everic-pure): EVERIC® pure Borosilicate Glass vials for ultimate drug stability. Proven delamination control and hydrolytic resistance for your pharmaceutical products - [EVERIC® plus](https://www.schott-pharma.com/en/products/vials/everic-plus): EVERIC® plus coated glass vials feature low leachable levels and reduced adsorption to ensure the stability of sensitive drug formulations - [EVERIC® care](https://www.schott-pharma.com/en/products/vials/everic-care): EVERIC® care pharmaceutical glass vials feature a hydrophobic coating that protects sensitive drugs from leachables in the alkaline pH range - [EVERIC® smart](https://www.schott-pharma.com/en/products/vials/everic-smart): SCHOTT Pharma’s smart containers are laser-marked with a unique code to enable high levels of traceability throughout the fill-and-finish process - [EVERIC® lyo](https://www.schott-pharma.com/en/products/vials/everic-lyo): EVERIC® lyo vials are designed to prevent fogging during lyophilization and improve residual emptying ## Ampoules | SCHOTT Pharma’s Glass Ampoules page showcases high‑quality borosilicate ampoules for safe containment of sterile injectable drugs and chemicals, with precise sealing, chemical resistance, and formats suited for vaccines, biologics, and sensitive pharmaceutical applications. - [Ampoules Anti-Counterfeiting (AC)](https://www.schott-pharma.com/en/products/glass-ampoules/anti-counterfeiting-ampoules): SCHOTT Pharma’s Ampoules Anti-Counterfeiting (AC) offer protection for pharmaceutical companies against the growing threat of drug counterfeiting - [Ampoules easyOPC](https://www.schott-pharma.com/en/products/glass-ampoules/ampoules-easy-opc): SCHOTT’s Ampoules easyOPC offer an optimized breakforce range for safe opening, reduced returns, lower costs, and enhanced drug stability - [Core Ampoules](https://www.schott-pharma.com/en/products/glass-ampoules/core-ampoules): SCHOTT Core Ampoules offer high hydrolytic resistance, an outstanding fill-and-finish process, and the choice of four different break-systems. ## Services | SCHOTT Pharma’s Services page outlines tailored support for pharmaceutical and biotech partners, including packaging optimization, regulatory and quality consulting, technical support, drug delivery system development, and customized solutions to enhance manufacturing and product performance. - [Pharma Regulatory Services I SCHOTT Pharma](https://www.schott-pharma.com/en/services/regulatory): SCHOTT Pharma’s Regulatory Services enable the seamless integration of primary packaging content into drug and medical device registrations - [Pharma Analytics | SCHOTT Pharma](https://www.schott-pharma.com/en/services/pharma-analytics): SCHOTT Pharma Analytics provides analytical testing that validates the compatibility of your containment solution to the requirements of your specific drug products - [Services | SCHOTT Pharma](https://www.schott-pharma.com/en/services): SCHOTT Pharma offers analytical testing, fill-and-finish optimization, plus sustainability and regulatory support services. ## SCHOTT Pharma Drug containment and delivery services | SCHOTT Pharma’s Containment Solutions page highlights customizable containment consulting and support for pharmaceutical packaging, including risk assessment, barrier strategies, compatibility testing, and optimized containment systems to ensure both the product safety and quality as well as regulatory compliance. - [Prototyping | SCHOTT Pharma](https://www.schott-pharma.com/en/services/containment-solutions/prototyping): SCHOTT Pharma offers a complete prototyping service for pharmaceutical packaging, including sample manufacture, feasibility and compatibility testing, and documentation - [Feasibility studies | SCHOTT Pharma](https://www.schott-pharma.com/en/services/containment-solutions/feasibility-study): SCHOTT Pharma offers a Feasibility studies Service that assesses the feasibility of a product packaging solution and its suitability for large-scale production - [Drug Containment and Delivery Services | SCHOTT Pharma](https://www.schott-pharma.com/en/services/containment-solutions): SCHOTT Pharma offers customized drug containment and delivery solutions, from design concept to industrialization, tailored to your specific needs. ## SCHOTT Pharma Analytics | SCHOTT Pharma’s Pharma Analytics page highlights a portfolio of analytical services for drug packaging and delivery systems, including material characterization, extractables and leachables testing, stability studies, and regulatory support to ensure quality, safety, and compliance for pharmaceutical products. - [Functional testing](https://www.schott-pharma.com/en/services/pharma-analytics/functional-testing): SCHOTT Pharma offers a functional testing of pharmaceutical packaging service for full regulatory compliance - [Packaging Component Characterization | SCHOTT Pharma](https://www.schott-pharma.com/en/services/pharma-analytics/packaging-component-characterization): Understand the components you use, to ensure safe storage of your drug with SCHOTT Pharma’s packaging component characterization. - [Extractables and leachables studies | SCHOTT Pharma](https://www.schott-pharma.com/en/services/pharma-analytics/extractables-leachables-studies): SCHOTT Pharma designs and executes extractables and leachables studies, interprets results, and compares drug containment solutions. - [Delamination Studies | SCHOTT Pharma](https://www.schott-pharma.com/en/services/pharma-analytics/glass-delamination): SCHOTT Pharma’s delamination screening helps pharma companies select ideal drug-container combinations and storage parameters for specific products. - [Particle Analysis | SCHOTT Pharma](https://www.schott-pharma.com/en/services/pharma-analytics/particle-analysis): SCHOTT Pharma investigates drug particles to identify root causes and ensure product safety through comprehensive studies. - [Container Closure Integrity Testing I SCHOTT Pharma](https://www.schott-pharma.com/en/services/pharma-analytics/container-closure-integrity-testing): SCHOTT Pharma offers a comprehensive CCI testing service that ensures the safety and efficacy of your pharmaceutical container. - [Compendial Testing | SCHOTT Pharma](https://www.schott-pharma.com/en/services/pharma-analytics/compendial-testing): SCHOTT Pharma performs compendial tests on drug containment systems to ensure compliance with pharmacopeia and international standards. - [Mechanical Stability Testing | SCHOTT Pharma](https://www.schott-pharma.com/en/services/pharma-analytics/mechanical-stability-testing): SCHOTT Pharma’s mechanical stability testing provides a solid basis for weak point analysis in production lines and container design. ## SCHOTT Pharma Fill-and-finish services | SCHOTT Pharma’s Fill and Finish page lists sterile manufacturing services including aseptic filling, inspection, and packaging of injectable drugs and biologics, with quality control, scalable production, and regulatory support to help pharma partners bring products to market safely. - [Fill-and-finish services | SCHOTT Pharma](https://www.schott-pharma.com/en/services/fill-and-finish): SCHOTT Pharma’s fill-and-finish services for syringes, cartridges and vials support the processing of containment solutions from small to commercial scale ## SCHOTT Pharma regulatory services | SCHOTT Pharma’s Regulatory page outlines support for pharmaceutical packaging and delivery systems, including guidance on global regulations, submission strategies, documentation, compliance assessment, and quality management intended to help partners meet regulatory requirements and streamline approvals. - [Letter of Authorization (LOA) | SCHOTT](https://www.schott-pharma.com/en/services/regulatory/pharma-letter-of-authorization-loa): SCHOTT Pharmaceutical Systems offers a wide range of regulatory services designed to make your drug registration process as smooth as possible. - [Packaging Dossiers I SCHOTT Pharma](https://www.schott-pharma.com/en/services/regulatory/pharmaceutical-packaging-dossiers): SCHOTT Pharma offers customized documentation packages for seamless integration into the final drug application dossier - [National Product Registrations | SCHOTT Pharma](https://www.schott-pharma.com/en/services/regulatory/pharmaceutical-product-registration): Learn how SCHOTT Pharma implements pharma product registration and is proactively preparing regulatory compliance and availability for its products. - [Drug Master Files | SCHOTT Pharma](https://www.schott-pharma.com/en/services/regulatory/drug-master-files-dmf-pharma): SCHOTT Pharma offers a complete service for generating, filing, and updating drug registrations in the USA, Canada, and China - [GSPR Dossiers | SCHOTT Pharma](https://www.schott-pharma.com/en/services/regulatory/medical-device-registration): SCHOTT Pharma offers its complete support in supplying dossiers to cover the General Safety and Performance Requirements (GSPR) ## SCHOTT Pharma Sustainability Services | SCHOTT Pharma’s Sustainability page focuses on services that the company provides to support environmental and social responsibility, such as ustainability performance reviews, EcoVadis ratings, and product carbon footprint assessments to help reduce emissions, improve supply chain sustainability, and work toward a net‑zero future. - [Sustainability in Pharmaceutical Packaging | SCHOTT Pharma](https://www.schott-pharma.com/en/services/sustainability): SCHOTT Pharma integrates environmental approaches into its products and solutions to supports pharma companies in meeting sustainability standards. ## SCHOTT Pharma Solutions | SCHOTT Pharma’s Solutions page presents integrated drug containment and delivery systems, combining packaging, analytics, fill-and-finish, and regulatory support. These end-to-end solutions help pharmaceutical and biotech partners improve safety, efficiency, and product performance across the lifecycle. - [Whitepaper Finding the perfect match I SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-solutions/pharmaceutical-manufacturing/improved-manufacturing-processes-with-sterile-solutions/whitepaper-finding-the-perfect-match): - [Whitepaper Standardized Packaging Solutions I SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-solutions/pharmaceutical-manufacturing/improved-manufacturing-processes-with-sterile-solutions/whitepaper-standardized-packaging): - [Whitepaper A winning combination I SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-solutions/pharmaceutical-manufacturing/improved-manufacturing-processes-with-sterile-solutions/whitepaper-winning-combination): - [cartriQ® integration for large-volume SC injections | SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-solutions/drug-packaging/large-volume-injections-biologics/cartriq-integration-sterile-large-volume): cartriQ® integration provides safe and stable SC delivery of large-volume biologics, supporting patient-friendly, home-based drug administration - [Biologics & Biosimilars – from research to regulatory compliance | SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-solutions/drug-packaging/biologics-biosimilars): Biologics & biosimilars bring new challenges: Find out how to bring them to market, from research about primary packaging solutions to regulatory compliance. - [USP <382> Functional Testing Solutions | SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-solutions/pharma-services/usp-382): Rigorous USP <382> testing for fully assembled drug‑filled systems, from package integrity and CCI checks to fragmentation analysis - [Fill-and-finish optimization | SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-solutions/pharma-services/fill-and-finish-optimization): With SCHOTT Pharma’s fill-and-finish optimization capabilities, breakages & interruptions in the filling process in the pharmaceutical industry are identified and eliminated. - [Drug submission preparation | SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-solutions/pharma-services/drug-submission-preparation): SCHOTT Pharma offers a comprehensive testing service for pharmaceutical packaging to ensure full regulatory compliance and patient safety - [Large-volume biologics | SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-solutions/drug-packaging/large-volume-injections-biologics): SCHOTT Pharma offers a range of primary packaging solutions for pen injectors, autoinjectors, on-body delivery systems, and infusion pumps - [Optimized polymer syringe nest design | SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-solutions/pharmaceutical-manufacturing/optimized-polymer-syringe-nest-design): SCHOTT Pharma’s new nest and tub system is the world’s first to hold 160 polymer syringes, reducing cycle time and costs while increasing the efficiency of your high-speed fill-and-finish lines. - [Small Batch Packaging Solutions | SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-solutions/pharmaceutical-manufacturing/small-batch-packaging-solutions): SCHOTT Pharma's small batch packaging solutions ensure reliable drug containment and delivery, and offer optimal sterile protection right from the start - [Diabetes Treatment | SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-solutions/drug-packaging/diabetes-treatment): SCHOTT Pharma offers a range of drug containment and drug delivery solutions for GLP-1-based diabetes treatment - [mRNA storage — Challenges of mRNA applications](https://www.schott-pharma.com/en/pharma-solutions/drug-packaging/mrna-storage): Browse SCHOTT Pharma‘s mRNA storage and mRNA vaccine packaging solutions and ensure container safety with our vial and syringe portfolio. - [Optimize your manufacturing process | SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-solutions/pharmaceutical-manufacturing/improved-manufacturing-processes-with-sterile-solutions): SCHOTT Pharma’s adaptiQ® ready-to-use (RTU) platform offers high flexibility, increased speed, and significant cost savings for fill-and-finish lines. - [Pharmaceutical track and trace solutions | SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-solutions/pharmaceutical-manufacturing/pharmaceutical-track-and-trace-individual-container): Explore SCHOTT Pharma´s pharmaceutical track and trace solutions for reducing risk of mix-ups for drug containers - [EVERIC® Vial | SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-solutions/platforms/everic-vial-solutions): SCHOTT Pharma's EVERIC® vials offer a flexible, modular design, bridging the needs of manufacturers and users for optimized performance - [Aseptic filling — Enhanced contamination control](https://www.schott-pharma.com/en/pharma-solutions/platforms/aseptic-filling): For improved contamination control in aseptic filling, explore SCHOTT iQ® Integribag, which overcomes the limitations of RTU containers and enhances safety. - [Obesity Treatment | SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-solutions/drug-packaging/obesity-treatment): SCHOTT Pharma offers drug containment and delivery solutions for GLP-1 obesity treatments, ensuring safe fill finish, storage, and administration. - [Antibody-Drug Conjugates Packaging | SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-solutions/drug-packaging/antibody-drug-conjugates): Address antibody-drug conjugate (ADC) challenges with packaging that ensures biologic stability, supports lyophilized formulations, and maintains ADC integrity - [Whitepaper Standardized Packaging Solutions I SCHOTT Pharma](https://www.schott-pharma.com/en/solutions/fill-and-finish/improved-manufacturing-processes-with-sterile-solutions/whitepaper-standardized-packaging): - [Whitepaper Finding the perfect match I SCHOTT Pharma](https://www.schott-pharma.com/en/solutions/fill-and-finish/improved-manufacturing-processes-with-sterile-solutions/whitepaper-finding-the-perfect-match): - [Whitepaper A winning combination I SCHOTT Pharma](https://www.schott-pharma.com/en/solutions/fill-and-finish/improved-manufacturing-processes-with-sterile-solutions/whitepaper-winning-combination): - [Aseptic filling — Enhanced contamination control](https://www.schott-pharma.com/en/solutions/fill-and-finish/aseptic-filling): For improved contamination control in aseptic filling, explore SCHOTT iQ® Integribag, which overcomes the limitations of RTU containers and enhances safety. - [Pharmaceutical track and trace solutions | SCHOTT Pharma](https://www.schott-pharma.com/en/solutions/fill-and-finish/pharmaceutical-track-and-trace-individual-container): Explore SCHOTT Pharma´s pharmaceutical track and trace solutions for reducing risk of mix-ups for drug containers - [Fill-and-finish optimization | SCHOTT Pharma](https://www.schott-pharma.com/en/solutions/fill-and-finish/fill-and-finish-optimization): With SCHOTT Pharma’s fill-and-finish optimization capabilities, breakages & interruptions in the filling process in the pharmaceutical industry are identified and eliminated. - [Glass delamination under control | Delamination of glass vials](https://www.schott-pharma.com/en/solutions/perfect-fit/glass-delamination-control): Explore SCHOTT Pharma solution that sets concrete steps pharmaceutical companies can take to minimize the risks of glass delamination. - [Optimize your manufacturing process | SCHOTT Pharma](https://www.schott-pharma.com/en/solutions/fill-and-finish/improved-manufacturing-processes-with-sterile-solutions): SCHOTT Pharma’s adaptiQ® ready-to-use (RTU) platform offers high flexibility, increased speed, and significant cost savings for fill-and-finish lines. - [Biologics & Biosimilars – from research to regulatory compliance | SCHOTT Pharma](https://www.schott-pharma.com/en/solutions/biologics-biosimilars): Biologics & biosimilars bring new challenges: Find out how to bring them to market, from research about primary packaging solutions to regulatory compliance. - [Antibody-Drug Conjugates Packaging | SCHOTT Pharma](https://www.schott-pharma.com/en/solutions/antibody-drug-conjugates): Address antibody-drug conjugate (ADC) challenges with packaging that ensures biologic stability, supports lyophilized formulations, and maintains ADC integrity - [Small Batch Packaging Solutions | SCHOTT Pharma](https://www.schott-pharma.com/en/solutions/fill-and-finish/small-batch-packaging-solutions): SCHOTT Pharma's small batch packaging solutions ensure reliable drug containment and delivery, and offer optimal sterile protection right from the start - [Optimized polymer syringe nest design | SCHOTT Pharma](https://www.schott-pharma.com/en/solutions/fill-and-finish/optimized-polymer-syringe-nest-design): SCHOTT Pharma’s new nest and tub system is the world’s first to hold 160 polymer syringes, reducing cycle time and costs while increasing the efficiency of your high-speed fill-and-finish lines. - [cartriQ® integration for large-volume SC injections | SCHOTT Pharma](https://www.schott-pharma.com/en/solutions/safe-and-easy-administration/large-volume-injections-biologics/cartriq-integration-sterile-large-volume): cartriQ® integration provides safe and stable SC delivery of large-volume biologics, supporting patient-friendly, home-based drug administration - [EVERIC® Vial | SCHOTT Pharma](https://www.schott-pharma.com/en/solutions/perfect-fit/everic-vial-solutions): SCHOTT Pharma's EVERIC® vials offer a flexible, modular design, bridging the needs of manufacturers and users for optimized performance - [Large-volume biologics | SCHOTT Pharma](https://www.schott-pharma.com/en/solutions/safe-and-easy-administration/large-volume-injections-biologics): SCHOTT Pharma offers a range of primary packaging solutions for pen injectors, autoinjectors, on-body delivery systems, and infusion pumps - [mRNA storage — Challenges of mRNA applications](https://www.schott-pharma.com/en/solutions/perfect-fit/mrna-storage): Browse SCHOTT Pharma‘s mRNA storage and mRNA vaccine packaging solutions and ensure container safety with our vial and syringe portfolio. - [Diabetes Treatment | SCHOTT Pharma](https://www.schott-pharma.com/en/solutions/safe-and-easy-administration/diabetes-treatment): SCHOTT Pharma offers a range of drug containment and drug delivery solutions for GLP-1-based diabetes treatment - [USP <382> Functional Testing Solutions | SCHOTT Pharma](https://www.schott-pharma.com/en/solutions/perfect-fit/usp-382): Rigorous USP <382> testing for fully assembled drug‑filled systems, from package integrity and CCI checks to fragmentation analysis - [Low filling volumes of drug applications | SCHOTT Pharma](https://www.schott-pharma.com/en/solutions/perfect-fit/drug-stability-low-filling-volumes): Visit our website and learn how to reduce the risk of leachable for your low filling volumes of sensitive drugs, with SCHOTT Pharma vials. - [Drug submission preparation | SCHOTT Pharma](https://www.schott-pharma.com/en/solutions/perfect-fit/drug-submission-preparation): SCHOTT Pharma offers a comprehensive testing service for pharmaceutical packaging to ensure full regulatory compliance and patient safety - [Drug containment solutions for biotech and biologics](https://www.schott-pharma.com/en/solutions/perfect-fit/drug-container-development-interaction-biotechs): Schott Pharma’s drug containment solutions for biotech and biologics. Explore seven top challenges of drug-container interaction for biotechs! - [Obesity Treatment | SCHOTT Pharma](https://www.schott-pharma.com/en/solutions/safe-and-easy-administration/obesity-treatment): SCHOTT Pharma offers drug containment and delivery solutions for GLP-1 obesity treatments, ensuring safe fill finish, storage, and administration. - [Pharma packaging solutions | SCHOTT Pharma](https://www.schott-pharma.com/en/solutions): Explore SCHOTT Pharma’s packaging solutions that aid Pharma companies, biotechs, and CDMOs in their operations. ## Expertise | SCHOTT Pharma’s Pharma Expertise page showcases its deep industry knowledge in drug containment, delivery systems, regulatory support, and manufacturing optimization, providing insights, best practices, and expert guidance to help partners solve complex challenges across pharma and biotech - [Glossary | SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-expertise/information-center/glossary): SCHOTT Pharma’s glossary includes the most important keywords, acronyms and general terminology used in the pharmaceutical pacacking industry. - [SCHOTT Pharma expertise & news](https://www.schott-pharma.com/en/pharma-expertise): Find answers to your pharma-related quest in the SCHOTT Pharma expertise section that, which includes trusted resources for both companies & individuals. ## SCHOTT Pharma Pharmaversity® | SCHOTT Pharma’s SCHOTT Pharmaversity page highlights educational offerings, training programs, and expert insights for pharmaceutical and biotech professionals, designed to build skills, deepen industry knowledge, and support best practices in drug packaging and delivery. - [Pharmaversity® | Pharma Education](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity): For valuable insight on industry topics, explore the Pharmaversity® to expand your pharma education with the help of leading glass and polymer experts. ## SCHOTT Pharma Knowledge-hub | SCHOTT Pharma’s Knowledge Hub page provides expert insights, technical articles, white papers, and industry resources to support pharmaceutical and biotech professionals with best practices, trends, data, and deep knowledge on drug containment, delivery, and regulatory topics. - [The online pharma course platform | Pharmaversity® knowledge hub | SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/knowledge-hub): Online pharma courses that provide the pharma industry with information on drug containment solutions and drug delivery systems - [Dosing Accuracy of Pre-Fillable Syringes for Aesthetic Use](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/evaluation-of-dosing-accuracy-of-pre-fillable-syringes-for-aesthetic-injections): Discover dosing accuracy in prefillable syringes for aesthetic injections. Download our whitepaper for insights on dermal fillers and skin rejuvenation. - [Tracking the Cracking](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/tracking-the-cracking): Download our whitepaper to discover how to optimize pharma fill-and-finish processes with strength testing and fractography. Enhance safety and efficiency - [Reducing Contamination in Vials with High-Performance Packaging](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/reduce-particle-contamination-in-ready-to-use-vials): Discover how high-performance materials in secondary packaging can significantly reduce particle contamination in ready-to-use vials, ensuring product safety and quality. - [Smoothly Through the Production Process: Best Practices](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/smoothly-through-the-production-process): Discover how to minimize glass vial breakage and enhance processing performance. Download our whitepaper to learn how EVERIC™ improves vial strength and reduces defects. - [PDA Journal: Medical Risks of Visible Particles in Injectables](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/industry-perspective-on-the-medical-risk-of-visible-particles-in-injectable-drug-products): - [From fragmentation to break-loose force: A complete USP <382> assessment in parenteral delivery systems](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/complete-usp-382-assessment-in-parenteral-delivery-systems): Download the whitepaper to discover the results of a comprehensive USP <382>-aligned evaluation. - [Ensuring robust drug delivery](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/ensuring-robust-drug-delivery-mechanical-chemical-performance-3ml-rtu-cartridges): Download this whitepaper to explore the key insights from a comprehensive study on the mechanical and chemical performance of 3 ml RTU cartridges. - [EVERIC® PURE – Safe Packaging from the Start](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/everic-pure-the-safe-option-right-from-the-start): Learn how the right container choice ensures patient safety and accelerates time-to-market. Download our whitepaper to mitigate risks and ensure drug stability - [Pharmaceutical Labeling for Pre-Filled Syringes: Best Practices](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/pharmaceutical-labeling-for-pre-filled-syringes): Download the whitepaper to explore the benefits of pre-filled syringes (PFS) and how functional labels enhance primary packaging with added functionalities. - [Cryogenic Storage Challenges for Container-Closure Systems](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/cryogenic-storage-challenges-for-container-closure-systems): Learn how to ensure container closure integrity for cell and gene therapies. Download our whitepaper to discover best practices for cryogenic storage. - [Selecting Polymer Prefilled Syringes for Low-Temp mRNA Vaccines](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/key-considerations-in-selecting-a-polymer-prefilled-syringe-for-low-temperature-mrna-vaccines): Download the whitepaper to understand how the shift from pandemic to endemic COVID-19 is changing vaccination strategies and impacting healthcare approaches. - [Improvements to Patient Safety: OPC Break System Opening Technique](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/improvements-to-patient-safety-the-opc-break-system-opening-technique): Download the whitepaper to learn how pharmaceutical companies can enhance ampoule safety and efficiency, improving user safety and operational productivity. - [Importance of Packaging Testing to Secure Drug Supply Chain](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/importance-of-packaging-compendial-testing-to-secure-the-parental-drug-supply-chain): Download the whitepaper to understand the causes of glass container breakage and how strength testing and fractography can help prevent failures and enhance durability. - [Extractable Studies for Injectables & Devices: USP & ISO Guidelines](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/taking-integrated-needle-safety-systems-for-prefilled-syringes-to-the-next-level): - [Solutions Magazine: Durable Cases for Every Need ](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/breakage-resistant-just-in-case): - [Comparative Extractable Studies for Injectables & Devices](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/comparative-extractable-studies-for-injectables-and-medical-devices): Download the whitepaper for an in-depth analysis of regulatory frameworks and methodologies for E&L studies, ensuring safety and compliance in pharmaceutical packaging. - [Efficient Fill-and-Finish Cuts Costs in EU Pharma](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/improved-fill-and-finish-processes-reduce-the-total-cost-of-ownership): Boost efficiency with pre-sterilized containers in fill-and-finish. Read the article now! - [Optimizing Fill-and-Finish: Beer Industry Innovations in Pharma](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/how-innovative-solution-from-the-beer-and-beverafe-industry-is-changing-the-pharma-industry): Discover how smart technology enhances pharma fill-and-finish efficiency. Download our whitepaper for real-world insights and improved operations. - [Winning Combination: Reducing Particles in RTU Packaging](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/reducing-particles-in-rtu-packaging): Discover how to minimize particles in RTU packaging with a holistic approach. Download our whitepaper for best practices and enhanced packaging quality. - [How Everic® Smooth Significantly Decreases Final Reject Rate](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/how-everic-smooth-significantly-decreases-final-reject-rate): Download the whitepaper to learn how EVERIC™ smooth vials by SCHOTT improve pharmaceutical filling processes, reducing defects and enhancing container strength. - [Optimizing Breakforce Range: Fewer Complaints, Reduced Injury Risk](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/optimizing-the-breakforce-range-towards-less-complains-and-reduced-risk-for-injuries): Download the whitepaper to explore the enduring success of glass ampoules and the various break systems used worldwide, enhancing pharmaceutical packaging. - [Strengths and Weaknesses of Different Pre-Filled Syringes in Hospitals](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/strengths-and-weaknesses-of-different-pre-filled-syringes-for-injections-in-hospitals): Download the whitepaper to learn about the critical role of IV drug administration in hospitals, its benefits, challenges, and best practices for patient safety. - [Assessing Barrel Materials for Prefilled Syringes in Hospitals](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/assessing-the-attributes-of-different-barrel-materials-for-prefilled-syringes): Download the whitepaper to discover key global trends shaping the future of IV drug administration, enhancing patient safety, sustainability, and hospital workflows. - [IPI: Why Do Pharmaceutical Glass Containers Break?](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/why-do-pharmaceutical-glass-containers-break): Download the whitepaper to understand the causes of glass container breakage and how strength testing and fractography can help prevent failures and enhance durability. - [Manufacturing Chemist: GLP-1 Drug Packaging](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/glp-1-based-drug-packaging): Review trends in GLP-1 drugs for diabetes and obesity, focusing on fill-and-finish and primary packaging. Crucial for drug safety and efficacy - [RTU Containers: No-Touch Transfer into Grade A Zones](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/end-to-end-qualification-of-rtu-product-containers-in-packaging-suitable-for-no-touch-transfer): Learn how No-Touch Transfer (NTT) ensures sterility in pharmaceutical packaging. Download the whitepaper now! - [On Drug Delivery: Packaging for Biologic Drugs](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/finding-the-right-packaging-for-biologic-drugs): Learn how syriQ BioPure® syringes advance biologic drug delivery. Download the whitepaper now! - [Pharmind: Optimizing Primary Packaging Inner Surface](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/optimizing-the-inner-surface-of-primary-packaging): Explore the impact of RTU technology on aseptic manufacturing. Download the whitepaper now! - [Medicine Maker: TCO Calculation for RTU](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/tco-calculation-for-rtu): - [APR E-Book: Primary Packaging for Optimized Fill + Finish](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/primary-packaging-for-optimized-fill-plus-finish): - [Medicine Maker: RTU Supplement](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/rtu-supplement): - [Effective Alternatives for Ammonium Sulfate Treated Pharmaceutical Glass Vials](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/effective-alternatives-for-ammonium-sulfate-treated-pharmaceutical-glass-vials): Explore the impact of RTU technology on aseptic manufacturing. Download the whitepaper now! - [Long-term storage effects on pharmaceutical proteins in glass and polymer prefilled syringes](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/storage-effects-on-pharmaceutical-proteins-in-glass-and-polymer-prefilled-syringes): This whitepaper provides evidence-based insights into how these material-dependent effects can help reduce stability risks, improve product quality, and support reliable shelf-life performance. - [High-quality containers as an investment in fill-and-finish optimization: A process analysis study](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/high-quality-containers-as-an-investment-in-fill-and-finish-optimization): This Pharmaversity® whitepaper explores how investing in high-quality pharmaceutical containers can significantly enhance fill-and-finish operations. - [Contract Pharma: Glass Flakes](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/glass-flakes): Glass delamination in pharma causes costly recalls. Learn how accelerated testing can identify safe containers and prevent issues before commercialization. - [Screening Glass Containers & Closures for Parenteral Solutions](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/a-systematic-approach-for-screening-glass-containers-elastomeric-closures): Learn how No-Touch Transfer (NTT) ensures sterility in pharmaceutical packaging. Download the whitepaper now! - [Drug Containment for Successful mRNA Drug Market Entry](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/drug-containment-considerations-for-bringing-mrna-drugs-successfully-to-the-market): Explore the future of mRNA therapies and the role of primary packaging in their success. Download the whitepaper now! - [Medicine Maker: The Smart Container](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/the-smart-container): Discover how smart containers revolutionize pharmaceutical fill-and-finish. Download the whitepaper now! - [On Drug Delivery: Packaging for Wearable Injection Devices](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/primary-packaging-for-wearable-injection-devices): Overview of wearable injector solutions and primary packaging. Read the article now! - [IPI: Best Practices for Glass Delamination Testing](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/best-practices-for-glass-delimination-testing-studies): Learn best practices for glass delamination testing. Download the whitepaper now! - [Medicine Maker: Sterility in RTU SCHOTT iQ® Integribag](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/sterilty-in-rtu-schott-iq-integribag): Enhance RTU drug containment with optimized aseptic transfer. Download the whitepaper now! - [PharmInd: Comparative Predictive Glass Delamination Study](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/comparative-predictive-glass-delamination-study): Uncover key insights on glass vial durability in pharmaceutical storage. Download the whitepaper now! - [Manufacturing Chemist: Standardized packaging solution for a fast time-to-market](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/standardized-packaging-solution-for-a-fast-time-to-market): Increase operational flexibility and reduce TCO with SCHOTT Pharma's RTU packaging. Learn more! - [PDA Journal: Roche Interferon Interactions on Glass Vials](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/roche-interferon-interactions-on-glass-vials-surfaces): - [How to choose the right vial: Influencing factors and solutions for liquid fills](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/how-to-choose-the-right-vial): This article provides a structured analysis of the key factors influencing vial selection for liquid fills. It outlines how variables such as filling volume, pH, temperature, leachable sensitivity, and drug registration status interact with container properties to affect drug performance. - [Manufacturing Chemist: EVERIC Family Advertorial](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/everic-familiy-advertorial): Discover innovative vial solutions for biologics and potent drugs. Download the whitepaper now! - [Storing Highly Sensitive Drugs: Best Practices Guide](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/how-to-store-highly-sensitive-drugs): Learn how to protect sensitive medications and ensure long-term stability. Download our whitepaper to explore effective storage and functional coatings. - [PDA Journal: Protein Adsorption to Glass Vials](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/protein-adsorption-to-glass-vials): Quantify protein loss to glass vials with a simple, accurate, and flexible fluorescent assay. Ideal for biopharmaceutical research - [Silicone Oil Effects in Pharmaceutical Glass Vials: An Analysis](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/silicone-oil-induced-effects-in-pharmaceutical-glass-vials): Download the whitepaper to explore strategies for assessing silicone-related challenges in pharmaceutical packaging, ensuring process optimization and packaging integrity. - [IPI: Testing Prefillable Glass Syringes per ISO 11040](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/functional-testing-of-prefillable-glass-syringes-aligned-with-iso-11040-guidelines): Explore the challenges and benefits of prefillable syringes in injectable combination products. ISO 11040-4 tests ensure reliability and quality control - [ON Drug Delivery: Packaging Material Identification](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/whitepapers/packaging-material-identification): Experts at SCHOTT Pharma Services discuss analytical techniques for identifying material components of primary containers for injectable drugs - ["Optimización del uso de ampollas: Impacto global "](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/como-optimizar-el-procesado-y-uso-de-las-ampollas): Descubra cómo optimizar el llenado de ampollas y enfrentar desafíos de manipulación, protegiendo a los pacientes de la falsificación. - [EVERIC® Vials: Enhancing Bulk Fill-and-Finish Efficiency](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/everic-strong-and-smooth-results-from-production-line-tests): EVERIC® vials minimize cosmetic defects and glass breakage in bulk fill-and-finish processes. Learn about their optimized strength and outer coating benefits. - [Vial, Stopper, Seal - a perfect match for efficiency and patient safety](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/vial-stopper-seal-a-perfect-match-for-efficiency-and-patient-safety): - [Delivering sensitive biologics with confidence - SCHOTT TOPPAC® cartridge meets the Maggie® autoinjector platform](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/delivering-sensitive-biologics-with-confidence): - [Innovative Solutions for Decarbonizing Pharma Supply Chains](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/decarbonizing-the-glass-packaging-supply-chain-with-fiolaxpro): Discover innovative solutions to decarbonize pharma supply chains. Learn how FIOLAX® Pro reduces CO2 emissions in primary packaging. Watch the webinar now! - [Inner Coatings for Drug Protection: SCHOTT TopLyo® & Type I Plus®](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/adjusting-pharmaceutical-containers-for-biologics-and-other-sensitive-drugs): Inner coatings like SCHOTT TopLyo® and Type I plus® protect sensitive drugs from environmental interactions, preserving efficacy and enhancing drug development. - [COC Pre-Filled Syringes: Safe, Functional Drug Delivery](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/pharmaceutical-labelling-for-prefilled-syringes-providing-more-than-just-information): COC pre-filled syringes offer safe drug delivery with functional labels enhancing protection and security. Learn about their benefits and innovative features. - [RTU vials for fill-and-finish flexibility](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/maximizing-fill-and-finish-flexibility-with-rtu-vials): Discover how adaptiQ® modular ready-to-use vials improve manufacturing flexibility, reduce TCO, and ensure patient safety in pharmaceutical packaging. - [Optimizing Fill & Finish: SCHOTT & SmartSkin Collaboration](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/smart-skin-technologies-optimizing-fill-and-finish-performance): Optimizing fill & finish with SCHOTT & SmartSkin drones reduces glass breakage and micro fractures. Gain insights on production line performance and packaging impact. - [Flexible Fill & Finish: Real-Time Changeovers at Groninger](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/increasing-flexibility-for-fast-changeovers-between-various-container-types): Efficiency and flexibility in fill & finish are crucial for small batch sizes. Learn how real-time changeovers and flexible machines with RTU containers improve processes. - [RFID-equipped prefilled syringes: Challenges and opportunities](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/challenges-and-opportunities-of-rfid-equipped-prefilled-syringes): Learn how RFID-equipped prefilled syringes can enhance drug administration, reduce errors, and streamline hospital workflows for better patient care. - [Deep Freeze Vial Storage: CCI & Strength Test Results](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/vials-for-deep-cold-storage-key-results): Discover how gene therapies and vaccines fare at –80°C. Learn about vial integrity, CCI, and strength test results for deep freezing conditions in this webinar. - [Optimize Ampoule Filling & Handling: Webinar Insights](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/how-to-optimize-processes-and-usage-of-ampoules): Join our webinar to optimize ampoule filling & handling. Learn how SCHOTT ampoules safeguard patients and tackle common processing challenges. - [EVERIC® Vials: Reducing Fill-and-Finish Disruptions](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/the-advantages-of-strength-optimized-vials-with-an-outer-coating): EVERIC® vials reduce fill-and-finish disruptions with optimized strength and outer coating, minimizing cosmetic defects and enhancing drug manufacturing efficiency - [Primary packaging for cryogenics: Options and challenges](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/primary-packaging-for-cryogenics): Explore container options and challenges in closure systems for cryogenic storage. Learn how to ensure packaging integrity for ultra-low temperatures. - [Reduce Medication Errors: Pre-Filled Syringe Solutions](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/how-can-pfs-help-to-optimize-drug-preparation): Learn how high-quality pre-filled syringes reduce medication errors, save costs, and address drug shortages in this joint session with AST - [Optimize Drug Stability: EVERIC® Pure Glass Vials](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/safe-and-fast-drug-development-choose-the-right-vial-from-the-start): Discover how EVERIC® pure glass vials enhance drug stability. Learn how increased formulation options lead to safer, faster time-to-market in this session. - [mRNA applications: Transitioning from vial to prefilled syringe ](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/mrna-applications-from-vial-to-prefilled-syringe): Explore how syriQ® glass prefilled syringes ensure robust performance for mRNA applications, maintaining integrity in cold storage conditions to -50°C. - [High-Quality COC Pre-Filled Syringes: Enhancing Patient Safety](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/minimizing-medical-errors-in-emergency-situations-schott-toppac-infuse): Pre-filled COC syringes enhance patient safety by reducing medical errors in critical treatments. Learn about their benefits, compatibility, and innovative solutions. - [Polymer Syringes: Reducing Drug Shortages & Errors](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/the-main-advantages-of-prefilled-syringes): Medication errors and drug shortages cost hospitals billions. Learn how polymer pre-fillable syringes can reduce these issues, save costs, and enhance patient safety. - [Choosing the right prefilled syringe: Glass vs polymer](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/key-aspects-when-selecting-a-prefilled-syringe): Explore the key differences between glass and polymer prefilled syringes to make informed decisions that enhance patient safety and care efficiency. - [Biologics Containment: Overcoming Storage Challenges](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/vials-for-biologics): Overcome biologics storage challenges with specialized containment solutions. Ensure integrity, reduce rejects, and enable track-and-trace at the container level - [Aseptic Filling: No-Touch-Transfer Packaging Solutions](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/assuring-sterility-of-rtu-containers-from-end-to-end): Discover No-Touch-Transfer solutions for aseptic filling. Ensure sterility of tubs and Tyvek® with innovative packaging and machining concepts - [Evaluate Fill-and-Finish Defects: Lab Method Insights](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/a-new-lab-method-to-assess-strength-of-different-vials): Discover a lab method to evaluate fill-and-finish defects on vials. Learn about the reproducible process and initial results in this insightful session. - [Custom COC Containers for Homecare Drug Delivery Devices](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/benefits-of-primary-container-customization-with-cyclic-olefin-copolymers-for-devices): Custom COC containers for homecare drug delivery devices ensure functionality and ease-of-use. Co-create with SCHOTT TOPPAC® unique for optimized drug stability and compatibility. - [Reducing Particles in Sterile Injectable Drug Packaging](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/particle-reduction-with-ready-to-use-vials-in-the-entire-value-chain): Sterile injectable drugs must be free from visible particulates. Learn how ready-to-use packaging reduces particles through optimized lid material and sealing. - [Boost Efficiency with RTU Vials: Lower Costs & Better Quality](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/reconsidering-fill-and-finish-processes-in-drug-manufacturing): Optimize your fill-and-finish processes with RTU vials like adaptiQ® from SCHOTT Pharma. Achieve lower costs, better quality, and higher flexibility. - [Innovative YpsoDose & cartriQ®: Efficient Drug Delivery](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/enabling-easier-self-administration-of-large-volume-injections): The combination of YpsoDose and cartriQ® ensures efficient processing and safe administration of injectable medication. Discover their innovative drug delivery solution. - [Preventing Glass Breakage: SmartSkin & SCHOTT Analytics](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/identifying-origins-for-glass-breakage-to-optimize-filling-lines): Glass breakage can cause downtime. Learn how SmartSkin's Quantifeel drones and SCHOTT's glass analytics identify and prevent breakage, optimizing production lines. - [Ensuring Sterility in Ready-to-Use Packaging: Techniques & Risks](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/achieving-and-assuring-sterility-in-ready-to-use-pharmaceutical-packaging): Sterility in ready-to-use packaging is crucial. Learn about sterilization techniques, processes, and the associated risks and benefits in aseptic fill & finish environments. - [How to Choose the Right Vial](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/how-to-choose-the-right-vial-part-2-fill-and-finish-lyophilization-and-freezing-selection-criteria): Learn how vial design reduces breakage and defects, cutting costs in fill-and-finish processes. - [Cold Storage for Prefilled Polymer Syringes:](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/cold-storage-for-prefilled-polymer-syringes): Learn how prefilled polymer syringes maintain integrity in ultra-cold storage. Explore key insights on testing & performance. - [Innovative Cancer Drug Packaging Solutions Webinar](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/antibody-andradionuclide-drug-conjugates-advanced-vial-solutions-for-cutting-edge-cancer-treatments): Explore SCHOTT Pharma's vial solutions for innovative cancer drugs, addressing stability, glass leachables, and light sensitivity challenges. - [Optimizing RTU Cartridges for Biologics Stability](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/performance-requirements-for-rtu-cartridges): Explore key considerations for optimizing RTU cartridges for biologics, including material compatibility, leachable profiles, and drug-container interactions. - [Streamlining Drug Submission with PartnerLab](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/what-to-test-and-what-not-to-test-that-is-the-question-for-your-drug-submission): Learn about drug submission complexities with SCHOTT Pharma's PartnerLab. Streamline testing, ensure regulatory compliance, and accelerate market entry. - [Advanced Vial Solutions for Biologics](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/how-to-choose-the-right-vial-for-next-generation-therapies): Explore SCHOTT Pharma's advanced vial solutions for biologics, addressing challenges like lyophilization, glass leachables, and dosage accuracy. - [Large Volume Autoinjectors Co-Development](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/a-stakeholder-centered-development-approach-for-large-volume-drug-delivery-solutions): Join SCHOTT Pharma and Ypsomed experts to explore the co-development of YpsoMate 5.5 autoinjector and syriQ BioPure® 5.5ml syringe for large volume injections. - [Preventing Glass Container Breakage in Pharma](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/strength-of-primary-packaging-glass-containers): Learn how to prevent glass container breakage in pharma. This webinar covers brittle failure concepts and handling practices to avoid downtime and recalls. - [SCHOTT Pharma's Contamination Control Strategy](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/how-to-comply-with-eu-gmp-annex-i-using-rtu-containers): Learn about SCHOTT Pharma's Contamination Control Strategy (CCS) and GMP compliance in our webinar, focusing on RTU containers and advanced filling concepts. - [Efficient Fill-and-Finish: Core Vials](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/core-vials-how-statistical-process-control-elevates-your-fill-and-finish-efficiency): Learn how Core vials improve container uniformity, reduce rejection rates, and boost fill-and-finish performance. - [Deep-Cold Storage Drugs: Challenges & Solutions](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/the-rise-of-deep-cold-storage-drugs): Explore deep-cold storage challenges for mRNA, saRNA, and DNA drugs in our webinar. Discover EVERIC® freeze, the first glass vial optimized for -80°C applications. - [Biologics Packaging Solutions with syriQ BioPure®](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/addressing-advanced-stakeholder-needs-in-biologics-a-case-study-on-pfs-and-coated-plunger): Explore syriQ BioPure® syringes and NeoFlex™ plungers in our webinar, addressing biologics packaging challenges, drug compatibility, and regulatory considerations. - [Advancing Large-Volume SC Autoinjection Solutions](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/advancing-insights-into-large-volume-subcutaneous-autoinjections): Join SHL Medical and SCHOTT Pharma's webinar to explore SC autoinjection challenges, literature review findings, and feasibility testing for large-volume biologics. - [Large Volume Subcutaneous Drug Delivery Solutions](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/simplifying-large-volume-subcutaneous-drug-administrations): Discover how SCHOTT TOPPAC® syringes and KORU devices simplify large volume subcutaneous drug delivery, enhancing user experience and accelerating market time. - [Innovative Solutions to Decarbonize Pharma Supply Chains](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/decarbonizing-the-glass-packaging-supply-chain-with-fiolaxpro): Discover how over 7,000 companies, including top pharma firms, are tackling climate change with innovative solutions like FIOLAX® Pro to reduce CO2 emissions. - [Custom Vial Packaging: Stability Studies & Delamination Control](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/everic-pure-a-new-vial-for-low-fill-volumes-with-full-delamination-control): Discover how individualized vial packaging enhances drug formulation stability. Learn about delamination control and comparative studies with standard vials. - [Speed, Stability, Efficiency: How the next generation of prefilled polymer syringes redefines healthcare](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/how-the-next-generation-of-prefilled-polymer-syringes-redefines-healthcare): This session explores how prefilled polymer syringes have significantly enhanced the safety and effectiveness of infusion therapy in hospitals, moving away from traditional vial-and-syringe systems. - [Optimize Biologics Storage with Advanced Glass Solutions](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/vials-for-biologics): Biologics need special glass surfaces to prevent leachables, ensure lyophilization, and maintain integrity at deep cold temperatures. Learn more here. - [Reduce Medication Errors & Costs with Pre-Filled Syringes](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/how-can-pfs-help-to-optimize-drug-preparation): Medication errors cause daily deaths and injuries in the US. Learn how pre-filled syringes can reduce errors, drug shortages, and healthcare costs. - [Sterility in RTU Packaging: Techniques & Benefits Explained](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/achieving-and-assuring-sterility-in-ready-to-use-pharmaceutical-packaging): Learn about sterilization techniques for RTU packaging, their processes, and the associated risks and benefits to ensure sterility in aseptic fill & finish environments. - [Glass vs polymer: Prefilled syringe variants](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/key-aspects-when-selecting-a-prefilled-syringe): Compare the key features of glass and polymer prefilled syringes to make informed decisions that enhance patient safety and medical care efficiency. - [Ensure Sterility in Aseptic Filling with No-Touch Transfer](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/assuring-sterility-of-rtu-containers-from-end-to-end): Ensure sterility in aseptic filling with No-Touch-Transfer, eliminating contamination risks and costly decontamination processes for pharma companies - [Achieve Net-Zero Pharma with Alliance to Zero Collaboration](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/designing-a-pathway-towards-net-zero-injection-devices): Achieve climate-neutral pharma products with Alliance to Zero. Learn how industry collaboration can mitigate the carbon footprint of autoinjectors. - [RFID-equipped prefilled syringes: Obstacles and outlooks ](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/challenges-and-opportunities-of-rfid-equipped-prefilled-syringes): Discover RFID-equipped prefilled syringes that enhance drug administration, reduce errors, and streamline hospital workflows for better patient care. - [Assess Vial Integrity for Deep Freezing Drug Storage](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/vials-for-deep-cold-storage-key-results): Discover vial integrity for deep freezing drugs at -80°C. Learn about CCI and strength tests ensuring stability for gene therapies and vaccines. - [Next-Gen Prefilled Polymer Syringes: Speed & Stability](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/how-the-next-generation-of-prefilled-polymer-syringes-redefines-healthcare): Discover how next-gen prefilled polymer syringes enhance healthcare with improved speed, stability, and efficiency. Learn more in our latest webinar. - [Efficient Fill-and-Finish: Core Vials](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/core-vials-how-statistical-process-control-elevates-your-fill-and-finish-efficiency): Learn how Core vials improve container uniformity, reduce rejection rates, and boost fill-and-finish performance. - [Optimización del uso de ampollas y su impacto global](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/como-optimizar-el-procesado-y-uso-de-las-ampollas): Descubra cómo maximizar el llenado de ampollas y superar los desafíos de manipulación, asegurando la protección de los pacientes. - [Cold Storage for Prefilled Polymer Syringes:](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/cold-storage-for-prefilled-polymer-syringes): Learn how prefilled polymer syringes maintain integrity in ultra-cold storage. Explore key insights on testing & performance. - [Optimize Ampoule Processing & Handling for Safety](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/how-to-optimize-processes-and-usage-of-ampoules): Learn how to optimize ampoule filling and handling, addressing common challenges and ensuring patient safety with SCHOTT ampoules. - [Latest lab test evaluates vial strength and fill-finish defects ](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/a-new-lab-method-to-assess-strength-of-different-vials): Discover the latest lab method designed to evaluate vial strength and detect fill-and-finish defects, providing key insights for product development. - [Easier self-administration with cartridge-based delivery devices](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/enabling-easier-self-administration-of-large-volume-injections): Learn how the YpsoDose and cartriQ® combo can add to a safe and efficient self-administration of large volume injections for injectable medications. - [Optimizing fill-and-finish processes for drug manufacturing](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/reconsidering-fill-and-finish-processes-in-drug-manufacturing): Explore how SCHOTT Pharma's RTU adaptiQ® vials enhance efficiency, quality, and flexibility in filling processes while reducing costs. - [Enhance Drug Stability with EVERIC® Pure Glass Vials](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/safe-and-fast-drug-development-choose-the-right-vial-from-the-start): Discover how EVERIC® pure glass vials enhance drug stability, increasing formulation options and speeding up time to market. - [Optimizing RTU Cartridges for Biologics Stability](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/performance-requirements-for-rtu-cartridges): Explore key considerations for RTU cartridges in biologics. Learn about material compatibility, leachables, and stability for optimal drug packaging. - [USP <382> - How to generate regulatory-ready data for drug development](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/usp-382-how-to-generate-regulatory-ready-data-for-drug-development): USP <382> changes how elastomer components are qualified - shifting from component‑level testing to system‑level suitability of the final packaging configuration. This raises new expectations for functional evidence and regulatory submissions. - [Innovative Large Volume Autoinjectors for SC Injections](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/a-stakeholder-centered-development-approach-for-large-volume-drug-delivery-solutions): Discover novel large volume autoinjectors for SC injections. Learn about co-development of YpsoMate 5.5 and syriQ BioPure® 5.5ml syringe in our Pharmaversity session. - [How to Choose the Right Vial](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/how-to-choose-the-right-vial-part-2-fill-and-finish-lyophilization-and-freezing-selection-criteria): Learn how vial design reduces breakage and defects, cutting costs in fill-and-finish processes. - [Innovative Cancer Drug Technologies & Packaging Solutions](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/antibody-andradionuclide-drug-conjugates-advanced-vial-solutions-for-cutting-edge-cancer-treatments): Discover innovative cancer drug technologies and packaging solutions. Learn how SCHOTT Pharma addresses stability, leachables, and light sensitivity. - [Revolutionizing Deep-Cold Storage for Biological Drugs](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/the-rise-of-deep-cold-storage-drugs): Explore deep-cold storage challenges for mRNA, saRNA, and DNA drugs. Discover EVERIC® freeze, the first glass vial optimized for -80°C applications. - [Advanced Vial Solutions for Biologics Stability](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/how-to-choose-the-right-vial-for-next-generation-therapies): Discover advanced vial solutions for biologics. Learn how to address stability, lyophilization, and leachables challenges in our webinar - [Advancing SC Autoinjection: Challenges & Solutions](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/advancing-insights-into-large-volume-subcutaneous-autoinjections): Explore SC autoinjection challenges and solutions. Join our webinar to learn about 60-second injections and 5.0 mL cartridges for biologics - [Mitigating Contamination Risks in Pharma Manufacturing](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/how-to-comply-with-eu-gmp-annex-i-using-rtu-containers): Learn about SCHOTT Pharma's CCS and GMP compliance strategies. Discover how RTU containers and advanced filling concepts minimize contamination risks. - [Streamlining Drug Submission: Testing Services Insights](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/what-to-test-and-what-not-to-test-that-is-the-question-for-your-drug-submission): Navigate drug submission complexities with SCHOTT Pharma's PartnerLab. Streamline testing for regulatory compliance and accelerate market submission. - [Large Volume Subcutaneous Drug Delivery Solutions](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/simplifying-large-volume-subcutaneous-drug-administrations): Discover how SCHOTT TOPPAC® syringes and KORU devices simplify large volume subcutaneous drug delivery, enhancing user experience and accelerating market time. - [Innovative Solutions for Biologics Packaging Challenges](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/addressing-advanced-stakeholder-needs-in-biologics-a-case-study-on-pfs-and-coated-plunger): Explore solutions for biologics packaging challenges. Learn about syriQ BioPure® and NeoFlex™ plunger in our joint Pharmaversity® session. - [Customizing Vials for Different Drug Formulations](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/everic-pure-a-new-vial-for-low-fill-volumes-with-full-delamination-control): Explore customized vials for different drug formulations. Learn about delamination control and stability studies in our comparative study with standard vials. - [Preventing Glass Breakage in Pharma Packaging](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/strength-of-primary-packaging-glass-containers): Learn how to prevent glass breakage in pharma packaging. Understand brittle failure concepts and improve handling and processing in our webinar. - [Enhancing Vial Strength & Performance in Pharm](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/everic-strong-and-smooth-results-from-production-line-tests): Discover how EVERIC® smooth vials enhance bulk fill-and-finish processes. Learn about optimizing vial strength and performance in our webinar. - [Options and challenges in primary packaging for cryogenics ](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/primary-packaging-for-cryogenics): Explore container options and challenges in closure systems for cryogenic storage and get more info on ensuring packaging integrity for low temperatures. - [COC Syringes: Enhancing Drug Packaging with Functional Labels](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/pharmaceutical-labelling-for-prefilled-syringes-providing-more-than-just-information): Discover the benefits of COC syringes and functional labels. Learn how to enhance drug packaging with UV-blocking, gas barrier properties, and security features. - [Optimize Fill & Finish: Reduce Breakage with SmartSkin](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/smart-skin-technologies-optimizing-fill-and-finish-performance): Optimize pharmaceutical Fill & Finish with SCHOTT & SmartSkin's drones, reducing glass breakage and improving production line performance through data insights. - [Optimize Drug Efficacy with SCHOTT Coatings](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/adjusting-pharmaceutical-containers-for-biologics-and-other-sensitive-drugs): Protect drug efficacy with SCHOTT TopLyo® & Type I plus® coatings, designed for biologics and sensitive drugs, ensuring stability and shelf life - [Pre-filled Syringes: Enhancing Patient Safety & Efficiency](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/minimizing-medical-errors-in-emergency-situations-schott-toppac-infuse): Explore how pre-filled syringes enhance patient safety and efficiency in critical hospital settings, minimizing errors and improving drug administration speed. - [Custom COC Containers: Enhancing Homecare Drug Delivery](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/benefits-of-primary-container-customization-with-cyclic-olefin-copolymers-for-devices): Discover how SCHOTT co-creates custom COC containers for homecare drug delivery devices, ensuring functionality, ease-of-use, and reduced time-to-market. - [Fill-and-finish flexibility with RTU vials](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/maximizing-fill-and-finish-flexibility-with-rtu-vials): Discover how adaptiQ® modular RTU vials improve manufacturing flexibility, minimize TCO, and ensure patient safety in pharmaceutical packaging. - [Reducing Particles in Sterile Injectables: Webinar Insights](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/particle-reduction-with-ready-to-use-vials-in-the-entire-value-chain): Discover how aligning lid material, adhesive, and sealing parameters reduces particles in sterile injectables, ensuring safety and efficacy in disease treatment. - [Flexible Fill & Finish: Quick Changeovers for Efficiency](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/increasing-flexibility-for-fast-changeovers-between-various-container-types): Join Groninger & SCHOTT in Crailsheim to see real-time format part changeovers, showcasing how flexible filling machines and RTU containers enhance efficiency in fill & finish. - [Reduce Drug Shortages & Errors with Polymer Syringes](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/the-main-advantages-of-prefilled-syringes): Reduce medication errors & drug shortages with polymer pre-fillable syringes, saving costs and enhancing patient safety in hospitals globally. - [Prevent Glass Breakage with SmartSkin & SCHOTT Tools](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/identifying-origins-for-glass-breakage-to-optimize-filling-lines): Prevent glass breakage with SmartSkin drones & SCHOTT analytics, identifying root causes to reduce downtime and optimize production lines - [mRNA applications: From vial to prefilled syringe](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/mrna-applications-from-vial-to-prefilled-syringe): Learn how syriQ® glass prefilled syringes guarantee robust performance for mRNA applications, maintaining integrity in cold storage conditions to -50°C. - [Optimize Pharma Fill-Finish with EVERIC® Strong & Smooth](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/webinars/the-advantages-of-strength-optimized-vials-with-an-outer-coating): Reduce pharmaceutical rejects with EVERIC® strong & smooth vials, featuring optimized strength and outer coating for efficient drug manufacturing - [Net-Zero Pharma: Reducing Autoinjector Carbon Footprint](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/podcasts/designing-a-pathway-towards-net-zero-injection-devices): Explore how industry collaboration in the Alliance to Zero is reducing the carbon footprint of autoinjectors for future climate-neutral pharmaceutical products. ## SCHOTT Pharma Blogs - [Container Closure Integrity (CCI) | SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-expertise/information-center/blog/container-closure-integrity): Discover how the perfect vial, stopper, and seal combination ensures robust container closure integrity, prevents pop-up/pop-off, and improves fill-and-finish efficiency. - [Custom COC containers: A paradigm shift in device development](https://www.schott-pharma.com/en/pharma-expertise/information-center/blog/custom-coc-containers-a-paradigm-shift-in-device-development): Tom van Ginneken discusses the advantages of polymer as a perfect fit for individualized containers. - [Critical advantages of smart primary packaging containers | SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-expertise/information-center/blog/advantages-smart-primary-packaging): SCHOTT Pharma smart containers are laser-marked with a unique code to enable high levels of traceability throughout the fill-and-finish process - [What is container closure integrity testing | SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-expertise/information-center/blog/what-is-container-closure-integrity-testing): Ensuring the integrity of container closures and the container itself is vital to maintaining a sterile barrier to potential contaminants and eliminating the risk of leaks. This article will provide an overview of container closure integrity testing (CCIT) and why it is crucial. - [Biosimilars and generics | SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-expertise/information-center/blog/biosimilars-generics): Key industry trends and the benefits of choosing the correct primary packaging in an evolving pharmaceutical landscape - [Diversity & inclusion at SCHOTT Pharma ](https://www.schott-pharma.com/en/pharma-expertise/information-center/blog/diversity-and-inclusion-at-schott-pharma): Diversity & inclusion at SCHOTT Pharma is the key to a company's success and the fuel of committed teams. - [Counterfeit drugs | SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-expertise/information-center/blog/counterfeit-drugs-protecting-patients): SCHOTT Pharma is putting patient’s health first with Ampoules AC! Discover how to protect patients from counterfeited drugs. - [Visual Inspection Systems | Schott Pharma](https://www.schott-pharma.com/en/pharma-expertise/information-center/blog/container-quality-automated-visual-inspection-systems): Improving pharmaceutical container quality with automated visual inspection systems - [Pathway to net-zero injection devices | SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-expertise/information-center/blog/designing-a-pathway-towards-net-zero-injection-devices): At SCHOTT Pharma, we believe net-zero emission products require solid cross-industry collaboration. - [Pharmaceutical product design: Safe for patients, sustainable for the planet I SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-expertise/information-center/blog/pharmaceutical-product-design): Discover how SCHOTT Pharma integrates Ecodesign to create pharmaceutical products that ensure patient safety and promote environmental sustainability. Learn about our commitment to climate neutrality by 2030. - [How to choose the best ampoules for your filling line | SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-expertise/information-center/blog/how-to-choose-the-best-ampoules-for-your-filling-line): Discover how to choose the best ampoules for your filling line. Understand the different ampoule forms and their suitability for different types of fill-and-finish machines. - [Best ampoule break-system | SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-expertise/information-center/blog/ampoules-break-systems): Read the blog article from Schott Pharma and discover how to choose the best break-system for your ampoule! - [Snap-on vials | SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-expertise/information-center/blog/snap-on-vials): SCHOTT Pharma produces snap-on vials made from high-quality FIOLAX® glass tubing, offering superior compatibility with various components in pharmaceutical applications. - [Why clinical trials fail | SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-expertise/information-center/blog/why-clinical-trials-fail): The common pitfalls and key challenges of clinical trials and how the correct packaging choices can mitigate risks and improve success rates - [Vial as a platform | SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-expertise/information-center/blog/drug-development-efficiency-vial-as-platform): How pre-tested packaging solutions such as Vial as a platform improve drug development efficiency and increase production safety - [How do RTU containers accelerate time-to-market?](https://www.schott-pharma.com/en/pharma-expertise/information-center/blog/how-do-rtu-container-fasten-time-to-market): Find out how RTU containers accelerate time-to-market and increase cash flow and patent lifetime while maintaining superior quality. - [Rise of ampoules in primary drug packaging | SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-expertise/information-center/blog/how-ampoules-became-the-worlds-most-popular-primary-packaging-for-drugs): SCHOTT Pharma explains how ampoules went from a 3rd century container for blood to the world’s most popular primary packaging for drugs - [Pharmaceutical standards for glass – dedicated testing strategies](https://www.schott-pharma.com/en/pharma-expertise/information-center/blog/rethinking-pharmaceutical-standards-for-glass-dedicated-testing-strategies): The US Pharmacopeia aims to create additional flexibility for packaging & storage requirements. Learn more about the challenges for testing strategies. - [Optimize fill-and-finish with RTU packaging I SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-expertise/information-center/blog/how-to-optimize-fill-and-finish-processes-with-sterile-drug-containment-solutions): Discover how RTU packaging optimizes fill-and-finish processes, reducing value chain complexity, ensuring patient safety, and accelerating time-to-market. - [What is a vial and how to choose the right one | SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-expertise/information-center/blog/what-is-a-vial): What is a vial? Learn about the components, types, and pharmaceutical applications of a vial, plus how to choose the right one - [SCHOTT Pharma redefining healthcare](https://www.schott-pharma.com/en/pharma-expertise/information-center/blog/redefining-healthcare-the-power-of-large-volume-sterile-cartridges): Redefining healthcare with large-volume sterile cartridges enabling easier, cost-effective subcutaneous drug delivery and at-home self-administration. - [Closed Loop Recycling | Pharmaceutical Packaging](https://www.schott-pharma.com/en/pharma-expertise/information-center/blog/closed-loop-recycling-initiative): Discover how closed loop recycling in pharmaceutical transport packaging can reduce virgin plastic demand. - [Reducing TCO with RTU packaging I SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-expertise/information-center/blog/reducing-total-cost-of-ownership-with-rtu-packaging): Learn how RTU SCHOTT Pharma adaptiQ glass vials reduce total cost of ownership, enhance drug stability, and boost product quality in pharmaceuticals. - [5 Steps for Particle Reduction in RTU Packaging in Pharma](https://www.schott-pharma.com/en/pharma-expertise/information-center/blog/5-steps-for-particle-reduction-in-rtu-packaging): Ensure particle reduction of RTU packaging & GMP Annex I compliance with our guide on how to effectively reduce particulate contamination. - [How to use a prefilled syringe | SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-expertise/information-center/blog/how-to-use-a-prefilled-syringe): Prefilled glass syringes (PFS) allow injectable drugs to be delivered in a single step. Learn more about how to use prefilled syringes and their application! - [Strategic partnership in pharma – SCHOTT Pharma & Bayer](https://www.schott-pharma.com/en/pharma-expertise/information-center/blog/strategic-partnership-pharma-bayer): SCHOTT Pharma and Bayer's strategic partnership enables to market of biotech medications safely and quickly using innovative primary packaging solutions. - [Pharmaceutical sterilization types: RTU containers](https://www.schott-pharma.com/en/pharma-expertise/information-center/blog/sterilization-types-pharmaceutical-industry): To achieve the mandatory sterility levels, different sterilization methods in pharmaceutical industry are applied for RTU packaging containers. - [Validate sterility in RTU packaging | SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-expertise/information-center/blog/validate-sterility-in-rtu-packaging): Validating sterility in RTU packaging is key to understanding the design of sterilization processes and its impact. Read this article and find out why! - [How pharmaceutical drug containers can enhance drug stability](https://www.schott-pharma.com/en/pharma-expertise/information-center/blog/drug-containers-for-enhanced-drug-stability): Enhanced drug stability through dedicated drug containers and pharmaceutical glass types are being utilized to find the ideal container. - [A new era of mRNA drug packaging is on the rise](https://www.schott-pharma.com/en/pharma-expertise/information-center/blog/mrna-drugs-packaging): Learn more about how mRNA drugs are impacting pharma primary packaging and the key considerations in this new era. - [Extractables testing explained I SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-expertise/information-center/blog/what-is-extractables-testing): Extractables testing is used to identify and analyze potentially harmful materials. This article is focused on extractable testing and its role in the pharma industry - [mRNA Covid-19 Vaccines: Vial to Syringe | SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-expertise/information-center/blog/from-vial-to-prefilled-syringe-mrna): SCHOTT Pharma explores if prefilled syringes are more suitable than multi-dose vials for COVID-19 vaccines as the pandemic evolves. - [Solving biotech’s drug containment challenges | SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-expertise/information-center/blog/solving-biotech-drug-containment-challenges): The growth in pharmaceutical formulations is challenging for pharmaceutical glass vial filling and handling, but EVERIC® meets that demand. - [SCHOTT Pharma blog — Your pharma knowledge base](https://www.schott-pharma.com/en/pharma-expertise/information-center/blog): The SCHOTT Pharma blog is your trusted ally in learning more about pharma trends and discovering the latest on SCHOTT Pharma’s products and services. ## SCHOTT Pharma Academy/Events/Certificates | SCHOTT Pharma’s Pharma Expertise resources include educational programs, events, and training through Pharmaversity Academy, plus access to certificates and industry information, helping pharmaceutical and biotech partners build knowledge, skills, and regulatory competence. - [Pharma academy live training | Pharmaversity® Academy | SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/academy): Pharmaversity® Academy is your live training partner for expert insights, advanced training, and the latest pharmaceutical innovations. Register now - [Pharma industry events | Pharmaversity® Events | SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-expertise/schott-pharmaversity/events): Pharmaversity® Events connect pharma professionals with each other and with SCHOTT Pharma experts in multiple events on selected topics - [Certificates | SCHOTT Pharma](https://www.schott-pharma.com/en/pharma-expertise/information-center/certificates): Download the latest SCHOTT Pharma certificates and documentation for facilities worldwide, including ISO 9001, 14001, 45001, and 15378 certifications. ## SCHOTT Pharma About Us | SCHOTT Pharma’s About Us page focuses on the company’s mission, values, and history, highlighting its role in drug containment and delivery, commitment to quality and innovation, global presence, and support for pharmaceutical and biotech partners in improving healthcare outcomes. - [ SCHOTT Pharma philosophy — Our purpose is you](https://www.schott-pharma.com/en/about-us/schott-pharma-philosophy): Human health matters and that drives us to join forces with both customers and industry leaders to provide the best possible patient-oriented experience. - [About SCHOTT Pharma — An industry leader](https://www.schott-pharma.com/en/about-us): Discover SCHOTT Pharma, a leader in pharmaceutical manufacturing, and explore its extensive product portfolio and science-based solutions. ## SCHOTT Pharma Media Releases | SCHOTT Pharma’s News and Media page features the latest press releases, company updates, financial results, events, and industry announcements on innovations, expansions, partnerships, and performance, keeping pharmaceutical and biotech stakeholders informed of developments. - [Media Kits | SCHOTT Pharma](https://www.schott-pharma.com/en/news-and-media/media-kits): The full range of SCHOTT Pharma Media Kits, from our role in the fight against COVID-19 - [MEDIA RELEASE | Circular packaging without compromising patient safety: SCHOTT Pharma, Corplex, and Takeda successfully demonstrated closed-loop recycling ](https://www.schott-pharma.com/en/news-and-media/media-releases/2024/schott-pharma-corplex-and-takeda-successfully-demonstrated-closed-loop-recycling): Circular packaging without compromising patient safety: SCHOTT Pharma, Corplex, and Takeda successfully demonstrated closed-loop recycling | MEDIA RELEASE - [Fairs and Events | SCHOTT Pharma](https://www.schott-pharma.com/en/news-and-media/fairs-and-events): The full range of specialist events, trade shows and conferences that will be presented by SCHOTT Pharma - [News and Media Contact Form| SCHOTT Pharma](https://www.schott-pharma.com/en/news-and-media/inquiry): Get in touch with our SCHOTT Pharma News & Media Team - [News and Media Contacts | SCHOTT Pharma](https://www.schott-pharma.com/en/news-and-media/contacts): Contact details for the SCHOTT Pharma News and Media team - [Tripling vial production capacity in the US | SCHOTT Pharma](https://www.schott-pharma.com/en/news-and-media/media-releases/2022/schott-pharma-plans-to-triple-vial-production-capacity-in-the-us): SCHOTT is making a double-digit million Euro investment to increase production of ready-to-use vials at its plant in Lebanon, Pennsylvania - [SCHOTT appoints Supervisory Board of SCHOTT Pharma](https://www.schott-pharma.com/en/news-and-media/media-releases/2023/schott-appoints-supervisory-board-of-schott-pharma-ag-and-co-kgaa): SCHOTT appoints Supervisory Board of SCHOTT Pharma AG & Co. KGaA - [Investment in ready-to-use cartridges | SCHOTT Pharma](https://www.schott-pharma.com/en/news-and-media/media-releases/2022/schott-announces-double-digit-million-euro-investment-in-ready-to-use-cartridge-production): MEDIA RELEASE: SCHOTT’s double-digit million Euro investment will significantly expand its production capacity of ready-to-use (RTU) cartridges - [SDAX inclusion achieved | SCHOTT Pharma](https://www.schott-pharma.com/en/news-and-media/media-releases/2023/schott-pharma-reaches-next-milestone-as-a-publicly-listed-company): Hello SDAX! SCHOTT Pharma reaches next milestone as a publicly listed company | MEDIA RELEASE - [Advanced treatments with RTU cartridges | SCHOTT Pharma](https://www.schott-pharma.com/en/news-and-media/media-releases/2023/advancing-treatments-with-ready-to-use-cartridges-from-schott-pharma): Advancing GLP-1 treatments, insulin, and large-volume injections with ready-to-use cartridges from SCHOTT Pharma | MEDIA RELEASE - [SCHOTT Pharma expands production with Hungarian government](https://www.schott-pharma.com/en/news-and-media/media-releases/2022/schott-and-hungarian-government-invest-in-cutting-edge-syringe-production): SCHOTT has made a 76 million Euro investment in a new production plant at Lukácsháza, Hungary to fulfil the global demand for glass prefillable syringes - [SCHOTT Pharma plans to expand cartridge production | SCHOTT](https://www.schott-pharma.com/en/news-and-media/media-releases/2022/schott-pharma-expands-cartridge-production-in-china-and-hungary): SCHOTT Pharma’s double-digit million Euro investment will significantly increase production capacity for pharmaceutical cartridges in Hungary and China - [SCHOTT and Serum Institute of India Announce Joint Venture for Pharmaceutical Packaging](https://www.schott-pharma.com/en/news-and-media/media-releases/2021/schott-and-serum-institute-of-india-announce-joint-venture-for-pharmaceutical-packaging): Media Release: Announcement Joint Venture for Pharmaceutical Packaging SCHOTT and Serum Institute of India - [Media Releases | SCHOTT Pharma](https://www.schott-pharma.com/en/news-and-media/media-releases): The latest media releases from SCHOTT Pharma - [Strong growth post-IPO | SCHOTT Pharma](https://www.schott-pharma.com/en/news-and-media/media-releases/2023/schott-pharma-delivers-right-after-ipo-with-strong-profitable-growth-for-the-full-year): SCHOTT Pharma delivers right after IPO with strong profitable growth for the full year, at the upper end of its guidance | MEDIA RELEASE - [SCHOTT Pharma establisches stand-alone company for growth](https://www.schott-pharma.com/en/news-and-media/media-releases/2022/schott-establishes-stand-alone-company-for-pharma-business-to-promote-further-growth): SCHOTT establishes stand-alone company for its pharma business to promote further growth | Media Release - [Pioneering deep-cold storage with polymer syringes](https://www.schott-pharma.com/en/news-and-media/media-releases/2023/safely-storing-deep-cold-medications-with-prefillable-polymer-syringes): First on the market: Safely storing deep-cold medications with prefillable polymer syringes from SCHOTT Pharma - [First stand-alone year | SCHOTT Pharma](https://www.schott-pharma.com/en/news-and-media/media-releases/2023/schott-pharma-strengthens-leading-position-in-the-first-year-as-stand-alone-company): Discover how SCHOTT Pharma has fortified its leading position in its first year as a stand-alone company, marking significant achievement and growth. - [Sustained growth in the first half of the FY | SCHOTT Pharma](https://www.schott-pharma.com/en/news-and-media/media-releases/2023/upholding-momentum-schott-pharma-sustains-strong-growth-in-the-first-half-of-fy-2023): Upholding momentum: SCHOTT Pharma sustains strong growth in the first half of FY 2023 | MEDIA RELEASE - [MEDIA RELEASE | SCHOTT Pharma with strong growth and record margin after solid year-end finish ](https://www.schott-pharma.com/en/news-and-media/media-releases/2024/schott-pharma-with-strong-growth-and-record-margin-after-solid-year-end-finish): SCHOTT Pharma with strong growth and record margin after solid year-end finish | MEDIA RELEASE - [MEDIA RELEASE | SCHOTT Pharma delivers strong third quarter results and raises FY 2024 revenue guidance](https://www.schott-pharma.com/en/news-and-media/media-releases/2024/schott-pharma-delivers-strong-third-quarter-results-and-raises-fy-2024-revenue-guidance): SCHOTT Pharma delivers strong third quarter results and raises FY 2024 revenue guidance | MEDIA RELEASE - [SCHOTT launches iQ® Integribag | SCHOTT](https://www.schott-pharma.com/en/news-and-media/media-releases/2022/schott-launches-iq-integribag): SCHOTT’s no-touch transfer solution for ready-to-use pharma containment and drug delivery solutions provides next-level sterile integrity - [MEDIA RELEASE | SCHOTT Pharma confirms outlook for FY 24 based on Q2 result](https://www.schott-pharma.com/en/news-and-media/media-releases/2024/schott-pharma-confirms-outlook-for-fy24-based-on-q2-results): SCHOTT Pharma confirms outlook for FY 24 based on Q2 results | MEDIA RELEASE - [MEDIA RELEASE | Transforming operational efficiency and sustainability: SCHOTT Pharma introduces nest design with more cavities for prefillable polymer syringes](https://www.schott-pharma.com/en/news-and-media/media-releases/2024/schott-pharma-introduces-nest-design-with-more-cavities-for-prefillable-polymer-syringes): Transforming operational efficiency and sustainability: SCHOTT Pharma introduces nest design with more cavities for prefillable polymer syringes | MEDIA RELEASE - [MEDIA RELEASE | Successful 2024 Annual General Meeting of SCHOTT Pharma: Shareholders approve all items on the agenda](https://www.schott-pharma.com/en/news-and-media/media-releases/2024/successful-2024-annual-general-meeting-of-schott-pharma): Successful 2024 Annual General Meeting of SCHOTT Pharma: Shareholders approve all items on the agenda | MEDIA RELEASE - [MEDIA RELEASE | SCHOTT Pharma and Nemera deliver verified pen injector platform with sterile cartridge system](https://www.schott-pharma.com/en/news-and-media/media-releases/2026/schott-pharma-and-nemera-deliver-verified-pen-injector-platform-with-sterile-cartridge-system): SCHOTT Pharma and Nemera deliver verified pen injector platform with sterile cartridge system | MEDIA RELEASE - [MEDIA RELEASE | SCHOTT Pharma expands portfolio for sensitive biologics with cartriQ® BioPure](https://www.schott-pharma.com/en/news-and-media/media-releases/2026/schott-pharma-expands-portfolio-for-sensitive-biologics-with-cartriq-biopure): SCHOTT Pharma expands portfolio for sensitive biologics with cartriQ® BioPure | MEDIA RELEASE - [MEDIA RELEASE | Next-level efficiency and sustainability: SCHOTT Pharma unveils innovative nest design for ready-to-use cartridges](https://www.schott-pharma.com/en/news-and-media/media-releases/2024/schott-pharma-unveils-innovative-nest-design-for-ready-to-use-cartridges): Next-level efficiency and sustainability: SCHOTT Pharma unveils innovative nest design for ready-to-use cartridges | MEDIA RELEASE - [MEDIA RELEASE | SCHOTT Pharma with positive start to financial year 2026; outlook confirmed](https://www.schott-pharma.com/en/news-and-media/media-releases/2026/schott-pharma-with-positive-start-to-financial-year-2026-outlook-confirmed): SCHOTT Pharma with positive start to financial year 2026; outlook confirmed | MEDIA RELEASE - [MEDIA RELEASE | Reducing packaging waste and CO2 footprint: SCHOTT Pharma introduces blister-free syringe concept ](https://www.schott-pharma.com/en/news-and-media/media-releases/2024/schott-pharma-introduces-blister-free-syringe-concept): Reducing packaging waste and CO2 footprint: SCHOTT Pharma introduces blister-free syringe concept | MEDIA RELEASE - [New prefillable syringes plant in Germany | SCHOTT Pharma](https://www.schott-pharma.com/en/news-and-media/media-releases/2022/schott-inaugurates-plant-for-prefillable-polymer-syringes-at-new-facility-in-germany): Discover SCHOTT Pharma's major investment in Germany to expand its production of prefillable polymer syringes to meet growing demand. - [Next decarbonizing program phase launched | SCHOTT Pharma ](https://www.schott-pharma.com/en/news-and-media/media-releases/2024/schott-pharma-launches-next-phase-of-decarbonizing-program): Net-zero supply chain: SCHOTT Pharma launches next phase of decarbonizing program | MEDIA RELEASE - [MEDIA RELEASE | Successful Annual General Meeting for SCHOTT Pharma: All resolutions approved](https://www.schott-pharma.com/en/news-and-media/media-releases/2026/successful-annual-general-meeting-for-schott-pharma-all-resolutions-approved): Successful Annual General Meeting for SCHOTT Pharma: All resolutions approved | MEDIA RELEASE - [New mRNA and gene therapy vials released | SCHOTT Pharma ](https://www.schott-pharma.com/en/news-and-media/media-releases/2024/schott-pharma-launches-new-vials-for-mrna-and-gene-therapy): Protecting drugs at deep-cold temperatures: SCHOTT Pharma launches new vials for mRNA and gene therapy | MEDIA RELEASE - [Achieving 2023 goals and ongoing growth | SCHOTT Pharma](https://www.schott-pharma.com/en/news-and-media/media-releases/2024/schott-pharma-delivers-on-2023-targets-and-continues-profitable-growth-trajectory): SCHOTT Pharma delivers on 2023 targets and continues profitable growth trajectory | MEDIA RELEASE - [MEDIA RELEASE | SCHOTT Pharma reports good start into fiscal year 2024](https://www.schott-pharma.com/en/news-and-media/media-releases/2024/schott-pharma-reports-good-start-into-fiscal-year-2024): SCHOTT Pharma reports good start into fiscal year 2024 | MEDIA RELEASE - [MEDIA RELEASE | SCHOTT Pharma appoints Tobias Erfurth as Head of Investor Relations](https://www.schott-pharma.com/en/news-and-media/media-releases/2024/schott-pharma-appoints-tobias-erfurth-as-head-of-investor-relations): SCHOTT Pharma appoints Tobias Erfurth as Head of Investor Relations | MEDIA RELEASE - [MEDIA RELEASE | Expanding prefillable glass syringe output: SCHOTT Pharma opens state-of-the-art production facility in Lukácsháza, Hungary](https://www.schott-pharma.com/en/news-and-media/media-releases/2024/schott-pharma-opens-state-of-the-art-production-facility-in-hungary): Expanding prefillable glass syringe output: SCHOTT Pharma opens state-of-the-art production facility in Lukácsháza, Hungary - [MEDIA RELEASE | SCHOTT Pharma celebrates first anniversary as a listed company on Frankfurt Stock Exchange](https://www.schott-pharma.com/en/news-and-media/media-releases/2024/schott-pharma-celebrates-first-anniversary-as-a-listed-company-on-frankfurt-stock-exchange): SCHOTT Pharma celebrates first anniversary as a listed company on Frankfurt Stock Exchange | MEDIA RELEASE - [MEDIA RELEASE | SCHOTT Pharma and KORU Medical Systems announce collaboration](https://www.schott-pharma.com/en/news-and-media/media-releases/2024/schott-pharma-and-koru-medical-systems-announce-collaboration): Simplifying subcutaneous drug administration: SCHOTT Pharma and KORU Medical Systems announce collaboration to advance large volume subcutaneous infusion | MEDIA RELEASE - [Breaking ground for cutting-edge production in Hungary](https://www.schott-pharma.com/en/news-and-media/media-releases/2022/schott-pharma-breaks-ground-for-cutting-edge-production-in-hungary): Find out how SCHOTT Pharma is expanding its global manufacturing network with a new production plant for prefillable glass syringes in Hungary. - [First sustainability report released | SCHOTT Pharma](https://www.schott-pharma.com/en/news-and-media/media-releases/2024/schott-pharma-releases-first-sustainability-report): Taking responsibility seriously: SCHOTT Pharma releases first sustainability report | MEDIA RELEASE - [MEDIA RELEASE | SCHOTT Pharma to Expand in the U.S. with New Prefillable Syringe Manufacturing Facility in Wilson, North Carolina](https://www.schott-pharma.com/en/news-and-media/media-releases/2024/schott-pharma-to-expand-in-the-us-with-new-prefillable-syringe-manufacturing-facility): SCHOTT Pharma to Expand in the U.S. with New Prefillable Syringe Manufacturing Facility in Wilson, North Carolina | MEDIA RELEASE - [MEDIA RELEASE | SCHOTT Pharma reinforces commitment to align its climate actions to the requirements of the Paris Agreement](https://www.schott-pharma.com/en/news-and-media/media-releases/2024/schott-pharma-reinforces-commitment-to-align-its-climate-actions): SCHOTT Pharma reinforces commitment to align its climate actions to the requirements of the Paris Agreement | MEDIA RELEASE - [MEDIA RELEASE | Driving subcutaneous self-injection of large volume doses: SCHOTT Pharma launches large format ready-to-use cartridges for on-body devices](https://www.schott-pharma.com/en/news-and-media/media-releases/2024/schott-pharma-launches-large-format-ready-to-use-cartridges-for-on-body-devices): Driving subcutaneous self-injection of large volume doses: SCHOTT Pharma launches large format ready-to-use cartridges for on-body devices | MEDIA RELEASE - [MEDIA RELEASE | Strengthening U.S. pharmaceutical supply: SCHOTT Pharma inaugurates expanded vial production in Lebanon, PA](https://www.schott-pharma.com/en/news-and-media/media-releases/2026/strengthening-us-pharmaceutical-supply-schott-pharma-inaugurates-expanded-vial-production): Strengthening U.S. pharmaceutical supply: SCHOTT Pharma inaugurates expanded vial production in Lebanon, PA | MEDIA RELEASE - [MEDIA RELEASE | SCHOTT Pharma polymer cartridge platform compatible with large-volume SHL Medical autoinjectors](https://www.schott-pharma.com/en/news-and-media/media-releases/2026/schott-pharma-polymer-cartridge-platform-compatible-with-large-volume-shl-medical-autoinjectors): SCHOTT Pharma polymer cartridge platform compatible with large-volume SHL Medical autoinjectors | MEDIA RELEASE - [MEDIA RELEASE | Promotion for SCHOTT Pharma: Listed on the MDAX for the first time](https://www.schott-pharma.com/en/news-and-media/media-releases/2024/schott-pharma-moves-up-to-mdax-for-first-time): Promotion for SCHOTT Pharma: Listed on the MDAX for the first time | MEDIA RELEASE - [MEDIA RELEASE | Accelerating drug submission: SCHOTT Pharma offers complete testing suite for container selection and drug submission preparation](https://www.schott-pharma.com/en/news-and-media/media-releases/2024/schott-pharma-offers-complete-testing-suite-for-container-selection-and-drug-submission-preparation): Accelerating drug submission: SCHOTT Pharma offers complete testing suite for container selection and drug submission preparation | MEDIA RELEASE - [MEDIA RELEASE | SCHOTT Pharma, Gerresheimer, and Stevanato Group announce strategic industry “Alliance for RTU” as market advance adoption of ready-to-use containers](https://www.schott-pharma.com/en/news-and-media/media-releases/2024/schott-pharma-gerresheimer-and-stevanato-group-announce-strategic-industry-alliance-for-rtu): SCHOTT Pharma, Gerresheimer, and Stevanato Group announce strategic industry “Alliance for RTU” as market advance adoption of ready-to-use containers | MEDIA RELEASE - [MEDIA RELEASE | SCHOTT Pharma continues growth path in the second quarter of fiscal year 2024](https://www.schott-pharma.com/en/news-and-media/media-releases/2024/schott-pharma-continues-growth-path-in-the-second-quarter-of-fiscal-year-2024): SCHOTT Pharma continues growth path in the second quarter of fiscal year 2024 | MEDIA RELEASE - [MEDIA RELEASE | SCHOTT Pharma Supervisory Board extends contract of CEO Andreas Reisse and appoints Reinhard Mayer as new CFO](https://www.schott-pharma.com/en/news-and-media/media-releases/2025/schott-pharma-extends-contract-of-ceo-andreas-reisse-and-appoints-reinhard-mayer-as-new-cfo): SCHOTT Pharma Supervisory Board extends contract of CEO Andreas Reisse and appoints Reinhard Mayer as new CFO | MEDIA RELEASE - [MEDIA RELEASE | SCHOTT Pharma and SHL Medical enhance home-based large-volume injections for patients](https://www.schott-pharma.com/en/news-and-media/media-releases/2025/schott-pharma-and-shl-medical-enhance-home-based-large-volume-injections-for-patients): SCHOTT Pharma and SHL Medical enhance home-based large-volume injections for patients | MEDIA RELEASE - [MEDIA RELEASE | SCHOTT Pharma records good start into fiscal year and confirms full year outlook](https://www.schott-pharma.com/en/news-and-media/media-releases/2025/schott-pharma-records-good-start-into-fiscal-year-and-confirms-full-year-outlook): SCHOTT Pharma records good start into fiscal year and confirms full year outlook | MEDIA RELEASE - [MEDIA RELEASE | SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance](https://www.schott-pharma.com/en/news-and-media/media-releases/2025/schott-pharmas-preliminary-results-for-fiscal-year-2025-outlook-fy-2026-update-of-mid-term-guidance): SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance | MEDIA RELEASE - [SCHOTT Pharma achieves strong financial results in FY 2023](https://www.schott-pharma.com/en/news-and-media/media-releases/2023/schott-pharma-with-strong-financial-performance-in-fiscal-year-2022): Learn more about the business development of SCHOTT Pharma in fiscal year 2022 - [MEDIA RELEASE | Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe](https://www.schott-pharma.com/en/news-and-media/media-releases/2025/schott-pharma-opens-production-facility-in-serbia-to-strengthen-competitiveness-in-europe): Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe | MEDIA RELEASE - [MEDIA RELEASE | Accelerating self-administration and homecare: SCHOTT Pharma launches large-volume prefillable glass syringe](https://www.schott-pharma.com/en/news-and-media/media-releases/2025/schott-pharma-launches-large-volume-prefillable-glass-syringe): Accelerating self-administration and homecare: SCHOTT Pharma launches large-volume prefillable glass syringe | MEDIA RELEASE - [MEDIA RELEASE | SCHOTT Pharma invests in sterile cartridge production in Hungary](https://www.schott-pharma.com/en/news-and-media/media-releases/2025/schott-pharma-invests-in-sterile-cartridge-production-in-hungary): SCHOTT Pharma invests in sterile cartridge production in Hungary | MEDIA RELEASE - [MEDIA RELEASE | SCHOTT Pharma, Takeda and Corplex bring closed-loop recycling system for pharmaceutical vial trays into operations](https://www.schott-pharma.com/en/news-and-media/media-releases/2026/schott-pharma-takeda-and-corplex-bring-closed-loop-recycling-system-for-pharmaceutical-vial-trays): SCHOTT Pharma, Takeda and Corplex bring closed-loop recycling system for pharmaceutical vial trays into operations | MEDIA RELEASE - [MEDIA RELEASE | SCHOTT Pharma launches EVERIC® lyo & amber vials for light-sensitive ADCs](https://www.schott-pharma.com/en/news-and-media/media-releases/2026/schott-pharma-launches-everic-lyo-and-amber-vials-for-light-sensitive-adcs): SCHOTT Pharma launches EVERIC® lyo & amber vials for light-sensitive ADCs | MEDIA RELEASE - [MEDIA RELEASE | SCHOTT Pharma with strong third quarter and on track for planned growth](https://www.schott-pharma.com/en/news-and-media/media-releases/2026/schott-pharma-with-strong-third-quarter-and-on-track-for-planned-growth): SCHOTT Pharma with strong third quarter and on track for planned growth | MEDIA RELEASE - [MEDIA RELEASE | SCHOTT Pharma with robust first half of the year and strong cash flow](https://www.schott-pharma.com/en/news-and-media/media-releases/2026/schott-pharma-with-robust-first-half-of-the-year-and-strong-cash-flow): SCHOTT Pharma with robust first half of the year and strong cash flow | MEDIA RELEASE - [SCHOTT Pharma reports strong performance for the year 2021](https://www.schott-pharma.com/en/news-and-media/media-releases/2022/schott-reports-successful-year-for-pharma-business-unit): MEDIA RELEASE: SCHOTT’s pharmaceutical business unit had a highly successful year in 2021, and aims to build upon this success - [MEDIA RELEASE | Redefining safety, efficiency, and sustainability: SCHOTT Pharma launches next generation polymer syringe system](https://www.schott-pharma.com/en/news-and-media/media-releases/2025/schott-pharma-launches-next-generation-polymer-syringe-system): Redefining safety, efficiency, and sustainability: SCHOTT Pharma launches next generation polymer syringe system | MEDIA RELEASE - [MEDIA RELEASE | Christian Mias to succeed Andreas Reisse as CEO of SCHOTT Pharma](https://www.schott-pharma.com/en/news-and-media/media-releases/2025/christian-mias-to-succeed-andreas-reisse-as-ceo-of-schott-pharma): Christian Mias to succeed Andreas Reisse as CEO of SCHOTT Pharma | MEDIA RELEASE - [MEDIA RELEASE | SCHOTT Pharma and Serum Institute of India welcomes new partner to Joint Venture in India; TPG makes strategic investment in SCHOTT Poonawalla](https://www.schott-pharma.com/en/news-and-media/media-releases/2025/schott-pharma-and-serum-institute-of-india-welcomes-new-partner-to-joint-venture-in-india): SCHOTT Pharma and Serum Institute of India welcomes new partner to Joint Venture in India; TPG makes strategic investment in SCHOTT Poonawalla | MEDIA RELEASE - [Expansion in Serbia | SCHOTT Pharma](https://www.schott-pharma.com/en/news-and-media/media-releases/2023/schott-pharma-invests-in-a-new-production-facility-in-serbia): SCHOTT Pharma successfully executes its expansion strategy and invests in a new production facility in Serbia | MEDIA RELEASE - [MEDIA RELEASE | SCHOTT Pharma delivers strong second quarter of fiscal year 2025](https://www.schott-pharma.com/en/news-and-media/media-releases/2025/schott-pharma-delivers-strong-second-quarter-of-fiscal-year-2025): SCHOTT Pharma delivers strong second quarter of fiscal year 2025 | MEDIA RELEASE - [MEDIA RELEASE | SCHOTT Pharma reports preliminary results for Q3 2025 and specifies FY 2025 guidance ](https://www.schott-pharma.com/en/news-and-media/media-releases/2025/schott-pharma-reports-preliminary-results-for-q3-2025-and-specifies-fy-2025-guidance): SCHOTT Pharma reports preliminary results for Q3 2025 and specifies FY 2025 guidance | MEDIA RELEASE - [MEDIA RELEASE | SCHOTT Pharma makes decarbonization measurable](https://www.schott-pharma.com/en/news-and-media/media-releases/2026/schott-pharma-makes-decarbonization-measurable): SCHOTT Pharma makes decarbonization measurable | MEDIA RELEASE - [MEDIA RELEASE | SCHOTT Pharma and Nemera launch first fully compatible large- volume passive safety system with prefillable glass syringe](https://www.schott-pharma.com/en/news-and-media/media-releases/2026/schott-pharma-and-nemera-launch-first-fully-compatible-large-volume-passive-safety-system): SCHOTT Pharma and Nemera launch first fully compatible large- volume passive safety system with prefillable glass syringe | MEDIA RELEASE - [MEDIA RELEASE | SCHOTT Pharma expands ready-to-use portfolio with sterile 1.5 ml cartridge](https://www.schott-pharma.com/en/news-and-media/media-releases/2025/schott-pharma-expands-ready-to-use-portfolio-with-sterile-one-point-five-ml-cartridge): SCHOTT Pharma expands ready-to-use portfolio with sterile 1.5 ml cartridge | MEDIA RELEASE - [MEDIA RELEASE | SCHOTT Pharma delivers on full-year revenue and profitability targets](https://www.schott-pharma.com/en/news-and-media/media-releases/2025/schott-pharma-delivers-on-full-year-revenue-and-profitability-targets): SCHOTT Pharma delivers on full-year revenue and profitability targets | MEDIA RELEASE - [MEDIA RELEASE | SCHOTT Pharma delivers solid final third-quarter results](https://www.schott-pharma.com/en/news-and-media/media-releases/2025/schott-pharma-delivers-solid-final-third-quarter-results): SCHOTT Pharma delivers solid final third-quarter results | MEDIA RELEASE - [MEDIA RELEASE | SCHOTT Pharma launches ready-to-use polymer cartridge](https://www.schott-pharma.com/en/news-and-media/media-releases/2025/schott-pharma-launches-ready-to-use-polymer-cartridge): SCHOTT Pharma launches ready-to-use polymer cartridge | MEDIA RELEASE - [MEDIA RELEASE | SCHOTT Pharma with successful Annual General Meeting: Shareholders approve all agenda items ](https://www.schott-pharma.com/en/news-and-media/media-releases/2025/schott-pharma-with-successful-annual-general-meeting): SCHOTT Pharma with successful Annual General Meeting: Shareholders approve all agenda items | MEDIA RELEASE - [MEDIA RELEASE | Protecting precious therapies: SCHOTT Pharma unveils polymer syringe for ultra-low temperature storage at -180 °C](https://www.schott-pharma.com/en/news-and-media/media-releases/2025/schott-pharma-unveils-polymer-syringe-for-ultra-low-temperature-storage-at-minus-180-degrees-celsius): Protecting precious therapies: SCHOTT Pharma unveils polymer syringe for ultra-low temperature storage at -180 °C | MEDIA RELEASE - [News and Media | SCHOTT Pharma](https://www.schott-pharma.com/en/news-and-media): The latest news and media releases from the international specialty glass manufacturer ## SCHOTT Pharma Sustainability | SCHOTT Pharma’s Sustainability page outlines the company’s environmental and social responsibility initiatives, including goals for climate action, resource efficiency, ethical supply chains, and community engagement to support sustainable healthcare and long‑term impact. - [Sustainable Products | SCHOTT Pharma](https://www.schott-pharma.com/en/about-us/sustainability/sustainable-products): SCHOTT Pharma is dedicated to reducing environmental impact through sustainable product design, supply chain optimization, and partnerships. Our efforts focus on eco-friendly materials and lifecycle management, contributing to climate change solutions. - [Climate Action | SCHOTT Pharma](https://www.schott-pharma.com/en/about-us/sustainability/climate-action): SCHOTT Pharma is committed to taking responsibility for the environmental impact of its business operations. - [Compliance | SCHOTT Pharma](https://www.schott-pharma.com/en/about-us/sustainability/compliance): Everything you need to know about SCHOTT Pharma’s compliance policies, including its Code of Conduct, ethical business practices, social responsibility, and corporate governance - [Sustainability | SCHOTT Pharma](https://www.schott-pharma.com/en/about-us/sustainability): Learn how SCHOTT Pharma advances sustainability across its value chain through responsible business practices, climate action, circularity initiatives, and resource efficiency. ## SCHOTT Pharma Other Pages - [Newsletter | SCHOTT Pharma](https://www.schott-pharma.com/en/newsletter): - [Disclaimer and legal information | SCHOTT Pharma](https://www.schott-pharma.com/en/disclaimer): Legal information for the use of the SCHOTT website. - [SCHOTT Pharma AG & Co. KGaA](https://www.schott-pharma.com/en/imprint): Here you can find our imprint with the legal information of SCHOTT. - [Data Protection Policy cvent](https://www.schott-pharma.com/en/data-protection-policy-cvent): Processing of your personal data by SCHOTT Pharma for the organization of events - [Terms and conditions | SCHOTT Pharma](https://www.schott-pharma.com/en/general-terms-and-conditions): Explore SCHOTT Pharma’s global terms and conditions for product delivery and sales, available in multiple languages. Download the relevant documents now. - [Data protection policy | SCHOTT Pharma](https://www.schott-pharma.com/en/data-protection-policy): Learn about SCHOTT Pharma's Data Protection Policy, including who controls your personal data and your rights regarding the protection of your data ## German ## Produkte | Die Produktseite von SCHOTT Pharma bietet einen Überblick über das Portfolio zur Medikamentenaufbewahrung und -verabreichung, einschließlich vorfüllbarer Glas- und Polymerspritzen, Karpulen, Fläschchen und Ampullen, die sämtlich für Pharma- und Biotech-Hersteller konzipiert wurden. - [Karpulen | SCHOTT Pharma](https://www.schott-pharma.com/de/produkte/pharmazeutische-karpulen): StandardLine, TopLine bis hin zu cartriQ® und SCHOTT TOPPAC®: unser Sortiment an Glaskarpulen dosiert Medikamente mit höchster Präzision. - [Ampullen | SCHOTT Pharma](https://www.schott-pharma.com/de/produkte/ampullen): Glasampullen von SCHOTT Pharma überzeugen durch ihre außergewöhnliche chemische Beständigkeit, Arzneimittelstabilität und präzise Abmessungen. - [Vorfüllbare Spritzen | SCHOTT Pharma](https://www.schott-pharma.com/de/produkte/spritzen): Entdecken Sie das SCHOTT Pharma Spritzensortiment in verschiedenen Größen für die sichere Lagerung unterschiedlicher Medikamente. Mehr erfahren! - [Glasfläschchen | SCHOTT Pharma ](https://www.schott-pharma.com/de/produkte/flaeschchen): SCHOTT Pharmas Glasfläschchen verbessern die Abfüll- und Fertigungseffizienz und erhöhen die langfristige Stabilität von Medikamenten. - [Pharmazeutische Verpackungen | SCHOTT Pharma ](https://www.schott-pharma.com/de/produkte): Als führender Anbieter pharmazeutischer Verpackungen bieten wir ein breites Produktportfolio von Spritzen, Ampullen, Karpulen und Fläschchen. ## Spritzen | Die Spritzen-Seite von SCHOTT Pharma präsentiert vorfüllbare pharmazeutische Spritzenlösungen aus Glas und fortschrittlichem Polymer für die sichere Lagerung und Verabreichung von Medikamenten. syriQ® und SCHOTT TOPPAC® Spritzen werden hervorgehoben, da sie darauf ausgelegt sind, Fehler zu minimieren, die Sicherheit zu erhöhen und ein breites Anwendungsspektrum von Impfstoffen bis hin zu Biologika zu unterstützen. - [SCHOTT TOPPAC® unique](https://www.schott-pharma.com/de/produkte/spritzen/schott-toppac-unique): Entdecken Sie die Polymercontainer von SCHOTT Pharma -individuell angepasste Wirkstoffbehälter für medizinische Anwendungen. Mehr erfahren! - [SCHOTT TOPPAC® infuse ](https://www.schott-pharma.com/de/produkte/spritzen/schott-toppac-infuse): Optimieren Sie Krankenhausprozesse und reduzieren Sie Medikationsfehler mit der SCHOTT TOPPAC® infuse. Mehr erfahren! - [syriQ®](https://www.schott-pharma.com/de/produkte/spritzen/syriq): Entdecken Sie syriQ®, die vorfüllbare Glasspritze für die Lagerung und Verabreichung einer Vielzahl von Impfstoffen. Mehr erfahren! - [syriQ BioPure® silicone-free](https://www.schott-pharma.com/de/produkte/spritzen/syriq-biopure-silicone-free): Entdecken Sie die gebrauchsfertige syriQ BioPure® silicone-free Glasspritze für die sichere Lagerung und Verabreichung silikonölempfindlicher Biologika. Mehr erfahren! - [syriQ BioPure®](https://www.schott-pharma.com/de/produkte/spritzen/syriq-biopure): Entdecken Sie die gebrauchsfertige syriQ BioPure® Glasspritze zur sicheren Lagerung und Verabreichung hochsensibler Biologika. Mehr erfahren! - [SCHOTT TOPPAC® Polymerspritzen](https://www.schott-pharma.com/de/produkte/spritzen/schott-toppac): Polymerspritzen von SCHOTT Pharma bieten eine zuverlässige Primärverpackungslösung für die langfristige Lagerung von Arzneimitteln. Mehr erfahren! - [SCHOTT TOPPAC® cosmetic](https://www.schott-pharma.com/de/produkte/spritzen/schott-toppac-cosmetic): Entdecken Sie die SCHOTT TOPPAC® cosmetic Polymerspritze für ästhetische Anwendungen. Mehr erfahren! - [SCHOTT TOPPAC® freeze](https://www.schott-pharma.com/de/produkte/spritzen/schott-toppac-freeze): Entdecken Sie SCHOTT TOPPAC® freeze Polymerspritzen für Wirkstoffe mit Tieftemperaturlagerung. Für Sicherheit bei jeder Anwendung. Mehr erfahren! ## Karpulen | Die Seite Pharmazeutische Karpulen von SCHOTT Pharma stellt Glas- und Polymerkarpulenlösungen für die präzise Medikamentendosierung in Pens, Autoinjektoren und tragbaren Systemen vor. Das Portfolio umfasst gebrauchsfertige, Doppelkammer- und hochbeständige Optionen, die für injizierbare Therapien und Biologika entwickelt wurden. - [Doppelkammerkarpulen (DC)](https://www.schott-pharma.com/de/produkte/pharmazeutische-karpulen/doppelkammer-karpulen): Die Doppelkammerkarpulen sind eine sichere Lösung für die Handhabung von lyophilisierten Arzneimitteln und ermöglichen eine präzise Dosierung. - [SCHOTT TOPPAC® Polymerkarpulen](https://www.schott-pharma.com/de/produkte/pharmazeutische-karpulen/schott-toppac-cartridge): Die SCHOTT TOPPAC® Polymerkarpule bietet hohe Integrität und zuverlässige Performance für empfindliche Biologika. Jetzt Mehr erfahren! - [cartriQ® Large Volume](https://www.schott-pharma.com/de/produkte/pharmazeutische-karpulen/cartriq-large-volume): Die cartriQ® großvolumigen Karpulen wurden für tragbare Injektionsgeräte entwickelt und bieten eine sichere Verabreichung von Medikamenten. - [Core Pharmazeutische Glaskarpulen](https://www.schott-pharma.com/de/produkte/pharmazeutische-karpulen/core-karpulen): Chemikalienresistente pharmazeutische Glaskarpulen, die eine präzise Toleranzen bieten, damit Patienten Medikamente selbst verabreichen können. - [Bruchfeste Karpulen (BR)](https://www.schott-pharma.com/de/produkte/pharmazeutische-karpulen/bruchsichere-karpulen): Bruchfeste Karpulen, die für härteste Bedingungen ausgelegt sind und die sichere Lagerung und Abgabe lebensrettender Arzneimittel gewährleisten. - [cartriQ®](https://www.schott-pharma.com/de/produkte/pharmazeutische-karpulen/cartriq): Die ready-to-use Karpulen sind mit vielen Autoinjektoren & Pen-Injektoren kompatibel und ideal für den Einsatz im Krankenhaus und zu Hause. ## Fläschchen | Die Fläschchen-Seite von SCHOTT Pharma präsentiert hochwertige Glasfläschchen, die speziell für injizierbare Arzneimittel, Impfstoffe und Biologika entwickelt wurden. Sie bieten chemische Beständigkeit, Maßgenauigkeit sowie gebrauchsfertige Optionen zur Unterstützung effizienter pharmazeutischer Abfüll- und Fertigstellungsprozesse. - [EVERIC® freeze](https://www.schott-pharma.com/de/produkte/flaeschchen/everic-freeze): EVERIC® freeze Glasfläschchen für Tiefkühllagerung gewährleistet Stabilität bei niedrigen Temperaturen, optimiert die pharmazeutische Gefriertrocknung! - [adaptiQ®](https://www.schott-pharma.com/de/produkte/flaeschchen/adaptiq): adaptiQ® sterile Fläschchen zur Steigerung der Effizienz, Sicherheit und Zuverlässigkeit von Herstellungsprozessen für injizierbare Arzneimittel. - [Core Fläschchen](https://www.schott-pharma.com/de/produkte/flaeschchen/core-flaeschchen): Entdecken Sie unsere Core Fläschchen TopLine & StandardLine für Arzneimittelstabilität, Produktionseffizienz und niedrige Betriebskosten. - [EVERIC® strong & smooth](https://www.schott-pharma.com/de/produkte/flaeschchen/everic-strong-smooth): Bruchfeste Fläschchen bieten eine höhere Geschwindigkeit für Bulk Fill-and-Finish Linien sowie ein geringeres Bruchrisiko und niedrigere Ausschussraten. - [EVERIC® amber Braunglasfläschen](https://www.schott-pharma.com/de/produkte/flaeschchen/everic-amber): EVERIC® amber Braunglasfläschen schützen lichtempfindliche Wirkstoffe wie ADCs vor Abbau und gewährleisten stabile Qualität. Jetzt mehr erfahren! - [EVERIC® plus](https://www.schott-pharma.com/de/produkte/flaeschchen/everic-plus): EVERIC® plus beschichtete Fläschchen haben geringe Auslaugwerte, um die Stabilität empfindlicher Arzneimittelformulierungen zu gewährleisten. - [EVERIC® pure](https://www.schott-pharma.com/de/produkte/flaeschchen/everic-pure): Die Fläschchen für Biologika - EVERIC® pure: Bewährte Delaminationskontrolle und Hydrolysebeständigkeit für Ihre pharmazeutischen Produkte. - [EVERIC® care](https://www.schott-pharma.com/de/produkte/flaeschchen/everic-care): EVERIC® care pharmazeutische Glasfläschchen verfügen über eine hydrophobe Beschichtung, die Arzneimittel im alkalischen pH-Bereich schützt. - [EVERIC® smart](https://www.schott-pharma.com/de/produkte/flaeschchen/everic-smart): Entdecken Sie unser Smart Packaging mit einzigartiger Lasermarkierung für eine hohe Rückverfolgbarkeit während des Fill-and-Finish Prozesses. - [EVERIC® lyo](https://www.schott-pharma.com/de/produkte/flaeschchen/everic-lyo): EVERIC® lyo Fläschchen wurden entwickelt, um Fogging während der Lyophilisierung zu verhindern und die Restentleerung zu verbessern. ## Ampullen | Die Seite Glasampullen von SCHOTT Pharma präsentiert hochwertige Borosilikatampullen für die sichere Aufbewahrung steriler, injizierbarer Arzneimittel und Chemikalien. Sie zeichnen sich durch präzise Versiegelung, chemische Beständigkeit und Formate aus, die für Impfstoffe, Biologika und empfindliche pharmazeutische Anwendungen geeignet sind. - [Ampullen Anti-Counterfeiting (AC)](https://www.schott-pharma.com/de/produkte/ampullen/ampullen-ac): Ampullen Anti-Counterfeiting (AC) von Schott Pharma bieten ein Sicherheitsnetz gegen alle potenziellen Gefahren von Arzneimittelfälschungen. - [Ampullen easyOPC](https://www.schott-pharma.com/de/produkte/ampullen/ampullen-easy-opc): Die Ampullen easyOPC bieten optimalen Bruchkraftbereich für sicheres Öffnen, weniger Rücksendungen, geringere Kosten & stabile Arzneimittelstabilität. - [Core Ampullen](https://www.schott-pharma.com/de/produkte/ampullen/core-ampullen): Core Ampullen bieten eine hohe Hydrolysebeständigkeit, einen hervorragenden Fill-and-Finish Prozess und vier verschiedene Bruchsysteme. ## Dienstleistungen | Die Services-Seite von SCHOTT Pharma bietet maßgeschneiderte Unterstützung für Pharma- und Biotech-Partner, einschließlich Verpackungsoptimierung, regulatorischer und Qualitätsberatung, technischem Support, Entwicklung von Systemen zur Arzneimittelverabreichung sowie kundenspezifischen Lösungen zur Verbesserung der Herstellungs- und Produktleistung. - [Regulatorische Dienstleistungen I SCHOTT Pharma](https://www.schott-pharma.com/de/services/regulatorische-dienstleistungen): Die regulatorischen Dienstleistungen von SCHOTT Pharma ermöglichen die nahtlose Integration von Inhalten zu den verwendeten Primärpackmitteln in die Zulassungsdokumentation von Medikamenten und Medizinprodukten - [Pharmaanalytische Services | SCHOTT Pharma](https://www.schott-pharma.com/de/services/pharmaanalytische-services): Die pharmaanalytischen Services von SCHOTT Pharma validieren Primärpackmittelsysteme in Hinblick auf die Anforderungen Ihres spezifischen Medikaments. - [Services | SCHOTT Pharma](https://www.schott-pharma.com/de/services): Das Angebot an Services von SCHOTT Pharma umfasst analytische Prüfungen, die Optimierung von Fill-and-Finish Prozessen sowie die Unterstützung bei Nachhaltigkeitszielen und regulatorischen Vorgaben ## SCHOTT Pharma Dienstleistungen zur Arzneimittelaufbewahrung und -verabreichung | Die Seite „Containment Solutions“ von SCHOTT Pharma bietet maßgeschneiderte Beratung und Unterstützung für die pharmazeutische Verpackungsaufbewahrung, einschließlich Risikobewertung, Barrierestrategien, Kompatibilitätstests und optimierten Containment-Systemen, um sowohl die Produktsicherheit und -qualität als auch die Einhaltung regulatorischer Anforderungen zu gewährleisten. - [Machbarkeitsstudien | SCHOTT Pharma](https://www.schott-pharma.com/de/services/primaerpackmittel-loesung/feasibility-study): SCHOTT Pharma bietet einen Service für Machbarkeitsstudien an, der die Machbarkeit einer Produktverpackungslösung sowie deren Eignung für die Großserienproduktion bewertet. - [Prototyping | SCHOTT Pharma](https://www.schott-pharma.com/de/services/primaerpackmittel-loesung/prototyping): SCHOTT Pharma bietet einen umfassenden Prototyping-Service für pharmazeutische Verpackungen, einschließlich Musterherstellung, Machbarkeits- und Kompatibilitätstests sowie Dokumentation. - [Services zur Entwicklung von Primärpackmittelsystemen I SCHOTT Pharma](https://www.schott-pharma.com/de/services/primaerpackmittel-loesung): SCHOTT Pharma bietet Services zur Entwicklung von Primärpackmittelsystemen – von der Designphase bis zur Industrialisierung. Jetzt mehr erfahren! ## SCHOTT Pharmaanalytik | Die Pharmaanalytik-Seite von SCHOTT Pharma präsentiert ein Portfolio analytischer Dienstleistungen für Arzneimittelverpackungs- und Verabreichungssysteme, einschließlich Materialcharakterisierung, Extractables- und Leachables-Tests, Stabilitätsstudien sowie regulatorische Unterstützung zur Sicherstellung von Qualität, Sicherheit und Compliance bei pharmazeutischen Produkten. - [Mechanische Stabilitätsprüfung | SCHOTT Pharma](https://www.schott-pharma.com/de/services/pharmaanalytische-services/mechanische-stabilitaetspruefung): Die mechanischen Stabilitätsprüfungen von pharmazeutischen Produkten durch SCHOTT Pharma bilden eine solide Grundlage für die Schwachstellenanalyse von Produktionslinien und Containerdesign - [Funktionsprüfung](https://www.schott-pharma.com/de/services/pharmaanalytische-services/funktionale-tests): SCHOTT Pharma bietet einen Service zur Funktionsprüfung von pharmazeutischen Verpackungen zur vollständigen Einhaltung gesetzlicher Vorschriften an - [Komponentencharakterisierung | SCHOTT Pharma](https://www.schott-pharma.com/de/services/pharmaanalytische-services/komponentencharakterisierung): Entdecken Sie mit SCHOTT Pharma, wie eine sichere Lagerung Ihres Medikaments und des von Ihnen verwendeten Primärpackmittelsystems gewährleistet wird. - [Extractables und Leachables Studien | SCHOTT Pharma](https://www.schott-pharma.com/de/services/pharmaanalytische-services/extractables-leachables-studien): SCHOTT Pharma übernimmt nicht nur die Entwicklung und Durchführung von Extractables und Leachables Studien, sondern interpretiert ebenfalls die Ergebnisse und vergleicht verschiedene Primärpackmittelsysteme für Ihre Arzneimittel. - [Delaminationsstudien | SCHOTT Pharma](https://www.schott-pharma.com/de/services/pharmaanalytische-services/glas-delamination): SCHOTT Pharma unterstützt Pharmaunternehmen mit maßgeschneiderten Delaminations-Screening-Studien bei der Auswahl der idealen Kombination aus Medikament und Primärpackmittel sowie der Festlegung der Lagerungsparameter für bestimmte Medikamente - [Partikelanalyse | SCHOTT Pharma](https://www.schott-pharma.com/de/services/pharmaanalytische-services/partikelanalyse): SCHOTT Pharma führt eine Reihe von Studien zur Untersuchung von Partikeln in Medikamenten mit dem Ziel durch, Ursachen zu ermitteln und erforderliche Maßnahmen zur Gewährleistung der Produktsicherheit zu bestimmen - [Integritätsprüfung von Containerverschlüssen I SCHOTT Pharma](https://www.schott-pharma.com/de/services/pharmaanalytische-services/verpackungsverschluss-integritaetspruefung): SCHOTT Pharma bietet einen umfassenden CCI-Testservice, der die Sicherheit und Wirksamkeit Ihres pharmazeutischen Behälters gewährleistet. - [Konformitätsprüfungen | SCHOTT Pharma](https://www.schott-pharma.com/de/services/pharmaanalytische-services/konformitaetspruefung): SCHOTT Pharma führt eine Reihe von Konformitätsprüfungen zu allen Aspekten von Primärpackmittelsystemen durch, um die vollständige Einhaltung der Pharmakopöe und internationaler Standards sicherzustellen ## SCHOTT Pharma Fill-and-Finish Services | Die Fill-and-Finish-Seite von SCHOTT Pharma bietet sterile Herstellungsdienstleistungen, einschließlich aseptischer Abfüllung, Inspektion und Verpackung von injizierbaren Arzneimitteln und Biologika, ergänzt durch Qualitätskontrolle, skalierbare Produktion und regulatorische Unterstützung, um Pharmapartnern zu ermöglichen, Produkte sicher auf den Markt zu bringen. - [Fill-and-Finish-Services | SCHOTT Pharma](https://www.schott-pharma.com/de/services/fill-and-finish): Die Fill-and-Finish Services von SCHOTT Pharma unterstützen die Verarbeitung von Medikamentenaufbewahrungslösungen im kleinen bis kommerziellen Maßstab ## Regulatorische Services von SCHOTT Pharma | Die Regulatorische Seite von SCHOTT Pharma bietet Unterstützung für pharmazeutische Verpackungs- und Verabreichungssysteme, einschließlich Leitlinien zu globalen Vorschriften, Einreichungsstrategien, Dokumentation, Compliance-Bewertung und Qualitätsmanagement, um Partner dabei zu unterstützen, regulatorische Anforderungen zu erfüllen und Zulassungsprozesse zu beschleunigen. - [Drug Master Files | SCHOTT Pharma](https://www.schott-pharma.com/de/services/regulatorische-dienstleistungen/drug-master-files-dmf): SCHOTT Pharma unterstützt über seien Regulatorischen Services die Erstellung, Einreichung und Aktualisierung von Arzneimittelzulassungen in den USA, Kanada und China - [Dossier zur Zulassung von Medizinprodukten | SCHOTT Pharma](https://www.schott-pharma.com/de/services/regulatorische-dienstleistungen/dossier-zulassung-medizinprodukte): SCHOTT Pharma bietet volle Unterstützung bei der Zulassung von Medizinprodukten durch die Bereitstellung von Medical Device Registration (MDR) Dossiers - [Letter of Authorization (LOA) | SCHOTT Pharma](https://www.schott-pharma.com/de/services/regulatorische-dienstleistungen/pharma-letter-of-authorization-loa): SCHOTT Pharma bietet ein breites Spektrum an regulatorischen Dienstleistungen, um den Registrierungsprozess Ihres Arzneimittels so reibungslos wie möglich zu gestalten. - [Pharmazeutische Packaging Dossiers I SCHOTT Pharma](https://www.schott-pharma.com/de/services/regulatorische-dienstleistungen/pharmazeutische-packaging-dossiers): SCHOTT Pharma bietet kundenspezifische Dokumentationspakete für eine nahtlose Integration in das endgültige Arzneimittel-Beantragungsdossier an - [Nationale Produktzulassungen | SCHOTT Pharma](https://www.schott-pharma.com/de/services/regulatorische-dienstleistungen/pharmaceutical-product-registration): Erfahren Sie, wie SCHOTT Pharma die Zulassung von Pharmaprodukten umsetzt und proaktiv die Einhaltung gesetzlicher Vorschriften und die Verfügbarkeit ihrer Produkte vorbereitet. ## SCHOTT Pharma Nachhaltigkeitsservices | Die Nachhaltigkeitsseite von SCHOTT Pharma konzentriert sich auf Dienstleistungen, die das Unternehmen zur Förderung der ökologischen und sozialen Verantwortung anbietet, wie beispielsweise Nachhaltigkeitsleistungsüberprüfungen, EcoVadis-Ratings und Bewertungen des Produkt-CO2-Fußabdrucks, um Emissionen zu reduzieren, die Nachhaltigkeit der Lieferkette zu verbessern und auf eine Netto-Null-Zukunft hinzuarbeiten. - [Nachhaltigkeit bei pharmazeutischen Verpackungen | SCHOTT Pharma](https://www.schott-pharma.com/de/services/nachhaltigkeit): SCHOTT Pharma integriert Umweltkonzepte in seine Produkte und Lösungen und unterstützt pharmazeutische Unternehmen beim Management ihrer Nachhaltigkeitskonformität ## SCHOTT Pharmalösungen | Die Solutions-Seite von SCHOTT Pharma präsentiert integrierte Systeme für die Medikamentenaufbewahrung und -verabreichung, die Verpackung, Analytik, Fill-and-Finish sowie regulatorische Unterstützung vereinen. Diese End-to-End-Lösungen unterstützen Pharma- und Biotech-Partner dabei, Sicherheit, Effizienz und Produktleistung über den gesamten Lebenszyklus hinweg zu optimieren. - [Whitepaper Das perfekte Match finden I SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-solutions/pharmaceutical-manufacturing/verbesserte-herstellungsprozesse-mit-sterilen-loesungen/whitepaper-das-perfekte-match-finden): - [Whitepaper Standardisierte Verpackungslösungen I SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-solutions/pharmaceutical-manufacturing/verbesserte-herstellungsprozesse-mit-sterilen-loesungen/whitepaper-standardisierte-verpackung): - [Whitepaper Eine erfolgreiche Kombination I SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-solutions/pharmaceutical-manufacturing/verbesserte-herstellungsprozesse-mit-sterilen-loesungen/whitepaper-erfolgreiche-kombination): - [mRNA-Technologie I Verpackung I Niedrige Temperaturen I Spritzen I Fläschchen | SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-solutions/drug-packaging/lagerung-mrna-arzeimittel): Fläschchen- und Spritzenportfolio um technische Probleme wie Kolbenbewegung, Container Closure Integrity des Behälters oder Sterilität bei mRNA mit niedrigen Temperaturen zu adressieren. - [Verpackungslösungen Diabetes-Behandlung | SCHOTT Pharma ](https://www.schott-pharma.com/de/pharma-solutions/drug-packaging/diabetes-behandlung): Entdecken Sie eine Reihe von Lösungen zur Aufbewahrung und Verabreichung von Medikamenten für die GLP-1-basierte Diabetes-Behandlung! - [Biologika und Biosimilars – von der Forschung bis zur regulatorischen Compliance | SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-solutions/drug-packaging/biologics-biosimilars): Biologika und Biosimilars stellen neue Herausforderungen dar: Erfahren Sie, wie Sie diese von der Forschung zu Primärverpackungslösungen bis hin zur Einhaltung regulatorischer Anforderungen erfolgreich auf den Markt bringen. - [Integration von cartriQ® in großvolumige SC-Injektionen](https://www.schott-pharma.com/de/pharma-solutions/drug-packaging/large-volume-biologics/cartriq-integration-sterile-large-volume): Die Integration von cartriQ® ermöglicht eine sichere und stabile subkutane Verabreichung großvolumiger Biologika und unterstützt eine patientenfreundliche Anwendung zu Hause. - [USP <382> Functional Testing Solutions | SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-solutions/pharma-services/usp-382): Rigorous USP <382> testing for fully assembled drug‑filled systems, from package integrity and CCI checks to fragmentation analysis - [Großvolumige Biologika | SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-solutions/drug-packaging/large-volume-biologics): SCHOTT Pharma bietet ein Sortiment an Primärverpackungslösungen für Pen-Injektoren, Autoinjektoren, On-Body-Delivery-Systeme und Infusionspumpen. - [Track&Trace-Lösungen | SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-solutions/pharmaceutical-manufacturing/track-and-trace-individuelle-container): Verfolgen Sie Ihren lasermarkierten Arzneimittelcontainer von der Produktion bis zum Endverbraucher und verlassen Sie sich auf die Rückverfolgbarkeit entlang der Lieferkette. - [Pharma Herstellungsprozesse optimieren | SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-solutions/pharmaceutical-manufacturing/verbesserte-herstellungsprozesse-mit-sterilen-loesungen): Optimieren Sie Ihre Herstellungsprozesse mit der adaptiQ® RTU Plattform, für erhöhte Geschwindigkeit & Kosteneinsparungen für Fill-and-Finish Anlagen! - [Antikörper-Wirkstoff-Konjugate Verpackung | SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-solutions/drug-packaging/antibody-drug-conjugates): Bewältigen Sie die Herausforderungen bei Antikörper-Wirkstoff-Konjugaten (ADCs) mit Verpackungen, die die biologische Stabilität gewährleisten, lyophilisierte Formulierungen unterstützen und die ADC-Integrität aufrechterhalten - [Minderung des Kontaminationsrisikos | SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-solutions/platforms/minderung-kontaminationsrisiko): Die aseptischen Abfülllösungen von SCHOTT Pharma bieten Sterilität auf höchstem Niveau, verbessern die Sicherheit und mindern das Kontaminationsrisiko - [Vorbereitung der Arzneimitteleinreichung | SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-solutions/pharma-services/vorbereitung-arzneimitteleinreichung): SCHOTT Pharma bietet Prüfservice für pharmazeutische Verpackungen, um Compliance und Patientensicherheit zu gewährleisten. Jetzt mehr erfahren! - [Fill-and-Finish Lösungen | SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-solutions/pharma-services/fill-finish-effizienz): SCHOTT Pharma's Fill-and-Finish Lösungen für Abfüll- und Fertigstellungslinien hilft Unternehmen dabei, Ausfallzeiten von Maschinen und Ausschussraten von Produkten zu minimieren - [Verpackungslösungen Adipositas-Behandlung | SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-solutions/drug-packaging/adipositas-behandlung): Entdecken Sie die Lösungen zur Aufbewahrung und Verabreichung von Medikamenten für die GLP-1-basierte Adipositas-Behandlung. Mehr erfahren! - [Whitepaper Eine erfolgreiche Kombination I SCHOTT Pharma](https://www.schott-pharma.com/de/loesungen/fill-and-finish/verbesserte-herstellungsprozesse-mit-sterilen-loesungen/whitepaper-erfolgreiche-kombination): - [Whitepaper Standardisierte Verpackungslösungen I SCHOTT Pharma](https://www.schott-pharma.com/de/loesungen/fill-and-finish/verbesserte-herstellungsprozesse-mit-sterilen-loesungen/whitepaper-standardisierte-verpackung): - [Whitepaper Das perfekte Match finden I SCHOTT Pharma](https://www.schott-pharma.com/de/loesungen/fill-and-finish/verbesserte-herstellungsprozesse-mit-sterilen-loesungen/whitepaper-das-perfekte-match-finden): - [Minderung des Kontaminationsrisikos | SCHOTT Pharma](https://www.schott-pharma.com/de/loesungen/fill-and-finish/minderung-kontaminationsrisiko): Die aseptischen Abfülllösungen von SCHOTT Pharma bieten Sterilität auf höchstem Niveau, verbessern die Sicherheit und mindern das Kontaminationsrisiko - [Fill-and-Finish Lösungen | SCHOTT Pharma](https://www.schott-pharma.com/de/loesungen/fill-and-finish/fill-finish-effizienz): SCHOTT Pharma's Fill-and-Finish Lösungen für Abfüll- und Fertigstellungslinien hilft Unternehmen dabei, Ausfallzeiten von Maschinen und Ausschussraten von Produkten zu minimieren - [Track&Trace-Lösungen | SCHOTT Pharma](https://www.schott-pharma.com/de/loesungen/fill-and-finish/track-and-trace-individuelle-container): Verfolgen Sie Ihren lasermarkierten Arzneimittelcontainer von der Produktion bis zum Endverbraucher und verlassen Sie sich auf die Rückverfolgbarkeit entlang der Lieferkette. - [Glasdelamination unter Kontrolle | SCHOTT Pharma](https://www.schott-pharma.com/de/loesungen/perfect-fit/delamination-kontrolle): SCHOTT Pharma legt konkrete Schritte fest, mit denen Pharma-Unternehmen das Risiko einer Glasdelamination minimieren können. - [Pharma Herstellungsprozesse optimieren | SCHOTT Pharma](https://www.schott-pharma.com/de/loesungen/fill-and-finish/verbesserte-herstellungsprozesse-mit-sterilen-loesungen): Optimieren Sie Ihre Herstellungsprozesse mit der adaptiQ® RTU Plattform, für erhöhte Geschwindigkeit & Kosteneinsparungen für Fill-and-Finish Anlagen! - [Biologika und Biosimilars – von der Forschung bis zur regulatorischen Compliance | SCHOTT Pharma](https://www.schott-pharma.com/de/loesungen/biologics-biosimilars): Biologika und Biosimilars stellen neue Herausforderungen dar: Erfahren Sie, wie Sie diese von der Forschung zu Primärverpackungslösungen bis hin zur Einhaltung regulatorischer Anforderungen erfolgreich auf den Markt bringen. - [Antikörper-Wirkstoff-Konjugate Verpackung | SCHOTT Pharma](https://www.schott-pharma.com/de/loesungen/antibody-drug-conjugates): Bewältigen Sie die Herausforderungen bei Antikörper-Wirkstoff-Konjugaten (ADCs) mit Verpackungen, die die biologische Stabilität gewährleisten, lyophilisierte Formulierungen unterstützen und die ADC-Integrität aufrechterhalten - [Verpackung für kleine Chargen | SCHOTT Pharma](https://www.schott-pharma.com/de/loesungen/fill-and-finish/verpackungsloesungen-kleine-chargen): Die Verpackung für kleine Chargen von SCHOTT Pharma gewährleistet zuverlässigen Produktschutz und optimale sterile Sicherheit von Anfang an. - [EVERIC® Fläschchen | SCHOTT Pharma](https://www.schott-pharma.com/de/loesungen/perfect-fit/everic-vial-solutions): Die EVERIC® Fläschchen von SCHOTT Pharma bieten ein flexibles, modulares Design, das die Anforderungen von Herstellern und Anwendern für eine optimierte Leistung verbindet. - [Optimiertes Polymer-Spritzennest-Design | SCHOTT Pharma](https://www.schott-pharma.com/de/loesungen/fill-and-finish/optimized-polymer-syringe-nest-design): Das neue Nest- und Tub-System von SCHOTT Pharma ist das weltweit erste, das 160 Polymerspritzen aufnimmt, wodurch die Zykluszeit und die Kosten reduziert und gleichzeitig die Effizienz Ihrer Hochgeschwindigkeits-Fill-and-Finish-Anlagen erhöht werden. - [Integration von cartriQ® in großvolumige SC-Injektionen](https://www.schott-pharma.com/de/loesungen/safe-and-easy-administration/large-volume-injections-biologics/cartriq-integration-sterile-large-volume): Die Integration von cartriQ® ermöglicht eine sichere und stabile subkutane Verabreichung großvolumiger Biologika und unterstützt eine patientenfreundliche Anwendung zu Hause. - [Großvolumige Biologika | SCHOTT Pharma](https://www.schott-pharma.com/de/loesungen/safe-and-easy-administration/large-volume-injections-biologics): SCHOTT Pharma bietet ein Sortiment an Primärverpackungslösungen für Pen-Injektoren, Autoinjektoren, On-Body-Delivery-Systeme und Infusionspumpen. - [Arzneimittel-Aufbewahrungslösungen für Biotech-Arzneimittelentwickler | SCHOTT Pharma](https://www.schott-pharma.com/de/loesungen/perfect-fit/wechselwirkung-arzneimittel-container-biotech): Glasfläschchen und -spritzen von SCHOTT bieten Biotech- und Biologika-Unternehmen bei der Entwicklung neuer Arzneimittel zahlreiche Vorteile - [mRNA-Technologie I Verpackung I Niedrige Temperaturen I Spritzen I Fläschchen | SCHOTT Pharma](https://www.schott-pharma.com/de/loesungen/perfect-fit/lagerung-mrna-arzeimittel): Fläschchen- und Spritzenportfolio um technische Probleme wie Kolbenbewegung, Container Closure Integrity des Behälters oder Sterilität bei mRNA mit niedrigen Temperaturen zu adressieren. - [Verpackungslösungen Adipositas-Behandlung | SCHOTT Pharma](https://www.schott-pharma.com/de/loesungen/safe-and-easy-administration/adipositas-behandlung): Entdecken Sie die Lösungen zur Aufbewahrung und Verabreichung von Medikamenten für die GLP-1-basierte Adipositas-Behandlung. Mehr erfahren! - [Vorbereitung der Arzneimitteleinreichung | SCHOTT Pharma](https://www.schott-pharma.com/de/loesungen/perfect-fit/vorbereitung-arzneimitteleinreichung): SCHOTT Pharma bietet Prüfservice für pharmazeutische Verpackungen, um Compliance und Patientensicherheit zu gewährleisten. Jetzt mehr erfahren! - [Geringe Füllmengen | SCHOTT Pharma](https://www.schott-pharma.com/de/loesungen/perfect-fit/medikamenten-stabilitaet-geringe-fuellmenge): Erfahren Sie, wie Sie mit SCHOTT Pharma Services das Auslaugungsrisiko für Ihre empfindlichen Arzneimittel mit geringer Füllmenge reduzieren können. - [USP <382> Functional Testing Solutions | SCHOTT Pharma](https://www.schott-pharma.com/de/loesungen/perfect-fit/usp-382): Rigorous USP <382> testing for fully assembled drug‑filled systems, from package integrity and CCI checks to fragmentation analysis - [Verpackungslösungen Diabetes-Behandlung | SCHOTT Pharma ](https://www.schott-pharma.com/de/loesungen/safe-and-easy-administration/diabetes-behandlung): Entdecken Sie eine Reihe von Lösungen zur Aufbewahrung und Verabreichung von Medikamenten für die GLP-1-basierte Diabetes-Behandlung! - [Lösungen | SCHOTT Pharma](https://www.schott-pharma.com/de/loesungen): Erfahren Sie mehr über die hochwertigen Lösungen von SCHOTT Pharma für die Medikamentenaufbewahrung und -verabreichung für Pharmaunternehmen, Biotechs und CDMOs. ## Fachwissen | Die Pharma-Expertise-Seite von SCHOTT Pharma präsentiert ihr umfassendes Branchenwissen in den Bereichen Arzneimittelaufbewahrung, Verabreichungssysteme, regulatorische Unterstützung und Herstellungsoptimierung und bietet Einblicke, Best Practices sowie Expertenrat, um Partner bei der Bewältigung komplexer Herausforderungen in der Pharma- und Biotechnologiebranche zu unterstützen. - [Glossar | SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-expertise/information-center/glossar): Das Glossar von SCHOTT Pharma enthält die wichtigsten Schlüsselbegriffe, Akronyme und die allgemeine Terminologie, die in der pharmazeutischen Verpackungsindustrie verwendet wird. - [Expertise | SCHOTT Pharma ](https://www.schott-pharma.com/de/pharma-expertise): Das gesamte Spektrum an Ressourcen und Wissen, das Unternehmen und Einzelpersonen für Lösungen zur Medikamentenaufbewahrung und -verabreichung von Medikamenten zur Verfügung steht ## SCHOTT Pharmaversity® | Die SCHOTT Pharmaversity-Seite von SCHOTT Pharma präsentiert Bildungsangebote, Trainingsprogramme und Expertenwissen für Fachkräfte aus der Pharma- und Biotech-Branche, die darauf ausgerichtet sind, Fähigkeiten zu entwickeln, Branchenkenntnisse zu vertiefen und Best Practices bei der Verpackung und Verabreichung von Arzneimitteln zu fördern. - [Pharmaversity® | Pharma-Schulung](https://www.schott-pharma.com/de/pharma-expertise/schott-pharmaversity): Für wertvolle Einblicke in Branchenthemen besuchen Sie die Pharmaversity®, um Ihre pharmazeutische Weiterbildung mit Unterstützung führender Glas- und Polymerexperten zu erweitern. ## SCHOTT Pharma Wissenszentrum | Die Knowledge Hub-Seite von SCHOTT Pharma bietet Experteneinblicke, technische Artikel, Whitepaper und Branchenressourcen, um Pharma- und Biotech-Fachleute mit Best Practices, Trends, Daten und umfassendem Wissen zu Themen der Medikamentenaufbewahrung, -verabreichung und regulatorischen Fragestellungen zu unterstützen. - [Großvolumige subkutane Verabreichungslösungen für Medikamente](https://www.schott-pharma.com/de/pharma-expertise/schott-pharmaversity/webinars/vereinfachung-der-subkutanen-verabreichung-grossvolumiger-arzneimittel): Erfahren Sie, wie SCHOTT TOPPAC® Spritzen und KRU-Geräte die großvolumige subkutane Verabreichung von Medikamenten vereinfachen, die Benutzererfahrung verbessern und die Markteinführungszeit verkürzen. ## SCHOTT Pharma Blogs - [Container Closure Integrity (CCI) | SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-expertise/information-center/blog/container-closure-integrity): Entdecken Sie, wie die perfekte Kombination aus Fläschchen, Stopfen und Dichtung eine robuste Behälterverschlussintegrität sichert, Pop-up/Pop-off verhindert und die Effizienz von Fill-and-Finish-Prozessen steigert. - [Paradigmenwechsel in der Geräteentwicklung I SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-expertise/information-center/blog/paradigmen-wechsel-device-entwicklung): Tom van Ginneken spricht über die Vorteile von Polymer als perfekte Lösung für individualisierte Behälter. - [Entscheidende Vorteile intelligenter Primärverpackungsbehälter | SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-expertise/information-center/blog/advantages-smart-primary-packaging): Die Smart Container von SCHOTT Pharma sind mit einem einzigartigen Code lasergekennzeichnet, um eine hohe Rückverfolgbarkeit während des gesamten Abfüll- und Endverarbeitungsprozesses zu gewährleisten. - [Was ist die Prüfung der Containerverschluss-Integrität? | SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-expertise/information-center/blog/what-is-container-closure-integrity-testing): Die Sicherstellung der Integrität von Containerverschlüssen und des Containers selbst ist unerlässlich, um eine sterile Barriere gegenüber potenziellen Verunreinigungen zu gewährleisten und das Risiko von Leckagen zu eliminieren. Dieser Artikel bietet einen Überblick über die Integritätsprüfung von Containerverschlüssen (CCIT) und erläutert, warum sie von entscheidender Bedeutung ist. - [Biosimilars und Generika | SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-expertise/information-center/blog/biosimilars-generics): Wichtige Branchentrends und die Vorteile der Auswahl der richtigen Primärverpackung in einer sich wandelnden Pharmalandschaft - [SCHOTT Pharma definiert die Gesundheitsversorgung neu](https://www.schott-pharma.com/de/pharma-expertise/information-center/blog/redefining-healthcare-the-power-of-large-volume-sterile-cartridges): Neudefinition des Gesundheitswesens durch großvolumige, sterile Karpulen, die eine einfachere und kosteneffiziente subkutane Medikamentenverabreichung sowie die Selbstverabreichung zu Hause ermöglichen. - [Warum klinische Studien scheitern | SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-expertise/information-center/blog/why-clinical-trials-fail): Die häufigsten Fallstricke und zentralen Herausforderungen klinischer Studien und wie die richtige Verpackungswahl Risiken mindern und die Erfolgsraten erhöhen kann - [Fläschchen als Plattform | SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-expertise/information-center/blog/drug-development-efficiency-vial-as-platform): Wie vorgetestete Verpackungslösungen wie Vial als Plattform die Effizienz der Arzneimittelentwicklung steigern und die Produktionssicherheit erhöhen - [Diversity & Inclusion bei SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-expertise/information-center/blog/diversity-and-inclusion-at-schott-pharma): Diversity & Inclusion ist bei SCHOTT Pharma der Schlüssel zum Unternehmenserfolg und der Motor für engagierte Teams. - [Gefälschte Arzneimittel | SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-expertise/information-center/blog/counterfeit-drugs-protecting-patients): SCHOTT Pharma stellt mit Ampoules AC die Gesundheit der Patienten in den Mittelpunkt! Erfahren Sie, wie Sie Patienten vor gefälschten Arzneimitteln schützen können. - [Visuelle Inspektionssysteme | Schott Pharma](https://www.schott-pharma.com/de/pharma-expertise/information-center/blog/container-quality-automated-visual-inspection-systems): Steigerung der Qualität von Arzneimittelbehältern durch automatisierte visuelle Inspektionssysteme - [Wie RTU-Container die Zeit bis zur Markteinführung verkürzen](https://www.schott-pharma.com/de/pharma-expertise/information-center/blog/wie-rtu-container-die-markteinführungszeit-verkürzen): Erfahren Sie, wie RTU-Container die Markteinführungszeit verkürzen, den Cashflow und die Patentlaufzeit erhöhen und gleichzeitig eine überlegene Qualität gewährleisten. - [Pharmazeutisches Produktdesign: Sicher für Patienten, nachhaltig für den Planeten I SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-expertise/information-center/blog/pharmaceutical-product-design): Entdecken Sie, wie SCHOTT Pharma Ökodesign integriert, um pharmazeutische Produkte zu schaffen, die die Patientensicherheit gewährleisten und die ökologische Nachhaltigkeit fördern. Informieren Sie sich über unser Engagement für Klimaneutralität bis 2030. - [So wählen Sie die optimalen Ampullen für Ihre Abfülllinie aus | SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-expertise/information-center/blog/how-to-choose-the-best-ampoules-for-your-filling-line): Entdecken Sie, wie Sie die optimalen Ampullen für Ihre Abfüllanlage auswählen. Verschaffen Sie sich einen Überblick über die verschiedenen Ampullenformen und deren Eignung für unterschiedliche Typen von Fill-and-Finish-Maschinen. - [Bestes Ampullen-Break-System | SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-expertise/information-center/blog/bruchsysteme-fuer-ampullen): Lesen Sie den Blogartikel von Schott Pharma und erfahren Sie, wie Sie das beste Break-System für Ihre Ampulle auswählen! - [Snap-on-Fläschchen | SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-expertise/information-center/blog/snap-on-vials): SCHOTT Pharma stellt Snap-on-Fläschchen aus hochwertigem FIOLAX®-Glasrohr her, die eine hervorragende Kompatibilität mit verschiedenen Komponenten in pharmazeutischen Anwendungen bieten. - [Wie Ampullen zur weltweit beliebtesten Primärverpackung für Arzneimittel wurden | SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-expertise/information-center/blog/wie-ampullen-zur-weltweit-beliebtesten-primaerverpackung-fuer-arzneimittel-wurden): SCHOTT Pharma erläutert, wie sich Ampullen von einem Behälter für Blut aus dem 3. Jahrhundert zur weltweit beliebtesten Primärverpackung für Arzneimittel entwickelt haben - [Optimierung von Fill-and-Finish mit RTU-Verpackungen I SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-expertise/information-center/blog/optimierung-von-fill-and-finish-prozessen-mit-sterilen-loesungen-zur-medikamentenaufbewahrung): Entdecken Sie, wie RTU-Verpackungen Fill-and-Finish-Prozesse optimieren, die Komplexität der Wertschöpfungskette reduzieren, die Patientensicherheit gewährleisten und die Markteinführungszeit beschleunigen. - [Pharmazeutische Standards für Glas – Spezielle Prüfstrategien](https://www.schott-pharma.com/de/pharma-expertise/information-center/blog/neue-standards-pharmaglas-testspezifische-strategien): Das US Pharmacopeia zielt darauf ab, zusätzliche Flexibilität bei den Anforderungen an Verpackung und Lagerung zu schaffen. Erfahren Sie mehr über die Herausforderungen beim Testen von Strategien. - [Was ist ein Fläschchen und wie wählt man das richtige aus? SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-expertise/information-center/blog/was-ist-ein-flaeschchen): Was ist ein Fläschchen? Erfahren Sie mehr über die Komponenten, Typen und pharmazeutischen Anwendungen eines Fläschchens sowie die Auswahl des richtigen Fläschchens - [Geschlossener Recyclingkreislauf | Pharmazeutische Verpackung](https://www.schott-pharma.com/de/pharma-expertise/information-center/blog/closed-loop-recycling-initiative): Entdecken Sie, wie Closed-Loop-Recycling bei pharmazeutischen Transportverpackungen den Bedarf an Neukunststoff reduzieren kann. - [Senkung der Gesamtbetriebskosten mit RTU-Verpackungen I SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-expertise/information-center/blog/senkung-der-gesamtbetriebskosten-durch-rtu-verpackungen): Entdecken Sie, wie RTU-Glasfläschchen (wie adaptiQ® von SCHOTT Pharma) die Gesamtbetriebskosten senken, die Arzneimittelstabilität verbessern und die Produktqualität in der Pharmaindustrie steigern. - [5 Schritte zur Partikelreduzierung bei RTU-Verpackungen in der Pharmaindustrie](https://www.schott-pharma.com/de/pharma-expertise/information-center/blog/5-schritte-zur-partikelreduzierung-in-rtu-verpackungen): Stellen Sie die Partikelreduzierung von RTU-Verpackungen und die Einhaltung von GMP Annex I mit unserem Leitfaden zur effektiven Reduzierung der Partikelkontamination sicher. - [Der Weg zu Netto-Null-Injektionsgeräten | SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-expertise/information-center/blog/entwicklung-eines-weges-zu-netto-null-injektionsgeräten): Wir bei SCHOTT Pharma glauben, dass Produkte mit Netto-Null-Emissionen eine solide branchenübergreifende Zusammenarbeit erfordern. - [Innovative Primärverpackungslösungen für Bayer | SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-expertise/information-center/blog/primaerverpackungsloesung-bayer): Die strategische Partnerschaft mit SCHOTT Pharma ermöglicht es Bayer, Biotech-Medikamente mit innovativen Primärverpackungslösungen sicherer und schneller zu vermarkten. - [Wofür wird eine vorgefüllte Glasspritze verwendet? | SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-expertise/information-center/blog/verwendung-vorgefuellte-glasspritze): Von Impfstoffen bis zu Langzeittherapien für chronische Erkrankungen – vorgefüllte Glasspritzen finden in zahlreichen Anwendungen und Bereichen Verwendung. - [Validierung und Aufrechterhaltung der Sterilität in RTU-Verpackungen | SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-expertise/information-center/blog/rtu-sterilitaet-validieren): Erfahren Sie mehr über die Sterilisation pharmazeutischer Verpackungen und wie die Sterilität eines Objekts mit dem Sterility Assurance Level (SAL) für ready-to-use (RTU) Container quantifiziert wird. - [Sterilität in RTU-Pharmaverpackungen | SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-expertise/information-center/blog/sterilitaet-in-rtu-verpackungen): Um streng regulierte Sterilitätsgrade zu gewährleisten, können im Bereich der RTU-Pharmaverpackung verschiedene Technologien eingesetzt werden. - [Wie können pharmazeutische Primärverpackungen die Stabilität von Arzneimitteln verbessern?](https://www.schott-pharma.com/de/pharma-expertise/information-center/blog/medikamenten-stabilitaet): Arzneimittelbehälter und Pharmaglas schützen Biologika und gewährleisten die Stabilität von Arzneimitteln. - [Extractable Studien erläutert I SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-expertise/information-center/blog/was-sind-extractable-studien): Extractable Studien werden zur Identifizierung und Analyse potenziell schädlicher Substanzen eingesetzt. Dieser Artikel konzentriert sich auf Extractable Studien und ihre Rolle in der Pharmaindustrie - [Wie mRNA-Medikamente die pharmazeutischen Primärverpackungen verändern I SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-expertise/information-center/blog/mrna-medikamente-veraendern-pharmazeutische-primaerverpackungen): Dieser Artikel befasst sich mit den Überlegungen, die die pharmazeutische Primärverpackung in einer neuen Ära der mRNA-Medikamentenlösungen beeinflussen. - [Umstellung von mRNA-Impfstoffen gegen Covid-19 von Fläschchen auf vorfüllbare Spritzen | SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-expertise/information-center/blog/von-fläschchen-zur-vorfüllbaren-spritze-mrna): Im Zuge der Coronapandemie untersucht SCHOTT Pharma, ob vorfüllbare Spritzen sich besser als Impfstoffbehälter eignen als Mehrdosenfläschchen. - [Lösungen für die Herausforderungen der Biotech-Medikamentenaufbewahrung mit Fläschchen | SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-expertise/information-center/blog/loesen-biotech-medikamente-herausforderungen): Die Zunahme pharmazeutischer Formulierungen stellt eine Herausforderung dar, doch SCHOTT EVERIC® erfüllt die Nachfrage bei Abfüllung und Handhabung. - [Blog I SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-expertise/information-center/blog): Discover trends and general background information about SCHOTT Pharma products and services, and the pharmaceutical packaging industry. ## SCHOTT Pharma Academy/Veranstaltungen/Zertifikate | Die Pharma-Expertise-Ressourcen von SCHOTT Pharma umfassen Bildungsprogramme, Veranstaltungen und Trainings über die Pharmaversity Academy sowie Zugang zu Zertifikaten und Brancheninformationen, die Pharma- und Biotech-Partner dabei unterstützen, Wissen, Fähigkeiten und regulatorische Kompetenz zu entwickeln. - [Zertifikate | SCHOTT Pharma](https://www.schott-pharma.com/de/pharma-expertise/information-center/zertifikate): Laden Sie SCHOTT Pharma Zertifikate und Dokumentationen zu zertifizierten Anlagen herunter. Erfahren Sie geprüfte Qualität – jetzt klicken! ## SCHOTT Pharma Über uns | Die „Über uns“-Seite von SCHOTT Pharma stellt die Mission, Werte und Geschichte des Unternehmens in den Mittelpunkt und betont dessen Rolle bei der Medikamentenaufbewahrung und -verabreichung, das Engagement für Qualität und Innovation, die globale Präsenz sowie die Unterstützung von Pharma- und Biotech-Partnern zur Verbesserung der Gesundheitsversorgung. - [Weil Gesundheit entscheidend ist | SCHOTT Pharma](https://www.schott-pharma.com/de/ueber-uns/because-human-health-matters): Gemeinsam mit Ihnen – unseren Kunden und Partnern – bemühen wir uns um das beste Patientenerlebnis. Aus einem einfachen Grund: Weil Gesundheit entscheidend ist. - [Über uns | pharmazeutische Produkte von SCHOTT Pharma](https://www.schott-pharma.com/de/ueber-uns): Als weltweit führendes Unternehmen für pharmazeutische Produkte entwickeln wir Medikamenten-Verpackungen für sichere und einfache Verabreichung. ## SCHOTT Pharma Pressemitteilungen | Die News- und Media-Seite von SCHOTT Pharma präsentiert die neuesten Pressemitteilungen, Unternehmensupdates, Finanzergebnisse, Veranstaltungen sowie Branchenankündigungen zu Innovationen, Expansionen, Partnerschaften und Leistungen und hält die Akteure der Pharma- und Biotech-Branche über aktuelle Entwicklungen informiert. - [Messen und Veranstaltungen | SCHOTT Pharma](https://www.schott-pharma.com/de/news-and-media/messen-und-events): Das gesamte Spektrum der Fachveranstaltungen, Messen und Konferenzen, die von SCHOTT Pharma präsentiert werden - [Pressemappen | SCHOTT Pharma](https://www.schott-pharma.com/de/news-and-media/media-kits): Alle Pressemappen von SCHOTT Pharma finden Sie hier - [Kontaktformular News and Media | SCHOTT Pharma](https://www.schott-pharma.com/de/news-and-media/bildanfrage): Kontaktieren Sie unser SCHOTT Pharma News & Media Team - [Ansprechpartner News and Media | SCHOTT Pharma](https://www.schott-pharma.com/de/news-and-media/kontakte): Kontaktdaten des SCHOTT Pharma News- and Mediateams - [SCHOTT und die ungarische Regierung investieren in hochmoderne Spritzenproduktion | SCHOTT](https://www.schott-pharma.com/de/news-and-media/media-releases/2022/schott-und-die-ungarische-regierung-investieren-in-hochmoderne-spritzenproduktion): SCHOTT hat 76 Millionen Euro in eine neue Produktionsanlage in Lukácsháza, Ungarn, investiert, um die weltweite Nachfrage nach vorfüllbaren Glasspritzen zu decken - [PRESSEINFO | Hallo SDAX! SCHOTT Pharma erreicht nächsten Meilenstein als börsennotiertes Unternehmen](https://www.schott-pharma.com/de/news-and-media/media-releases/2023/schott-pharma-erreicht-naechsten-meilenstein-als-boersennotiertes-unternehmen): Hallo SDAX! SCHOTT Pharma erreicht nächsten Meilenstein als börsennotiertes Unternehmen | PRESSEINFO - [PRESSEMELDUNG | Auf Erfolgskurs: SCHOTT Pharma wächst weiterhin stark im ersten Halbjahr des Geschäftsjahres 2023](https://www.schott-pharma.com/de/news-and-media/media-releases/2023/auf-erfolgskurs-schott-pharma-waechst-weiterhin-stark-im-ersten-halbjahr-des-geschaeftsjahres-2023): Auf Erfolgskurs: SCHOTT Pharma wächst weiterhin stark im ersten Halbjahr des Geschäftsjahres 2023 | PRESSEMELDUNG - [SCHOTT Pharma plant Ausbau der Karpulenproduktion | SCHOTT](https://www.schott-pharma.com/de/news-and-media/media-releases/2022/schott-pharma-baut-produktion-fuer-karpulen-in-china-und-ungarn-aus): Zweistellige Millioneninvestition von SCHOTT Pharma erhöht die Produktionskapazität für pharmazeutische Karpulen in Ungarn und China erheblich - [PRESSEINFO: SCHOTT bestellt Aufsichtsrat der SCHOTT Pharma AG & Co. KGaA | SCHOTT](https://www.schott-pharma.com/de/news-and-media/media-releases/2023/schott-bestellt-aufsichtsrat-der-schott-pharma-ag-und-co-kg): SCHOTT bestellt Aufsichtsrat der SCHOTT Pharma AG & Co. KGaA - [Pressemitteilungen | SCHOTT Pharma](https://www.schott-pharma.com/de/news-and-media/media-releases): Die neuesten Pressemitteilungen von SCHOTT Pharma - [Serum Institute of India steigt bei SCHOTT Kaisha ein](https://www.schott-pharma.com/de/news-and-media/media-releases/2021/schott-and-serum-institute-of-india-announce-joint-venture-for-pharmaceutical-packaging): Medienmitteilung: Announcement Joint Venture for Pharmaceutical Packaging SCHOTT and Serum Institute of India - [PRESSE INFO | SCHOTT Pharma erreicht Jahresziele direkt nach Börsengang: Starkes profitables Wachstum für das Geschäftsjahr am oberen Ende der Prognose](https://www.schott-pharma.com/de/news-and-media/media-releases/2023/schott-pharma-erreicht-jahresziele-direkt-nach-boersengang): SCHOTT Pharma erreicht Jahresziele direkt nach Börsengang: Starkes profitables Wachstum für das Geschäftsjahr am oberen Ende der Prognose | PRESSE INFO - [Media Release | SCHOTT establishes stand-alone company for its pharma business to promote further growth](https://www.schott-pharma.com/de/news-and-media/media-releases/2022/schott-gruendet-eigene-gesellschaft-fuer-pharma-geschaeft): SCHOTT establishes stand-alone company for its pharma business to promote further growth | Media Release - [Presseinfo | GLP-1-Medikamente, Insulin und großvolumige Injektionen mit vorsterilisierten Karpulen von SCHOTT Pharma sicher aufbewahren](https://www.schott-pharma.com/de/news-and-media/media-releases/2023/glp-1-medikamente-insulin-und-grossvolumige-injektionen-mit-vorsterilisierten-karpulen-von-schott-pharma-sicher-aufbewahren): GLP-1-Medikamente, Insulin und großvolumige Injektionen mit vorsterilisierten Karpulen von SCHOTT Pharma sicher aufbewahren | Presseinfo - [PRESSEINFO | Erstes Jahr als eigenständiges Unternehmen: SCHOTT Pharma stärkt führende Position](https://www.schott-pharma.com/de/news-and-media/media-releases/2023/erstes-jahr-als-eigenstaendiges-unternehmen-schott-pharma-staerkt-fuehrende-position): Nach dem ersten Jahr als eigenständiges Unternehmen sieht Andreas Reisse SCHOTT Pharma bestens positioniert, um von den langfristigen Markttrends zu profitieren. SCHOTT Pharma stärkt führende Position im ersten Jahr als eigenständiges Unternehmen - [PRESSEINFO: Bis zu -100 °C: Neue Polymerspritzen von SCHOTT Pharma bewahren tiefgekühlte Medikamente sicher auf | SCHOTT](https://www.schott-pharma.com/de/news-and-media/media-releases/2023/neue-polymerspritzen-bewahren-tiefgekuehlte-medikamente-sicher-auf): Bis zu -100 °C: Neue Polymerspritzen von SCHOTT Pharma bewahren tiefgekühlte Medikamente sicher auf - [ PRESSEINFO | Verpackungsrecycling ohne Kompromisse bei der Patientensicherheit: SCHOTT Pharma, Corplex und Takeda demonstrieren Recycling im geschlossenen Kreislauf ](https://www.schott-pharma.com/de/news-and-media/media-releases/2024/schott-pharma-corplex-and-takeda-demonstrieren-recycling-im-geschlossenen-kreislauf): Verpackungsrecycling ohne Kompromisse bei der Patientensicherheit: SCHOTT Pharma, Corplex und Takeda demonstrieren Recycling im geschlossenen Kreislauf | PRESSEINFO - [PRESSEINFO | SCHOTT Pharma erreicht starkes Wachstum und Rekordmarge nach gutem Jahresendspurt ](https://www.schott-pharma.com/de/news-and-media/media-releases/2024/schott-pharma-erreicht-starkes-wachstum-und-rekordmarge-nach-gutem-jahresendspurt): SCHOTT Pharma erreicht starkes Wachstum und Rekordmarge nach gutem Jahresendspurt | PRESSEINFO - [PRESSEINFO | SCHOTT Pharma erzielt starke Ergebnisse im dritten Quartal und erhöht Umsatzprognose für das Geschäftsjahr 2024 ](https://www.schott-pharma.com/de/news-and-media/media-releases/2024/schott-pharma-erzielt-starke-ergebnisse-im-dritten-quartal-und-erhoeht-umsatzprognose-fuer-das-geschaeftsjahr-2024): SCHOTT Pharma erzielt starke Ergebnisse im dritten Quartal und erhöht Umsatzprognose für das Geschäftsjahr 2024 | PRESSEINFO - [PRESSEINFO | Effizient und nachhaltig: SCHOTT Pharma führt neues Nestdesign mit erhöhter Anzahl an vorfüllbaren Polymerspritzen ein](https://www.schott-pharma.com/de/news-and-media/media-releases/2024/schott-pharma-fuehrt-neues-nestdesign-mit-erhoehter-anzahl-an-vorfuellbaren-polymerspritzen-ein): Effizient und nachhaltig: SCHOTT Pharma führt neues Nestdesign mit erhöhter Anzahl an vorfüllbaren Polymerspritzen ein | PRESSEINFO - [PRESSEINFORMATION | SCHOTT Pharma bestätigt Prognose für das Geschäftsjahr 2024 anlässlich seiner Q2-Ergebnisse](https://www.schott-pharma.com/de/news-and-media/media-releases/2024/schott-pharma-prognose-geschaeftsjahr-2024-anlaesslich-q2-ergebnisse): SCHOTT Pharma bestätigt Prognose für das Geschäftsjahr 2024 anlässlich seiner Q2-Ergebnisse | PRESSEINFORMATION - [SCHOTT bringt iQ® Integribag auf den Markt | SCHOTT](https://www.schott-pharma.com/de/news-and-media/media-releases/2022/schott-führt-iq-integribag-ein): Die berührungslose Transferlösung von SCHOTT für gebrauchsfertige Lösungen zur Eindämmung von Pharmazeutika und zur Arzneimittelabgabe bietet eine neue Dimension der sterilen Integrität - [PRESSEMITTEILUNG | SCHOTT Pharma, Takeda und Corplex haben die erste vollständige Lieferung von Fläschchen in Trays aus recyceltem Material abgeschlossen. Bild: SCHOTT Pharma ](https://www.schott-pharma.com/de/news-and-media/media-releases/2026/schott-pharma-takeda-und-corplex-setzen-kreislaufloesung-fuer-pharmazeutische-trays-im-betriebsablauf-ein): SCHOTT Pharma, Takeda und Corplex haben die erste vollständige Lieferung von Fläschchen in Trays aus recyceltem Material abgeschlossen. Bild: SCHOTT Pharma | PRESSEMITTEILUNG - [PRESSEINFO | Effizient und nachhaltig: SCHOTT Pharma präsentiert innovatives Nestdesign für vorsterilisierte Karpulen](https://www.schott-pharma.com/de/news-and-media/media-releases/2024/schott-pharma-praesentiert-innovatives-nestdesign-fuer-vorsterilisierte-karpulen): Effizient und nachhaltig: SCHOTT Pharma präsentiert innovatives Nestdesign für vorsterilisierte Karpulen | PRESSEINFO - [PRESSEINFO | SCHOTT Pharma startet positiv ins Geschäftsjahr 2026 und bestätigt Prognose](https://www.schott-pharma.com/de/news-and-media/media-releases/2026/schott-pharma-startet-positiv-ins-geschaeftsjahr-2026-und-bestaetigt-prognose): SCHOTT Pharma startet positiv ins Geschäftsjahr 2026 und bestätigt Prognose | PRESSEINFO - [PRESSEINFO | SCHOTT Pharma und Nemera bieten verifizierte Pen‑Injektor-Plattform mit sterilem Karpulensystem](https://www.schott-pharma.com/de/news-and-media/media-releases/2026/schott-pharma-und-nemera-bieten-verifizierte-pen‑injektor-plattform-mit-sterilem-karpulensystem): SCHOTT Pharma und Nemera bieten verifizierte Pen‑Injektor-Plattform mit sterilem Karpulensystem | PRESSEINFO - [PRESSEINFO | Partnerschaft von SCHOTT Pharma und KORU Medical zur Optimierung der großvolumigen subkutanen Infusion](https://www.schott-pharma.com/de/news-and-media/media-releases/2024/partnerschaft-von-schott-pharma-und-koru-medical-zur-optimierung-der-grossvolumigen-subkutanen-infusion): Subkutane Verabreichung von Medikamenten vereinfachen: Partnerschaft von SCHOTT Pharma und KORU Medical zur Optimierung der großvolumigen subkutanen Infusion | PRESSEINFO - [PRESSEINFO | Abfall und CO2-Fußabdruck reduzieren: SCHOTT Pharma stellt Konzept für Spritzen ohne Blisterverpackung vor ](https://www.schott-pharma.com/de/news-and-media/media-releases/2024/schott-pharma-stellt-konzept-fuer-spritzen-ohne-blisterverpackung-vor): Abfall und CO2-Fußabdruck reduzieren: SCHOTT Pharma stellt Konzept für Spritzen ohne Blisterverpackung vor | PRESSEINFO - [SCHOTT eröffnet neue Anlage für vorfüllbare Spritzen am neuen deutschen Standort | SCHOTT](https://www.schott-pharma.com/de/news-and-media/media-releases/2022/schott-weiht-neues-werk-fuer-vorfuellbare-polymerspritzen-ein): PRESSEINFORMATION: Der internationale Technologiekonzern investiert einen dreistelligen Millionenbetrag in sein Werk in Müllheim, Deutschland, um die Produktion von vorfüllbaren Polymerspritzen zu erweitern - [PRESSEINFORMATION | Nachhaltige Lieferkette: SCHOTT Pharma startet nächste Phase des Dekarbonisierungsprogramms](https://www.schott-pharma.com/de/news-and-media/media-releases/2024/schott-pharma-startet-naechste-phase-des-dekarbonisierungsprogramms): Nachhaltige Lieferkette: SCHOTT Pharma startet nächste Phase des Dekarbonisierungsprogramms | PRESSEINFORMATION - [PRESSEINFO | Erfolgreiche Hauptversammlung für SCHOTT Pharma: Alle Beschlussvorschläge angenommen](https://www.schott-pharma.com/de/news-and-media/media-releases/2026/erfolgreiche-hauptversammlung-fuer-schott-pharma-alle-beschlussvorschlaege-angenommen): Erfolgreiche Hauptversammlung für SCHOTT Pharma: Alle Beschlussvorschläge angenommen | PRESSEINFO - [PRESSEINFO | SCHOTT Pharma, Gerresheimer und die Stevanato Group geben strategische Industrieallianz für RTU bekannt, um die Einführung von Ready-to-Use-Lösungen im Markt voranzutreiben](https://www.schott-pharma.com/de/news-and-media/media-releases/2024/schott-pharma-gerresheimer-und-stevanato-group-schliessen-strategische-allianz-fuer-rtu): SCHOTT Pharma, Gerresheimer und die Stevanato Group geben strategische Industrieallianz für RTU bekannt, um die Einführung von Ready-to-Use-Lösungen im Markt voranzutreiben | PRESSEINFO - [PRESSEMITTEILUNG | Schutz von Medikamenten bei Tiefkühltemperaturen: SCHOTT Pharma präsentiert neue Fläschchen für mRNA- und Gentherapie](https://www.schott-pharma.com/de/news-and-media/media-releases/2024/schott-pharma-launches-new-vials-for-mrna-and-gene-therapy): Schutz von Medikamenten bei Tiefkühltemperaturen: SCHOTT Pharma präsentiert neue Fläschchen für mRNA- und Gentherapie auf dem Markt | PRESSEMITTEILUNG - [PRESSEINFO | SCHOTT Pharma erreicht Jahresziele für 2023 und setzt profitablen Wachstumskurs fort](https://www.schott-pharma.com/de/news-and-media/media-releases/2024/schott-pharma-erreicht-jahresziele-fuer-2023-und-setzt-profitablen-wachstumskurs-fort): SCHOTT Pharma erreicht Jahresziele für 2023 und setzt profitablen Wachstumskurs fort | PRESSEINFO - [PRESSEINFO | SCHOTT Pharma feiert einjähriges Jubiläum an der Frankfurter Wertpapierbörse](https://www.schott-pharma.com/de/news-and-media/media-releases/2024/schott-pharma-feiert-einjaehriges-jubilaeum-an-der-frankfurter-wertpapierboerse): SCHOTT Pharma feiert einjähriges Jubiläum an der Frankfurter Wertpapierbörse | PRESSEINFO - [PRESSEINFO | SCHOTT Pharma ernennt Tobias Erfurth zum Leiter Investor Relations](https://www.schott-pharma.com/de/news-and-media/media-releases/2024/schott-pharma-ernennt-tobias-erfurth-zum-leiter-investor-relations): SCHOTT Pharma ernennt Tobias Erfurth zum Leiter Investor Relations | PRESSEINFO - [PRESSEINFO | Erweiterung der Produktion von vorfüllbaren Glasspritzen: SCHOTT Pharma eröffnet hochmoderne Produktionsstätte im ungarischen Lukácsháza](https://www.schott-pharma.com/de/news-and-media/media-releases/2024/schott-pharma-eroeffnet-hochmoderne-produktionsstaette-in-ungarn): Erweiterung der Produktion von vorfüllbaren Glasspritzen: SCHOTT Pharma eröffnet hochmoderne Produktionsstätte im ungarischen Lukácsháza | PRESSEINFO - [SCHOTT Pharma macht den ersten Spatenstich für eine hochmoderne Produktion in Ungarn | SCHOTT](https://www.schott-pharma.com/de/news-and-media/media-releases/2022/schott-pharma-legt-grundstein-fuer-hochmoderne-glasspritzen-produktion): Der Bau eines neuen Produktionszentrums für vorfüllbare Glasspritzen (PFS) in Lukácsháza, Ungarn, hat begonnen. Damit wird das globale Produktionsnetzwerk von SCHOTT Pharma um eine zweite Anlage erweitert - [PRESSEINFO | Verantwortung ernst nehmen: SCHOTT Pharma veröffentlicht ersten Nachhaltigkeitsbericht](https://www.schott-pharma.com/de/news-and-media/media-releases/2024/schott-pharma-veroeffentlicht-ersten-nachhaltigkeitsbericht): Verantwortung ernst nehmen: SCHOTT Pharma veröffentlicht ersten Nachhaltigkeitsbericht | PRESSEINFO - [PRESSEINFO | Subkutane Selbstmedikation fördern: SCHOTT Pharma bringt vorsterilisierte großvolumige Karpulen für tragbare Injektoren auf den Markt](https://www.schott-pharma.com/de/news-and-media/media-releases/2024/schott-pharma-bringt-vorsterilisierte-grossvolumige-karpulen-fuer-tragbare-injektoren-auf-den-markt): Subkutane Selbstmedikation fördern: SCHOTT Pharma bringt vorsterilisierte großvolumige Karpulen für tragbare Injektoren auf den Markt | PRESSEINFO - [PRESSEINFO | SCHOTT Pharma expandiert in den USA mit neuer Produktionsstätte für vorfüllbare Spritzen](https://www.schott-pharma.com/de/news-and-media/media-releases/2024/schott-pharma-expandiert-in-den-usa-mit-neuer-produktionsstaette-fuer-vorfuellbare-spritzen): SCHOTT Pharma expandiert in den USA mit neuer Produktionsstätte für vorfüllbare Spritzen | PRESSEINFO - [PRESSEINFO | SCHOTT Pharma richtet Klimaschutzmaßnahmen an den Anforderungen des Pariser Abkommens aus](https://www.schott-pharma.com/de/news-and-media/media-releases/2024/schott-pharma-richtet-klimaschutzmassnahmen-an-den-anforderungen-des-pariser-abkommens-aus): SCHOTT Pharma richtet Klimaschutzmaßnahmen an den Anforderungen des Pariser Abkommens aus | PRESSEINFO - [PRESSEINFO | Medikamente schneller zulassen: SCHOTT Pharma bietet umfassende Suite an analytischen Dienstleistungen zur Wahl der richtigen Aufbewahrungslösung und Vorbereitung auf die Zulassung](https://www.schott-pharma.com/de/news-and-media/media-releases/2024/schott-pharma-bietet-umfassende-suite-an-analytischen-dienstleistungen): Medikamente schneller zulassen: SCHOTT Pharma bietet umfassende Suite an analytischen Dienstleistungen zur Wahl der richtigen Aufbewahrungslösung und Vorbereitung auf die Zulassung | PRESSEINFO - [PRESSEINFO | Aufstieg für SCHOTT Pharma: Erstmalige Aufnahme in den MDAX](https://www.schott-pharma.com/de/news-and-media/media-releases/2024/schott-pharma-steigt-erstmalig-in-den-mdax-auf): Aufstieg für SCHOTT Pharma: Erstmalige Aufnahme in den MDAX | PRESSEINFO - [PRESSEINFO | SCHOTT Pharma meldet guten Start ins Geschäftsjahr 2024](https://www.schott-pharma.com/de/news-and-media/media-releases/2024/schott-pharma-meldet-guten-start-ins-geschaeftsjahr-2024): SCHOTT Pharma meldet guten Start ins Geschäftsjahr 2024 | PRESSEINFO - [PRESSEINFO | Stärkung der Lieferketten in den USA: SCHOTT Pharma nimmt erweiterte Produktion für Fläschchen in Betrieb](https://www.schott-pharma.com/de/news-and-media/media-releases/2026/staerkung-der-lieferketten-in-den-usa-schott-pharma-nimmt-erweiterte-produktion-fuer-flaeschchen-in-betrieb): Stärkung der Lieferketten in den USA: SCHOTT Pharma nimmt erweiterte Produktion für Fläschchen in Betrieb | PRESSEINFO - [PRESSEINFORMATION | SCHOTT Pharma erweitert Portfolio für sensible Biologika mit cartriQ® BioPure](https://www.schott-pharma.com/de/news-and-media/media-releases/2026/schott-pharma-erweitert-portfolio-fuer-sensible-biologika-mit-cartriq-biopure): SCHOTT Pharma erweitert Portfolio für sensible Biologika mit cartriQ® BioPure | PRESSEINFORMATION - [PRESSEINFO | SCHOTT Pharma setzt Wachstumskurs im zweiten Quartal des Geschäftsjahres 2024 fort ](https://www.schott-pharma.com/de/news-and-media/media-releases/2024/schott-pharma-setzt-wachstumskurs-im-zweiten-quartal-des-geschaeftsjahres-2024-fort): SCHOTT Pharma setzt Wachstumskurs im zweiten Quartal des Geschäftsjahres 2024 fort | PRESSEINFO - [PRESSEINFO | Erfolgreiche erste Hauptversammlung von SCHOTT Pharma – Investoren stimmen allen Tagesordnungspunkten zu](https://www.schott-pharma.com/de/news-and-media/media-releases/2024/erfolgreiche-erste-hauptversammlung-von-schott-pharma): Erfolgreiche erste Hauptversammlung von SCHOTT Pharma – Investoren stimmen allen Tagesordnungspunkten zu | PRESSEINFO - [PRESSEINFO: SCHOTT Pharma mit starker finanzieller Performance im Geschäftsjahr 2022 | SCHOTT](https://www.schott-pharma.com/de/news-and-media/media-releases/2023/schott-pharma-mit-starker-finanzieller-performance-im-geschaeftsjahr-2022): Erfahren Sie mehr über die Geschäftsentwicklung von SCHOTT Pharma im Geschäftsjahr 2022 - [PRESSEINFO | SCHOTT Pharma Aufsichtsrat verlängert Vertrag von CEO Andreas Reisse und ernennt Reinhard Mayer zum neuen CFO](https://www.schott-pharma.com/de/news-and-media/media-releases/2025/schott-pharma-verlaengert-vertrag-von-ceo-andreas-reisse-und-ernennt-reinhard-mayer-zum-neuen-cfo): SCHOTT Pharma Aufsichtsrat verlängert Vertrag von CEO Andreas Reisse und ernennt Reinhard Mayer zum neuen CFO | PRESSEINFO - [PRESSEINFO | SCHOTT Pharma und SHL Medical vereinfachen großvolumige Injektionen zu Hause](https://www.schott-pharma.com/de/news-and-media/media-releases/2025/schott-pharma-und-shl-medical-vereinfachen-grossvolumige-injektionen-zu-hause): SCHOTT Pharma und SHL Medical vereinfachen großvolumige Injektionen zu Hause | Presseinfo - [PRESSEINFO | SCHOTT Pharma startet gut ins neue Geschäftsjahr und bestätigt Prognose für 2025](https://www.schott-pharma.com/de/news-and-media/media-releases/2025/schott-pharma-startet-gut-ins-neue-geschaeftsjahr-und-bestaetigt-prognose-fuer-2025): SCHOTT Pharma startet gut ins neue Geschäftsjahr und bestätigt Prognose für 2025 | PRESSEINFO - [PRESSEINFORMATION | SCHOTT Pharmas vorläufige Ergebnisse für das Geschäftsjahr 2025; Ausblick für das Geschäftsjahr 2026 und aktualisierte Mittelfristprognose](https://www.schott-pharma.com/de/news-and-media/media-releases/2025/schott-pharmas-vorlaeufige-ergebnisse-fuer-das-geschaeftsjahr-2025-ausblick-geschaeftsjahr-2026-und-aktualisierte-mittelfristprognose): SCHOTT Pharmas vorläufige Ergebnisse für das Geschäftsjahr 2025; Ausblick für das Geschäftsjahr 2026 und aktualisierte Mittelfristprognose | PRESSEINFORMATION - [PRESSEINFO | Nächster Expansionsmeilenstein erreicht: SCHOTT Pharma eröffnet Produktionsstätte in Serbien zur Stärkung der Wettbewerbsfähigkeit in Europa](https://www.schott-pharma.com/de/news-and-media/media-releases/2025/schott-pharma-eroeffnet-produktionsstaette-in-serbien-zur-staerkung-der-wettbewerbsfaehigkeit-in-europa): Nächster Expansionsmeilenstein erreicht: SCHOTT Pharma eröffnet Produktionsstätte in Serbien zur Stärkung der Wettbewerbsfähigkeit in Europa | PRESSEINFO - [PRESSEINFO | Sicherheit, Effizienz und Nachhaltigkeit neu definiert: SCHOTT Pharma bringt neue Generation Polymerspritzen auf den Markt](https://www.schott-pharma.com/de/news-and-media/media-releases/2025/schott-pharma-bringt-neue-generation-polymerspritzen-auf-den-markt): Sicherheit, Effizienz und Nachhaltigkeit neu definiert: SCHOTT Pharma bringt neue Generation Polymerspritzen auf den Markt | PRESSEINFO - [PRESSEINFO | SCHOTT Pharma mit robustem erstem Halbjahr und starkem Cashflow](https://www.schott-pharma.com/de/news-and-media/media-releases/2026/schott-pharma-mit-robustem-erstem-halbjahr-und-starkem-cashflow): SCHOTT Pharma mit robustem erstem Halbjahr und starkem Cashflow | PRESSEINFO - [PRESSEINFO | SCHOTT Pharma bringt EVERIC® lyo & amber Fläschchen für lichtempfindliche ADCs auf den Markt](https://www.schott-pharma.com/de/news-and-media/media-releases/2026/schott-pharma-bringt-everic-lyo-and-amber-flaeschchen-fuer-lichtempfindliche-adcs-auf-den-markt): SCHOTT Pharma bringt EVERIC® lyo & amber Fläschchen für lichtempfindliche ADCs auf den Markt | PRESSEINFO - [PRESSEINFO | SCHOTT Pharma mit starkem dritten Quartal auf geplantem Wachstumskurs](https://www.schott-pharma.com/de/news-and-media/media-releases/2026/schott-pharma-mit-starkem-dritten-quartal-auf-geplantem-wachstumskurs): SCHOTT Pharma mit starkem dritten Quartal auf geplantem Wachstumskurs | PRESSEINFO - [PRESSEINFO | SCHOTT Pharma Polymerkarpulenplattform mit großvolumigen Autoinjektoren von SHL Medical kompatibel](https://www.schott-pharma.com/de/news-and-media/media-releases/2026/schott-pharma-polymerkarpulenplattform-mit-grossvolumigen-autoinjektoren-von-shl-medical-kompatibel): SCHOTT Pharma Polymerkarpulenplattform mit großvolumigen Autoinjektoren von SHL Medical kompatibel | PRESSEINFO - [SCHOTT verzeichnet erfolgreiches Jahr für seine Pharma-Sparte | SCHOTT](https://www.schott-pharma.com/de/news-and-media/media-releases/2022/schott-meldet-erfolgreiches-jahr-für-pharma-sparte): MEDIA RELEASE: Die Pharma-Sparte von SCHOTT blickt auf ein sehr erfolgreiches Jahr 2021 zurück und möchte auf diesem Erfolg weiter aufbauen - [PRESSEINFO | SCHOTT Pharma und Serum Institute of India begrüßen neuen Partner in Joint Venture in Indien; TPG investiert in SCHOTT Poonawalla](https://www.schott-pharma.com/de/news-and-media/media-releases/2025/schott-pharma-und-serum-institute-of-india-begruessen-neuen-partner-in-joint-venture-in-indien): SCHOTT Pharma und Serum Institute of India begrüßen neuen Partner in Joint Venture in Indien; TPG investiert in SCHOTT Poonawalla | PRESSEINFO - [PRESSEINFO | Christian Mias wird Nachfolger von Andreas Reisse als CEO von SCHOTT Pharma](https://www.schott-pharma.com/de/news-and-media/media-releases/2025/christian-mias-wird-nachfolger-von-andreas-reisse-als-ceo-von-schott-pharma): Christian Mias wird Nachfolger von Andreas Reisse als CEO von SCHOTT Pharma | PRESSEINFO - [PRESSEINFO | Medikamente zu Hause selbst verabreichen: SCHOTT Pharma bringt großvolumige Glasspritze auf den Markt](https://www.schott-pharma.com/de/news-and-media/media-releases/2025/schott-pharma-bringt-grossvolumige-glasspritze-auf-den-markt): Medikamente zu Hause selbst verabreichen: SCHOTT Pharma bringt großvolumige Glasspritze auf den Markt | PRESSEINFO - [PRESSEINFO | SCHOTT Pharma mit erfolgreicher Hauptversammlung – Aktionärinnen und Aktionäre stimmen allen Tagesordnungspunkten zu](https://www.schott-pharma.com/de/news-and-media/media-releases/2025/schott-pharma-mit-erfolgreicher-hauptversammlung): PRESSINFO | SCHOTT Pharma mit erfolgreicher Hauptversammlung – Aktionärinnen und Aktionäre stimmen allen Tagesordnungspunkten zu - [PRESSE INFO | SCHOTT Pharma setzt Expansionsstrategie erfolgreich fort und investiert in neue Produktionsstätte in Serbien](https://www.schott-pharma.com/de/news-and-media/media-releases/2023/schott-pharma-investiert-in-neue-produktionsstaette-in-serbien): SCHOTT Pharma setzt Expansionsstrategie erfolgreich fort und investiert in neue Produktionsstätte in Serbien | PRESSE INFO - [PRESSEINFO | SCHOTT Pharma erzielt solide Ergebnisse im dritten Quartal](https://www.schott-pharma.com/de/news-and-media/media-releases/2025/schott-pharma-erzielt-solide-endgueltige-ergebnisse-im-dritten-quartal): SCHOTT Pharma erzielt solide Ergebnisse im dritten Quartal | PRESSEINFO - [PRESSEINFO | SCHOTT Pharma veröffentlicht vorläufiges Ergebnis für das dritte Quartal 2025 und präzisiert Prognose für das Geschäftsjahr 2025 ](https://www.schott-pharma.com/de/news-and-media/media-releases/2025/schott-pharma-veroeffentlicht-vorlaeufiges-ergebnis-fuer-das-dritte-quartal-2025-und-praezisiert-prognose-fuer-das-geschaeftsjahr-2025): SCHOTT Pharma veröffentlicht vorläufiges Ergebnis für das dritte Quartal 2025 und präzisiert Prognose für das Geschäftsjahr 2025 | PRESSEINFO - [PRESSEINFO | SCHOTT Pharma macht Dekarbonisierung messbar](https://www.schott-pharma.com/de/news-and-media/media-releases/2026/schott-pharma-macht-dekarbonisierung-messbar): SCHOTT Pharma macht Dekarbonisierung messbar | PRESSEINFO - [PRESSEINFO | SCHOTT Pharma und Nemera bringen voll kompatibles passives Safety System für großvolumige vorfüllbare Glasspritzen auf den Markt](https://www.schott-pharma.com/de/news-and-media/media-releases/2026/schott-pharma-und-nemera-bringen-voll-kompatibles-passives-safety-system-fuer-grossvolumige-vorfuellbare-glasspritzen): SCHOTT Pharma und Nemera bringen voll kompatibles passives Safety System für großvolumige vorfüllbare Glasspritzen auf den Markt | PRESSEINFO - [PRESSEINFO | SCHOTT Pharma erreicht Jahresziele für Umsatz und Profitabilität](https://www.schott-pharma.com/de/news-and-media/media-releases/2025/schott-pharma-erreicht-jahresziele-fuer-umsatz-und-profitabilitaet): SCHOTT Pharma erreicht Jahresziele für Umsatz und Profitabilität | PRESSEINFO - [PRESSEINFO | SCHOTT Pharma bringt sterile Karpule aus Polymer auf den Markt](https://www.schott-pharma.com/de/news-and-media/media-releases/2025/schott-pharma-bringt-sterile-karpule-aus-polymer-auf-den-markt): SCHOTT Pharma bringt sterile Karpule aus Polymer auf den Markt | PRESSEINFO - [PRESSEINFO | SCHOTT Pharma erweitert Ready-to-use-Portfolio um sterile 1,5 ml Karpule](https://www.schott-pharma.com/de/news-and-media/media-releases/2025/schott-pharma-erweitert-ready-to-use-portfolio-um-sterile-eineinhalb-ml-karpule): SCHOTT Pharma erweitert Ready-to-use-Portfolio um sterile 1,5 ml Karpule | PRESSEINFO - [PRESSEINFO | SCHOTT Pharma investiert in die Produktion steriler Karpulen in Ungarn](https://www.schott-pharma.com/de/news-and-media/media-releases/2025/schott-pharma-investiert-in-die-produktion-steriler-karpulen-in-ungarn): SCHOTT Pharma investiert in die Produktion steriler Karpulen in Ungarn | PRESSEINFO - [PRESSEINFO | SCHOTT Pharma stellt Polymerspritze für die Tiefkühllagerung empfindlicher Medikamente bis -180 °C vor](https://www.schott-pharma.com/de/news-and-media/media-releases/2025/schott-pharma-stellt-polymerspritze-fuer-die-tiefkuehllagerung-empfindlicher-medikamente-bis-minus-180-grad-celsius-vor): SCHOTT Pharma stellt Polymerspritze für die Tiefkühllagerung empfindlicher Medikamente bis -180 °C vor | PRESSEINFO - [PRESSEINFO | SCHOTT Pharma schließt starkes zweites Quartal im Geschäftsjahr 2025 ab](https://www.schott-pharma.com/de/news-and-media/media-releases/2025/schott-pharma-schließt-starkes-zweites-quartal-im-geschaeftsjahr-2025-ab): SCHOTT Pharma schließt starkes zweites Quartal im Geschäftsjahr 2025 ab | PRESSEINFO - [News and Media | SCHOTT Pharma](https://www.schott-pharma.com/de/news-and-media): Aktuelle News und Pressemitteilungen des Pioniers für Aufbewahrungs- und Verabreichungssysteme für Medikamente ## SCHOTT Pharma Nachhaltigkeit | Die Nachhaltigkeitsseite von SCHOTT Pharma stellt die Initiativen des Unternehmens zur ökologischen und sozialen Verantwortung dar, einschließlich der Ziele für Klimaschutz, Ressourceneffizienz, ethische Lieferketten und gesellschaftliches Engagement, um eine nachhaltige Gesundheitsversorgung und langfristige Wirkung zu fördern. - [Klimaschutz | SCHOTT Pharma](https://www.schott-pharma.com/de/ueber-uns/nachhaltigkeit/klimaschutz): SCHOTT Pharma übernimmt Verantwortung für die Umweltauswirkungen seiner Geschäftstätigkeit. - [Nachhaltige Produkte | SCHOTT Pharma](https://www.schott-pharma.com/de/ueber-uns/nachhaltigkeit/nachhaltige-produkte): SCHOTT Pharma engagiert sich dafür, die Umweltbelastung durch nachhaltiges Produktdesign, optimierte Lieferketten und Partnerschaften zu reduzieren. Unser Fokus liegt auf umweltfreundlichen Materialien und einem ganzheitlichen Lebenszyklusmanagement, um einen Beitrag zur Lösung des Klimawandels zu leisten. - [Compliance | SCHOTT Pharma](https://www.schott-pharma.com/de/ueber-uns/nachhaltigkeit/compliance): Alles, was Sie über die Compliance-Richtlinien von SCHOTT Pharma wissen müssen, einschließlich des Verhaltenskodex, ethischer Geschäftspraktiken, sozialer Verantwortung und Unternehmensführung. - [Nachhaltigkeit | SCHOTT Pharma](https://www.schott-pharma.com/de/ueber-uns/nachhaltigkeit): Erfahren Sie, wie SCHOTT Pharma Nachhaltigkeit entlang der gesamten Wertschöpfungskette durch verantwortungsvolles Handeln, Klimaschutz, Kreislaufwirtschaft und Ressourceneffizienz vorantreibt. ## SCHOTT Pharma Sonstige Seiten - [Haftungsausschluss und rechtliche Hinweise | SCHOTT Pharma](https://www.schott-pharma.com/de/disclaimer): Rechtliche Hinweise zur Nutzung der SCHOTT Website. - [Newsletter | SCHOTT Pharma](https://www.schott-pharma.com/de/newsletter): - [SCHOTT Pharma AG & Co. KGaA](https://www.schott-pharma.com/de/impressum): Hier finden Sie unser Impressum mit den rechtlichen Hinweisen von SCHOTT. - [Datenschutzrichtlinie | SCHOTT Pharma](https://www.schott-pharma.com/de/datenschutzrichtlinie): Unsere Datenschutzrichtlinie. Datenschutz ist uns wichtig, deshalb möchten wir, dass Sie sich beim Besuch unserer Internetseiten sicher fühlen. - [Allgemeine Geschäftsbedingungen | SCHOTT Pharma](https://www.schott-pharma.com/de/allgemeine-geschaeftsbedingungen): Hier finden Sie unsere Allgemeinen Geschäftsbedingungen und rechtliche Rahmenbedingungen für die pharma Industrie. Mehr erfahren! - [Datenschutzrichtlinie cvent](https://www.schott-pharma.com/de/datenschutzrichtlinie-cvent): Verarbeitung Ihrer personenbezogenen Daten durch SCHOTT Pharma für die Organisation von Veranstaltungen ## 中文 ## 产品 | SCHOTT Pharma 的产品页面概述了其药物包装和给药产品组合，包括预灌封玻璃和聚合物注射器、卡式瓶、注射剂瓶和安瓿瓶，所有产品均专为制药和生物技术制造商设计。 - [肖特注射器-预灌封玻璃注射器-免洗免灭注射器-聚合物注射器 | 肖特医药](https://www.schott-pharma.com/zh/products/syringes): 肖特的注射器系列包含预灌封注射器, 玻璃注射器, 聚合物注射器,syriQ系列注射器和TOPPAC系列注射器等稳定的长期给药解决方案.肖特医药提供免洗免灭注射器用于高效灌封 - [肖特卡式瓶-免洗免灭玻璃卡式瓶-双腔卡式瓶-医药解决方案 | 肖特医药](https://www.schott-pharma.com/zh/products/pharmaceutical-cartridges): 肖特的卡式瓶系列包含免洗免灭玻璃卡式瓶, 双腔卡式瓶, 和耐破损卡式瓶等稳健可靠的高精确给药系统。肖特医药提供标准线和高端线两种质量等级,保证高精确给药 - [肖特安瓿瓶-easyOPC玻璃安瓿瓶标准安瓶-医药包装解决方案 | 肖特医药](https://www.schott-pharma.com/zh/products/ampoules): 肖特的药用玻璃安瓿瓶系列包含标准线安瓿瓶,easyOPC安瓿瓶和防伪安瓿瓶等高质量医用包装解决方案.肖特医药提供1ml至30ml安瓿瓶以满足您的给药需求 - [肖特玻璃注射剂瓶西林瓶-EVERIC注射剂瓶-adaptiQ注射剂瓶 | 肖特医药](https://www.schott-pharma.com/zh/products/vials): 肖特医药的注射剂瓶系列包括EVERIC,TopLyo,Type I plus,adatiQ和高端线系列.肖特注射剂瓶用I型硼硅玻璃制成,具有很高的化学稳定性,可确保安全地存储液体药物制剂. - [肖特医药药物容器给药解决方案-注射器-安瓿瓶-卡式瓶-注射剂瓶 | 肖特医药 ](https://www.schott-pharma.com/zh/products): 探索肖特医药的全面产品线,包括玻璃和聚合物材质的注射器,卡式瓶,注射剂瓶和安瓿瓶系列.肖特医药提供可靠安全的药物容器和给药解决方案 ## 注射器 | SCHOTT Pharma 的注射器页面展示了其采用玻璃和先进聚合物制造的预灌封药用注射器解决方案，确保药物的安全储存与输送。页面重点介绍 syriQ® 和 SCHOTT TOPPAC® 注射器，这些产品旨在减少错误、提升安全性，并支持从疫苗到生物制剂等多种应用。 - [SCHOTT TOPPAC® unique](https://www.schott-pharma.com/zh/products/syringes/schott-toppac-unique): 肖特TOPPAC unique免洗免灭聚合物预灌封注射器,适用于多种药物治疗需求,提供定制化给药解决方案. 肖特医药提供1ml至50ml注射器, 1ml至20ml卡式瓶满足您的治疗给药需求 - [syriQ®](https://www.schott-pharma.com/zh/products/syringes/syriq): 肖特syriQ无菌玻璃预灌封注射器是一体化容器和注射装置, 适用于储存和注射各类疫苗. 肖特医药提供0.5ml至3ml注射器以满足您的给药需求 - [SCHOTT TOPPAC® 聚合物注射器](https://www.schott-pharma.com/zh/products/syringes/schott-toppac): 肖特TOPPAC系列无菌预灌封注射器, 由先进COC聚合物制成, 提供多样化的初级包装解决方案.肖特医药提供1ml至50ml注射器以满足您的长期储存和给药需求 - [SCHOTT TOPPAC® infuse](https://www.schott-pharma.com/zh/products/syringes/schott-toppac-infuse): 肖特TOPPAC infuse免洗免灭聚合物预灌封注射器专为输液治疗需求设计,采用高品质COC材料制成,提高药物稳定性.肖特医药提供5ml至50ml注射器以满足您的给药需求. - [无硅油 syriQ BioPure®](https://www.schott-pharma.com/zh/products/syringes/syriq-biopure-silicone-free): 肖特医药的无硅油 syriQ BioPure® 免洗免灭玻璃预灌封注射器采用无硅油玻璃筒和活塞，专为敏感生物制剂开发，可在药物的整个寿命周期内保持一致的高稳定性和滑动力 - [syriQ BioPure®](https://www.schott-pharma.com/zh/products/syringes/syriq-biopure): 肖特医药的免洗免灭玻璃预灌封注射器专为复杂的生物制剂而开发，能够最大限度地减少药物与容器之间的相互作用 - [SCHOTT TOPPAC® cosmetic 医美系列 ](https://www.schott-pharma.com/zh/products/syringes/schott-toppac-cosmetic): 肖特 TOPPAC® cosmetic 免洗免灭聚合物预灌封注射器是专为使用透明质酸和肉毒杆菌毒素（BoNT）的医美应用而开发 - [SCHOTT TOPPAC® freeze](https://www.schott-pharma.com/zh/products/syringes/schott-toppac-freeze): 肖特 TOPPAC freeze 免洗免灭聚合物预灌封注射器,用于低温冷冻储存药物.肖特医药提供极端低温下可靠的给药解决方案,确保药品稳定性与储存安全 ## 卡式瓶 | SCHOTT Pharma 的药用卡式瓶页面介绍了其玻璃和聚合物卡式瓶解决方案，适用于笔式注射器、自动注射器及可穿戴系统中的精准给药。产品组合涵盖即用型、双腔室和高耐用性选项，专为注射疗法和生物制剂设计。 - [肖特TOPPAC卡式瓶-免洗免灭型聚合物卡式瓶-医药解决方案](https://www.schott-pharma.com/zh/products/pharmaceutical-cartridges/schott-toppac-cartridge): 肖特医药TOPPAC D 免洗免灭型聚合物卡式瓶,符合 ISO 标准,专用于高敏感性生物制剂给药. 立即点击了解肖特TOPPAC®聚合物卡式瓶系列相关信息 - [肖特卡式瓶-双腔卡式瓶-适用冻干药物复溶的灭菌玻璃卡式瓶](https://www.schott-pharma.com/zh/products/pharmaceutical-cartridges/cartridges-double-chamber): 肖特双腔玻璃卡式瓶通过活塞隔开两种药物成分, 适用于敏感药物的复溶和自我给药, 提供高质量给药解决方案. 肖特医药根据需求定制卡式瓶以满足您的给药需求 - [肖特卡式瓶-cartriQ®大容量卡式瓶-免洗免灭药用玻璃卡式瓶](https://www.schott-pharma.com/zh/products/pharmaceutical-cartridges/cartriq-large-volume): 肖特 cartriQ® 大容量卡式瓶提供免洗免灭医药包装, 为长期注射药物提供稳定的大容量存储解决方案. 肖特医药可应需求提供10ml或者其他规格的卡式瓶以满足您的给药需求 - [肖特耐破损卡式瓶-适用紧急医药-免洗免灭药用玻璃卡式瓶 ](https://www.schott-pharma.com/zh/products/pharmaceutical-cartridges/cartridges-break-resistant): 肖特耐破损药用玻璃卡式瓶,采用化学强化玻璃制成,可确保在任何情况下安全储存药物,适用于苛刻条件.肖特医药提供原尺寸卡式瓶以及非无菌规格,确保更换便捷,满足您的需求. - [肖特卡式瓶-高端线和标准线卡式瓶-免洗免灭玻璃卡式瓶 ](https://www.schott-pharma.com/zh/products/pharmaceutical-cartridges/core-cartridges): 肖特高端线和标准线药用卡式瓶,为自我给药和临床医生提供高效给药解决方案,保证药物稳定与性能.肖特医药提供标准线与高端线两种质量等级,1ml至20ml卡式瓶,满足您的需求 - [肖特卡式瓶-多肽和蛋白质药物卡式瓶-cartriQ灭菌卡式瓶 ](https://www.schott-pharma.com/zh/products/pharmaceutical-cartridges/cartriq): 肖特 cartriQ 高性能高精度免洗免灭药用玻璃卡式瓶, 为多肽与蛋白质药物注射剂提供高效给药解决方案。提供1.5 ml和3.0 ml小容量卡式瓶, 满足您的自我给药需求 ## 玻璃瓶产品组合 | SCHOTT Pharma 的注射剂瓶页面重点介绍了专为注射药物、疫苗和生物制剂设计的高质量玻璃瓶，具备优异的耐化学性、尺寸精度以及即用型选项，助力高效的药品灌装与封装流程。 - [EVERIC® freeze](https://www.schott-pharma.com/zh/products/vials/everic-freeze): 肖特医药 EVERIC® freeze专为深冷存储设计的药用玻璃瓶,可承受-80°C极端温度,适用于mRNA疫苗,基因治疗等生物制剂. 提供多种规格及即用型选择 - [EVERIC® strong & smooth](https://www.schott-pharma.com/zh/products/vials/everic-strong-smooth): 肖特EVERIC strong&smooth注射剂瓶,通过优化玻璃接触及负荷,降低外观缺陷与碎瓶风险,减少粘连问题,提升灌装线效率.肖特提供安全与高效生产的药品包装解决方案 - [EVERIC® amber](https://www.schott-pharma.com/zh/products/vials/everic-amber): 肖特医药 EVERIC® amber 专为高灵敏度光敏药物设计的棕色药用注射剂瓶,采用FIOLAX®棕色硼硅玻璃,精确控制光透过率, 确保药物稳定性与疗效 - [肖特注射剂瓶-标准线高端线玻璃注射剂瓶-医药包装解决方案](https://www.schott-pharma.com/zh/products/vials/core-vials): 肖特医药标准线与高端线药用玻璃注射剂瓶,提供卓越的化学稳定性与机械强度,确保液体制剂和冻干药物的长期稳定性.肖特医药提供2R至100R注射剂瓶满足您的药物包装解决方案 - [肖特注射剂瓶-adaptiQ免洗免灭医用玻璃注射剂瓶-标准化包装](https://www.schott-pharma.com/zh/products/vials/adaptiq): 肖特医药adaptiQ免洗免灭医用玻璃注射剂瓶.采用标准化二级包装,优化药品生产流程,提高灵活性,生产效率和患者安全性.满足你的药品包装需 - [EVERIC® plus](https://www.schott-pharma.com/zh/products/vials/everic-plus): 肖特 EVERIC® plus 涂层玻璃瓶具有低浸出物水平与低吸附特性，确保高敏感性药物制剂的稳定性。 - [EVERIC® pure](https://www.schott-pharma.com/zh/products/vials/everic-pure): 肖特EVERIC pure药用玻璃注射剂瓶,具有均匀内表面,提升低灌装量药品的稳定性,提升脱片控制,降低浸出物含量.保证敏感药物稳定性.肖特提供2R至50R注射剂瓶以满足您的需求 - [EVERIC® care](https://www.schott-pharma.com/zh/products/vials/everic-care): 肖特EVERIC care药用玻璃注射剂瓶,在超大pH范围内保障药物的化学稳定性,为敏感药物提供高品质药物包装解决方案,满提升药物有效性和患者安全性 - [EVERIC® lyo](https://www.schott-pharma.com/zh/products/vials/everic-lyo): 肖特EVERIC® lyo药用玻璃注射剂瓶专为冻干药物设计,具有疏水性与零游离硅油设计,有效防雾化爬壁,提升药物稳定性与品质.肖特医药可应需求提供2R-50R注射剂瓶以满足您的包装需求. - [EVERIC® smart](https://www.schott-pharma.com/zh/products/vials/everic-smart): 肖特医药的EVERIC® smart智能容器通过激光刻蚀唯一码,在整个灌装封装流程中实现药品可追溯性,实现单瓶级精准追踪与批次透明管理 ## 安瓿瓶 | SCHOTT Pharma 的安瓿瓶页面展示了高品质硼硅酸盐安瓿瓶，能够安全存储无菌注射药物和化学品，具备精确密封、优异耐化学性，并提供适用于疫苗、生物制剂及敏感制药应用的多种规格。 - [肖特安瓿瓶-防伪安瓿瓶-药用玻璃安瓿瓶-防造假药品包装](https://www.schott-pharma.com/zh/products/ampoules/ampoules-ac): 肖特防伪安瓿瓶,可有效防止药品造假的药用玻璃安瓿瓶,保护珍贵药物和知识产权的医药包装解决方案.肖特医药提供1ml至30ml防伪安瓿瓶以满足您的给药需求. - [肖特安瓿瓶-easyOPC 易开型安瓿瓶-玻璃药用安瓶-医药包装解决方案](https://www.schott-pharma.com/zh/products/ampoules/ampoules-easy-opc): 肖特easyOPC 易开型安瓿瓶,可安全轻松地打开的药用玻璃安瓿瓶,严格折断力控制,适合急症治疗的医药包装解决方案.肖特医药提供1ml至20ml easyOPC 易开型安瓿瓶以满足您的给药需求. - [肖特安瓿瓶-可安全折断安瓶-标准线药用无菌玻璃安瓿瓶](https://www.schott-pharma.com/zh/products/ampoules/core-ampoules): 肖特标准线安瓿瓶采用具有化学稳定性的高耐水性玻璃制造,确保高效的灌装与封装工艺,并提供适合制药行业的四种折断系统,提升药品包装的安全性和稳定性. ## 服务 | SCHOTT Pharma 的服务页面概述了为制药和生物技术合作伙伴量身定制的支持，包括包装优化、法规与质量咨询、技术支持、给药系统开发，以及定制化解决方案，以提升制造和产品性能。 - [肖特医疗器械法规档案-医药法规服务 | 肖特医药](https://www.schott-pharma.com/zh/services/regulatory): 肖特医药法规服务助力药品及医疗器械所有者整合初级药用包装信息至注册流程,提供 DMF 提交,国家产品注册,eCTD 格式档案等支持等.立即点击获取肖特医药专业支持 - [医药包装分析测试服务-药品包装选择与合规注册| 肖特医药 ](https://www.schott-pharma.com/zh/services/pharma-analytics): 肖特医药提供专业分析服务,通过检测验证包装方案与药品要求匹配度,生成医药包装方案,凭借超 40 年经验助力解决包装挑战,为药品登记注册准备合规证明 - [肖特医药包装分析服务与测试-法规注册-可持续包装解决方案|肖特医药 ](https://www.schott-pharma.com/zh/services): 肖特医药包装提供各种服务和分析,包括分析测试,灌装与封装优化以及提供可持续发展和法规方面的支持 ## SCHOTT Pharma 药物包装与给药服务 | SCHOTT Pharma 的容器解决方案页面重点介绍了可定制的药品包装容器咨询与支持，包括风险评估、屏障策略、相容性测试以及优化的容器系统，旨在确保产品的安全与质量，并满足法规合规要求。 - [可行性研究 | SCHOTT医药](https://www.schott-pharma.com/zh/services/containment-solutions/feasibility-study): SCHOTT 医药提供可行性研究服务，评估产品包装解决方案的可行性及其对大规模生产的适用性。 - [原型设计 | SCHOTT医药](https://www.schott-pharma.com/zh/services/containment-solutions/prototyping): SCHOTT Pharma 为药品包装提供完整的原型设计服务，包括样品制造、可行性与兼容性测试以及文档记录。 - [肖特药物包装与给药服务解决方案-药物包装设计 | 肖特医药 ](https://www.schott-pharma.com/zh/services/containment-solutions): 肖特医药包装提供全面的药物包装与给药服务,根据企业的特定要求,肖特提供开发从设计理念到工业化的定制化解决方案 ## SCHOTT 医药分析 | SCHOTT Pharma 的“医药分析”页面重点展示了针对药品包装和给药系统的分析服务组合，包括材料表征、可提取物与浸出物测试、稳定性研究以及法规支持，旨在确保药品的质量、安全性和合规性。 - [肖特医药机械稳定性测试服务-药品包装机械强度验证与工艺优化方案 | 肖特医药 ](https://www.schott-pharma.com/zh/services/pharma-analytics/mechanical-stability-testing): 肖特医药提供专业的药品机械稳定性测试服务,涵盖压力敏感型产品的机械强度规格制定与验证,支撑产品规格合规与生产工艺优化 - [功能测试](https://www.schott-pharma.com/zh/services/pharma-analytics/functional-testing): 肖特医药提供药品包装功能测试服务，确保完全符合法规 - [肖特医药包装材料识别ToF-SIMS分析-药品包装材料性能评估|肖特医药 ](https://www.schott-pharma.com/zh/services/pharma-analytics/packaging-component-characterization): 肖特医药提供专业的包装组件表征分析服务,包括弹性体和玻璃材料成分鉴定,性能比较评估,功能性表面涂层检测等,帮助制药企业确保药品包装安全性和合规性 - [可提取物和浸出物研究-肖特医药安全评估服务 | 肖特医药 ](https://www.schott-pharma.com/zh/services/pharma-analytics/extractables-leachables-studies): 肖特医药包装服务涵盖设计和执行可提取物和浸出物研究,同时负责解释研究结果,比较不同的药物包装方案,协助您选择容器解决方案 - [肖特医药玻璃脱片研究-药物容器相容性分析与风险管控方案| 肖特医药 ](https://www.schott-pharma.com/zh/services/pharma-analytics/glass-delamination): 肖特医药根据客户需求进行脱片筛选研究，帮助制药公司为特定药品选择理想的容器以及合适的存储方案 - [肖特医药包装药品微粒分析-医药包装微粒检测 | 肖特医药 ](https://www.schott-pharma.com/zh/services/pharma-analytics/particle-analysis): 肖特医药包装的微粒分析服务帮助企业锁定注射用药物中的可见与亚可见颗粒,助您根因调查, 确保产品安全 - [容器密封完整性测试 I 肖特医药](https://www.schott-pharma.com/zh/services/pharma-analytics/container-closure-integrity-testing): 肖特医药提供全面的容器密封完整性测试服务，确保您药品容器的安全性和有效性。 - [肖特医药药典检验服务-材料合规与医药包装安全验证 | 肖特医药 ](https://www.schott-pharma.com/zh/services/pharma-analytics/pharmacopoeia-test): 肖特医药提供专业药典检验服务,覆盖美国,欧洲,日本和中国药典等多国药典及国际标准,针对药物接触材料开展合规测试,助力药品注册与生命周期监测 ## SCHOTT Pharma 灌装和封装服务 | SCHOTT Pharma 的灌装和完成页面列出了无菌生产服务，包括注射药物和生物制剂的无菌灌装、检验和包装，并提供质量控制、可扩展的生产能力以及法规支持，助力制药合作伙伴安全地将产品推向市场。 - [肖特医药灌装与封装服务-包装容器解决方案 | 肖特医药 ](https://www.schott-pharma.com/zh/services/fill-and-finish): 肖特医药针对注射器、卡式瓶和注射剂瓶的灌封服务支持处理从小规模到商业规模的包装容器解决方案 ## SCHOTT医药监管服务 | SCHOTT Pharma的法规页面概述了对药品包装和给药系统的支持，包括全球法规、提交策略、文件、合规评估及质量管理方面的指导，旨在协助合作伙伴满足监管要求并优化审批流程。 - [肖特医药包装授权书 (LOA) | 肖特制药 ](https://www.schott-pharma.com/zh/services/regulatory/loa): 肖特药用系统提供一系列法规咨询服务，包含NMPA, EMA,FD授权服务,立即点击咨询 - [肖特医药药品包装档案服务 - 合规文档解决方案 | 肖特医药 ](https://www.schott-pharma.com/zh/services/regulatory/pharmaceutical-packaging-dossiers): 肖特医药提供药品包装档案服务,支持符合各地法规要求的文档准备,涵盖定制化包装档案包,助力无缝集成至药品应用档案,满足欧盟,南美,澳大利亚等地区需求 - [肖特医药药品注册支持-预注册档案与全球法规服务 | 肖特医药 ](https://www.schott-pharma.com/zh/services/regulatory/pharmaceutical-product-registration): 肖特医药的药品产品注册服务提供专业的法规支持与注册指导,涵盖各类药品包装相关注册事务,协助药企高效,合规地完成产品注册流程 - [肖特医药 药品主文件 (DMF) 药品包装服务-合规注册与监管支持 | 肖特医药](https://www.schott-pharma.com/zh/services/regulatory/drug-master-files-dmf-pharma): 肖特医药专注提供药品主文件 (DMF) 专业服务，覆盖药品包装相关 DMF 注册,合规文档准备,支持美国,加拿大,中国等多地药品注册需求 - [肖特医药医疗器械注册（MDR）档案 | 肖特医药 ](https://www.schott-pharma.com/zh/services/regulatory/medical-device-registration): 肖特制药提供定制化医疗器械注册（MDR）档案包,涵盖容器系统全合规文档,支持公告机构意见申请,助力客户满足欧盟 MDR 法规要求,高效完成医疗器械注册流程 ## SCHOTT医药可持续发展服务 | SCHOTT Pharma的可持续发展页面重点介绍公司为支持环境与社会责任所提供的服务，例如可持续性绩效评审、EcoVadis评级以及产品碳足迹评估，旨在帮助减少排放、提升供应链可持续性，并推动实现净零排放的未来。 - [肖特医药包装可持续发展服务-可持续包装解决方案 | 肖特医药 ](https://www.schott-pharma.com/zh/services/sustainability): 肖特医药致力于可持续医药包装,以及为企业提供可持续发展评估,点击了解更多碳足迹评估与净零排放 ## SCHOTT医药解决方案 | SCHOTT Pharma 的解决方案页面展示了集成的药物包装与给药系统，融合了包装、分析、灌装与封装以及法规支持。这些端到端解决方案助力制药和生物技术合作伙伴在整个产品生命周期内提升安全性、效率和产品性能。 - [《寻找完美匹配》白皮书 I 肖特医药](https://www.schott-pharma.com/zh/pharma-solutions/pharmaceutical-manufacturing/improved-manufacturing-processes-with-sterile-solutions/whitepaper-finding-the-perfect-match): - [《标准化包装解决方案》白皮书 I 肖特医药](https://www.schott-pharma.com/zh/pharma-solutions/pharmaceutical-manufacturing/improved-manufacturing-processes-with-sterile-solutions/whitepaper-standardized-packaging): - [《成功的组合》白皮书 I 肖特医药](https://www.schott-pharma.com/zh/pharma-solutions/pharmaceutical-manufacturing/improved-manufacturing-processes-with-sterile-solutions/whitepaper-winning-combination): - [用于大容量 SC 注射的 cartriQ® 集成 | SCHOTT Pharma](https://www.schott-pharma.com/zh/pharma-solutions/drug-packaging/large-volume-biologics/cartriq-integration-sterile-large-volume): cartriQ® 集成实现了大容量生物制剂的安全稳定皮下输送，支持患者友好的居家给药 - [生物制剂与生物仿制药——从研发到法规合规 | SCHOTT医药](https://www.schott-pharma.com/zh/pharma-solutions/drug-packaging/biologics-biosimilars): 生物制剂和生物仿制药带来了新的挑战：了解如何将它们推向市场，涵盖从初级包装解决方案的研究到法规合规的全过程。 - [USP <382> 功能测试解决方案 | SCHOTT 医药](https://www.schott-pharma.com/zh/pharma-solutions/pharma-services/usp-382): 对完全组装的药物灌装系统进行严格的 USP <382> 测试，涵盖从包装完整性和 CCI 检查到碎裂分析全过程 - [大容量生物制品 | SCHOTT医药](https://www.schott-pharma.com/zh/pharma-solutions/drug-packaging/large-volume-biologics): SCHOTT Pharma 为笔式注射器、自动注射器、体穿式给药系统和输液泵提供多种初级包装解决方案 - [肖特mRNA疫苗包装解决方案-低温安全存储mRNA-预灌封注射器| 肖特医药 ](https://www.schott-pharma.com/zh/pharma-solutions/drug-packaging/storage-of-mrna-drugs): 肖特针对低温mRNA应用,提供多种规格注射剂瓶,TOPPAC聚合物预灌封注射器和syriQ玻璃预灌封注射器.为mRNA技术各生命周期提供医药包装解决与容器相容性测试,加快上市速度. - [糖尿病治疗 | 肖特医药](https://www.schott-pharma.com/zh/pharma-solutions/drug-packaging/diabetes-treatment): 肖特医药为基于 GLP-1 的糖尿病治疗提供多种药物包装和给药解决方案 - [肖特药品包装追踪-智能药品追踪-数据代码追溯药品容器 | 肖特医药 ](https://www.schott-pharma.com/zh/pharma-solutions/pharmaceutical-manufacturing/track-and-trace-individual-container): 肖特医药提供基于药品容器的包装追踪解决方案与数据代码技术,实现药品跟踪与追溯,降低混淆风险,优化药品灌装和封装过程,确保药品从生产到最终用户全生命周期追踪. - [药物申报准备 | 肖特医药](https://www.schott-pharma.com/zh/pharma-solutions/pharma-services/drug-submission-preparation): 肖特医药提供全面的药品包装测试服务，确保完全合规和患者安全 - [肖特药物灌装效率优化-EVERIC strong smooth注射剂瓶 | 肖特医药 ](https://www.schott-pharma.com/zh/pharma-solutions/pharma-services/filling-line-efficiency): 肖特医药为优化药物灌装封装效率,推出专利产品SmartSkin复制容器和EVERIC strong&smooth注射剂瓶医药包装方案.实现生产实时监测,提升注射剂瓶强度,减少损坏,提升生产效率. - [肖特药物防污染-药物污染风险解决方案-iQ Integribag包装 | 肖特医药 ](https://www.schott-pharma.com/zh/pharma-solutions/platforms/contamination-risk-mitigation): 肖特医药为降低污染风险,为制药行提供药物包装防污染解决方案,运用iQ Integribag双层袋包装系统支持非接触式运输,解决运输过程中的污染风险,增加药物稳定性与安全性. - [肥胖症治疗 | 肖特医药](https://www.schott-pharma.com/zh/pharma-solutions/drug-packaging/obesity-treatment): 肖特医药为基于 GLP-1 的肥胖症药物提供多种药品包装和给药解决方案，可安全有效地完成灌装、储存和给药过程 - [抗体偶联药物包装 |SCHOTT医药](https://www.schott-pharma.com/zh/pharma-solutions/drug-packaging/antibody-drug-conjugates): 通过确保生物稳定性、支持冻干配方并保持 ADC 完整性的包装，应对抗体-药物偶联物 （ADC） 挑战 - [《寻找完美匹配》白皮书 I 肖特医药](https://www.schott-pharma.com/zh/solutions/fill-and-finish/improved-manufacturing-processes-with-sterile-solutions/whitepaper-finding-the-perfect-match): - [《标准化包装解决方案》白皮书 I 肖特医药](https://www.schott-pharma.com/zh/solutions/fill-and-finish/improved-manufacturing-processes-with-sterile-solutions/whitepaper-standardized-packaging): - [《成功的组合》白皮书 I 肖特医药](https://www.schott-pharma.com/zh/solutions/fill-and-finish/improved-manufacturing-processes-with-sterile-solutions/whitepaper-winning-combination): - [肖特玻璃脱片控制-EVERIC pure注射剂瓶改善可浸出物水平 | 肖特医药](https://www.schott-pharma.com/zh/solutions/perfect-fit/delamination-control): 肖特医药针对玻璃脱片难题,推出EVERIC pure注射剂瓶,通过优化瓶跟区域,全面降低脱片风险,为制药行业提供可靠的医药包装和给药解决方案,保障患者安全. - [肖特药物防污染-药物污染风险解决方案-iQ Integribag包装 | 肖特医药 ](https://www.schott-pharma.com/zh/solutions/fill-and-finish/contamination-risk-mitigation): 肖特医药为降低污染风险,为制药行提供药物包装防污染解决方案,运用iQ Integribag双层袋包装系统支持非接触式运输,解决运输过程中的污染风险,增加药物稳定性与安全性. - [肖特药物灌装效率优化-EVERIC strong smooth注射剂瓶 | 肖特医药 ](https://www.schott-pharma.com/zh/solutions/fill-and-finish/filling-line-efficiency): 肖特医药为优化药物灌装封装效率,推出专利产品SmartSkin复制容器和EVERIC strong&smooth注射剂瓶医药包装方案.实现生产实时监测,提升注射剂瓶强度,减少损坏,提升生产效率. - [肖特药品包装追踪-智能药品追踪-数据代码追溯药品容器 | 肖特医药 ](https://www.schott-pharma.com/zh/solutions/fill-and-finish/track-and-trace-individual-container): 肖特医药提供基于药品容器的包装追踪解决方案与数据代码技术,实现药品跟踪与追溯,降低混淆风险,优化药品灌装和封装过程,确保药品从生产到最终用户全生命周期追踪. - [生物制剂与生物仿制药——从研发到法规合规 | SCHOTT医药](https://www.schott-pharma.com/zh/solutions/biologics-biosimilars): 生物制剂和生物仿制药带来了新的挑战：了解如何将它们推向市场，涵盖从初级包装解决方案的研究到法规合规的全过程。 - [抗体偶联药物包装 |SCHOTT医药](https://www.schott-pharma.com/zh/solutions/antibody-drug-conjugates): 通过确保生物稳定性、支持冻干配方并保持 ADC 完整性的包装，应对抗体-药物偶联物 （ADC） 挑战 - [EVERIC® 西林瓶 | SCHOTT 医药](https://www.schott-pharma.com/zh/solutions/perfect-fit/everic-vial-solutions): SCHOTT Pharma 的 EVERIC® 注射剂瓶采用灵活的模块化设计，兼顾制造商与用户对优化性能的需求。 - [小批量包装解决方案 | SCHOTT 医药](https://www.schott-pharma.com/zh/solutions/fill-and-finish/small-batch-packaging-solutions): SCHOTT Pharma 的小批量包装解决方案可确保可靠的药物容器密封性和给药性能，并从一开始就提供最佳的无菌保护。 - [用于大容量 SC 注射的 cartriQ® 集成 | SCHOTT Pharma](https://www.schott-pharma.com/zh/solutions/safe-and-easy-administration/large-volume-injections-biologics/cartriq-integration-sterile-large-volume): cartriQ® 集成实现了大容量生物制剂的安全稳定皮下输送，支持患者友好的居家给药 - [优化的聚合物注射器巢设计 | SCHOTT 医药](https://www.schott-pharma.com/zh/solutions/fill-and-finish/optimized-polymer-syringe-nest-design): SCHOTT Pharma 的新型巢盒系统是全球首款可容纳 160 支聚合物注射器的系统，能够缩短周期时间并降低成本，同时提升高速灌装与封装生产线的效率。 - [大容量生物制品 | SCHOTT医药](https://www.schott-pharma.com/zh/solutions/safe-and-easy-administration/large-volume-injections-biologics): SCHOTT Pharma 为笔式注射器、自动注射器、体穿式给药系统和输液泵提供多种初级包装解决方案 - [肖特mRNA疫苗包装解决方案-低温安全存储mRNA-预灌封注射器| 肖特医药 ](https://www.schott-pharma.com/zh/solutions/perfect-fit/storage-of-mrna-drugs): 肖特针对低温mRNA应用,提供多种规格注射剂瓶,TOPPAC聚合物预灌封注射器和syriQ玻璃预灌封注射器.为mRNA技术各生命周期提供医药包装解决与容器相容性测试,加快上市速度. - [肥胖症治疗 | 肖特医药](https://www.schott-pharma.com/zh/solutions/safe-and-easy-administration/obesity-treatment): 肖特医药为基于 GLP-1 的肥胖症药物提供多种药品包装和给药解决方案，可安全有效地完成灌装、储存和给药过程 - [糖尿病治疗 | 肖特医药](https://www.schott-pharma.com/zh/solutions/safe-and-easy-administration/diabetes-treatment): 肖特医药为基于 GLP-1 的糖尿病治疗提供多种药物包装和给药解决方案 - [USP <382> 功能测试解决方案 | SCHOTT 医药](https://www.schott-pharma.com/zh/solutions/perfect-fit/usp-382): 对完全组装的药物灌装系统进行严格的 USP <382> 测试，涵盖从包装完整性和 CCI 检查到碎裂分析全过程 - [肖特低浸出物水平注射剂瓶-低灌装量药物包装解决方案 | 肖特医药](https://www.schott-pharma.com/zh/solutions/perfect-fit/drug-stability-low-fill-volumes): 肖特医药推出的EVERIC pure注射剂瓶,能够有效解决低灌装量药物的浸出物问题,提供药物稳定性解决方案,保障低灌装量注射剂的安全储存与高效给药,满足您的医药包装需求 - [药物申报准备 | 肖特医药](https://www.schott-pharma.com/zh/solutions/perfect-fit/drug-submission-preparation): 肖特医药提供全面的药品包装测试服务，确保完全合规和患者安全 - [肖特医药包装-生物技术药品容器-敏感药品包装解决方案 | 肖特医药 ](https://www.schott-pharma.com/zh/solutions/perfect-fit/drug-container-interaction-biotechs): 肖特医药为制药行业和新兴生物技术提供药物包装解决方案,解决包括浸出物,蛋白质吸附,雾化爬壁,pH值偏移,玻璃脱片,铝敏感及放射性等七大问题,保障敏感药物的稳定性与安全性. - [肖特医药包装-专业药物储存与包装解决方案-药物包装支持 | 肖特医药](https://www.schott-pharma.com/zh/solutions): 肖特医药为制药行业提供专业的药物包装和给药解决方案,助力解决包括药物与容器互相作用,mRNA低温存储,玻璃脱片,低灌装量下药物稳定性,污染风险和药物追溯等六大挑战. ## 专业知识 | SCHOTT Pharma 的制药专业知识页面展示了其在药物包装、给药系统、监管支持和生产优化方面的深厚行业知识，提供洞察、最佳实践和专家指导，协助合作伙伴解决制药和生物技术领域的复杂挑战。 - [术语表 | 肖特医药](https://www.schott-pharma.com/zh/pharma-expertise/information-center/glossary): 肖特医药的术语表包含药用包装行业中使用的最重要的关键词、缩略词和一般术语。 - [您的制药知识库 | SCHOTT Pharma](https://www.schott-pharma.com/zh/pharma-expertise/information-center): - [肖特医药包装知识平台-药物包装和给药知识-医药博客 | 肖特医药 ](https://www.schott-pharma.com/zh/pharma-expertise): 探索肖特医药解决方案,从医药术语表到创新医药世界.了解肖特提供的领先包装技术与服务,查看肖特全球合规性证书与博客 ## SCHOTT Pharmaversity® | SCHOTT Pharma 的 SCHOTT Pharmaversity 页面重点展示了针对制药和生物技术专业人士的教育课程、培训项目以及专家见解，旨在提升技能、深化行业知识，并支持药品包装与给药领域的最佳实践。 - [药学院® | 医药教育](https://www.schott-pharma.com/zh/pharma-expertise/schott-pharmaversity): 有关行业主题的宝贵见解，请探索Pharmaversity®，在领先的玻璃与聚合物专家的帮助下，拓展您的制药教育。 ## SCHOTT Pharma博客 - [容器密封完整性（CCI） | SCHOTT医药](https://www.schott-pharma.com/zh/pharma-expertise/information-center/blog/container-closure-integrity): 了解完美的注射剂瓶、瓶塞和密封组合如何确保容器密封完整性，防止瓶塞弹出/脱落，并提升灌装与封装效率。 - [器械开发的模式转变 I 肖特医药](https://www.schott-pharma.com/zh/pharma-expertise/information-center/blog/a-paradigm-shift-in-device-development): Tom van Ginneken 介绍了聚合物作为理想个性化容器所具有的优势。 - [智能初级包装容器的核心优势 | SCHOTT医药](https://www.schott-pharma.com/zh/pharma-expertise/information-center/blog/advantages-smart-primary-packaging): SCHOTT Pharma 智能容器通过激光标记唯一代码，实现整个灌装与封装流程的高度可追溯性。 - [什么是容器密封完整性检测 | SCHOTT 医药](https://www.schott-pharma.com/zh/pharma-expertise/information-center/blog/what-is-container-closure-integrity-testing): 确保容器密封件及容器本身的完整性，对于维持抵御潜在污染物的无菌屏障并消除泄漏风险至关重要。本文将概述容器密封完整性测试（CCIT）及其关键意义。 - [闭环回收 | 药品包装](https://www.schott-pharma.com/zh/pharma-expertise/information-center/blog/closed-loop-recycling-initiative): 了解药品运输包装中的闭环回收如何减少原生塑料需求。 - [生物类似药和仿制药 | SCHOTT医药](https://www.schott-pharma.com/zh/pharma-expertise/information-center/blog/biosimilars-generics): 主要行业趋势，以及在不断变化的制药领域中选择正确初级包装的优势 - [什么是注射剂瓶以及如何选择合适的注射剂瓶 | SCHOTT 医药](https://www.schott-pharma.com/zh/pharma-expertise/information-center/blog/what-is-a-vial): 什么是注射剂瓶？了解注射剂瓶的成分、类型和制药应用，以及如何选择合适的注射剂瓶 - [SCHOTT Pharma 重新定义医疗健康](https://www.schott-pharma.com/zh/pharma-expertise/information-center/blog/redefining-healthcare-the-power-of-large-volume-sterile-cartridges): 使用大容量无菌卡式瓶重新定义医疗保健，实现更便捷、经济高效的皮下给药及居家自我给药。 - [临床试验失败的原因 | SCHOTT医药](https://www.schott-pharma.com/zh/pharma-expertise/information-center/blog/why-clinical-trials-fail): 临床试验的常见陷阱与关键挑战，以及正确的包装选择如何降低风险并提升成功率 - [视觉检测系统 | SCHOTT 医药](https://www.schott-pharma.com/zh/pharma-expertise/information-center/blog/container-quality-automated-visual-inspection-systems): 通过自动化视觉检测系统提升药品容器质量 - [假药 | SCHOTT Pharma](https://www.schott-pharma.com/zh/pharma-expertise/information-center/blog/counterfeit-drugs-protecting-patients): SCHOTT Pharma 以患者健康为首要考量，推出 Ampoules AC！了解如何防护患者免受假药危害。 - [SCHOTT Pharma 的多样性与包容性](https://www.schott-pharma.com/zh/pharma-expertise/information-center/blog/diversity-and-inclusion-at-schott-pharma): SCHOTT Pharma 的多元化与包容性是公司成功的关键，也是推动团队投入的动力。 - [玻璃瓶即平台 | SCHOTT医药](https://www.schott-pharma.com/zh/pharma-expertise/information-center/blog/drug-development-efficiency-vial-as-platform): 预先测试的包装解决方案（如 Vial 作为平台）如何提升药物开发效率并增强生产安全性 - [制药产品设计：对患者安全，对地球可持续 I SCHOTT Pharma](https://www.schott-pharma.com/zh/pharma-expertise/information-center/blog/pharmaceutical-product-design): 了解 SCHOTT 医药如何整合生态设计，打造既保障患者安全又促进环境可持续性的药品。了解我们对 2030 年前实现气候中和的承诺。 - [使用 RTU 包装降低总拥有成本 I 肖特医药](https://www.schott-pharma.com/zh/pharma-expertise/information-center/blog/reducing-total-cost-of-ownership-with-rtu-packaging): 了解肖特医药 adaptiQ 免洗免灭玻璃注射剂瓶如何降低总拥有成本，提高药物稳定性并提高药品质量。 - [设计通向净零排放注射装置的路线 | 肖特医药](https://www.schott-pharma.com/zh/pharma-expertise/information-center/blog/designing-a-pathway-towards-net-zero-injection-devices): 在肖特医药，我们相信净零排放产品需要坚实的跨行业合作。 - [卡扣式注射剂瓶 | SCHOTT 医药](https://www.schott-pharma.com/zh/pharma-expertise/information-center/blog/snap-on-vials): SCHOTT Pharma 生产由高品质 FIOLAX® 玻璃管制成的卡扣式注射剂瓶，与制药应用中的各种组件具有出色的兼容性。 - [如何为灌装线选好安瓿瓶 | 肖特医药](https://www.schott-pharma.com/zh/pharma-expertise/information-center/blog/如何为您的灌装线选好安瓿瓶): 了解如何为您的灌装线选好安瓿瓶 了解不同的安瓿瓶及其适用的各类灌封设备。 - [最佳安瓿瓶折断系统 | SCHOTT 医药](https://www.schott-pharma.com/zh/pharma-expertise/information-center/blog/ampoules-break-systems): 阅读 Schott Pharma 的博客文章，了解如何为您的安瓿瓶选择最佳的折断系统！ - [减少制药行业免洗免灭包装中颗粒的 5 个步骤](https://www.schott-pharma.com/zh/pharma-expertise/information-center/blog/5-steps-for-particle-reduction-in-rtu-packaging): 通过关于如何有效减少微粒污染的指南，确保减少免洗免灭包装的微粒并符合 GMP 附件 I 的要求。 - [免洗免灭容器如何加快上市时间？](https://www.schott-pharma.com/zh/pharma-expertise/information-center/blog/how-rtu-packaging-fasten-time-to-market): 了解免洗免灭容器如何加快上市时间，提高现金流和专利期限，同时保持卓越的质量。 - [安瓿瓶如何成为广受世界欢迎的药物初级包装 | 肖特医药](https://www.schott-pharma.com/zh/pharma-expertise/information-center/blog/how-ampoules-became-the-worlds-most-popular-primary-packaging-for-drugs): 肖特医药介绍了安瓿瓶如何从第三世纪的盛血容器发展成为广受世界欢迎的药物初级包装 - [如何使用免洗免灭包装优化灌装与封装 I 肖特医药](https://www.schott-pharma.com/zh/pharma-expertise/information-center/blog/how-to-optimize-fill-and-finish-processes-with-sterile-drug-containment-solutions): 了解免洗免灭包装如何优化灌装与封装过程、降低价值链复杂性、确保患者安全并加快上市。 - [玻璃制药标准 – 专用测试策略](https://www.schott-pharma.com/zh/pharma-expertise/information-center/blog/rethinking-pharmaceutical-standards-for-glass-dedicated-testing-strategies): 美国药典旨在为包装和储存要求提供更大的灵活性。详细了解测试策略所面临的挑战。 - [如何使用预灌封注射器 | SCHOTT 医药](https://www.schott-pharma.com/zh/pharma-expertise/information-center/blog/how-to-use-a-prefilled-syringe): 预灌封玻璃注射器（PFS）可一步完成注射药物的给药。进一步了解如何使用预灌封注射器及其应用！ - [拜耳的初级包装创新解决方案 | 肖特医药](https://www.schott-pharma.com/zh/pharma-expertise/information-center/blog/primary-packaging-solution-for-bayer): 拜耳与肖特医药进行战略合作，使用创新的初级包装解决方案，以更安全、更快速的方式上市了生物技术药物。 - [可提取物检测解释 I 肖特医药](https://www.schott-pharma.com/zh/pharma-expertise/information-center/blog/what-is-extractables-testing): 可提取物检测用于识别和分析潜在有害材料。本文重点介绍可提取物检测及其在制药行业中的作用 - [药品容器如何提升药物稳定性](https://www.schott-pharma.com/zh/pharma-expertise/information-center/blog/how-can-pharmaceutical-drug-containers-enhance-drug-stability): 通过专用药物容器和药用玻璃类型提升药物稳定性，以找到理想的容器。 - [免洗免灭包装无菌性的验证和维护 | 肖特医药](https://www.schott-pharma.com/zh/pharma-expertise/information-center/blog/validate-sterility-rtu-packaging): 详细了解药物包装的灭菌方法以及如何通过免洗免灭（RTU）容器的无菌保证水平（SAL）来量化无菌性。 - [免洗免灭药用包装的无菌性 | 肖特医药](https://www.schott-pharma.com/zh/pharma-expertise/information-center/blog/sterilization-types-pharmaceutical-industry): 为了确保受到严格管控的无菌水平，免洗免灭药用包装领域会采用不同的技术。 - [mRNA药物如何改变药物内包材 I 肖特医药](https://www.schott-pharma.com/zh/pharma-expertise/information-center/blog/how-mrna-drugs-change-pharmaceutical-primary-packaging): 本文探讨了在mRNA药物新时代下，影响药品初包装的相关因素 - [将 mRNA 新冠疫苗从注射剂瓶转移到预灌封注射器 | 肖特医药](https://www.schott-pharma.com/zh/pharma-expertise/information-center/blog/from-vial-to-prefilled-syringe-mrna): 随着新冠疫情的不断发展，肖特医药研究预灌封注射器是否比用于疫苗容器的多剂量注射剂瓶更合适。 - [解决生物技术领域的药物容器挑战 | SCHOTT 医药](https://www.schott-pharma.com/zh/pharma-expertise/information-center/blog/solving-biotech-drug-containment-challenges): 药物配方的增长对药用玻璃瓶的灌装和处理提出了挑战，而 EVERIC® 则满足了这一需求。 - [肖特医药博客-专业医药知识库 | 肖特医药 ](https://www.schott-pharma.com/zh/pharma-expertise/information-center/blog): 肖特医药博客聚焦制药企业热门主题,提供安瓿瓶选型,无菌玻璃注射剂瓶成本控制,免洗免灭包装优化等专业内容, 帮助您了解更多医药发展趋势及服务信息 ## SCHOTT Pharma Academy/活动/证书 | SCHOTT Pharma 的制药专业知识资源涵盖通过 Pharmaversity Academy 提供的教育项目、活动和培训，并可获取证书及行业信息，助力制药和生物技术合作伙伴提升知识、技能和合规能力。 - [肖特医药证书-医药证书下载-玻璃技术证书-医药包装证书 | 肖特医药 ](https://www.schott-pharma.com/zh/pharma-expertise/information-center/certificates): 肖特医药证书,下载全球工厂的医药合规性证书和相关文档,包括亚洲,欧洲,北美洲和南美洲各个国家和地区的包装证书,玻璃技术证书等. ## SCHOTT医药 关于我们 | SCHOTT Pharma 的“关于我们”页面聚焦于公司的使命、价值观和历史，突出其在药物包装与给药领域的作用、对质量与创新的承诺、全球布局，以及对制药和生物技术合作伙伴提升医疗健康成果的支持。 - [因为人类健康至关重要 | 肖特医药](https://www.schott-pharma.com/zh/about-us/because-human-health-matters): 与您一起——我们的客户和合作伙伴——共同致力于提供最佳的患者体验。原因很简单——因为人体健康至关重要。 - [关于肖特医药-百年医药包装品牌历史 | 肖特医药 ](https://www.schott-pharma.com/zh/about-us): 肖特医药致力于为全世界人们提供以科学为基石的专业医疗包装解决方案.点击查看全球范围内肖特医药办事处 ## SCHOTT Pharma 媒体发布 | SCHOTT Pharma 的新闻与媒体页面汇集了关于创新、扩张、合作伙伴关系、绩效等方面的最新新闻稿、公司动态、财务业绩、活动及行业公告，帮助制药和生物技术领域的利益相关者及时掌握最新进展。 - [肖特医药媒体资料包下载 | 肖特医药 ](https://www.schott-pharma.com/zh/news-and-media/media-kits): 一站式获取肖特医药最新媒体资料包,包含高清品牌图片,肖特医药新闻故事.点击获取更多一手媒体资料 - [肖特医药展会与活动-全球行业会议及展览动态|肖特医药 ](https://www.schott-pharma.com/zh/news-and-media/fairs-and-events): 肖特医药的业务遍及13个国家/地区,并参与众多行业活动、展会和相关会议.点击查看我们的活动日历,随时了解最新动态 - [肖特医药新闻与媒体联系垂询 | 肖特医药 ](https://www.schott-pharma.com/zh/news-and-media/inquiry): 如要获取有关媒体新闻稿或有关肖特医药的详细信息,填写下方表格与肖特医药媒体团队获得联系 - [肖特医药新闻与媒体垂询 | 肖特医药 ](https://www.schott-pharma.com/zh/news-and-media/contacts): 简单填写表格,获取与肖特医药媒体团队的联系,欢迎垂询相关信息 - [媒体新闻稿：肖特任命肖特医药股份公司监事会 | SCHOTT](https://www.schott-pharma.com/zh/news-and-media/media-releases/2023/schott-appoints-supervisory-board-of-schott-pharma-ag-and-co-kgaa): 肖特任命肖特医药股份公司监事会 - [肖特医药与匈牙利政府合作扩大生产](https://www.schott-pharma.com/zh/news-and-media/media-releases/2022/schott-and-hungarian-government-invest-in-cutting-edge-syringe-production): 肖特在匈牙利卢卡奇哈佐工厂投资7600万欧元建造全新生产设施，以满足全球对玻璃预灌封注射器的需求 - [肖特医药计划扩大卡式瓶生产 | SCHOTT](https://www.schott-pharma.com/zh/news-and-media/media-releases/2022/schott-pharma-expands-cartridge-production-in-china-and-hungary): 肖特医药上千万欧元投资将显著提高药用卡式瓶在匈牙利和中国的产能 - [肖特宣布投资免洗免灭卡式瓶生产 | 肖特](https://www.schott-pharma.com/zh/news-and-media/media-releases/2022/schott-announces-double-digit-million-euro-investment-in-ready-to-use-cartridge-production): 媒体新闻稿：肖特数千万欧元投资将显著扩大其免洗免灭 卡式瓶的产能 - [肖特医药新闻与媒体中心| 肖特医药 ](https://www.schott-pharma.com/zh/news-and-media/media-releases): 点击查看肖特医药官方新闻稿,第一时间获取产品上市,法规更新,战略合作及可持续发展等权威资讯 - [新闻稿 | 肖特医药在首次公开募股后全年盈利增长强劲，达到其预期的上限](https://www.schott-pharma.com/zh/news-and-media/media-releases/2023/schott-pharma-delivers-right-after-ipo-with-strong-profitable-growth-for-the-full-year): 肖特医药在首次公开募股后全年盈利增长强劲，达到其预期的上限 | 新闻稿 - [媒体发布 | 使用肖特医药免洗免灭卡式瓶推进 GLP-1 治疗、胰岛素和大容量注射](https://www.schott-pharma.com/zh/news-and-media/media-releases/2023/advancing-treatments-with-ready-to-use-cartridges-from-schott-pharma): 使用肖特医药的免洗免灭卡式瓶推进 GLP-1 治疗、胰岛素和大容量注射 | 媒体发布 - [新闻稿 | 肖特为其医药业务成立独立公司，推动进一步发展](https://www.schott-pharma.com/zh/news-and-media/media-releases/2022/schott-establishes-stand-alone-company-for-pharma-business-to-promote-further-growth): 肖特为其医药业务成立独立公司，推动进一步发展 | 新闻稿 - [新闻稿 | 独立一周年：肖特医药继续巩固行业领先地位](https://www.schott-pharma.com/zh/news-and-media/media-releases/2023/schott-pharma-strengthens-leading-position-in-the-first-year-as-stand-alone-company): Andreas Reisse 回顾了肖特医药成为独立实体后的第一年历程，认为该公司定位良好，能够充分利用市场的长期趋势。独立一周年：肖特医药继续巩固行业领先地位 - [新闻稿 | 保持势头：肖特医药2023上半财年保持强劲增长势头](https://www.schott-pharma.com/zh/news-and-media/media-releases/2023/upholding-momentum-schott-pharma-sustains-strong-growth-in-the-first-half-of-fy-2023): 保持势头：肖特医药上半个 2023 财年保持强劲增长势头 | 新闻稿 - [媒体中心-肖特医药,Corplez和武田制药成功展示闭环回收系统 | 肖特医药 ](https://www.schott-pharma.com/zh/news-and-media/media-releases/2024/schott-pharma-corplex-and-takeda-successfully-demonstrated-closed-loop-recycling): 肖特医药,Corplex与武田制药共同演示如何以90% 回收料制成全新注射剂瓶实现注射类药物包装的闭环循环,降低碳排与原料消耗,了解技术细节与下一步商业化计划 - [肖特推出 iQ® Integribag | SCHOTT](https://www.schott-pharma.com/zh/news-and-media/media-releases/2022/schott-launches-iq-integribag): 肖特的非接触式运输解决方案为免洗免灭药物包装和给药解决方案提供更高水平的无菌完整性 - [媒体发布 | 净零排放供应链：肖特医药启动下一阶段脱碳计划](https://www.schott-pharma.com/zh/news-and-media/media-releases/2024/schott-pharma-launches-next-phase-of-decarbonizing-program): 净零排放供应链：肖特医药开启脱碳计划的下一阶段 | 媒体发布 - [新闻稿 | 在低温条件下保护药物：肖特医药推出适用于 mRNA 药物和基因治疗的全新注射剂瓶](https://www.schott-pharma.com/zh/news-and-media/media-releases/2024/schott-pharma-launches-new-vials-for-mrna-and-gene-therapy): 在低温环境下保护药物：肖特医药推出用于 mRNA 药物和基因治疗的全新注射剂瓶 | 新闻稿 - [新闻稿 | 肖特医药实现 2023 年目标，继续保持盈利增长轨迹](https://www.schott-pharma.com/zh/news-and-media/media-releases/2024/schott-pharma-delivers-on-2023-targets-and-continues-profitable-growth-trajectory): 肖特医药实现 2023 年目标，继续保持盈利增长轨迹 - [新闻稿 | 认真履行责任：肖特医药发布首份可持续发展报告](https://www.schott-pharma.com/zh/news-and-media/media-releases/2024/schott-pharma-releases-first-sustainability-report): 认真履行责任：肖特医药发布首份可持续发展报告 | 新闻稿 - [肖特医药最先进的生产基地在匈牙利启用 | SCHOTT](https://www.schott-pharma.com/zh/news-and-media/media-releases/2022/schott-pharma-breaks-ground-for-cutting-edge-production-in-hungary): 位于匈牙利Lukácsháza的全新玻璃预灌封注射器生产基地开始施工，这是肖特医药全球生产网络新增的第二家工厂 - [媒体新闻稿：肖特医药 2022 财年的强劲财务业绩表现 | SCHOTT](https://www.schott-pharma.com/zh/news-and-media/media-releases/2023/schott-pharma-with-strong-financial-performance-in-fiscal-year-2022): 详细了解肖特医药 2022 财年的业务发展 - [新闻稿 | 肖特医药成功实施扩张战略，在塞尔维亚投资建造新工厂](https://www.schott-pharma.com/zh/news-and-media/media-releases/2023/schott-pharma-invests-in-a-new-production-facility-in-serbia): 肖特医药成功实施扩张战略，在塞尔维亚投资建造新工厂 | 新闻稿 - [肖特报告称其制药事业部度过了辉煌的一年 | 肖特](https://www.schott-pharma.com/zh/news-and-media/media-releases/2022/schott-reports-successful-year-for-pharma-business-unit): 媒体新闻稿： 肖特的制药事业部在 2021 年取得了巨大成功，并希望在此成功基础上再接再厉 - [肖特医药新闻与媒体中心-医药行业动态与洞察| 肖特医药 ](https://www.schott-pharma.com/zh/news-and-media): 点击获取肖特医药官方新闻稿,媒体资料,行业报告及活动预告,随时了解医药包装创新,法规更新与可持续发展 ## SCHOTT医药可持续发展 | SCHOTT Pharma 的可持续发展页面概述了公司在环境和社会责任方面的举措，包括气候行动目标、资源效率、道德供应链以及社区参与，旨在支持可持续医疗保健并实现长期影响。 - [可持续性产品](https://www.schott-pharma.com/zh/about-us/sustainability/sustainable-products): 肖特医药致力于通过可持续的产品设计、供应链优化和合作伙伴关系减少对环境的影响。我们致力于采用环保材料和生命周期管理，为气候变化解决方案做出贡献。 - [合规 | SCHOTT医药](https://www.schott-pharma.com/zh/about-us/sustainability/compliance): 您需要了解的关于 SCHOTT 医药合规政策的所有信息，包括其行为准则、道德商业规范、社会责任以及公司治理。 - [可持续发展 | SCHOTT Pharma](https://www.schott-pharma.com/zh/about-us/sustainability): 了解 SCHOTT Pharma 如何通过负责任的商业实践、气候行动、循环经济举措以及资源效率，推动其整个价值链的可持续发展。 ## SCHOTT Pharma 其他页面 - [时事通讯 | 肖特医药](https://www.schott-pharma.com/zh/newsletter): - [网站数据保护政策 | 肖特医药 ](https://www.schott-pharma.com/zh/data-protection-policy): 点击了解更多有关肖特数据保护政策的信息,包括我们将如何控制您的个人数据以及您对保护自己数据的权利 - [肖特医药网站说明 | 肖特医药 ](https://www.schott-pharma.com/zh/imprint): 查阅肖特医药的网站说明与法律信息 - [条款与条件 | SCHOTT医药](https://www.schott-pharma.com/zh/general-terms-and-conditions): 了解 SCHOTT Pharma 的全球产品交付与销售条款和条件，支持多种语言版本。立即下载相关文件。 - [肖特医药免责声明-肖特医药法律信息-肖特版权-肖特商标保护| 肖特医药 ](https://www.schott-pharma.com/zh/disclaimer): 肖特网站内所有法律信息仅适用肖特本品牌网站,产品及服务介绍不等于销售要约,不承担任何下载和AI翻译风险,肖特网站所有内容和肖特商标严禁擅用 ## Portuguese ## Produtos | A página de Produtos da SCHOTT Pharma oferece uma visão geral de seu portfólio de contenção e administração de medicamentos, incluindo seringas de vidro e polímero pré-envasadas, carpules, frascos e ampolas, todos desenvolvidos para fabricantes farmacêuticos e de biotecnologia. - [Carpules | Carpules RTU | SCHOTT Pharma](https://www.schott-pharma.com/pt/produtos/carpules-farmaceuticos): De RTU a cartriQ® e TOPPAC®, os carpules SCHOTT Pharma garantem doses precisas com soluções versáteis para qualquer aplicação farmacêutica. - [Ampolas de Vidro para Medicamentos](https://www.schott-pharma.com/pt/produtos/ampolas): Ampolas SCHOTT Pharma oferecem alta resistência química, precisão dimensional, controle cosmético rigoroso e estabilidade para medicamentos. - [Seringas | SCHOTT Pharma](https://www.schott-pharma.com/pt/produtos/seringas): A linha de seringas da SCHOTT Pharma garante armazenamento estável e aplicação segura de medicamentos com solução pronta para envasar. - [Frascos SCHOTT Farmacêuticos | SCHOTT](https://www.schott-pharma.com/pt/produtos/frascos): Frascos da SCHOTT Pharma aumentam a estabilidade dos medicamentos e otimizam processos de envase e acabamento com eficiência. - [Produtos | SCHOTT Pharma](https://www.schott-pharma.com/pt/produtos): SCHOTT Pharma oferece ampla linha de embalagens: seringas, ampolas, carpules e frascos de vidro e polímero para aplicações farmacêuticas diversas. ## Seringas | A página de seringas da SCHOTT Pharma apresenta suas soluções de seringas farmacêuticas pré-envasadas, fabricadas em vidro e polímero avançado, para armazenamento e administração segura de medicamentos. Destaca as seringas syriQ® e SCHOTT TOPPAC®, desenvolvidas para reduzir erros, aumentar a segurança e atender a uma ampla variedade de aplicações, desde vacinas até produtos biológicos. - [SCHOTT TOPPAC® unique](https://www.schott-pharma.com/pt/produtos/seringas/schott-toppac-unique): Recipientes para medicamentos de polímero prontos para uso e pré-carregáveis, com recursos e dimensões personalizáveis para tratamentos médicos individualizados - [syriQ®](https://www.schott-pharma.com/pt/produtos/seringas/syriq): As seringas de vidro pré-carregáveis syriQ® garantem segurança e eficiência para uma ampla variedade de vacinas inativadas, vivas atenuadas, conjugadas e de mRNA - [SCHOTT TOPPAC®](https://www.schott-pharma.com/pt/produtos/seringas/schott-toppac): Seringas pré-carregáveis da SCHOTT Pharma oferecem solução versátil para armazenar e administrar medicamentos com segurança a longo prazo. - [SCHOTT TOPPAC® infuse](https://www.schott-pharma.com/pt/produtos/seringas/schott-toppac-infuse): Seringas de polímero prontas para envasar com alta estabilidade, propriedades de barreira e adaptador Luer Lock de fácil conexão para terapia de infusão - [syriQ BioPure®](https://www.schott-pharma.com/pt/produtos/seringas/syriq-biopure): As seringas syriQ BioPure® foram especialmente desenvolvidas para medicamentos biotecnológicos complexos, com mínima interação entre medicamento e recipiente - [syriQ BioPure® silicone-free](https://www.schott-pharma.com/pt/produtos/seringas/syriq-biopure-sem-silicone): Seringas sem silicone desenvolvidas para produtos sensíveis, com alta estabilidade e força de deslizamento consistente durante a vida útil do medicamento - [SCHOTT TOPPAC® cosmetic](https://www.schott-pharma.com/pt/produtos/seringas/schott-toppac-cosmetic): As seringas prontas para uso SCHOTT TOPPAC® cosmetic foram desenvolvidas para tratamentos estéticos que envolvem ácido hialurônico e toxina botulínica (BoNT) - [SCHOTT TOPPAC® freeze](https://www.schott-pharma.com/pt/produtos/seringas/toppac-seringas-de-congelamento): A seringa de congelamento SCHOTT TOPPAC® freeze é a solução perfeita para medicamentos que requerem armazenamento em baixa temperatura. Explore agora mesmo! ## Carpules | A página Cartuchos farmacêuticos da SCHOTT Pharma apresenta suas soluções de cartuchos de vidro e polímero para dosagem precisa de medicamentos em canetas, autoinjetores e sistemas vestíveis. O portfólio inclui opções prontas para uso, de câmara dupla e de alta durabilidade, desenvolvidas para terapias injetáveis e produtos biológicos. - [Carpule de polímero SCHOTT TOPPAC](https://www.schott-pharma.com/pt/produtos/carpules-farmaceuticos/schott-toppac-cartridge): Descubra o carpule de polímero SCHOTT TOPPAC®, projetado para eficiência, integridade e confiabilidade na administração de medicamentos em ambientes clínicos e domiciliares. - [Carpules com câmara dupla | Carpules DC](https://www.schott-pharma.com/pt/produtos/carpules-farmaceuticos/carpules-camara-dupla): Carpules DC da SCHOTT Pharma permitem manuseio seguro de liofilizados, com alta precisão de dose e estabilidade para formulações sensíveis. - [cartriQ® Large Volume](https://www.schott-pharma.com/pt/produtos/carpules-farmaceuticos/cartriq-grande-volume): Os carpules grandes de vidro cartriQ® Large Volume são projetados para dispositivos de uso individual, com administração segura, confiável e de fácil utilização - [Core Carpules](https://www.schott-pharma.com/pt/produtos/carpules-farmaceuticos/core-carpules): Carpules de vidro SCHOTT Pharma oferecem alta resistência química e precisão, permitindo autoadministração segura de medicamentos de longo prazo. - [Carpules Break Resistant (BR)](https://www.schott-pharma.com/pt/produtos/carpules-farmaceuticos/cartridges-break-resistant): Carpules resistentes a quebras da SCHOTT suportam condições exigentes e oferecem segurança extra para medicamentos que salvam vidas. - [cartriQ®](https://www.schott-pharma.com/pt/produtos/carpules-farmaceuticos/cartriq): Parte da plataforma SCHOTT iQ®, o cartriQ® entrega carpules RTU para biológicos, ideais para dispositivos portáteis de injeção. ## Frascos | A página Frascos da SCHOTT Pharma destaca frascos de vidro de alta qualidade, desenvolvidos para medicamentos injetáveis, vacinas e produtos biológicos, oferecendo resistência química, precisão dimensional e opções prontas para uso, a fim de apoiar processos eficientes de envase e acabamento farmacêutico. - [EVERIC® freeze](https://www.schott-pharma.com/pt/produtos/frascos/everic-freeze): Conheça EVERIC® freeze, um recipiente de vidro para o armazenamento de vacinas de mRNA e DNA, bem como terapias de genes e ultrafrios - [Core Frascos](https://www.schott-pharma.com/pt/produtos/frascos/core-frascos): Frascos StandardLine e TopLine da SCHOTT Pharma oferecem armazenamento seguro e melhoram a eficiência no envase de medicamentos sensíveis. - [Frascos de vidro âmbar EVERIC®](https://www.schott-pharma.com/pt/produtos/frascos/everic-amber): Os frascos de vidro âmbar EVERIC® oferecem proteção superior contra a luz para conjugados droga-anticorpo (ADCs) e outros produtos biológicos sensíveis, garantindo estabilidade e eficácia. Saiba mais! - [EVERIC® strong & smooth](https://www.schott-pharma.com/pt/produtos/frascos/everic-strong-smooth): Os frascos EVERIC® strong & smooth oferecem maior velocidade para linhas de envase e acabamento em grande volume, menor risco de quebra e menor taxa de rejeição - [Frasco adaptiQ®](https://www.schott-pharma.com/pt/produtos/frascos/adaptiq): O frasco adaptiQ® SCHOTT é feito em vidro borossilicato e vem em embalagem RTU: pré-lavada, esterilizada e pronta para uso. - [EVERIC® plus](https://www.schott-pharma.com/pt/produtos/frascos/everic-plus): Frascos EVERIC® plus da SCHOTT Pharma protegem medicamentos sensíveis com revestimento que reduz lixiviáveis e adsorção de proteínas. - [EVERIC® pure](https://www.schott-pharma.com/pt/produtos/frascos/everic-pure): Frascos esterilizados EVERIC® pure garantem estabilidade, menos delaminação, menor variação de pH e baixos níveis de substâncias lixiviáveis. - [EVERIC® care](https://www.schott-pharma.com/pt/produtos/frascos/everic-care): O revestimento dos frascos de vidro farmacêutico EVERIC® care protege medicamentos sensíveis contra substâncias lixiviáveis na faixa de pH alcalino - [EVERIC® smart](https://www.schott-pharma.com/pt/produtos/frascos/everic-smart): Os frascos inteligentes da SCHOTT Pharma com código Datamatrix garantem rastreabilidade, segurança e eficiência nos processos farmacêuticos modernos. - [EVERIC® lyo](https://www.schott-pharma.com/pt/produtos/frascos/everic-lyo): Frascos SCHOTT Pharma para liofilização com revestimento hidrofóbico que reduz fogging, resíduos e rupturas no bolo liofilizado. ## Ampolas | A página Ampolas de vidro da SCHOTT Pharma apresenta ampolas de borossilicato de alta qualidade para a contenção segura de medicamentos injetáveis e produtos químicos estéreis, com vedação precisa, resistência química e formatos apropriados para vacinas, biológicos e aplicações farmacêuticas sensíveis. - [Ampolas Antifalsificação (AC)](https://www.schott-pharma.com/pt/produtos/ampolas/ampoules-ac): A ampola AC da SCHOTT protege contra falsificação, oferecendo segurança extra para empresas farmacêuticas e medicamentos que salvam vidas. - [Ampolas easyOPC | Ampola Abre Fácil](https://www.schott-pharma.com/pt/produtos/ampolas/ampoules-easy-opc): Ampolas easyOPC da SCHOTT Pharma têm alta resistência à quebra, reduzem devoluções e custos, mantendo a estabilidade de medicamentos sensíveis. - [Ampolas de Vidro | Core Ampolas ](https://www.schott-pharma.com/pt/produtos/ampolas/core-ampolas): As ampolas de vidro Core StandardLine da SCHOTT Pharma oferecem alta resistência hidrolítica, excelente envase e acabamento e três tipos de aberturas diferentes ## Serviços | A página de Serviços da SCHOTT Pharma apresenta o suporte personalizado para parceiros farmacêuticos e de biotecnologia, incluindo otimização de embalagens, consultoria regulatória e de qualidade, suporte técnico, desenvolvimento de sistemas de administração de medicamentos e soluções customizadas para aprimorar o desempenho da fabricação e dos produtos. - [Serviços regulatórios farmacêuticos SCHOTT Pharma ](https://www.schott-pharma.com/pt/servicos/regulatorio): Os serviços regulatórios da SCHOTT Pharma permitem a integração perfeita do conteúdo da embalagem primária aos registros de medicamentos e dispositivos médicos - [Serviços de Análise Farmacêutica | SCHOTT Pharma](https://www.schott-pharma.com/pt/servicos/analise-farmaceutica): A SCHOTT Pharma Analytics fornece serviços de análise farmacêutica que validam a compatibilidade de sua solução de contenção com os requisitos dos medicamentos - [Serviços para Indústria Farmacêutica SCHOTT Pharma | SCHOTT Pharma](https://www.schott-pharma.com/pt/servicos): Os serviços e análises para a indústria farmacêutica da SCHOTT Pharma Services incluem testes de envase e acabamento, além de suporte regulamentar ## SCHOTT Pharma Serviços de contenção e administração de medicamentos | A página Soluções de contenção da SCHOTT Pharma destaca consultoria e suporte de contenção personalizáveis para embalagens farmacêuticas, incluindo avaliação de riscos, estratégias de barreira, testes de compatibilidade e sistemas de contenção otimizados para garantir a segurança e a qualidade do produto, bem como a conformidade regulatória. - [Estudos de viabilidade | SCHOTT Pharma](https://www.schott-pharma.com/pt/servicos/solucoes-para-contencao/feasibility-study): A SCHOTT Pharma oferece um serviço de estudos de viabilidade que avalia a viabilidade de uma solução de embalagem de produto e sua adequação para produção em larga escala. - [Prototipagem | SCHOTT Pharma](https://www.schott-pharma.com/pt/servicos/solucoes-para-contencao/prototyping): A SCHOTT Pharma oferece um serviço completo de prototipagem para embalagens farmacêuticas, incluindo a fabricação de amostras, testes de viabilidade e compatibilidade, além de documentação. - [Embalagens Medicamentos | Contenção e Administração](https://www.schott-pharma.com/pt/servicos/solucoes-para-contencao): SCHOTT Pharma oferece solução personalizada de contenção e administração de medicamentos, do design à industrialização, conforme suas necessidades. ## SCHOTT Pharma Analytics | A página Pharma Analytics da SCHOTT Pharma destaca um portfólio de serviços analíticos para sistemas de embalagem e administração de medicamentos, incluindo caracterização de materiais, testes de extraíveis e lixiviáveis, estudos de estabilidade e suporte regulatório, assegurando a qualidade, segurança e conformidade de produtos farmacêuticos. - [Testes de estabilidade mecânica | SCHOTT Pharma](https://www.schott-pharma.com/pt/servicos/analise-farmaceutica/teste-de-estabilidade-mecanica): Os testes de estabilidade mecânica de produtos farmacêuticos da SCHOTT Pharma criam uma base sólida para a análise de pontos fracos de linhas de produção e design de recipientes - [Testes funcionais](https://www.schott-pharma.com/pt/servicos/analise-farmaceutica/testes-funcionais): A SCHOTT Pharma oferece um serviço de testes funcionais de embalagens farmacêuticas para obter conformidade regulatória total - [Análise de embalagens e caracterização dos componentes | SCHOTT Pharma](https://www.schott-pharma.com/pt/servicos/analise-farmaceutica/caracterizacao-de-componentes-de-embalagem): Entenda os componentes que você usa para garantir o armazenamento seguro de seu medicamento com a caracterização de componentes de embalagem da SCHOTT Pharma. - [Estudos de extraíveis e lixiviáveis | SCHOTT Pharma](https://www.schott-pharma.com/pt/servicos/analise-farmaceutica/estudos-extraiveis-e-lixiviaveis): A SCHOTT Pharma não só elabora e executa estudos de extraíveis e lixiviáveis, como também interpreta os resultados e compara diferentes soluções de contenção de medicamentos. - [Análise de Delaminação de Vidro | SCHOTT Pharma ](https://www.schott-pharma.com/pt/servicos/analise-farmaceutica/delaminacao-do-vidro): A SCHOTT Pharma realiza triagens de delaminação sob medida para ajudar na escolha ideal de recipientes e condições de armazenamento de medicamentos. - [Serviços de Análise de Partículas | SCHOTT Pharma](https://www.schott-pharma.com/pt/servicos/analise-farmaceutica/analise-de-particulas): A SCHOTT Pharma investiga partículas em medicamentos para identificar causas e garantir segurança na produção farmacêutica. - [Testes de Integridade de Fechamento de Recipientes I SCHOTT Pharma](https://www.schott-pharma.com/pt/servicos/analise-farmaceutica/testes-de-integridade-de-fechamento-de-recipientes): A SCHOTT Pharma oferece um serviço abrangente de testes de CCIT que garante a segurança e a eficácia do seu recipiente farmacêutico. - [Testes compendiais | SCHOTT Pharma](https://www.schott-pharma.com/pt/servicos/analise-farmaceutica/teste-compendial): A SCHOTT Pharma realiza testes rigorosos nos sistemas de contenção para garantir conformidade com farmacopeias e normas internacionais. ## SCHOTT Pharma Serviços de envase e acabamento | A página de Envase e Acabamento da SCHOTT Pharma apresenta serviços de fabricação estéril, incluindo envase asséptico, inspeção e embalagem de medicamentos injetáveis e biológicos, com controle de qualidade, produção escalável e suporte regulatório para ajudar os parceiros farmacêuticos a levar produtos ao mercado com segurança. - [Serviços de Envase de Medicamentos e Acabamento | SCHOTT Pharma](https://www.schott-pharma.com/pt/servicos/envase-e-acabamento): Serviços de envase e acabamento da SCHOTT Pharma para seringas, carpules e frascos ajudam o processamento de soluções de contenção em escala pequena a comercial ## SCHOTT Serviços regulatórios farmacêuticos | A página Regulatório da SCHOTT Pharma apresenta o suporte para embalagens farmacêuticas e sistemas de entrega, incluindo orientação sobre regulamentações globais, estratégias de submissão, documentação, avaliação de conformidade e gestão da qualidade, com o objetivo de ajudar os parceiros a atender aos requisitos regulatórios e agilizar as aprovações. - [Dossiê de registro de dispositivos médicos (MDR) | SCHOTT Pharma](https://www.schott-pharma.com/pt/servicos/regulatorio/registro-de-dispositivo-medico): A SCHOTT Pharma oferece todo o suporte no fornecimento de Dossiês de registro de dispositivos médicos (MDR) - [Carta de Autorização (LOA) | SCHOTT Pharma](https://www.schott-pharma.com/pt/servicos/regulatorio/carta-de-autorizacao-loa): A SCHOTT Pharmaceutical Systems oferece uma ampla variedade de serviços normativos concebidos para tornar o seu processo de registro de medicamentos o mais tranquilo possível. - [Dossiê de Embalagem Farmacêutica | SCHOTT Pharma](https://www.schott-pharma.com/pt/servicos/regulatorio/dossie-de-embalagem-farmaceutica): A SCHOTT Pharma oferece pacotes de documentação personalizados para integração perfeita com o dossiê final de aplicação de medicamentos - [Registro de Medicamentos | Dossiê Farmacêutico](https://www.schott-pharma.com/pt/servicos/regulatorio/registro-de-produto-farmaceutico): SCHOTT Pharma agiliza registro de produtos e se antecipa à conformidade regulatória para garantir disponibilidade no mercado. - [Drug Master Files | SCHOTT Pharma](https://www.schott-pharma.com/pt/servicos/regulatorio/drug-master-files-dmf-pharma): A SCHOTT Pharma oferece um serviço completo para gerar, registrar e atualizar registros de medicamentos nos EUA, Canadá e China ## Serviços de Sustentabilidade da SCHOTT Pharma | A página de Sustentabilidade da SCHOTT Pharma destaca os serviços que a empresa oferece para apoiar a responsabilidade ambiental e social, como revisões de desempenho em sustentabilidade, classificações EcoVadis e avaliações de pegada de carbono do produto, visando reduzir emissões, aprimorar a sustentabilidade da cadeia de suprimentos e avançar rumo a um futuro de emissões líquidas zero. - [Sustentabilidade em embalagens farmacêuticas | SCHOTT Pharma](https://www.schott-pharma.com/pt/servicos/sustentabilidade): A SCHOTT Pharma integra abordagens ambientais a seus produtos e soluções, e apoia as empresas farmacêuticas na gestão de sua conformidade com a sustentabilidade ## Soluções SCHOTT Pharma | A página de Soluções da SCHOTT Pharma apresenta sistemas integrados de contenção e administração de medicamentos, combinando embalagem, análises, envase e acabamento, além de suporte regulatório. Essas soluções completas ajudam parceiros farmacêuticos e de biotecnologia a aprimorar a segurança, a eficiência e o desempenho do produto ao longo de todo o ciclo de vida. - [White paper Encontrando o par perfeito I SCHOTT Pharma](https://www.schott-pharma.com/pt/pharma-solutions/pharmaceutical-manufacturing/improved-manufacturing-processes-with-sterile-solutions/white-paper-encontrando-o-par-perfeito): - [White paper Uma combinação vencedora I SCHOTT Pharma](https://www.schott-pharma.com/pt/pharma-solutions/pharmaceutical-manufacturing/improved-manufacturing-processes-with-sterile-solutions/white-paper-combinação-vencedora): - [White paper Soluções de embalagem padronizadas I SCHOTT Pharma](https://www.schott-pharma.com/pt/pharma-solutions/pharmaceutical-manufacturing/improved-manufacturing-processes-with-sterile-solutions/white-paper-embalagens-padronizadas): - [White paper Uma combinação vencedora I SCHOTT Pharma](https://www.schott-pharma.com/pt/solucoes/envase-e-acabamento/improved-manufacturing-processes-with-sterile-solutions/white-paper-combinação-vencedora): - [Integração cartriQ® para injeções SC de grande volume | SCHOTT Pharma](https://www.schott-pharma.com/pt/pharma-solutions/drug-packaging/large-volume-biologics/cartriq-integration-sterile-large-volume): A integração do cartriQ® proporciona uma administração SC segura e estável de produtos biológicos de grande volume, facilitando a administração domiciliar de medicamentos de forma amigável ao paciente. - [Biologics & Biossimilares – da pesquisa à conformidade regulatória | SCHOTT Pharma](https://www.schott-pharma.com/pt/pharma-solutions/drug-packaging/biologics-biosimilars): Biológicos e biossimilares apresentam novos desafios: Saiba como introduzi-los no mercado, desde a pesquisa sobre soluções de embalagens primárias até a conformidade regulatória. - [USP <382> Soluções de Testes Funcionais | SCHOTT Pharma](https://www.schott-pharma.com/pt/pharma-solutions/pharma-services/usp-382): Testes rigorosos conforme a USP <382> para sistemas preenchidos com medicamentos e totalmente montados, abrangendo desde verificações de integridade da embalagem e CCI até análise de fragmentação - [Biológicos de grande volume | SCHOTT Pharma](https://www.schott-pharma.com/pt/pharma-solutions/drug-packaging/large-volume-biologics): A SCHOTT Pharma oferece uma gama de soluções de embalagem primária para pen injectors, autoinjetores, sistemas de entrega on-body e bombas de infusão. - [Armazenamento mRNA | Embalagem de Vacinas ](https://www.schott-pharma.com/pt/pharma-solutions/drug-packaging/armazenamento-de-farmacos-mrna): Frascos e seringas que resolvem problemas técnicos, como movimento do êmbolo, integridade do fechamento ou esterilidade para mRNA de baixa temperatura - [Embalagens de conjugados anticorpo-medicamento | SCHOTT Pharma](https://www.schott-pharma.com/pt/pharma-solutions/drug-packaging/antibody-drug-conjugates): Enfrente os desafios do conjugado anticorpo-fármaco (ADC) com embalagens que garantem a estabilidade biológica, suportam formulações liofilizadas e mantêm a integridade do ADC - [Tratamento do diabetes | SCHOTT Pharma](https://www.schott-pharma.com/pt/pharma-solutions/drug-packaging/diabetes-treatment): A SCHOTT Pharma oferece uma linha de soluções de contenção e administração de medicamentos para o tratamento do diabetes baseado em GLP-1 - [Controle de contaminação | SCHOTT Pharma ](https://www.schott-pharma.com/pt/pharma-solutions/platforms/miticacao-do-risco-de-contaminacao): As soluções de envase asséptico da SCHOTT Pharma oferecem integridade estéril de alto nível, aumentam as medidas de segurança e reduzem o risco de contaminação - [Soluções de Rastreabilidade de Medicamentos | SCHOTT Pharma](https://www.schott-pharma.com/pt/pharma-solutions/pharmaceutical-manufacturing/controle-e-rastreamento-de-container-individual): Soluções para a rastreabilidade de medicamentos desde a produção até o usuário final, contando com a capacidade de rastreio ao longo da cadeia de suprimento. - [Preparação para Submissão de Medicamentos | SCHOTT](https://www.schott-pharma.com/pt/pharma-solutions/pharma-services/preparação-para-a-submissão-de-medicamentos): A SCHOTT Pharma oferece serviço abrangente de teste de embalgens e preparação para a submissão de medicamentos, garantindo segurança e conformidade regulatória - [Soluções de Envase Farmacêutico | SCHOTT Pharma ](https://www.schott-pharma.com/pt/pharma-solutions/pharma-services/eficiencia-do-envase-e-acabamento): A gama de soluções da SCHOTT Pharma para linhas de envase farmacêutico e acabamento ajuda as empresas a minimizar interrupções, paralisações e taxas de rejeição - [Embalagens para GLP-1 | SCHOTT Pharma ](https://www.schott-pharma.com/pt/pharma-solutions/drug-packaging/obesity-treatment): Conheça as soluções de contenção e administração de medicamentos para obesidade baseados em GLP-1 da SCHOTT Pharma, com armazenamento e administração seguros - [White paper Encontrando o par perfeito I SCHOTT Pharma](https://www.schott-pharma.com/pt/solucoes/envase-e-acabamento/improved-manufacturing-processes-with-sterile-solutions/white-paper-encontrando-o-par-perfeito): - [White paper Soluções de embalagem padronizadas I SCHOTT Pharma](https://www.schott-pharma.com/pt/solucoes/envase-e-acabamento/improved-manufacturing-processes-with-sterile-solutions/white-paper-embalagens-padronizadas): - [Controle de contaminação | SCHOTT Pharma ](https://www.schott-pharma.com/pt/solucoes/envase-e-acabamento/miticacao-do-risco-de-contaminacao): As soluções de envase asséptico da SCHOTT Pharma oferecem integridade estéril de alto nível, aumentam as medidas de segurança e reduzem o risco de contaminação - [Soluções de Rastreabilidade de Medicamentos | SCHOTT Pharma](https://www.schott-pharma.com/pt/solucoes/envase-e-acabamento/controle-e-rastreamento-de-container-individual): Soluções para a rastreabilidade de medicamentos desde a produção até o usuário final, contando com a capacidade de rastreio ao longo da cadeia de suprimento. - [Soluções de Envase Farmacêutico | SCHOTT Pharma ](https://www.schott-pharma.com/pt/solucoes/envase-e-acabamento/eficiencia-do-envase-e-acabamento): A gama de soluções da SCHOTT Pharma para linhas de envase farmacêutico e acabamento ajuda as empresas a minimizar interrupções, paralisações e taxas de rejeição - [Delaminação de vidro sob controle | SCHOTT Pharma](https://www.schott-pharma.com/pt/solucoes/ajuste-perfeito/controle-de-delaminacao): A SCHOTT Pharma estabelece etapas concretas que as empresas farmacêuticas podem adotar para minimizar os riscos de delaminação do vidro. - [Biologics & Biossimilares – da pesquisa à conformidade regulatória | SCHOTT Pharma](https://www.schott-pharma.com/pt/solucoes/biologics-biosimilars): Biológicos e biossimilares apresentam novos desafios: Saiba como introduzi-los no mercado, desde a pesquisa sobre soluções de embalagens primárias até a conformidade regulatória. - [Embalagens de conjugados anticorpo-medicamento | SCHOTT Pharma](https://www.schott-pharma.com/pt/solucoes/antibody-drug-conjugates): Enfrente os desafios do conjugado anticorpo-fármaco (ADC) com embalagens que garantem a estabilidade biológica, suportam formulações liofilizadas e mantêm a integridade do ADC - [Soluções de embalagem para pequenos lotes | SCHOTT Pharma](https://www.schott-pharma.com/pt/solucoes/envase-e-acabamento/small-batch-packaging-solutions): As soluções de embalagem para pequenos lotes da SCHOTT Pharma garantem a contenção e a administração confiáveis de medicamentos, além de oferecerem proteção estéril ideal desde o início. - [Integração cartriQ® para injeções SC de grande volume | SCHOTT Pharma](https://www.schott-pharma.com/pt/solucoes/safe-and-easy-administration/large-volume-injections-biologics/cartriq-integration-sterile-large-volume): A integração do cartriQ® proporciona uma administração SC segura e estável de produtos biológicos de grande volume, facilitando a administração domiciliar de medicamentos de forma amigável ao paciente. - [Design otimizado de berço para seringas de polímero | SCHOTT Farmacêutica](https://www.schott-pharma.com/pt/solucoes/envase-e-acabamento/optimized-polymer-syringe-nest-design): O novo sistema de berço e cuba da SCHOTT Pharma é o primeiro do mundo a acomodar 160 seringas de polímero, reduzindo o tempo de ciclo e os custos, ao mesmo tempo em que aumenta a eficiência das suas linhas de envase e acabamento de alta velocidade. - [FRASCO EVERIC® | SCHOTT Pharma](https://www.schott-pharma.com/pt/solucoes/ajuste-perfeito/everic-vial-solutions): Os frascos EVERIC® da SCHOTT Pharma apresentam um design flexível e modular, conectando as necessidades de fabricantes e usuários para um desempenho otimizado. - [Biológicos de grande volume | SCHOTT Pharma](https://www.schott-pharma.com/pt/solucoes/safe-and-easy-administration/large-volume-injections-biologics): A SCHOTT Pharma oferece uma gama de soluções de embalagem primária para pen injectors, autoinjetores, sistemas de entrega on-body e bombas de infusão. - [Contenção de medicamentos biotecnológicos | SCHOTT](https://www.schott-pharma.com/pt/solucoes/ajuste-perfeito/interacao-entre-medicamento-biotecnologico-e-recipiente): Os frascos e seringas de vidro da SCHOTT oferecem um leque de vantagens na contenção de medicamentos biológicos e biotecnológicos. Confira! - [Armazenamento mRNA | Embalagem de Vacinas ](https://www.schott-pharma.com/pt/solucoes/ajuste-perfeito/armazenamento-de-farmacos-mrna): Frascos e seringas que resolvem problemas técnicos, como movimento do êmbolo, integridade do fechamento ou esterilidade para mRNA de baixa temperatura - [Embalagens para GLP-1 | SCHOTT Pharma ](https://www.schott-pharma.com/pt/solucoes/safe-and-easy-administration/obesity-treatment): Conheça as soluções de contenção e administração de medicamentos para obesidade baseados em GLP-1 da SCHOTT Pharma, com armazenamento e administração seguros - [Preparação para Submissão de Medicamentos | SCHOTT](https://www.schott-pharma.com/pt/solucoes/ajuste-perfeito/preparação-para-a-submissão-de-medicamentos): A SCHOTT Pharma oferece serviço abrangente de teste de embalgens e preparação para a submissão de medicamentos, garantindo segurança e conformidade regulatória - [Estabilidade de Medicamentos | SCHOTT Pharma ](https://www.schott-pharma.com/pt/solucoes/ajuste-perfeito/estabilidade-de-medicamento-com-baixo-volume-de-envase): Maior estabilidade farmacêutica para seus medicamentos sensíveis com baixo nível de envase com o SCHOTT Pharma Services. - [USP <382> Soluções de Testes Funcionais | SCHOTT Pharma](https://www.schott-pharma.com/pt/solucoes/ajuste-perfeito/usp-382): Testes rigorosos conforme a USP <382> para sistemas preenchidos com medicamentos e totalmente montados, abrangendo desde verificações de integridade da embalagem e CCI até análise de fragmentação - [Tratamento do diabetes | SCHOTT Pharma](https://www.schott-pharma.com/pt/solucoes/safe-and-easy-administration/diabetes-treatment): A SCHOTT Pharma oferece uma linha de soluções de contenção e administração de medicamentos para o tratamento do diabetes baseado em GLP-1 - [Soluções em Embalagens Farmacêuticas | SCHOTT Pharma](https://www.schott-pharma.com/pt/solucoes): Saiba mais sobre as soluções em embalagens farmacêuticas da SCHOTT Pharma para empresas farmacêuticas, de biotecnologia e CDMOs. ## Áreas de atuação | A página Pharma Expertise da SCHOTT Pharma demonstra seu profundo conhecimento do setor em contenção de medicamentos, sistemas de administração, suporte regulatório e otimização de fabricação, oferecendo insights, melhores práticas e orientação especializada para ajudar os parceiros a solucionar desafios complexos em toda a indústria farmacêutica e biotecnológica. - [Glossário | SCHOTT Pharma](https://www.schott-pharma.com/pt/especialidade/centro-de-informacoes/glossario): O glossário da SCHOTT Pharma inclui as palavras-chave mais importantes, acrônimos e terminologia geral usados na indústria de embalagens farmacêuticas. - [Especialização | SCHOTT Pharma ](https://www.schott-pharma.com/pt/especialidade): A gama completa de recursos e conhecimentos disponíveis para empresas e indivíduos para soluções de contenção e administração de medicamentos ## SCHOTT Pharmaversity® | A página SCHOTT Pharmaversity da SCHOTT Pharma destaca ofertas educacionais, programas de treinamento e insights de especialistas para profissionais farmacêuticos e de biotecnologia, desenvolvidos para aprimorar habilidades, aprofundar o conhecimento do setor e apoiar as melhores práticas em embalagem e entrega de medicamentos. - [Pharmaversity® | Educação Farmacêutica](https://www.schott-pharma.com/pt/especialidade/schott-pharmaversity): Para obter informações valiosas sobre temas do setor, explore a Pharmaversity® para ampliar sua formação farmacêutica com o apoio dos principais especialistas em vidro e polímeros. ## Blogs SCHOTT Pharma - [Integridade de fechamento de recipientes (CCI) | SCHOTT Pharma](https://www.schott-pharma.com/pt/especialidade/centro-de-informacoes/blog/container-closure-integrity): Descubra como a combinação perfeita de frasco, rolha e vedação assegura uma integridade robusta do fechamento do recipiente, previne pop-up/pop-off e aprimora a eficiência do envase e acabamento. - [Dispositivos para Administração de Medicamentos I SCHOTT Pharma](https://www.schott-pharma.com/pt/especialidade/centro-de-informacoes/blog/mudanca-de-paradigma-no-desenvolvimento-de-dispositivos): Descubra como recipientes personalizados em COC estão transformando o design de dispositivos farmacêuticos e melhorando a administração de medicamentos. - [Vantagens críticas dos recipientes inteligentes de embalagem primária | SCHOTT Pharma](https://www.schott-pharma.com/pt/especialidade/centro-de-informacoes/blog/advantages-smart-primary-packaging): Os recipientes inteligentes da SCHOTT Pharma são marcados a laser com um código exclusivo para possibilitar altos níveis de rastreabilidade em todo o processo de envase e acabamento. - [O que é teste de integridade de fechamento de recipientes | SCHOTT Farmacêutica](https://www.schott-pharma.com/pt/especialidade/centro-de-informacoes/blog/what-is-container-closure-integrity-testing): Garantir a integridade dos fechamentos dos recipientes e do próprio recipiente é fundamental para manter uma barreira estéril contra potenciais contaminantes e eliminar o risco de vazamentos. Este artigo apresentará uma visão geral do teste de integridade de fechamento de recipiente (CCIT) e explicará por que ele é crucial. - [Biossimilares e genéricos | SCHOTT Pharma](https://www.schott-pharma.com/pt/especialidade/centro-de-informacoes/blog/biosimilars-generics): Principais tendências do setor e os benefícios de escolher a embalagem primária adequada em um cenário farmacêutico em constante evolução - [Reciclagem em circuito fechado | Embalagem farmacêutica](https://www.schott-pharma.com/pt/especialidade/centro-de-informacoes/blog/closed-loop-recycling-initiative): Descubra como a reciclagem em circuito fechado nas embalagens de transporte farmacêutico pode reduzir a demanda por plástico virgem. - [SCHOTT Pharma redefinindo a assistência à saúde](https://www.schott-pharma.com/pt/especialidade/centro-de-informacoes/blog/redefining-healthcare-the-power-of-large-volume-sterile-cartridges): Redefinindo os cuidados de saúde com cartuchos estéreis de grande volume, que possibilitam uma administração subcutânea de medicamentos mais fácil e econômica, além da autoadministração domiciliar. - [Diversidade e inclusão na SCHOTT Pharma](https://www.schott-pharma.com/pt/especialidade/centro-de-informacoes/blog/diversity-and-inclusion-at-schott-pharma): A diversidade e a inclusão na SCHOTT Pharma são a chave para o sucesso da empresa e o combustível de equipes comprometidas. - [Por que os ensaios clínicos fracassam | SCHOTT Farmacêutica](https://www.schott-pharma.com/pt/especialidade/centro-de-informacoes/blog/why-clinical-trials-fail): As armadilhas comuns e os principais desafios dos ensaios clínicos e como as escolhas corretas de embalagem podem mitigar riscos e aumentar as taxas de sucesso - [Medicamentos falsificados | SCHOTT Pharma](https://www.schott-pharma.com/pt/especialidade/centro-de-informacoes/blog/counterfeit-drugs-protecting-patients): SCHOTT Pharma está colocando a saúde do paciente em primeiro lugar com Ampolas AC! Descubra como proteger os pacientes contra medicamentos falsificados. - [Sistemas de Inspeção Visual | Schott Pharma](https://www.schott-pharma.com/pt/especialidade/centro-de-informacoes/blog/container-quality-automated-visual-inspection-systems): Aprimorando a qualidade de recipientes farmacêuticos com sistemas automatizados de inspeção visual - [Redução Custo Total de Propriedade com embalagens RTU I SCHOTT Pharma](https://www.schott-pharma.com/pt/especialidade/centro-de-informacoes/blog/redução-do-custo-total-de-propriedade-com-embalagens-rtu): Frascos RTU esterilizados reduzem o TCO, aumentam a eficiência no envase e melhoram a qualidade e segurança na produção farmacêutica - [Design de produtos farmacêuticos: seguro para os pacientes, sustentável para o planeta | SCHOTT Pharma](https://www.schott-pharma.com/pt/especialidade/centro-de-informacoes/blog/pharmaceutical-product-design): Descubra como a SCHOTT Pharma integra o Ecodesign para desenvolver produtos farmacêuticos que asseguram a segurança do paciente e promovem a sustentabilidade ambiental. Saiba mais sobre nosso compromisso com a neutralidade climática até 2030. - [Como escolher ampolas para medicamento | SCHOTT Pharma](https://www.schott-pharma.com/pt/especialidade/centro-de-informacoes/blog/como-escolher-as-melhores-ampolas-para-a-sua-linha-de-envase): Escolha as melhores ampolas para sua linha de envase. Entenda os formatos ideais para diferentes máquinas e processos de acabamento. - [Melhor sistema de abertura de ampolas | SCHOTT Pharma](https://www.schott-pharma.com/pt/especialidade/centro-de-informacoes/blog/sistemas-de-ruptura-de-ampolas): Leia o artigo do blog da Schott Pharma e descubra como escolher o melhor break-system para a sua ampola! - [Frascos Snap-on | SCHOTT Pharma](https://www.schott-pharma.com/pt/especialidade/centro-de-informacoes/blog/snap-on-vials): A SCHOTT Pharma produz frascos snap-on fabricados com tubos de vidro FIOLAX® de alta qualidade, proporcionando compatibilidade superior com diversos componentes em aplicações farmacêuticas. - [Frasco como plataforma | SCHOTT Pharma](https://www.schott-pharma.com/pt/especialidade/centro-de-informacoes/blog/drug-development-efficiency-vial-as-platform): Como as soluções de embalagem pré-testadas, como o Vial como plataforma, melhoram a eficiência do desenvolvimento de medicamentos e aumentam a segurança da produção - [Recipientes RTU e o tempo de comercialização](https://www.schott-pharma.com/pt/especialidade/centro-de-informacoes/blog/como-recipiente-rtu-reduz-o-tempo-de-comercialização): Descubra como os recipientes RTU aceleram o tempo de comercialização e aumentam o fluxo de caixa e a vida útil da patente, mantendo uma qualidade superior. - [Padrões farmacêuticos para vidro – estratégias de testes dedicadas](https://www.schott-pharma.com/pt/especialidade/centro-de-informacoes/blog/repensar-padrões-farmacêuticos-para-estratégias-de-teste-dedicadas-ao-vidro): A Farmacopeia dos EUA tem como objetivo criar flexibilidade adicional para os requisitos de embalagem e armazenamento. Saiba mais sobre os desafios das estratégias de teste. - [O que é ampola e por que ela domina a indústria | SCHOTT Pharma](https://www.schott-pharma.com/pt/especialidade/centro-de-informacoes/blog/o-que-sao-ampolas-na-medicina-embalagem-primaria): Saiba por que as ampolas de vidro se tornaram a embalagem primária mais usada no mundo, com alta segurança, integridade e proteção ao medicamento. - [Otimizando o Processo de Envase | SCHOTT Pharma](https://www.schott-pharma.com/pt/especialidade/centro-de-informacoes/blog/como-otimizar-processo-de-envase-de-medicamentos): Descubra como a embalagem RTU otimiza o processo de envase e acabamento, garantindo a segurança do paciente e acelerando a comercialização - [O que é um frasco e como escolher o correto | SCHOTT Farmacêutica](https://www.schott-pharma.com/pt/especialidade/centro-de-informacoes/blog/o-que-e-um-frasco): O que é um frasco? Saiba mais sobre os componentes, tipos e aplicações farmacêuticas de um frasco, além de como escolher o correto - [Dispositivos de Injeção Com Emissões Zero | SCHOTT Pharma](https://www.schott-pharma.com/pt/especialidade/centro-de-informacoes/blog/projetar-um-caminho-rumo-a-dispositivos-de-injeção-com-emissões-zero): Na SCHOTT Pharma, acreditamos que os produtos com emissões zero exigem uma colaboração sólida entre setores. - [Controle de Partículas em Embalagens RTU: 5 Etapas](https://www.schott-pharma.com/pt/especialidade/centro-de-informacoes/blog/5-etapas-para-a-redução-de-partículas-em-embalagens-rtu): Garanta a redução de partículas da embalagem RTU e a conformidade com o Anexo I das BPF com o guia sobre como reduzir efetivamente a contaminação por partículas - [Soluções em embalagens para a Bayer | SCHOTT Pharma](https://www.schott-pharma.com/pt/especialidade/centro-de-informacoes/blog/solucao-em-embalagem-primaria-para-o-bayer): Parceria com a SCHOTT Pharma permite que a Bayer comercialize medicamentos biotecnológicos de forma segura e rápida, com soluções em embalagens primárias. - [Seringa de Vidro Pronta Para o Envase: Para Que Serve? | SCHOTT Pharma](https://www.schott-pharma.com/pt/especialidade/centro-de-informacoes/blog/uso-seringa-de-vidro-pronta-para-envasar): De vacinas até terapias de longo prazo para condições crônicas, as seringas de vidro prontas para o envase são usadas em aplicações e configurações diferentes. - [Solucionando os desafios de contenção de medicamentos biotecnológicos com frascos | SCHOTT Pharma ](https://www.schott-pharma.com/pt/especialidade/centro-de-informacoes/blog/resolvendo-desafios-de-contencao-de-medicamentos-biotecnologicos): O crescimento de formulações farmacêuticas é desafiador para o envase e manuseio de frascos de vidro farmacêutico, mas o SCHOTT EVERIC® atende a essa demanda. - [Esterilização em embalagens farmacêuticas RTU | SCHOTT Pharma](https://www.schott-pharma.com/pt/especialidade/centro-de-informacoes/blog/esterilizacao-na-embalagem-rtu): Para garantir níveis de esterilidade rigorosamente regulamentados, diferentes tecnologias podem ser aplicadas no setor de embalagens farmacêuticas RTU. - [Esterilização de embalagens RTU | SCHOTT Pharma ](https://www.schott-pharma.com/pt/especialidade/centro-de-informacoes/blog/validar-esterilizacao-de-embalagem-rtu): Saiba mais sobre a esterilização de embalagens farmacêuticas e como quantificá-la usando o grau de garantia de esterilização de recipientes prontos para uso. - [Recipientes para Medicamentos | Blog | SCHOTT Pharma](https://www.schott-pharma.com/pt/especialidade/centro-de-informacoes/blog/como-os-recipientes-farmaceuticos-podem-melhorar-a-estabilidade-dos-medicamentos): Saiba qual a importância das embalagens e dos recipientes para a estabilidade do medicamento. - [Testes de substâncias extraíveis explicados I SCHOTT Pharma](https://www.schott-pharma.com/pt/especialidade/centro-de-informacoes/blog/o-que-é-teste-de-substâncias-extraíveis): Testes de substâncias extraíveis identificam materiais nocivos. Entenda seu papel essencial na segurança da indústria farmacêutica - [Embalagem de medicamentos mRNA | SCHOTT Pharma](https://www.schott-pharma.com/pt/especialidade/centro-de-informacoes/blog/como-os-medicamentos-mrna-mudam-a-embalagens-farmaceuticas-primarias): Este artigo explora as considerações que influenciam a embalagem farmacêutica primária em uma nova era de soluções de medicamentos de mRNA. - [Dose única mRNA mais prática | SCHOTT Pharma ](https://www.schott-pharma.com/pt/especialidade/centro-de-informacoes/blog/de-frasco-para-seringas-prontas-para-o-envase-mrna): SCHOTT Pharma avalia se seringas prontas para encher são mais eficazes que frascos multidose na distribuição de vacinas mRNA contra a COVID-19. - [Blog | Embalagens Farmacêuticas | SCHOTT Pharma ](https://www.schott-pharma.com/pt/especialidade/centro-de-informacoes/blog): Descubra tendências e informações gerais sobre os produtos e serviços da SCHOTT Pharma e sobre a indústria de embalagens farmacêuticas. ## SCHOTT Pharma Academy/Eventos/Certificados | Os recursos de Pharma Expertise da SCHOTT Pharma incluem programas educacionais, eventos e treinamentos por meio da Pharmaversity Academy, além de acesso a certificados e informações do setor, auxiliando parceiros farmacêuticos e de biotecnologia a desenvolver conhecimento, habilidades e competência regulatória. - [Certificados | ISO | SCHOTT Pharma ](https://www.schott-pharma.com/pt/especialidade/centro-de-informacoes/certificados): Baixe certificados ISO da SCHOTT Pharma e comprove padrões globais de qualidade, segurança e conformidade em embalagens farmacêuticas. ## SCHOTT Pharma Quem Somos | A página Sobre Nós da SCHOTT Pharma foca na missão, nos valores e na história da empresa, destacando seu papel na contenção e entrega de medicamentos, seu compromisso com a qualidade e inovação, presença global e suporte a parceiros farmacêuticos e de biotecnologia na melhoria dos resultados em saúde. - [Filosofia SCHOTT | Porque a saúde humana importa ](https://www.schott-pharma.com/pt/sobre-nos/porque-a-saude-humana-importa): Junto com clientes e parceiros, a SCHOTT Pharma busca oferecer a melhor experiência ao paciente — porque a saúde humana importa. - [SCHOTT Pharma no Brasil e no Mundo | SCHOTT Pharma](https://www.schott-pharma.com/pt/sobre-nos): SCHOTT Pharma projeta soluções científicas para tornar medicamentos seguros e fáceis de usar, como líder global na indústria farmacêutica. ## Comunicados de Imprensa da SCHOTT Pharma | A página de notícias e mídia da SCHOTT Pharma apresenta os mais recentes comunicados de imprensa, atualizações da empresa, resultados financeiros, eventos e anúncios do setor sobre inovações, expansões, parcerias e desempenho, mantendo as partes interessadas das áreas farmacêutica e de biotecnologia informadas sobre os desenvolvimentos. - [Feiras e Eventos SCHOTT Pharma ](https://www.schott-pharma.com/pt/noticias-e-midia/feiras-e-eventos): A série completa de eventos especializados, feiras e conferências que será apresentada pela SCHOTT Pharma - [Mídia Kit SCHOTT Pharma](https://www.schott-pharma.com/pt/noticias-e-midia/media-kits): Explore os kits de mídia da SCHOTT Pharma com imagens, dados e conteúdos sobre soluções farmacêuticas inovadoras - [Notícias e contato com a mídia | SCHOTT Pharma ](https://www.schott-pharma.com/pt/noticias-e-midia/consulta): Entre em contato com a nossa equipe de notícias e mídia da SCHOTT Pharma - [Notícias e contatos com a mídia | SCHOTT Pharma ](https://www.schott-pharma.com/pt/noticias-e-midia/contatos): Detalhes de contato da equipe de Notícias e Mídia da SCHOTT Pharma - [A SCHOTT Pharma planeja triplicar a capacidade de produção de frascos nos EUA | SCHOTT](https://www.schott-pharma.com/pt/noticias-e-midia/media-releases/2022/schott-pharma-plans-to-triple-vial-production-capacity-in-the-us): A SCHOTT está fazendo um investimento de dois dígitos de milhões de euros para aumentar a produção de frascos prontos para uso em sua fábrica de Lebanon, Pensilvânia - [COMUNICADO DE IMPRENSA: SCHOTT nomeia Conselho de Supervisão da SCHOTT Pharma AG & Co. KGaA | SCHOTT](https://www.schott-pharma.com/pt/noticias-e-midia/media-releases/2023/schott-appoints-supervisory-board-of-schott-pharma-ag-and-co-kgaa): SCHOTT nomeia Conselho de Supervisão da SCHOTT Pharma AG & Co. KGaA - [COMUNICADO DE IMPRENSA | Avanço em tratamentos GLP-1, insulina e injeções de grande volume com carpules prontos para uso da SCHOTT Pharma](https://www.schott-pharma.com/pt/noticias-e-midia/media-releases/2023/advancing-treatments-with-ready-to-use-cartridges-from-schott-pharma): Avanço em tratamentos GLP-1, insulina e injeções de grande volume com carpules prontos para uso da SCHOTT Pharma | COMUNICADO DE IMPRENSA - [A SCHOTT e o governo húngaro investem na produção de seringas de última geração | SCHOTT](https://www.schott-pharma.com/pt/noticias-e-midia/media-releases/2022/schott-and-hungarian-government-invest-in-cutting-edge-syringe-production): A SCHOTT fez um investimento de 76 milhões de euros em uma nova fábrica de produção em Lukácsháza, na Hungria, para atender à demanda global por seringas de vidro prontas para envasar - [A SCHOTT Pharma planeja expandir a produção de carpules | SCHOTT](https://www.schott-pharma.com/pt/noticias-e-midia/media-releases/2022/schott-pharma-expands-cartridge-production-in-china-and-hungary): O investimento na casa de dois dígitos de milhões de euros da SCHOTT Pharma aumentará significativamente a capacidade de produção de carpules farmacêuticos na Hungria e na China - [A SCHOTT anuncia investimento na produção de carpules prontos para uso | SCHOTT](https://www.schott-pharma.com/pt/noticias-e-midia/media-releases/2022/schott-announces-double-digit-million-euro-investment-in-ready-to-use-cartridge-production): COMUNICADO DE IMPRENSA: O investimento de dois dígitos de milhões de euros da SCHOTT expandirá significativamente a sua capacidade de produção de carpules prontos para uso (RTU) - [COMUNICADO DE IMPRENSA | A SCHOTT Pharma apresenta um forte crescimento rentável para todo o ano logo após a IPO, no limite superior de sua orientação](https://www.schott-pharma.com/pt/noticias-e-midia/media-releases/2023/schott-pharma-delivers-right-after-ipo-with-strong-profitable-growth-for-the-full-year): A SCHOTT Pharma apresenta um forte crescimento rentável para todo o ano logo após a IPO, no limite superior de sua orientação | COMUNICADO DE IMPRENSA - [Comunicado de imprensa | A SCHOTT estabelece uma empresa independente para que seus negócios farmacêuticos promovam um crescimento ainda maior](https://www.schott-pharma.com/pt/noticias-e-midia/media-releases/2022/schott-establishes-stand-alone-company-for-pharma-business-to-promote-further-growth): A SCHOTT estabelece uma empresa independente para que seus negócios farmacêuticos promovam um crescimento ainda maior | Comunicado de imprensa - [COMUNICADO DE IMPRENSA | A SCHOTT Pharma fortalece sua posição de liderança no primeiro ano como empresa independente](https://www.schott-pharma.com/pt/noticias-e-midia/media-releases/2023/schott-pharma-strengthens-leading-position-in-the-first-year-as-stand-alone-company): Refletindo sobre o primeiro ano da SCHOTT Pharma como entidade independente, Andreas Reisse vê a empresa idealmente posicionada para aproveitar as tendências de longo prazo do mercado. A SCHOTT Pharma fortalece sua posição de liderança no primeiro ano como empresa independente - [COMUNICADO DE IMPRENSA | No ritmo certo: A SCHOTT Pharma mantém um forte crescimento no primeiro semestre do ano fiscal de 2023](https://www.schott-pharma.com/pt/noticias-e-midia/media-releases/2023/upholding-momentum-schott-pharma-sustains-strong-growth-in-the-first-half-of-fy-2023): No ritmo certo: A SCHOTT Pharma mantém um forte crescimento no primeiro semestre do ano fiscal de 2023 | COMUNICADO DE IMPRENSA - [SCHOTT e Serum Institute of India anunciam joint venture de embalagens farmacêuticas](https://www.schott-pharma.com/pt/noticias-e-midia/media-releases/2021/schott-and-serum-institute-of-india-announce-joint-venture-for-pharmaceutical-packaging): Comunicado de imprensa: Anúncio de joint venture de embalagens farmacêuticas – SCHOTT e Serum Institute of India - [A SCHOTT lança a iQ® Integribag | SCHOTT](https://www.schott-pharma.com/pt/noticias-e-midia/media-releases/2022/schott-launches-iq-integribag): A solução de transferência sem toque da SCHOTT para soluções prontas para uso em contenção farmacêutica e administração de medicamentos fornece integridade estéril de alto nível - [A SCHOTT abre uma nova fábrica de seringas prontas para o envase em uma nova instalação na Alemanha | SCHOTT](https://www.schott-pharma.com/pt/noticias-e-midia/media-releases/2022/schott-inaugurates-plant-for-prefillable-polymer-syringes-at-new-facility-in-germany): COMUNICADO DE IMPRENSA: O grupo de tecnologia internacional investiu três dígitos de milhões de euros em sua fábrica em Müllheim, na Alemanha, para expandir a produção de seringas de polímero prontas para o envase - [COMUNICADO DE IMPRENSA | Cadeia de suprimento com zero emissões líquidas de carbono: A SCHOTT Pharma inicia a próxima fase do programa de descarbonização](https://www.schott-pharma.com/pt/noticias-e-midia/media-releases/2024/schott-pharma-launches-next-phase-of-decarbonizing-program): Cadeia de suprimento com zero emissões líquidas de carbono: A SCHOTT Farma inicia a próxima fase do programa de descarbonização | COMUNICADO DE IMPRENSA - [COMUNICADO DE IMPRENSA | Proteção de medicamentos em temperaturas ultrafrias: A SCHOTT Pharma lança novos frascos para mRNA e terapia de genes](https://www.schott-pharma.com/pt/noticias-e-midia/media-releases/2024/schott-pharma-launches-new-vials-for-mrna-and-gene-therapy): Proteção de medicamentos ultrafrios: A SCHOTT Pharma lança novos frascos para mRNA e terapia de genes | COMUNICADO DE IMPRENSA - [COMUNICADO DE IMPRENSA | Assumindo a responsabilidade seriamente: SCHOTT Pharma lança primeiro relatório de sustentabilidade](https://www.schott-pharma.com/pt/noticias-e-midia/media-releases/2024/schott-pharma-releases-first-sustainability-report): Assumindo a responsabilidade seriamente: SCHOTT Pharma lança primeiro relatório de sustentabilidade | COMUNICADO DE IMPRENSA - [A SCHOTT Pharma é pioneira na produção de ponta na Hungria | SCHOTT](https://www.schott-pharma.com/pt/noticias-e-midia/media-releases/2022/schott-pharma-breaks-ground-for-cutting-edge-production-in-hungary): A construção começou em um novo centro de produção de seringas de vidro prontas para envasar (PFS) em Lukácsháza, na Hungria, adicionando uma segunda instalação à rede global de fabricação da SCHOTT Pharma - [COMUNICADO DE IMPRENSA | A SCHOTT Pharma alcança as metas de 2023 e continua a trajetória de crescimento rentável](https://www.schott-pharma.com/pt/noticias-e-midia/media-releases/2024/schott-pharma-delivers-on-2023-targets-and-continues-profitable-growth-trajectory): A SCHOTT Pharma atende às metas de 2023 e continua a trajetória de crescimento rentável | COMUNICADO DE IMPRENSA - [COMUNICADO DE IMPRENSA: SCHOTT Pharma apresenta forte desempenho financeiro no ano fiscal de 2022 | SCHOTT](https://www.schott-pharma.com/pt/noticias-e-midia/media-releases/2023/schott-pharma-with-strong-financial-performance-in-fiscal-year-2022): Saiba mais sobre o desenvolvimento dos negócios da SCHOTT Pharma no ano fiscal de 2022 - [SCHOTT comunica um ano de sucesso para sua unidade de negócios farmacêuticos | SCHOTT](https://www.schott-pharma.com/pt/noticias-e-midia/media-releases/2022/schott-reports-successful-year-for-pharma-business-unit): COMUNICADO DE IMPRENSA: A unidade de negócios farmacêuticos da SCHOTT teve um ano altamente bem-sucedido em 2021 e pretende expandir esse sucesso - [COMUNICADO DE IMPRENSA | A SCHOTT Pharma executa com sucesso sua estratégia de expansão e investe em uma nova unidade de produção na Sérvia](https://www.schott-pharma.com/pt/noticias-e-midia/media-releases/2023/schott-pharma-invests-in-a-new-production-facility-in-serbia): A SCHOTT Pharma executa com sucesso sua estratégia de expansão e investe em uma nova unidade de produção na Sérvia | COMUNICADO DE IMPRENSA - [Comunicados de Imprensa | Press Releases SCHOTT Pharma ](https://www.schott-pharma.com/pt/noticias-e-midia/media-releases): Confira os últimos press releases da SCHOTT Pharma sobre inovação, resultados e avanços em soluções farmacêuticas de alta qualidade - [Notícias e mídia | SCHOTT Pharma](https://www.schott-pharma.com/pt/noticias-e-midia): As mais recentes notícias e comunicados de imprensa da fabricante internacional de vidros especiais ## SCHOTT Pharma Sustentabilidade | A página de Sustentabilidade da SCHOTT Pharma apresenta as iniciativas de responsabilidade ambiental e social da empresa, incluindo metas para ação climática, eficiência de recursos, cadeias de suprimentos éticas e engajamento comunitário, visando apoiar a saúde sustentável e gerar impacto a longo prazo. - [Conformidade | SCHOTT Pharma](https://www.schott-pharma.com/pt/sobre-nos/sustentabilidade/compliance): Tudo o que você precisa saber sobre as políticas de conformidade da SCHOTT Pharma, incluindo o seu Código de Conduta, práticas comerciais éticas, responsabilidade social e governança corporativa. - [Sustentabilidade | SCHOTT Pharma](https://www.schott-pharma.com/pt/sobre-nos/sustentabilidade): Saiba como a SCHOTT Pharma impulsiona a sustentabilidade em toda a sua cadeia de valor por meio de práticas empresariais responsáveis, ação climática, iniciativas de circularidade e eficiência no uso de recursos. ## SCHOTT Pharma Outras Páginas - [Boletim informativo | SCHOTT Pharma](https://www.schott-pharma.com/pt/boletim-informativo): - [SCHOTT Pharma AG & Co. KGaA](https://www.schott-pharma.com/pt/versao-para-impressao): Aqui você pode encontrar a nossa versão para impressão com as informações legais da SCHOTT. - [Termos e condições gerais | SCHOTT Pharma](https://www.schott-pharma.com/pt/termos-e-condicoes-gerais): - [Política de proteção de dados | SCHOTT Pharma](https://www.schott-pharma.com/pt/politica-de-protecao-de-dados): Saiba mais sobre a Política de Proteção de Dados da SCHOTT, incluindo quem controla seus dados pessoais e seus direitos em relação à proteção de seus dados - [Termos de isenção de responsabilidade e informações legais | SCHOTT Pharma](https://www.schott-pharma.com/pt/isencao-de-responsabilidade): Informações legais para o uso do site da SCHOTT. ## Spanish ## Productos | La página de productos de SCHOTT Pharma ofrece una visión general de su portafolio de contención y administración de fármacos, que incluye jeringas precargables de vidrio y polímero, cartuchos, viales y ampollas, todos diseñados para fabricantes farmacéuticos y biotecnológicos. - [Cartuchos farmacéuticos | SCHOTT Pharma ](https://www.schott-pharma.com/es/productos/cartuchos-farmaceuticos): La gama de cartuchos farmacéuticos de SCHOTT Pharma dispensa medicamentos en dosis excepcionalmente precisas para cualquier situación médica. - [Ampollas de vidrio | SCHOTT Pharma ](https://www.schott-pharma.com/es/productos/ampollas): Para obtener una resistencia química excepcional y asegurar la estabilidad de los farmacos, explore las ampollas de vidrio de SCHOTT Pharma. - [Jeringas | SCHOTT Pharma](https://www.schott-pharma.com/es/productos/jeringas): Explora la amplia gama de tipos de jeringas de SCHOTT Pharma, disponibles en diferentes formatos y flexibles para almacenar diversos medicamentos. - [Viales | SCHOTT Pharma ](https://www.schott-pharma.com/es/productos/viales): Los viales de vidrio de SCHOTT Pharma mejoran la eficiencia del llenado y acabado y aumentan la estabilidad a largo plazo de los medicamentos. - [Productos Farmacéuticos | SCHOTT Pharma](https://www.schott-pharma.com/es/productos): Si busca un fabricante de productos farmacéuticos de confianza, SCHOTT Pharma ofrece una cartera diversa que abarca desde viales hasta ampollas. ## Jeringas | La página de jeringas de SCHOTT Pharma presenta sus soluciones de jeringas farmacéuticas precargables fabricadas en vidrio y polímeros avanzados para un almacenamiento y una administración seguros de medicamentos. Destaca las jeringas syriQ® y SCHOTT TOPPAC®, diseñadas para reducir errores, mejorar la seguridad y respaldar una amplia variedad de aplicaciones, desde vacunas hasta productos biológicos. - [SCHOTT TOPPAC® unique](https://www.schott-pharma.com/es/productos/jeringas/schott-toppac-unique): Explora los envases de polímero de SCHOTT Pharma, que ofrecen una variedad de formatos personalizables para tratamientos médicos personalizados. - [SCHOTT TOPPAC® infuse](https://www.schott-pharma.com/es/productos/jeringas/schott-toppac-infuse): Optimice su entorno hospitalario y reduzca errores médicos con jeringa de infusion SCHOTT TOPPAC®, disponible en un formato prellenable de COC. - [syriQ® jeringa de vidrio](https://www.schott-pharma.com/es/productos/jeringas/syriq-jeringa-de-vidrio): Descubra syriQ®, la jeringa de vidrio precargada que garantiza la seguridad de vacunas inactivadas, vivas atenuadas, conjugadas y de ARNm. - [syriQ BioPure® sin silicona](https://www.schott-pharma.com/es/productos/jeringas/syriq-biopure-sin-silicona): Descubre syriQ BioPure® jeringas sin silicona y listas para usar con cilindros de vidrio que ofrecen un almacenamiento estable para medicamentos. - [SCHOTT TOPPAC® jeringas de polímero](https://www.schott-pharma.com/es/productos/jeringas/schott-toppac): SCHOTT Pharma's jeringas de polímero ofrecen una solución de empaque primario adecuada para el almacenamiento y de medicamentos a largo plazo. - [syriQ BioPure®](https://www.schott-pharma.com/es/productos/jeringas/syriq-biopure): Descubra syriQ BioPure®, nuestra jeringa biopure para productos biológicos que minimiza el riesgo de interacciones entre medicamentos y envases. - [SCHOTT TOPPAC® cosmetic](https://www.schott-pharma.com/es/productos/jeringas/schott-toppac-cosmetic): Explora la jeringa cosmética SCHOTT TOPPAC® desarrollada para tratamientos cosméticos que incluyen ácido hialurónico y toxina botulínica (BoNT)! - [SCHOTT TOPPAC® freeze](https://www.schott-pharma.com/es/productos/jeringas/schott-toppac-freeze): Descubre SCHOTT TOPPAC® freeze, diseñada como jeringa para medicamentos congelados y lista para usar. Confianza y seguridad en cada aplicación. ## Cartuchos | La página de cartuchos farmacéuticos de SCHOTT Pharma presenta sus soluciones de cartuchos de vidrio y polímero para la dosificación precisa de medicamentos en plumas, autoinyectores y sistemas portátiles. El portafolio incluye opciones listas para usar, de doble cámara y de alta durabilidad, diseñadas para terapias inyectables y biológicos. - [SCHOTT TOPPAC® cartucho de polímero](https://www.schott-pharma.com/es/productos/cartuchos-farmaceuticos/schott-toppac-cartridge): Descubra el cartucho de polímero SCHOTT TOPPAC® que ofrece eficiencia y fiabilidad en la administración de fármacos en entornos clínicos y del hogar. - [Carpules Double Chamber (DC)](https://www.schott-pharma.com/es/productos/cartuchos-farmaceuticos/cartuchos-doble-camara): Los cartuchos de vidrio doble cámara ofrecen una solución segura y eficaz para medicamentos liofilizados, garantizando una dosificación precisa. - [cartriQ® Large Volume](https://www.schott-pharma.com/es/productos/cartuchos-farmaceuticos/cartriq-gran-volumen): Descubre cartriQ® Large Volume: cartuchos de vidrio de gran volumen, seguros y confiables para aplicaciones farmacéuticas avanzadas. - [Core Carpules](https://www.schott-pharma.com/es/productos/cartuchos-farmaceuticos/core-cartuchos): Los cartuchos Core son cartuchos farmacéuticos de vidrio disponibles en calidad StandardLine y TopLine, ideales para dispositivos de autoinyección. - [Carpules Break Resistant (BR)](https://www.schott-pharma.com/es/productos/cartuchos-farmaceuticos/cartuchos-rotura-resistentes): Cartuchos resistentes a roturas diseñados para soportar las condiciones adversas, garantizando el almacenamiento y la distribución de medicamentos. - [cartriQ®](https://www.schott-pharma.com/es/productos/cartuchos-farmaceuticos/cartriq): Cartuchos RTU para medicamentos sensibles, diseñados para autoinyectores ## Viales | La página de viales de SCHOTT Pharma destaca viales de vidrio de alta calidad diseñados para fármacos inyectables, vacunas y productos biológicos, que ofrecen resistencia química, precisión dimensional y opciones listas para usar, respaldando procesos farmacéuticos eficientes de llenado y acabado. - [EVERIC® freeze](https://www.schott-pharma.com/es/productos/viales/everic-freeze): El vial para almacenamiento en frío profundo EVERIC® freeze asegura estabilidad a bajas temperaturas y optimiza la liofilización farmacéutica. - [EVERIC® strong & smooth](https://www.schott-pharma.com/es/productos/viales/everic-strong-smooth-resistente): El vial resistente a roturas de SCHOTT Pharma ofrece una mayor velocidad para las líneas de llenado y acabado a granel. - [adaptiQ®](https://www.schott-pharma.com/es/productos/viales/adaptiq-viales-esteriles): Viales estériles diseñados para mejorar la eficiencia, la seguridad y la fiabilidad de los procesos de fabricación de medicamentos inyectables. - [EVERIC® amber](https://www.schott-pharma.com/es/productos/viales/everic-amber): Vial ámbar de alta calidad para proteger medicamentos sensibles a la luz. Descubre EVERIC® amber y mejora la seguridad de tus formulaciones. - [Viales Core](https://www.schott-pharma.com/es/productos/viales/core-viales-de-medicamentos): Descubra los viales Core de SCHOTT Pharma fabricados en vidrio borosilicato: estabilidad, eficiencia y bajo coste con la calidad TopLine y StandardLine. - [EVERIC® plus](https://www.schott-pharma.com/es/productos/viales/everic-plus): Proteja sus fármacos con EVERIC® plus, viales para medicamentos sensibles con recubrimiento que minimiza lixiviables y adsorción de proteínas. - [EVERIC® pure](https://www.schott-pharma.com/es/productos/viales/everic-pure): Viales para productos biológicos EVERIC® pure con superficie uniforme que garantiza estabilidad, baja lixiviación y protección de sus formulaciones. - [EVERIC® care](https://www.schott-pharma.com/es/productos/viales/everic-care): Los viales de vidrio farmacéuticos EVERIC® care cuentan con recubrimiento hidrofóbico que protege fármacos sensibles de lixiviables en pH alcalino. - [EVERIC® smart](https://www.schott-pharma.com/es/productos/viales/everic-smart): Envases inteligentes de SCHOTT Pharma con código datamatrix que garantizan trazabilidad, seguridad y eficiencia en procesos farmacéuticos modernos. - [EVERIC® lyo](https://www.schott-pharma.com/es/productos/viales/everic-lyo): El vial liofilizado EVERIC® lyo está diseñado para evitar el empañamiento durante la liofilización y mejorar el vaciado residual. ## Ampollas | La página de ampollas de vidrio de SCHOTT Pharma presenta ampollas de borosilicato de alta calidad para la contención segura de fármacos inyectables y productos químicos estériles, con sellado preciso, resistencia química y formatos adecuados para vacunas, biológicos y aplicaciones farmacéuticas sensibles. - [Ampollas Anti-Counterfeiting (AC)](https://www.schott-pharma.com/es/productos/ampollas/ampollas-ac): Las Ampollas Anti-Counterfeiting (AC) de SCHOTT Pharma ofrecen protección a las empresas farmacéuticas contra la falsificación de medicamentos. - [Ampollas easyOPC](https://www.schott-pharma.com/es/productos/ampollas/ampollas-easy-opc): Las ampollas de apertura fácil de SCHOTT Pharma garantizan una apertura segura, menores costes y una mayor estabilidad del fármaco. - [Core Ampollas](https://www.schott-pharma.com/es/productos/ampollas/core-ampollas): Las Core Ampollas de SCHOTT Pharma ofrecen un excelente proceso de llenado y acabado y la posibilidad de elegir entre cuatro sistemas de rotura. ## Servicios | La página de servicios de SCHOTT Pharma presenta el soporte personalizado para socios farmacéuticos y biotecnológicos, que incluye la optimización del envasado, consultoría regulatoria y de calidad, soporte técnico, desarrollo de sistemas de administración de medicamentos y soluciones personalizadas para mejorar la fabricación y el rendimiento del producto. - [Asuntos Regulatorios Farmacéuticos | SCHOTT Pharma ](https://www.schott-pharma.com/es/servicios/farma-regulatorio): Asuntos regulatorios farmacéuticos de SCHOTT Pharma facilitan la integración de productos en registros de medicamentos, con apoyo regulatorio global. - [Análisis Farmacéutico | SCHOTT Pharma ](https://www.schott-pharma.com/es/servicios/analisis-farmaceutico): Descubra la gama de servicios de análisis farmacéutico de SCHOTT Pharma, que abarca desde la delaminación hasta las pruebas recomendadas. - [Servicios Farmacéuticos | SCHOTT Pharma ](https://www.schott-pharma.com/es/servicios): Nuestros servicios farmacéuticos incluyen análisis y optimización de llenado y acabado, además de brindar servicios de sostenibilidad y apoyo regulatorio. ## SCHOTT Pharma Servicios de contención y administración de medicamentos | La página de Soluciones de Contención de SCHOTT Pharma destaca la consultoría de contención personalizable y el soporte para el envasado farmacéutico, incluyendo la evaluación de riesgos, las estrategias de barrera, las pruebas de compatibilidad y los sistemas de contención optimizados, para garantizar tanto la seguridad y la calidad del producto como el cumplimiento normativo. - [Estudios de viabilidad | SCHOTT Pharma](https://www.schott-pharma.com/es/servicios/soluciones-de-contencion-farmaceutica/feasibility-study): SCHOTT Pharma ofrece un servicio de estudios de viabilidad que evalúa la factibilidad de una solución de envasado de productos y su idoneidad para la producción a gran escala. - [Prototipado | SCHOTT Pharma](https://www.schott-pharma.com/es/servicios/soluciones-de-contencion-farmaceutica/prototyping): SCHOTT Pharma ofrece un servicio integral de creación de prototipos para envases farmacéuticos, que incluye la fabricación de muestras, pruebas de viabilidad y compatibilidad, así como la documentación. - [Soluciones de Envases Farmacéuticos | SCHOTT Pharma ](https://www.schott-pharma.com/es/servicios/soluciones-de-contencion-farmaceutica): Soluciones de Envases Farmacéuticos | SCHOTT Pharma Conoce las soluciones de envases farmacéuticos de SCHOTT Pharma, asegurando un almacenamiento seguro y eficaz. ¡Contáctanos hoy mismo! ## Análisis de SCHOTT Pharma | La página Pharma Analytics de SCHOTT Pharma destaca un portafolio de servicios analíticos para sistemas de envasado y administración de medicamentos, que incluye la caracterización de materiales, pruebas de extraíbles y lixiviables, estudios de estabilidad y soporte regulatorio para garantizar la calidad, seguridad y cumplimiento de los productos farmacéuticos. - [Pruebas de Estabilidad Mecánica | SCHOTT Pharma](https://www.schott-pharma.com/es/servicios/analisis-farmaceutico/pruebas-de-estabilidad-mecanica): Explore las pruebas de estabilidad mecánica de productos farmacéuticos para evitar roturas y utilice los resultados para optimizar la línea de producción. - [Pruebas funcionales de envases farmacéuticos ](https://www.schott-pharma.com/es/servicios/analisis-farmaceutico/pruebas-funcionales-de-envases-farmaceuticos): SCHOTT Pharma ofrece pruebas funcionales de envases farmacéuticos para asegurar el cumplimiento normativo y la validación del sistema. - [Análisis de componentes del empaque farmacéutico ](https://www.schott-pharma.com/es/servicios/analisis-farmaceutico/componentes-del-empaque-farmaceutico): Descubre más sobre los componentes del empaque farmacéutico con diversos métodos de identificación y pruebas de rendimiento de SCHOTT Pharma. - [Pruebas de Extraíbles y Lixiviables | SCHOTT Pharma ](https://www.schott-pharma.com/es/servicios/analisis-farmaceutico/pruebas-de-extraibles-y-lixiviables): Descubra cómo las pruebas de extraíbles y lixiviables evalúan los riesgos de interacción envase-medicamento según normas USP 1663 y USP 1664. - [Pruebas de Delaminación | SCHOTT Pharma ](https://www.schott-pharma.com/es/servicios/analisis-farmaceutico/pruebas-de-delaminacion): Con pruebas de delaminación de vidrio de SCHOTT Pharma, elija el envase de vidrio adecuado para su medicamento. - [Análisis de Partículas | Análisis Farmacéutico](https://www.schott-pharma.com/es/servicios/analisis-farmaceutico/analisis-de-particulas): SCHOTT Pharma realiza análisis de partículas centrándose en su tamaño y formato para investigar la causa raíz y garantizar la seguridad del paciente. - [Pruebas CCIT | SCHOTT Pharma](https://www.schott-pharma.com/es/servicios/analisis-farmaceutico/pruebas-ccit): Las pruebas CCIT de SCHOTT Pharma garantizan la integridad, seguridad y eficacia de sus envases farmacéuticos según los estándares más exigentes. - [Pruebas Compendiales | SCHOTT Pharma](https://www.schott-pharma.com/es/servicios/analisis-farmaceutico/pruebas-compendiales): Explora los servicios de pruebas compendiales de SCHOTT Pharma para garantizar la conformidad con la farmacopea y estándares internacionales. ## Servicios de llenado y acabado de SCHOTT Pharma | La página de llenado y acabado de SCHOTT Pharma presenta los servicios de fabricación estéril, incluidos el llenado aséptico, la inspección y el envasado de medicamentos inyectables y productos biológicos, con control de calidad, producción escalable y soporte regulatorio para ayudar a los socios farmacéuticos a llevar productos al mercado de manera segura. - [Llenado y Acabado Farmacéutico | SCHOTT Pharma ](https://www.schott-pharma.com/es/servicios/llenado-y-acabado): Explora nuestros servicios de llenado y acabado farmacéutico para soluciones de contención a pequeña escala, enfocados en eficiencia y compatibilidad. ## Servicios regulatorios de SCHOTT Pharma | La página de Regulación de SCHOTT Pharma presenta el soporte para el envasado farmacéutico y los sistemas de administración, incluyendo la orientación sobre regulaciones globales, estrategias de presentación, documentación, evaluación de cumplimiento y gestión de calidad, con el objetivo de ayudar a los socios a cumplir con los requisitos normativos y agilizar las aprobaciones. - [Carta de Autorización LoA | SCHOTT Pharma ](https://www.schott-pharma.com/es/servicios/farma-regulatorio/carta-de-autorizacion): Solicite su carta de autorización hoy completando el formulario LOA y SCHOTT Pharma le ayudará a finalizar el proceso de registro de su medicamento. - [Dossier de Envases Farmacéuticos | SCHOTT Pharma](https://www.schott-pharma.com/es/servicios/farma-regulatorio/dossier-de-envases-farmaceuticos): Para una presentación eficaz de un dossier de envases farmacéuticos único y completo en el formato adecuado, solicite apoyo a SCHOTT Pharma. - [Registro de Productos Farmacéuticos | SCHOTT Pharma](https://www.schott-pharma.com/es/servicios/farma-regulatorio/registro-de-productos-farmaceuticos): Prepárese para el registro de productos farmacéuticos específico de cada país y presente su expediente regulatorio con el apoyo de SCHOTT Pharma. - [Dossier de Registro de un Medicamento DMF | SCHOTT Pharma ](https://www.schott-pharma.com/es/servicios/farma-regulatorio/dossier-registro-de-medicamento-dmf): Prepare su dossier de registro de un medicamento (DMF) para las regiones EE. UU., Canadá y China fácilmente con el apoyo de SCHOTT Pharma. - [Reglamento de Dispositivos Médicos MDR | SCHOTT Pharma](https://www.schott-pharma.com/es/servicios/farma-regulatorio/registro-de-dispositivos-medicos): Para expedientes completos y personalizados para el registro de dispositivos médicos (MDR), puede confiar en los servicios de SCHOTT Pharma. ## Servicios de Sostenibilidad de SCHOTT Pharma | La página de Sostenibilidad de SCHOTT Pharma se centra en los servicios que la empresa ofrece para respaldar la responsabilidad ambiental y social, como las revisiones de desempeño de sostenibilidad, las calificaciones de EcoVadis y las evaluaciones de la huella de carbono de los productos, con el objetivo de reducir las emisiones, mejorar la sostenibilidad de la cadena de suministro y avanzar hacia un futuro de cero emisiones netas. - [Sostenibilidad Farmacéutica | SCHOTT Pharma ](https://www.schott-pharma.com/es/servicios/sostenibilidad-farmaceutica): Colabora con SCHOTT Pharma para promover sostenibilidad farmacéutica y desarrollar envases sostenibles. ## Soluciones farmacéuticas de SCHOTT | La página de soluciones de SCHOTT Pharma presenta sistemas integrados de contención y administración de fármacos, que combinan envasado, analítica, llenado y acabado, y soporte normativo. Estas soluciones integrales ayudan a los socios farmacéuticos y biotecnológicos a mejorar la seguridad, la eficiencia y el rendimiento del producto a lo largo de todo el ciclo de vida. - [Whitepaper Finding the perfect match I SCHOTT Pharma](https://www.schott-pharma.com/es/pharma-solutions/pharmaceutical-manufacturing/soluciones-esteriles-de-contencion-de-medicamentos/whitepaper-find-the-perfect-match): - [Whitepaper A winning combination I SCHOTT Pharma](https://www.schott-pharma.com/es/pharma-solutions/pharmaceutical-manufacturing/soluciones-esteriles-de-contencion-de-medicamentos/whitepaper-winning-combination): - [Whitepaper Standardized Packaging Solutions I SCHOTT Pharma](https://www.schott-pharma.com/es/pharma-solutions/pharmaceutical-manufacturing/soluciones-esteriles-de-contencion-de-medicamentos/whitepaper-standardized-packaging): - [Whitepaper A winning combination I SCHOTT Pharma](https://www.schott-pharma.com/es/soluciones/llenado-aseptico/soluciones-esteriles-de-contencion-de-medicamentos/whitepaper-winning-combination): - [Integración de cartriQ® para inyecciones SC de alto volumen | SCHOTT Pharma](https://www.schott-pharma.com/es/pharma-solutions/drug-packaging/large-volume-biologics/cartriq-integration-sterile-large-volume): La integración de cartriQ® proporciona una administración SC segura y estable de productos biológicos de gran volumen, facilitando una administración de fármacos en el hogar, cómoda para el paciente. - [Biológicos y biosimilares: de la investigación al cumplimiento normativo | SCHOTT Pharma](https://www.schott-pharma.com/es/pharma-solutions/drug-packaging/biologics-biosimilars): Los productos biológicos y biosimilares presentan nuevos desafíos: Descubra cómo llevarlos al mercado, desde la investigación de soluciones de envasado primario hasta el cumplimiento normativo. - [USP <382> Soluciones de ensayo funcional | SCHOTT Pharma](https://www.schott-pharma.com/es/pharma-solutions/pharma-services/usp-382): Rigurosas pruebas USP <382> para sistemas completamente ensamblados y llenos de fármaco, que abarcan desde la integridad del empaque y las comprobaciones de CCI hasta el análisis de fragmentación. - [Biológicos de gran volumen | SCHOTT Pharma](https://www.schott-pharma.com/es/pharma-solutions/drug-packaging/large-volume-biologics): SCHOTT Pharma ofrece una gama de soluciones de envase primario para inyectores de pluma, autoinyectores, sistemas de administración en el cuerpo y bombas de infusión. - [Almacenamiento de ARNm Ideal | SCHOTT Pharma](https://www.schott-pharma.com/es/pharma-solutions/drug-packaging/almacenamiento-de-arnm): Explore soluciones de almacenamiento de ARNm utilizando jeringas de polímero para preservar la integridad de los medicamentos en bajas temperaturas. - [Empaque de conjugados anticuerpo-fármaco | SCHOTT Pharma](https://www.schott-pharma.com/es/pharma-solutions/drug-packaging/antibody-drug-conjugates): Aborde los desafíos del conjugado anticuerpo-fármaco (ADC) con un empaque que garantice la estabilidad biológica, respalde formulaciones liofilizadas y mantenga la integridad del ADC - [Soluciones de envasado para diabetes tipo 2 | SCHOTT Pharma](https://www.schott-pharma.com/es/pharma-solutions/drug-packaging/envasado-diabetes-tipo-2): SCHOTT Pharma ofrece soluciones de envasado para diabetes tipo 2, asegurando la administración confiable de medicamentos basados en GLP-1. - [Seguimiento y Localización | SCHOTT Pharma](https://www.schott-pharma.com/es/pharma-solutions/pharmaceutical-manufacturing/soluciones-seguimiento-y-localizacion): Soluciones de seguimiento y localización para envases de medicamentos: SCHOTT Pharma establece nuevos estándares en trazabilidad farmacéutica - [Soluciones Estériles de Contención de Medicamentos ](https://www.schott-pharma.com/es/pharma-solutions/pharmaceutical-manufacturing/soluciones-esteriles-de-contencion-de-medicamentos): Optimice los procesos de fabricación con soluciones estériles de contención de medicamentos y reduzca los costes con el apoyo de SCHOTT Pharma. - [Optimización de Llenado y Acabado | SCHOTT Pharma ](https://www.schott-pharma.com/es/pharma-solutions/pharma-services/eficiencia-llenado-y-acabado): Descubre cómo asegurar la optimización del proceso de llenado y acabado mientras reduciendo costos y garantizando la integridad del producto. - [Preparación de la presentación de medicamentos | SCHOTT Pharma](https://www.schott-pharma.com/es/pharma-solutions/pharma-services/preparacion-de-presentacion-de-medicamentos): SCHOTT Pharma le acompaña en todo el proceso de preparación de medicamentos, asegurando eficacia y seguridad para el paciente. - [Llenado Aséptico para Control de Contaminación](https://www.schott-pharma.com/es/pharma-solutions/platforms/mitigación-del-riesgo-de-contaminación): Reduzca el riesgo de contaminación en el llenado aséptico con nuestras soluciones RTU que garantizan la seguridad y esterilidad de los envases. - [Soluciones de envasado para el tratamiento de la obesidad | SCHOTT Pharma ](https://www.schott-pharma.com/es/pharma-solutions/drug-packaging/envasado-obesidad): SCHOTT Pharma ofrece soluciones de envasado para el tratamiento de la obesidad con GLP-1, garantizando almacenamiento seguro, compatibilidad y soporte regulatorio global. - [Whitepaper Finding the perfect match I SCHOTT Pharma](https://www.schott-pharma.com/es/soluciones/llenado-aseptico/soluciones-esteriles-de-contencion-de-medicamentos/whitepaper-find-the-perfect-match): - [Whitepaper Standardized Packaging Solutions I SCHOTT Pharma](https://www.schott-pharma.com/es/soluciones/llenado-aseptico/soluciones-esteriles-de-contencion-de-medicamentos/whitepaper-standardized-packaging): - [Llenado Aséptico para Control de Contaminación](https://www.schott-pharma.com/es/soluciones/llenado-aseptico/mitigación-del-riesgo-de-contaminación): Reduzca el riesgo de contaminación en el llenado aséptico con nuestras soluciones RTU que garantizan la seguridad y esterilidad de los envases. - [Seguimiento y Localización | SCHOTT Pharma](https://www.schott-pharma.com/es/soluciones/llenado-aseptico/soluciones-seguimiento-y-localizacion): Soluciones de seguimiento y localización para envases de medicamentos: SCHOTT Pharma establece nuevos estándares en trazabilidad farmacéutica - [Determinación de Vidrio Controlada | SCHOTT Pharma](https://www.schott-pharma.com/es/soluciones/ajuste-perfecto/delaminacion-de-vidrio): Para aumentar la durabilidad del producto, detecte y resuelva rápidamente los problemas de delaminación del vidrio con servicios de SCHOTT Pharma. - [Optimización de Llenado y Acabado | SCHOTT Pharma ](https://www.schott-pharma.com/es/soluciones/llenado-aseptico/eficiencia-llenado-y-acabado): Descubre cómo asegurar la optimización del proceso de llenado y acabado mientras reduciendo costos y garantizando la integridad del producto. - [Soluciones Estériles de Contención de Medicamentos ](https://www.schott-pharma.com/es/soluciones/llenado-aseptico/soluciones-esteriles-de-contencion-de-medicamentos): Optimice los procesos de fabricación con soluciones estériles de contención de medicamentos y reduzca los costes con el apoyo de SCHOTT Pharma. - [Biológicos y biosimilares: de la investigación al cumplimiento normativo | SCHOTT Pharma](https://www.schott-pharma.com/es/soluciones/biologics-biosimilars): Los productos biológicos y biosimilares presentan nuevos desafíos: Descubra cómo llevarlos al mercado, desde la investigación de soluciones de envasado primario hasta el cumplimiento normativo. - [Empaque de conjugados anticuerpo-fármaco | SCHOTT Pharma](https://www.schott-pharma.com/es/soluciones/antibody-drug-conjugates): Aborde los desafíos del conjugado anticuerpo-fármaco (ADC) con un empaque que garantice la estabilidad biológica, respalde formulaciones liofilizadas y mantenga la integridad del ADC - [Soluciones de envasado para pequeños lotes | SCHOTT Pharma](https://www.schott-pharma.com/es/soluciones/llenado-aseptico/small-batch-packaging-solutions): Las soluciones de envasado de lotes pequeños de SCHOTT Pharma garantizan una contención y administración confiables del fármaco, y ofrecen una protección estéril óptima desde el principio. - [Integración de cartriQ® para inyecciones SC de alto volumen | SCHOTT Pharma](https://www.schott-pharma.com/es/soluciones/safe-and-easy-administration/large-volume-injections-biologics/cartriq-integration-sterile-large-volume): La integración de cartriQ® proporciona una administración SC segura y estable de productos biológicos de gran volumen, facilitando una administración de fármacos en el hogar, cómoda para el paciente. - [Diseño optimizado de nido para jeringas de polímero | SCHOTT Pharma](https://www.schott-pharma.com/es/soluciones/llenado-aseptico/optimized-polymer-syringe-nest-design): El nuevo sistema de nido y cuba de SCHOTT Pharma es el primero en el mundo capaz de alojar 160 jeringas poliméricas, lo que reduce el tiempo y los costos de ciclo, a la vez que incrementa la eficiencia de sus líneas de llenado y acabado de alta velocidad. - [EVERIC® Vial | SCHOTT Pharma](https://www.schott-pharma.com/es/soluciones/ajuste-perfecto/everic-vial-solutions): Los viales EVERIC® de SCHOTT Pharma ofrecen un diseño flexible y modular, que conecta las necesidades de fabricantes y usuarios para un rendimiento optimizado. - [Biológicos de gran volumen | SCHOTT Pharma](https://www.schott-pharma.com/es/soluciones/safe-and-easy-administration/large-volume-injections-biologics): SCHOTT Pharma ofrece una gama de soluciones de envase primario para inyectores de pluma, autoinyectores, sistemas de administración en el cuerpo y bombas de infusión. - [Almacenamiento de ARNm Ideal | SCHOTT Pharma](https://www.schott-pharma.com/es/soluciones/ajuste-perfecto/almacenamiento-de-arnm): Explore soluciones de almacenamiento de ARNm utilizando jeringas de polímero para preservar la integridad de los medicamentos en bajas temperaturas. - [Soluciones de envasado para el tratamiento de la obesidad | SCHOTT Pharma ](https://www.schott-pharma.com/es/soluciones/safe-and-easy-administration/envasado-obesidad): SCHOTT Pharma ofrece soluciones de envasado para el tratamiento de la obesidad con GLP-1, garantizando almacenamiento seguro, compatibilidad y soporte regulatorio global. - [Soluciones de envasado para diabetes tipo 2 | SCHOTT Pharma](https://www.schott-pharma.com/es/soluciones/safe-and-easy-administration/envasado-diabetes-tipo-2): SCHOTT Pharma ofrece soluciones de envasado para diabetes tipo 2, asegurando la administración confiable de medicamentos basados en GLP-1. - [Volúmenes de Llenado Bajos | SCHOTT Pharma ](https://www.schott-pharma.com/es/soluciones/ajuste-perfecto/volumenes-de-llenado-bajos): Descubra soluciones confiables de SCHOTT Pharma para niveles bajos de lixiviación en aplicaciones de volúmenes de llenado bajos de medicamentos. - [Preparación de la presentación de medicamentos | SCHOTT Pharma](https://www.schott-pharma.com/es/soluciones/ajuste-perfecto/preparacion-de-presentacion-de-medicamentos): SCHOTT Pharma le acompaña en todo el proceso de preparación de medicamentos, asegurando eficacia y seguridad para el paciente. - [USP <382> Soluciones de ensayo funcional | SCHOTT Pharma](https://www.schott-pharma.com/es/soluciones/ajuste-perfecto/usp-382): Rigurosas pruebas USP <382> para sistemas completamente ensamblados y llenos de fármaco, que abarcan desde la integridad del empaque y las comprobaciones de CCI hasta el análisis de fragmentación. - [Contenedores de Medicamentos para Biotecnología](https://www.schott-pharma.com/es/soluciones/ajuste-perfecto/contenedores-de-medicamentos-para-biotecnologia): Descubre cómo los contenedores de medicamentos para biotecnología de SCHOTT Pharma son la solución ideal para productos biológicos. - [Soluciones de Envasado Farmacéutico | SCHOTT Pharma](https://www.schott-pharma.com/es/soluciones): Explore la gama de soluciones de envasado de SCHOTT Pharma que apoyan las empresas farmacéuticas, biotecnológicas y CDMO en sus operaciones. ## Experiencia | La página Pharma Expertise de SCHOTT Pharma demuestra su profundo conocimiento de la industria en la contención de medicamentos, sistemas de administración, soporte regulatorio y optimización de la fabricación, proporcionando información, mejores prácticas y orientación experta para ayudar a los socios a resolver desafíos complejos en los sectores farmacéutico y biotecnológico. - [Glosario Farmacéutico | SCHOTT Pharma](https://www.schott-pharma.com/es/experiencia/centro-de-informacion/glosario-farmaceutico): Utilice el extenso glosario farmacéutico de SCHOT Pharma para familiarizarse con términos de tecnología farmacéutica menos conocidos. - [Experiencia farmacéutica | SCHOTT Pharma ](https://www.schott-pharma.com/es/experiencia): Utilice la experiencia de SCHOTT Pharma para conocer temas de industria farmacéutica y encontrar recursos confiables para obtener más información. ## SCHOTT Pharma Pharmaversity® | La página SCHOTT Pharmaversity de SCHOTT Pharma destaca las ofertas educativas, los programas de formación y las perspectivas de expertos para profesionales farmacéuticos y biotecnológicos, diseñados para desarrollar habilidades, profundizar el conocimiento de la industria y respaldar las mejores prácticas en el envasado y la administración de medicamentos. - [Pharmaversity® | Educación farmacéutica](https://www.schott-pharma.com/es/experiencia/schott-pharmaversity): Para obtener información valiosa sobre temas de la industria, explore Pharmaversity® para ampliar su formación farmacéutica con la ayuda de destacados expertos en vidrio y polímeros. ## Blogs de SCHOTT Pharma - [Integridad del cierre de contenedor (CCI) | SCHOTT Pharma](https://www.schott-pharma.com/es/experiencia/centro-de-informacion/schott-pharma-blog/container-closure-integrity): Descubra cómo la combinación perfecta de vial, tapón y sello garantiza una integridad sólida del cierre del envase, previene el pop-up/pop-off y mejora la eficiencia del llenado y acabado. - [Un cambio de paradigma en el desarrollo de dispositivos I SCHOTT Pharma](https://www.schott-pharma.com/es/experiencia/centro-de-informacion/schott-pharma-blog/innovaciones-en-dispositivos-farmaceuticos): Tom van Ginneken analiza las ventajas del polímero como material perfecto para envases personalizados. - [Ventajas clave de los envases primarios inteligentes | SCHOTT Pharma](https://www.schott-pharma.com/es/experiencia/centro-de-informacion/schott-pharma-blog/advantages-smart-primary-packaging): Los envases inteligentes de SCHOTT Pharma están marcados con láser con un código único para garantizar altos niveles de trazabilidad a lo largo de todo el proceso de llenado y acabado. - [¿Qué es la prueba de integridad de cierre de envases? | SCHOTT Pharma](https://www.schott-pharma.com/es/experiencia/centro-de-informacion/schott-pharma-blog/what-is-container-closure-integrity-testing): Garantizar la integridad de los cierres de los envases y del propio envase es fundamental para mantener una barrera estéril frente a posibles contaminantes y eliminar el riesgo de fugas. Este artículo ofrece una visión general de las pruebas de integridad de cierre de contenedores (CCIT) y explica por qué son cruciales. - [Biosimilares y genéricos | SCHOTT Pharma](https://www.schott-pharma.com/es/experiencia/centro-de-informacion/schott-pharma-blog/biosimilars-generics): Tendencias clave de la industria y beneficios de elegir el envase primario adecuado en un panorama farmacéutico en evolución - [Reciclaje de ciclo cerrado | Envasado farmacéutico](https://www.schott-pharma.com/es/experiencia/centro-de-informacion/schott-pharma-blog/closed-loop-recycling-initiative): Descubra cómo el reciclaje en circuito cerrado en los envases de transporte farmacéutico puede reducir la demanda de plástico virgen. - [SCHOTT Pharma redefine la atención sanitaria](https://www.schott-pharma.com/es/experiencia/centro-de-informacion/schott-pharma-blog/redefining-healthcare-the-power-of-large-volume-sterile-cartridges): Redefiniendo la atención médica con cartuchos estériles de gran volumen que facilitan una administración subcutánea de medicamentos más sencilla y rentable, así como la autoadministración en el hogar. - [Diversidad e inclusión en SCHOTT Pharma](https://www.schott-pharma.com/es/experiencia/centro-de-informacion/schott-pharma-blog/diversity-and-inclusion-at-schott-pharma): La diversidad y la inclusión en SCHOTT Pharma son clave para el éxito de la empresa y el motor de equipos comprometidos. - [Medicamentos falsificados | SCHOTT Pharma](https://www.schott-pharma.com/es/experiencia/centro-de-informacion/schott-pharma-blog/counterfeit-drugs-protecting-patients): SCHOTT Pharma pone la salud del paciente en primer lugar con las Ampoules AC. Descubra cómo proteger a los pacientes de los medicamentos falsificados. - [Sistemas de inspección visual | Schott Pharma](https://www.schott-pharma.com/es/experiencia/centro-de-informacion/schott-pharma-blog/container-quality-automated-visual-inspection-systems): Mejorando la calidad de los envases farmacéuticos con sistemas automatizados de inspección visual - [Reducción del costo total de propiedad con el envasado RTU I SCHOTT Pharma](https://www.schott-pharma.com/es/experiencia/centro-de-informacion/schott-pharma-blog/reducción-del-costo-total-de-propiedad-con-el-empaque-rtu): Descubra cómo los viales de vidrio RTU como SCHOTT Pharma adaptiQ reducen el costo total de propiedad, mejoran la estabilidad de los medicamentos y aumentan la calidad de los productos farmacéuticos. - [Diseño de productos farmacéuticos: seguro para los pacientes, sostenible para el planeta I SCHOTT Pharma](https://www.schott-pharma.com/es/experiencia/centro-de-informacion/schott-pharma-blog/pharmaceutical-product-design): Descubra cómo SCHOTT Pharma integra el ecodiseño para crear productos farmacéuticos que garantizan la seguridad del paciente y promueven la sostenibilidad medioambiental. Conozca nuestro compromiso con la neutralidad climática para 2030. - [Cómo elegir las mejores ampollas para su línea de llenado | SCHOTT Pharma](https://www.schott-pharma.com/es/experiencia/centro-de-informacion/schott-pharma-blog/how-to-choose-the-best-ampoules-for-your-filling-line): Descubra cómo elegir las mejores ampollas para su línea de llenado. Conozca las diferentes formas de ampollas y su idoneidad para los distintos tipos de máquinas de llenado y acabado. - [Mejor sistema de apertura de ampollas | SCHOTT Pharma](https://www.schott-pharma.com/es/experiencia/centro-de-informacion/schott-pharma-blog/sistemas-de-rotura-de-ampollas): Lea el artículo del blog de Schott Pharma y descubra cómo elegir el mejor sistema de apertura para sus ampollas. - [Por qué fallan los ensayos clínicos | SCHOTT Pharma](https://www.schott-pharma.com/es/experiencia/centro-de-informacion/schott-pharma-blog/why-clinical-trials-fail): Los escollos comunes y los principales desafíos de los ensayos clínicos y cómo la elección adecuada de empaque puede mitigar riesgos y mejorar las tasas de éxito - [Vial como plataforma | SCHOTT Pharma](https://www.schott-pharma.com/es/experiencia/centro-de-informacion/schott-pharma-blog/drug-development-efficiency-vial-as-platform): Cómo las soluciones de envasado preprobadas, como Vial como plataforma, mejoran la eficiencia en el desarrollo de fármacos y aumentan la seguridad en la producción - [Viales de encaje a presión | SCHOTT Pharma](https://www.schott-pharma.com/es/experiencia/centro-de-informacion/schott-pharma-blog/snap-on-vials): SCHOTT Pharma produce viales a presión fabricados con tubos de vidrio FIOLAX® de alta calidad, que ofrecen una compatibilidad superior con diversos componentes en aplicaciones farmacéuticas. - [¿Cómo aceleran los contenedores RTU el tiempo de comercialización?](https://www.schott-pharma.com/es/experiencia/centro-de-informacion/schott-pharma-blog/cómo-acortar-el-tiempo-de-comercialización-de-los-contenedores-rtu): Descubra cómo los contenedores RTU aceleran el tiempo de comercialización y aumentan el flujo de efectivo y la vida útil de las patentes, manteniendo al mismo tiempo una calidad superior. - [Cinco pasos para la reducción de partículas en el envasado RTU en la industria farmacéutica](https://www.schott-pharma.com/es/experiencia/centro-de-informacion/schott-pharma-blog/5-pasos-para-la-reducción-de-partículas-en-el-empaque-rtu): Garantice la reducción de partículas del envase RTU y la conformidad con el Anexo I de GMP con nuestra guía sobre cómo reducir eficazmente la contaminación por partículas. - [Estándares farmacéuticos para vidrio: estrategias de ensayo específicas](https://www.schott-pharma.com/es/experiencia/centro-de-informacion/schott-pharma-blog/replanteando-los-estándares-farmacéuticos-para-estrategias-de-pruebas-dedicadas-al-vidrio): La Farmacopea de los Estados Unidos tiene como objetivo crear una mayor flexibilidad para los requisitos de envasado y almacenamiento. Conozca más sobre los desafíos relacionados con las estrategias de prueba. - [Cómo las ampollas se convirtieron en el envase primario para medicamentos más popular del mundo | SCHOTT](https://www.schott-pharma.com/es/experiencia/centro-de-informacion/schott-pharma-blog/how-ampoules-became-the-worlds-most-popular-primary-packaging-for-drugs): SCHOTT Pharma explica cómo las ampollas pasaron de un recipiente para sangre del siglo tercero a convertirse en el envase primario para medicamentos más popular del mundo - [Cómo optimizar el llenado y el sellado con el envasado RTU I SCHOTT Pharma](https://www.schott-pharma.com/es/experiencia/centro-de-informacion/schott-pharma-blog/how-to-optimize-fill-and-finish-processes-with-sterile-drug-containment-solutions): Descubra cómo los envases listo para usar optimizan los procesos de llenado y acabado, reduciendo la complejidad de la cadena de valor, garantizando la seguridad del paciente y acelerando el tiempo de comercialización. - [Qué es un vial y cómo elegir el adecuado | SCHOTT Farmacia](https://www.schott-pharma.com/es/experiencia/centro-de-informacion/schott-pharma-blog/que-es-un-vial): ¿Qué es un vial? Conozca los componentes, tipos y aplicaciones farmacéuticas de un vial, además de cómo elegir el adecuado - [Ruta hacia dispositivos de inyección con cero emisiones netas | SCHOTT Pharma](https://www.schott-pharma.com/es/experiencia/centro-de-informacion/schott-pharma-blog/diseñar-una-ruta-hacia-los-dispositivos-de-inyección-cero-neto): En SCHOTT Pharma, creemos que los productos con cero emisiones netas requieren una sólida colaboración intersectorial. - [¿Para qué se utiliza una jeringa de vidrio prellenada? | SCHOTT Pharma](https://www.schott-pharma.com/es/experiencia/centro-de-informacion/schott-pharma-blog/como-usar-una-jeringa-precargada): Desde vacunas hasta terapias a largo plazo para afecciones crónicas, las jeringas de vidrio precargadas se utilizan en diversas aplicaciones y entornos diferentes. - [Soluciones de envase primario para Bayer | SCHOTT Pharma](https://www.schott-pharma.com/es/experiencia/centro-de-informacion/schott-pharma-blog/colaboracion-farmaceutica): La asociación estratégica con SCHOTT Pharma permite a Bayer comercializar medicamentos biotecnológicos de una manera más segura y rápida utilizando soluciones innovadoras de envasado primario. - [Solucionando los desafíos de almacenamiento de medicamentos con viales | SCHOTT Pharma](https://www.schott-pharma.com/es/experiencia/centro-de-informacion/schott-pharma-blog/soluciones-de-contencion-farmaceutica): El crecimiento de las formulaciones farmacéuticas es un desafío en cuanto al llenado y manejo de las ampolletas de vidrio farmacéuticas, pero SCHOTT EVERIC® satisface esa demanda. - [Esterilidad en envases farmacéuticos listos para usar | SCHOTT Pharma](https://www.schott-pharma.com/es/experiencia/centro-de-informacion/schott-pharma-blog/lograr-esterilidad-envasado-rtu): Para garantizar unos niveles de esterilidad estrictamente regulados, se pueden aplicar diferentes tecnologías en el sector de envases farmacéuticos listos para usar. - [Esterilización Farmacéutica con Óxido de Etileno](https://www.schott-pharma.com/es/experiencia/centro-de-informacion/schott-pharma-blog/esterilizacion-farmaceutica): Aprende más sobre la esterilización farmacéutica en soluciones de envasado farmacéutico RTU y cómo lograrla con esterilización con óxido de etileno. - [Cómo los medicamentos de ARNm modifican al envase primario farmacéutico I SCHOTT Pharma](https://www.schott-pharma.com/es/experiencia/centro-de-informacion/schott-pharma-blog/embalaje-de-medicamentos-de-arnm): Este artículo explora los puntos clave que influyen en el envasado farmacéutico primario en una nueva era de soluciones farmacológicas de ARNm. - [Estabilidad de Medicamentos Optimizada | SCHOTT Pharma ](https://www.schott-pharma.com/es/experiencia/centro-de-informacion/schott-pharma-blog/estabilidad-de-los-medicamentos): Garantice la estabilidad de los medicamentos eligiendo el envase adecuado de vidrio o polímero en la gama de productos de SCHOTT Pharma. - [Explicación de las pruebas de sustancias extraíbles](https://www.schott-pharma.com/es/experiencia/centro-de-informacion/schott-pharma-blog/pruebas-de-extraibles): Las pruebas de extraíbles se utilizan para identificar y analizar materiales potencialmente dañinos que podrían transferirse a un paciente cuando se utiliza un medicamento o dispositivo médico. Este artículo del blog se enfocará en las pruebas de extraíbles y su papel esencial en la industria farmacéutica. - [Transición de las vacunas mRNA contra el Covid-19 de vial a las jeringas prellenadas | SCHOTT Pharma](https://www.schott-pharma.com/es/experiencia/centro-de-informacion/schott-pharma-blog/transicion-de-las-vacunas-de-arnm): A medida que la pandemia de COVID-19 se desarrolla, SCHOTT Pharma investiga si las jeringas prellenadas de dosis única son más adecuadas que los viales de dosis múltiples como envase para las vacunas. - [SCHOTT Pharma Blog I Para Fabricantes Farmacéuticos](https://www.schott-pharma.com/es/experiencia/centro-de-informacion/schott-pharma-blog): Descubre el blog de SCHOTT Pharma para obtener información confiable sobre la industria farmacéutica. Mantente al tanto de noticias regularmente. ## SCHOTT Pharma Academy/Eventos/Certificados | Los recursos de experiencia farmacéutica de SCHOTT Pharma incluyen programas educativos, eventos y capacitación a través de Pharmaversity Academy, además de acceso a certificados e información del sector, lo que ayuda a los socios farmacéuticos y biotecnológicos a desarrollar conocimientos, habilidades y competencia regulatoria. - [Certificados | SCHOTT Pharma](https://www.schott-pharma.com/es/experiencia/centro-de-informacion/certificados): Explore la gama de jeringas, viales, cartuchos y ampolletas prellenadas certificados de SCHOTT. Innovación y seguridad en cada producto. ¡Descubra más! ## SCHOTT Pharma Acerca de nosotros | La página Acerca de SCHOTT Pharma se centra en la misión, los valores y la historia de la empresa, destacando su papel en la contención y administración de fármacos, su compromiso con la calidad y la innovación, su presencia global y su apoyo a los socios farmacéuticos y biotecnológicos en la mejora de los resultados en salud. - [Porque la salud humana es importante | SCHOTT Pharma](https://www.schott-pharma.com/es/sobre-schott-pharma/porque-la-salud-humana-importa): Junto con usted, nuestros clientes y socios, nos esforzamos por ofrecer la mejor experiencia al paciente. Por una razón muy sencilla, porque la salud humana es importante. - [Sobre SCHOTT Pharma | Líder en fabricación farmacéutica ](https://www.schott-pharma.com/es/sobre-schott-pharma): Obtenga más información sobre SCHOTT Pharma, el líder de la industria farmacéutica, y familiarícese con su amplio portafolio de productos y soluciones. ## Comunicados de prensa de SCHOTT Pharma | La página de noticias y medios de SCHOTT Pharma presenta los últimos comunicados de prensa, actualizaciones de la empresa, resultados financieros, eventos y anuncios del sector sobre innovaciones, expansiones, asociaciones y rendimiento, manteniendo informados a los actores farmacéuticos y biotecnológicos sobre los desarrollos. - [Ferias y eventos | SCHOTT Pharma](https://www.schott-pharma.com/es/noticias-y-medios/ferias-y-eventos): Todos los eventos especializados, ferias comerciales y conferencias que SCHOTT Pharma presentará - [Media kits | SCHOTT Pharma](https://www.schott-pharma.com/es/noticias-y-medios/media-kits): Todos los media kits de SCHOTT, desde nuestro desempeño en la lucha contra el COVID-19 - [Formulario de contacto para prensa y noticias| SCHOTT Pharma](https://www.schott-pharma.com/es/noticias-y-medios/consulta): Póngase en contacto con nuestro equipo de prensa y noticias de SCHOTT Pharma - [Personas de contacto de medios y noticias | SCHOTT Pharma](https://www.schott-pharma.com/es/noticias-y-medios/contactos): Datos de contacto del equipo de medios y noticias de SCHOTT Pharma - [SCHOTT Pharma planea triplicar su capacidad de producción de viales en EE. UU. | SCHOTT](https://www.schott-pharma.com/es/noticias-y-medios/notas-de-prensa/2022/schott-pharma-plans-to-triple-vial-production-capacity-in-the-us): SCHOTT está realizando una inversión de varios millones de euros para aumentar la producción de viales listos para usar en su planta de Líbano, Pensilvania - [COMUNICADO DE PRENSA | ¡Hola SDAX! SCHOTT Pharma alcanza el siguiente hito como empresa cotizada en la bolsa de valores](https://www.schott-pharma.com/es/noticias-y-medios/notas-de-prensa/2023/schott-pharma-reaches-next-milestone-as-a-publicly-listed-company): ¡Hola, SDAX! SCHOTT Pharma alcanza el siguiente hito como empresa cotizada en bolsa | COMUNICADO DE PRENSA - [COMUNICADO DE MEDIOS | Avance en tratamientos con GLP-1, insulina e inyecciones de gran volumen con cartuchos listos para usar de SCHOTT Pharma](https://www.schott-pharma.com/es/noticias-y-medios/notas-de-prensa/2023/advancing-treatments-with-ready-to-use-cartridges-from-schott-pharma): Tratamientos avanzados con GLP-1, insulina e inyecciones de gran volumen con cartuchos listos para usar de SCHOTT Pharma | COMUNICADO DE PRENSA - [SCHOTT y el gobierno húngaro invierten en la producción de jeringas de última generación | SCHOTT](https://www.schott-pharma.com/es/noticias-y-medios/notas-de-prensa/2022/schott-and-hungarian-government-invest-in-cutting-edge-syringe-production): SCHOTT ha realizado una inversión de 76 millones de euros en una nueva planta de producción en Lukácsháza, Hungría, para satisfacer la demanda mundial de jeringas prellenadas de vidrio - [SCHOTT Pharma planea ampliar la producción de cartuchos | SCHOTT](https://www.schott-pharma.com/es/noticias-y-medios/notas-de-prensa/2022/schott-pharma-expande-la-producción-de-cartuchos-en-china-y-hungría): La inversión de varios millones de euros de SCHOTT Pharma aumentará significativamente la capacidad de producción de cartuchos farmacéuticos en Hungría y China - [SCHOTT anuncia su inversión en la producción de cartuchos listos para usar | SCHOTT](https://www.schott-pharma.com/es/noticias-y-medios/notas-de-prensa/2022/schott-announces-double-digit-million-euro-investment-in-ready-to-use-cartridge-production): NOTA DE PRENSA: La inversión de varios millones de euros de SCHOTT ampliará significativamente su capacidad de producción de cartuchos listos para usar (RTU) - [SCHOTT y el Serum Institute of India anuncian una alianza conjunta de envasado farmacéutico](https://www.schott-pharma.com/es/noticias-y-medios/notas-de-prensa/2021/schott-and-serum-institute-of-india-announce-joint-venture-for-pharmaceutical-packaging): Comunicado de prensa: SCHOTT y el Serum Institute of India anuncian una alianza conjunta de envasado farmacéutico - [COMUNICADO DE PRENSA | SCHOTT Pharma ofrece un fuerte crecimiento rentable para todo el año justo después de la IPO, en el extremo superior de su guía](https://www.schott-pharma.com/es/noticias-y-medios/notas-de-prensa/2023/schott-pharma-delivers-right-after-ipo-with-strong-profitable-growth-for-the-full-year): SCHOTT Pharma ofrece un fuerte crecimiento rentable para todo el año justo después de la IPO, en el extremo superior de su guía | COMUNICADO DE PRENSA - [Comunicado de prensa | SCHOTT establece una empresa independiente para su negocio farmacéutico con el fin de promover un mayor crecimiento](https://www.schott-pharma.com/es/noticias-y-medios/notas-de-prensa/2022/schott-establishes-stand-alone-company-for-pharma-business-to-promote-further-growth): SCHOTT establece una empresa independiente para su negocio farmacéutico con el fin de promover un mayor crecimiento | Comunicado de prensa - [NOTA DE PRENSA: Por primera vez en el mercado: Almacenamiento seguro de medicamentos a temperaturas extremadamente bajas con jeringas de polímero listas para llenar de SCHOTT Pharma | SCHOTT](https://www.schott-pharma.com/es/noticias-y-medios/notas-de-prensa/2023/safely-storing-deep-cold-medications-with-prefillable-polymer-syringes): Por primera vez en el mercado: Almacenamiento seguro de medicamentos a temperaturas extremadamente bajas con las jeringas de polímero listas para llenar de SCHOTT Pharma - [COMUNICADO DE PRENSA | SCHOTT Pharma refuerza su posición de liderazgo en el primer año como empresa independiente](https://www.schott-pharma.com/es/noticias-y-medios/notas-de-prensa/2023/schott-pharma-strengthens-leading-position-in-the-first-year-as-stand-alone-company): Al reflexionar sobre el primer año de SCHOTT Pharma como entidad independiente, Andreas Reisse ve a la empresa en una posición ideal para capitalizar las tendencias del mercado a largo plazo. SCHOTT Pharma refuerza su posición de liderazgo en el primer año como empresa independiente - [COMUNICADO DE PRENSA | Impulso de mantenimiento: SCHOTT Pharma mantiene un fuerte crecimiento en el primer semestre del ejercicio fiscal 2023](https://www.schott-pharma.com/es/noticias-y-medios/notas-de-prensa/2023/upholding-momentum-schott-pharma-sustains-strong-growth-in-the-first-half-of-fy-2023): Momento de retención: SCHOTT Pharma mantiene un fuerte crecimiento en el primer semestre del ejercicio fiscal 2023 | COMUNICADO DE PRENSA - [SCHOTT presenta iQ® Integribag | SCHOTT](https://www.schott-pharma.com/es/noticias-y-medios/notas-de-prensa/2022/schott-presenta-iq-integribag): La solución de transferencia sin contacto de SCHOTT para soluciones de contención y suministro de medicamentos listas para usar brinda una integridad estéril de última generación - [SCHOTT abre una nueva planta de jeringas precargables en una nueva planta alemana | SCHOTT](https://www.schott-pharma.com/es/noticias-y-medios/notas-de-prensa/2022/schott-inaugurates-plant-for-prefillable-polymer-syringes-at-new-facility-in-germany): NOTA DE PRENSA: El grupo tecnológico internacional ha invertido varios millones de euros en su planta de Müllheim (Alemania) para ampliar su producción de jeringas de polímero precargables - [COMUNICADO DE PRENSA | Cadena de suministro con cero emisiones netas: SCHOTT Pharma lanza la siguiente fase del programa de descarbonización](https://www.schott-pharma.com/es/noticias-y-medios/notas-de-prensa/2024/schott-pharma-launches-next-phase-of-decarbonizing-program): Cadena de suministro con cero emisiones netas: SCHOTT Pharma lanza la siguiente fase del programa de descarbonización | COMUNICADO DE PRENSA - [COMUNICADO DE PRENSA | Tomarnos la responsabilidad en serio: SCHOTT Pharma publica el primer informe de sostenibilidad](https://www.schott-pharma.com/es/noticias-y-medios/notas-de-prensa/2024/schott-pharma-releases-first-sustainability-report): Tomar la responsabilidad con seriedad SCHOTT Pharma publica su primer informe de sostenibilidad | COMUNICADO DE PRENSA - [SCHOTT Pharma abre camino para una producción de última generación en Hungría | SCHOTT](https://www.schott-pharma.com/es/noticias-y-medios/notas-de-prensa/2022/schott-pharma-breaks-ground-for-cutting-edge-production-in-hungary): La construcción de un nuevo centro de producción de jeringas de vidrio precargables (PFS) ya ha iniciado en Lukácsháza, Hungría, sumando una segunda instalación a la red de fabricación global de SCHOTT Pharma - [NOTA DE PRENSA: SCHOTT Pharma con un sólido rendimiento financiero en el año 2022 | SCHOTT](https://www.schott-pharma.com/es/noticias-y-medios/notas-de-prensa/2023/schott-pharma-with-strong-financial-performance-in-fiscal-year-2022): Amplíe información sobre el desarrollo empresarial de SCHOTT Pharma en el año 2022 - [SCHOTT informa de un año exitoso para su unidad de negocio farmacéutica | SCHOTT](https://www.schott-pharma.com/es/noticias-y-medios/notas-de-prensa/2022/schott-informa-de-un-año-exitoso-para-la-unidad-de-negocio-farmacéutica): NOTA DE PRENSA: La unidad de negocio farmacéutica de SCHOTT tuvo un año muy exitoso en 2021 y apunta a consolidar este éxito - [COMUNICADO DE PRENSA | SCHOTT Pharma ejecuta con éxito su estrategia de expansión e invierte en una nueva planta de producción en Serbia](https://www.schott-pharma.com/es/noticias-y-medios/notas-de-prensa/2023/schott-pharma-invests-in-a-new-production-facility-in-serbia): SCHOTT Pharma ejecuta con éxito su estrategia de expansión e invierte en una nueva planta de producción en Serbia | COMUNICADO DE PRENSA - [Notas de prensa | SCHOTT Pharma](https://www.schott-pharma.com/es/noticias-y-medios/notas-de-prensa): Las últimas notas de prensa de SCHOTT Pharma - [Noticias y medios | SCHOTT Pharma](https://www.schott-pharma.com/es/noticias-y-medios): Últimas noticias y notas de prensa del fabricante internacional de vidrio especial ## Sostenibilidad de SCHOTT Pharma | La página de Sostenibilidad de SCHOTT Pharma expone las iniciativas de responsabilidad ambiental y social de la empresa, incluidos los objetivos de acción climática, eficiencia de recursos, cadenas de suministro éticas y compromiso con la comunidad para respaldar una atención sanitaria sostenible y un impacto a largo plazo. - [Cumplimiento | SCHOTT Pharma](https://www.schott-pharma.com/es/sobre-schott-pharma/sostenibilidad/compliance): Todo lo que necesita saber sobre las políticas de cumplimiento de SCHOTT Pharma, incluido su Código de Conducta, prácticas empresariales éticas, responsabilidad social y gobernanza corporativa. - [Sostenibilidad | SCHOTT Pharma](https://www.schott-pharma.com/es/sobre-schott-pharma/sostenibilidad): Descubra cómo SCHOTT Pharma impulsa la sostenibilidad a lo largo de toda su cadena de valor mediante prácticas empresariales responsables, acción climática, iniciativas de circularidad y eficiencia en el uso de los recursos. ## SCHOTT Pharma Otras páginas - [Boletín informativo | SCHOTT Pharma](https://www.schott-pharma.com/es/boletín-informativo): - [SCHOTT Pharma AG & Co. KGaA](https://www.schott-pharma.com/es/pie-de-imprenta): Aquí encontrará nuestro pie de imprenta con la información legal de SCHOTT. - [Términos y condiciones generales | SCHOTT Pharma](https://www.schott-pharma.com/es/terminos-y-condiciones-generales): - [Política de protección de datos| SCHOTT Pharma](https://www.schott-pharma.com/es/politica-de-proteccion-de-datos): Para SCHOTT Pharma, la protección de datos es muy importante. Obtenga más información sobre cómo SCHOTT Pharma se ocupa de sus datos. - [Exención de responsabilidad e información legal | SCHOTT Pharma](https://www.schott-pharma.com/es/aviso-legal): Información legal para el uso del sitio web de SCHOTT. ## Français ## Produits | La page Produits de SCHOTT Pharma offre un aperçu de son portefeuille de solutions de stockage et d’administration de médicaments, comprenant des seringues, des cartouches, des flacons et des ampoules pré-remplissables en verre et en polymère, tous conçus pour les fabricants pharmaceutiques et biotechnologiques. - [Cartouches | SCHOTT Pharma](https://www.schott-pharma.com/fr/produits/cartouches): La gamme de cartouches SCHOTT Pharma permet de distribuer des médicaments à des doses extrêmement précises pour toutes situations médicales. - [Ampoules | SCHOTT Pharma](https://www.schott-pharma.com/fr/produits/ampoules): Découvrez nos ampoules pour une résistance chimique exceptionnelle, stabilité optimale des médicaments et des dimensions précises. - [Seringues | SCHOTT Pharma](https://www.schott-pharma.com/fr/produits/seringues): Découvrez la gamme de seringues SCHOTT Pharma, disponible en plusieurs formats pour le stockage sûr de différents médicaments. En savoir plus ! - [Flacons | SCHOTT Pharma ](https://www.schott-pharma.com/fr/produits/flacons-pharmaceutiques): Les flacons SCHOTT Pharma améliorent l'efficacité du remplissage et de la fabrication et augmentent la stabilité à long terme des médicaments, offrant ainsi de nombreux avantages. - [Emballages Pharmaceutiques | SCHOTT Pharma ](https://www.schott-pharma.com/fr/produits): En tant que fournisseur leader d'emballages pharmaceutiques, on offre un large portefeuille de produits : Seringues, ampoules, cartouches et flacons. ## Seringues | La page Seringues de SCHOTT Pharma présente ses solutions de seringues pharmaceutiques pré-remplissables en verre et en polymère avancé, assurant un stockage et une administration sécurisés des médicaments. Elle met en avant les seringues syriQ® et SCHOTT TOPPAC®, conçues pour réduire les erreurs, améliorer la sécurité et répondre à un large éventail d’applications, allant des vaccins aux produits biologiques. - [SCHOTT TOPPAC® unique](https://www.schott-pharma.com/fr/produits/seringues/schott-toppac-unique-): Découvrez les contenants polymères SCHOTT Pharma avec formats personnalisables pour les traitements médicaux personnalisés. En savoir plus ! - [Seringues en polymère SCHOTT TOPPAC®](https://www.schott-pharma.com/fr/produits/seringues/schott-toppac): Nos Seringues en polymère offrent une solution de conditionnement primaire fiable pour le stockage longue durée des médicaments. En savoir plus ! - [SCHOTT TOPPAC® infuse](https://www.schott-pharma.com/fr/produits/seringues/schott-toppac-infuse): Optimisez l’environnement hospitalier et réduisez les erreurs médicales avec la seringue pour perfusion SCHOTT TOPPAC®. En savoir plus ! - [Seringue en verre syriQ®](https://www.schott-pharma.com/fr/produits/seringues/syriq): Découvrez syriQ®, la seringue en verre préremplissable conçue pour les vaccins inactivés, atténués, conjugués et à ARNm. En savoir plus ! - [syriQ BioPure®](https://www.schott-pharma.com/fr/produits/seringues/syriq-biopure): Découvrez syriQ BioPure® seringues pour produits biologiques conçue pour minimiser les interactions entre médicament & emballage. En savoir plus ! - [syriQ BioPure® sans silicone](https://www.schott-pharma.com/fr/produits/seringues/syriq-biopure-silicone-free): Découvrez les seringues syriQ BioPure® sans silicone, prêtes à l’emploi, avec corps en verre pour un stockage stable des médicaments. En savoir plus ! - [SCHOTT TOPPAC® cosmetic](https://www.schott-pharma.com/fr/produits/seringues/schott-toppac-cosmetic): La seringue SCHOTT TOPPAC® cosmetic, conçue pour les traitements esthétiques à l’acide hyaluronique et à la toxine botulinique. En savoir plus ! - [SCHOTT TOPPAC® freeze](https://www.schott-pharma.com/fr/produits/seringues/schott-toppac-freeze): Découvrez SCHOTT TOPPAC® freeze, la seringue prête à l’emploi pour stockage à basse température pour une sécurité à chaque usage. En savoir plus ! ## Cartouches | La page Cartouches pharmaceutiques de SCHOTT Pharma présente ses solutions de cartouches en verre et en polymère pour un dosage précis des médicaments dans des stylos, des auto-injecteurs et des dispositifs portables. Le portefeuille comprend des options prêtes à l’emploi, à double chambre et à haute durabilité, conçues pour les thérapies injectables et les biologiques. - [SCHOTT TOPPAC® cartouche en polymère](https://www.schott-pharma.com/fr/produits/cartouches/schott-toppac-cartridge): Cartouches en polymère SCHOTT TOPPAC® offrent stabilité, intégrité et fiabilité pour l’administration de produits biologiques sensibles. En savoir plus ! - [Cartouches à double chambre (DC)](https://www.schott-pharma.com/fr/produits/cartouches/cartouches-a-double-chambre): Les cartouches à double chambre offrent une solution sûre et efficace pour la manipulation des médicaments lyophilisés afin de garantir un dosage précis. - [cartriQ® Large Volume](https://www.schott-pharma.com/fr/produits/cartouches/cartriq-large-volume): Les cartouches grand volume cartriQ® conçues pour les dispositifs d'injection portables une administration sûre des médicaments pour les patients. - [Cartouches Pharmaceutiques Core](https://www.schott-pharma.com/fr/produits/cartouches/core-cartouches): Nos cartouches pharmaceutiques core offrent une résistance chimique élevée, permettant ainsi aux patients d'auto-administrer leurs médicaments. - [Cartouches incassables (BR) ](https://www.schott-pharma.com/fr/produits/cartouches/cartouches-incassables): Nos cartouches incassables (BR) résistent aux conditions difficiles et garantissent le stockage et l'administration en toute sécurité de médicaments vitaux. - [cartriQ®](https://www.schott-pharma.com/fr/produits/cartouches/cartriq): Cartouches prêtes à l'emploi cartriQ® compatibles avec divers auto-injecteurs et stylos injecteurs, et idéales pour un usage à l'hôpital et à domicile. ## Flacons en Verre | La page Flacons de SCHOTT Pharma met en avant des flacons en verre de haute qualité, conçus pour les médicaments injectables, les vaccins et les produits biologiques, offrant une résistance chimique, une précision dimensionnelle et des options prêtes à l’emploi pour soutenir des processus pharmaceutiques de remplissage et de finition efficaces. - [EVERIC® freeze](https://www.schott-pharma.com/fr/produits/flacons-pharmaceutiques/everic-freeze): Le flacon pour stockage à très basse température EVERIC® freeze garantit la stabilité à basse température et optimise la lyophilisation pharmaceutique! - [EVERIC® strong & smooth](https://www.schott-pharma.com/fr/produits/flacons-pharmaceutiques/everic-strong-smooth): Le flacon incassable offre une vitesse accrue pour les lignes fill-and-finish en vrac, ainsi qu'un risque réduit de casse et des taux de rejet plus faibles. - [EVERIC® amber flacons ambrés](https://www.schott-pharma.com/fr/produits/flacons-pharmaceutiques/everic-amber): Les flacons ambrés EVERIC® amber offrent une protection optimale contre la lumière pour les produits sensibles comme les ADC. En savoir plus ! - [adaptiQ®](https://www.schott-pharma.com/fr/produits/flacons-pharmaceutiques/adaptiq): Flacons stériles adaptiQ® en verre borosilicaté de haute qualité dans des emballages secondaires standard prélavés et préstérilisés Ready-to-use (RTU) - [Flacons Médicament Core](https://www.schott-pharma.com/fr/produits/flacons-pharmaceutiques/core-flacon): Flacons Médicament Core TopLine et StandardLine garantissent la stabilité des médicaments, l'efficacité de la production et un faible coût de possession. - [EVERIC® pure](https://www.schott-pharma.com/fr/produits/flacons-pharmaceutiques/everic-pure): Flacons de médicaments biologiques EVERIC® Pure: un contrôle éprouvé du délamination et une résistance à l'hydrolyse des produits pharmaceutiques. - [EVERIC® plus](https://www.schott-pharma.com/fr/produits/flacons-pharmaceutiques/everic-plus): Les flacons revêtus EVERIC® plus présentent de faibles niveaux de lixiviation et une adsorption réduite pour une stabilité des médicaments sensibles. - [EVERIC® care](https://www.schott-pharma.com/fr/produits/flacons-pharmaceutiques/everic-care): Les flacons pharmaceutiques EVERIC® Care: revêtement hydrophobe protègent les médicaments sensibles contre les substances lixiviables à pH alcalin. - [EVERIC® smart](https://www.schott-pharma.com/fr/produits/flacons-pharmaceutiques/everic-smart): Découvrez notre emballage intelligent SCHOTT Pharma avec un code unique qui permet une traçabilité optimale tout au long du processus Fill-and-Finish. - [EVERIC® lyo](https://www.schott-pharma.com/fr/produits/flacons-pharmaceutiques/everic-lyo): EVERIC® lyo vials are designed to prevent fogging during lyophilization and improve residual emptying ## Ampoules | La page Ampoules en verre de SCHOTT Pharma met en avant des ampoules en borosilicate de haute qualité, assurant un confinement sûr des médicaments injectables et des produits chimiques stériles, avec une étanchéité précise, une résistance chimique, ainsi que des formats adaptés aux vaccins, aux produits biologiques et aux applications pharmaceutiques sensibles. - [Ampoules Anti-Contrefaçon (AC)](https://www.schott-pharma.com/fr/produits/ampoules/ampoules-ac): Les Ampoules Anti-Contrefaçon (AC) de SCHOTT Pharma offrent une protection contre la menace croissante de la contrefaçon de médicaments. - [Ampoules easyOPC](https://www.schott-pharma.com/fr/produits/ampoules/ampoules-easy-opc): Ampoules easyOPC : rupture optimisée pour ouverture sûre, réduction des retours, des coûts moindres et meilleure stabilité des médicaments. - [Ampoules Pharmaceutiques Core](https://www.schott-pharma.com/fr/produits/ampoules/core-ampoules): Ampoules pharmaceutiques Core : résistance à l'hydrolyse, processus Fill-and-Finish exceptionnel et un choix entre quatre systèmes de rupture différents. ## Services pharmaceutiques | La page Services de SCHOTT Pharma présente un accompagnement sur mesure pour les partenaires pharmaceutiques et biotechnologiques, comprenant l’optimisation de l’emballage, le conseil en réglementation et en qualité, l’assistance technique, le développement de systèmes d’administration de médicaments, ainsi que des solutions personnalisées visant à améliorer la fabrication et la performance des produits. - [Services Réglementaires I SCHOTT Pharma ](https://www.schott-pharma.com/fr/services/services-reglementaires): Services réglementaires pour intégrer des contenus liés aux emballages utilisés dans la procédure d'autorisation de mise sur le marché des médicaments. - [Services d'Analyse Pharmaceutique | SCHOTT Pharma](https://www.schott-pharma.com/fr/services/analyse-pharmaceutique): Services d'analyse pharmaceutique SCHOTT Pharma valident les systèmes d'emballage primaire en fonction des exigences de votre médicament. - [Services pharmaceutiques | SCHOTT Pharma ](https://www.schott-pharma.com/fr/services): Services pharmaceutiques allant des tests analytiques à au soutien des objectifs de développement durable & des normes réglementaires. En savoir plus ! ## SCHOTT Pharma Services de stockage et d’administration de médicaments | La page Solutions de confinement de SCHOTT Pharma met en avant des services de conseil et d’accompagnement personnalisables pour le confinement dans l’emballage pharmaceutique, incluant l’évaluation des risques, les stratégies de barrière, les tests de compatibilité et des systèmes de confinement optimisés afin d’assurer la sécurité et la qualité du produit ainsi que la conformité réglementaire. - [Études de faisabilité | SCHOTT Pharma](https://www.schott-pharma.com/fr/services/developpement-emballages-pharmaceutiques/feasibility-study): SCHOTT Pharma propose un service d’études de faisabilité qui examine la faisabilité d’une solution d’emballage de produit ainsi que son adéquation à une production à grande échelle. - [Prototypage | SCHOTT Pharma](https://www.schott-pharma.com/fr/services/developpement-emballages-pharmaceutiques/prototyping): SCHOTT Pharma propose un service complet de prototypage pour l’emballage pharmaceutique, comprenant la fabrication d’échantillons, les tests de faisabilité et de compatibilité, ainsi que la documentation. - [Développement d'emballages pharmaceutiques | SCHOTT Pharma](https://www.schott-pharma.com/fr/services/developpement-emballages-pharmaceutiques): Découvrez nos services/solutions pour le développement de d'emballage pharmaceutique primaire personnalisés, de la conception à l'industrialisation. ## Analyse pharmaceutique SCHOTT | La page Pharma Analytics de SCHOTT Pharma présente un portefeuille de services analytiques pour les systèmes d’emballage et d’administration de médicaments, comprenant la caractérisation des matériaux, les tests d’extractibles et de lixiviables, les études de stabilité ainsi que le support réglementaire afin d’assurer la qualité, la sécurité et la conformité des produits pharmaceutiques. - [Test de Stabilité Mécanique | SCHOTT Pharma](https://www.schott-pharma.com/fr/services/analyse-pharmaceutique/test-de-stabilite): Test de stabilité mécanique de produits pharmaceutiques comme base pour l'analyse des points faibles des lignes de production des conteneurs. - [Tests fonctionnels](https://www.schott-pharma.com/fr/services/analyse-pharmaceutique/functional-testing): SCHOTT Pharma propose un service de tests fonctionnels des emballages pharmaceutiques pour garantir une conformité réglementaire complète. - [Composants d'Emballage Pharmaceutiques | SCHOTT Pharma](https://www.schott-pharma.com/fr/services/analyse-pharmaceutique/composants-emballage-pharmaceutiques): Les composants d'emballage pharmaceutiques garantissent un stockage sûr de votre médicament et de votre système d'emballage primaire. - [Études sur les Extractibles et les Lixiviables | SCHOTT Pharma ](https://www.schott-pharma.com/fr/services/analyse-pharmaceutique/etudes-extractibles-lixiviables): Études extractibles et les lixiviables de SCHOTT Pharma. Identifier les risques d'interactions entre le médicament et le conditionnement primaire. - [Études sur la Délamination du Verre | SCHOTT Pharma](https://www.schott-pharma.com/fr/services/analyse-pharmaceutique/delamination-du-verre): Études de délaminage pour faciliter la sélection de la combinaison de contenants & des paramètres de stockage pour des médicaments spécifiques. - [Particle Analysis | SCHOTT Pharma](https://www.schott-pharma.com/fr/services/analyse-pharmaceutique/analyse-de-particules): SCHOTT Pharma conducts a series of investigative studies into particles found in drugs to discover the root causes and steps required to ensure product safety - [Test d’intégrité de fermeture des conteneurs I SCHOTT Pharma](https://www.schott-pharma.com/fr/services/analyse-pharmaceutique/test-d’intégrité-du-système-de-fermeture-du-conteneur): SCHOTT Pharma propose un service complet de tests CCI garantissant la sécurité et l’efficacité de votre contenant pharmaceutique. - [Contrôle de conformité des matériaux pharmaceutiques | SCHOTT Pharma](https://www.schott-pharma.com/fr/services/analyse-pharmaceutique/controle-de-conformite): Le contrôle de conformité sur tous les aspects des systèmes d'emballage primaire afin de respecter la pharmacopée et les normes internationales. ## Services Fill-and-Finish de SCHOTT Pharma | La page Fill-and-Finish de SCHOTT Pharma présente les services de fabrication stérile, comprenant le remplissage aseptique, l’inspection et l’emballage des médicaments injectables et des produits biologiques, avec contrôle qualité, production évolutive et accompagnement réglementaire afin d’aider les partenaires pharmaceutiques à mettre leurs produits sur le marché en toute sécurité. - [Services Fill-and-Finish pour l'Industrie Pharmaceutique | SCHOTT Pharma](https://www.schott-pharma.com/fr/services/fill-and-finish): Fill-and-Finish SCHOTT Pharma soutiennent le traitement des solutions d'emballage pour les médicaments à petite échelle ou à échelle commerciale. ## Services réglementaires de SCHOTT Pharma | La page Réglementation de SCHOTT Pharma présente le soutien apporté pour les emballages pharmaceutiques et les systèmes d’administration, incluant des conseils sur les réglementations mondiales, les stratégies de soumission, la documentation, l’évaluation de la conformité et la gestion de la qualité, afin d’aider les partenaires à satisfaire aux exigences réglementaires et à optimiser les processus d’approbation. - [Dossier pour Approbation de Dispositifs Médicaux (MDR) | SCHOTT Pharma](https://www.schott-pharma.com/fr/services/services-reglementaires/approbation-dispositifs-medicaux): SCHOTT Pharma offre une assistance complète pour l'autorisation des dispositifs médicaux en fournissant des dossiers Medical Device Regulation (MDR) - [Lettre d'autorisation (LOA) | SCHOTT Pharma](https://www.schott-pharma.com/fr/services/services-reglementaires/lettres-autorisation): SCHOTT Pharma offre des services réglementaires, y compris la préparation de lettres d'autorisation pour faciliter le l'enregistrement des médicaments. - [Dossiers d'Emballage Pharmaceutique | SCHOTT Pharma ](https://www.schott-pharma.com/fr/services/services-reglementaires/dossiers-emballage-pharmaceutique): Nous proposons des ensembles de documentation personnalisés pour des intégrations transparentes dans les dossiers d'emballage pharmaceutique. - [Autorisation de Mise sur le Marché des Produits Pharmaceutiques | SCHOTT Pharma](https://www.schott-pharma.com/fr/services/services-reglementaires/autorisation-de-mise-sur-le-marche): L'autorisation de mise sur le marché des médicaments et préparation proactive de la conformité réglementaire et de la disponibilité de leurs produits. - [Drug Master Files (DMF) | SCHOTT Pharma](https://www.schott-pharma.com/fr/services/services-reglementaires/drug-master-files-dmf): Nos Drug Master Files soutiennent la création, la soumission & l'autorisation de mise sur le marché des médicaments aux USA, au Canada & en Chine. ## Services de développement durable de SCHOTT Pharma | La page Développement durable de SCHOTT Pharma met l’accent sur les services proposés par l’entreprise pour soutenir la responsabilité environnementale et sociale, tels que les revues de performance en matière de durabilité, les notations EcoVadis et les évaluations de l’empreinte carbone des produits, afin de contribuer à la réduction des émissions, à l’amélioration de la durabilité de la chaîne d’approvisionnement et à la progression vers un avenir net zéro. - [Le Développement Durable dans l'Industrie Pharmaceutique | SCHOTT Pharma](https://www.schott-pharma.com/fr/services/developpement-durable-pharma): SCHOTT Pharma intègre des concepts environnementaux et soutient la gestion pharmaceutique de la conformité au développement durable pharma ## Solutions SCHOTT Pharma | La page Solutions de SCHOTT Pharma présente des systèmes intégrés de confinement et d’administration de médicaments, combinant conditionnement, analyses, remplissage et finition, ainsi que support réglementaire. Ces solutions de bout en bout permettent aux partenaires pharmaceutiques et biotechnologiques d’améliorer la sécurité, l’efficacité et la performance des produits tout au long du cycle de vie. - [Whitepaper Finding the perfect match I SCHOTT Pharma](https://www.schott-pharma.com/fr/pharma-solutions/pharmaceutical-manufacturing/solution-sterile-conditionnement-medicaments/whitepaper-finding-the-perfect-match): - [Whitepaper Standardized Packaging Solutions I SCHOTT Pharma](https://www.schott-pharma.com/fr/pharma-solutions/pharmaceutical-manufacturing/solution-sterile-conditionnement-medicaments/whitepaper-standardized-packaging): - [Whitepaper A winning combination I SCHOTT Pharma](https://www.schott-pharma.com/fr/pharma-solutions/pharmaceutical-manufacturing/solution-sterile-conditionnement-medicaments/whitepaper-winning-combination): - [Conservation du Vaccin ARNm à Basse Température ](https://www.schott-pharma.com/fr/pharma-solutions/drug-packaging/conservation-du-vaccin-arnm): Conservation du vaccin ARNm pour résoudre les problèmes techniques tels que le mouvement du piston ou la stérilité de l'ARNm à basse température - [Intégration de cartriQ® pour les injections SC à grand volume | SCHOTT Pharma](https://www.schott-pharma.com/fr/pharma-solutions/drug-packaging/large-volume-biologics/cartriq-integration-sterile-large-volume): L’intégration de cartriQ® assure une administration SC sûre et stable des produits biologiques de grand volume, facilitant ainsi une administration de médicaments à domicile, conviviale pour le patient. - [Produits biologiques et biosimilaires – de la recherche à la conformité aux exigences réglementaires | SCHOTT Pharma](https://www.schott-pharma.com/fr/pharma-solutions/drug-packaging/biologics-biosimilars): Les produits biologiques et les biosimilaires présentent de nouveaux défis : découvrez comment les commercialiser, depuis la recherche sur les solutions d’emballage primaire jusqu’à la conformité réglementaire. - [Solutions de tests fonctionnels USP <382> | SCHOTT Pharma](https://www.schott-pharma.com/fr/pharma-solutions/pharma-services/usp-382): Tests rigoureux selon USP <382> pour les systèmes entièrement assemblés et remplis de médicaments, allant de la vérification de l’intégrité de l’emballage et des contrôles CCI à l’analyse de la fragmentation - [Produits biologiques à grand volume | SCHOTT Pharma](https://www.schott-pharma.com/fr/pharma-solutions/drug-packaging/large-volume-biologics): SCHOTT Pharma propose une gamme de solutions d’emballage primaire pour les injecteurs à stylo, les auto-injecteurs, les systèmes d’administration portés sur le corps et les pompes à perfusion. - [Traitement du diabète | SCHOTT Pharma ](https://www.schott-pharma.com/fr/pharma-solutions/drug-packaging/traitement-du-diabete): Nos solutions de conditionnement et d’administration de médicaments optimisées pour le traitement du diabète à base de GLP-1. En savoir plus ! - [Solution de Conditionnement Stérile des Médicaments | SCHOTT Pharma](https://www.schott-pharma.com/fr/pharma-solutions/pharmaceutical-manufacturing/solution-sterile-conditionnement-medicaments): La solution de conditionnement stérile de SCHOTT Pharma, pour réduire les coûts et améliorer le processus de fabrication des produits pharmaceutiques. - [Emballage des conjugués anticorps-médicaments | SCHOTT Pharma](https://www.schott-pharma.com/fr/pharma-solutions/drug-packaging/antibody-drug-conjugates): Relevez les défis des conjugués anticorps-médicaments (ADC) avec des emballages qui garantissent la stabilité biologique, prennent en charge les formulations lyophilisées et maintiennent l’intégrité de l’ADC - [Remplissage Aseptique – Contrôle Accru de la Contamination ](https://www.schott-pharma.com/fr/pharma-solutions/platforms/reduction-risque-de-contamination-remplissage-aseptique): Meilleur contrôle du contamination lors du remplissage aseptique. SCHOTT iQ® Integribag contre les limites des conteneurs RTU & améliore la sécurité. - [Solutions Track and Trace Pharmaceutique | SCHOTT Pharma ](https://www.schott-pharma.com/fr/pharma-solutions/pharmaceutical-manufacturing/track-and-trace-pharma): Découvrez nos solutions Track and Trace des produits pharmaceutiques pour réduire le risque de confusion des contenants de médicaments. - [Préparation de la soumission de médicaments | SCHOTT Pharma](https://www.schott-pharma.com/fr/pharma-solutions/pharma-services/preparation-soumission-medicament): Préparation de la soumission de médicaments : tests complets d’emballages pour une conformité totale et la sécurité des patients. Contactez-nous ! - [Optimisation du Processus Fill-and-Finish | SCHOTT Pharma ](https://www.schott-pharma.com/fr/pharma-solutions/pharma-services/efficacite-fill-and-finish): L'optimisation du Fill-and-Finish permet d'identifier et d'éliminer les ruptures et les interruptions dans le processus de remplissage pharmaceutique. - [Traitement de l'obésité | SCHOTT Pharma ](https://www.schott-pharma.com/fr/pharma-solutions/drug-packaging/traitement-obesite): Nos solutions d'emballage et d'administration de médicaments SCHOTT Pharma pour les traitements de l'obésité par GLP-1. En savoir plus ! - [Whitepaper A winning combination I SCHOTT Pharma](https://www.schott-pharma.com/fr/solutions/fill-and-finish/solution-sterile-conditionnement-medicaments/whitepaper-winning-combination): - [Whitepaper Standardized Packaging Solutions I SCHOTT Pharma](https://www.schott-pharma.com/fr/solutions/fill-and-finish/solution-sterile-conditionnement-medicaments/whitepaper-standardized-packaging): - [Whitepaper Finding the perfect match I SCHOTT Pharma](https://www.schott-pharma.com/fr/solutions/fill-and-finish/solution-sterile-conditionnement-medicaments/whitepaper-finding-the-perfect-match): - [Remplissage Aseptique – Contrôle Accru de la Contamination ](https://www.schott-pharma.com/fr/solutions/fill-and-finish/reduction-risque-de-contamination-remplissage-aseptique): Meilleur contrôle du contamination lors du remplissage aseptique. SCHOTT iQ® Integribag contre les limites des conteneurs RTU & améliore la sécurité. - [Optimisation du Processus Fill-and-Finish | SCHOTT Pharma ](https://www.schott-pharma.com/fr/solutions/fill-and-finish/efficacite-fill-and-finish): L'optimisation du Fill-and-Finish permet d'identifier et d'éliminer les ruptures et les interruptions dans le processus de remplissage pharmaceutique. - [Solutions Track and Trace Pharmaceutique | SCHOTT Pharma ](https://www.schott-pharma.com/fr/solutions/fill-and-finish/track-and-trace-pharma): Découvrez nos solutions Track and Trace des produits pharmaceutiques pour réduire le risque de confusion des contenants de médicaments. - [La Délamination du Verre Pharma sous Contrôle | SCHOTT Pharma ](https://www.schott-pharma.com/fr/solutions/perfect-fit/controle-delamination-verre-pharma): SCHOTT Pharma définit des étapes concrètes permettant aux entreprises pharmaceutiques de minimiser le risque de délamination du verre pharma. - [Solution de Conditionnement Stérile des Médicaments | SCHOTT Pharma](https://www.schott-pharma.com/fr/solutions/fill-and-finish/solution-sterile-conditionnement-medicaments): La solution de conditionnement stérile de SCHOTT Pharma, pour réduire les coûts et améliorer le processus de fabrication des produits pharmaceutiques. - [Produits biologiques et biosimilaires – de la recherche à la conformité aux exigences réglementaires | SCHOTT Pharma](https://www.schott-pharma.com/fr/solutions/biologics-biosimilars): Les produits biologiques et les biosimilaires présentent de nouveaux défis : découvrez comment les commercialiser, depuis la recherche sur les solutions d’emballage primaire jusqu’à la conformité réglementaire. - [Emballage des conjugués anticorps-médicaments | SCHOTT Pharma](https://www.schott-pharma.com/fr/solutions/antibody-drug-conjugates): Relevez les défis des conjugués anticorps-médicaments (ADC) avec des emballages qui garantissent la stabilité biologique, prennent en charge les formulations lyophilisées et maintiennent l’intégrité de l’ADC - [Solutions d’emballage pour petits lots | SCHOTT Pharma](https://www.schott-pharma.com/fr/solutions/fill-and-finish/small-batch-packaging-solutions): Les solutions d’emballage pour petits lots de SCHOTT Pharma assurent un confinement et une administration fiables des médicaments, tout en offrant une protection stérile optimale dès le début. - [Flacon EVERIC® | SCHOTT Pharma](https://www.schott-pharma.com/fr/solutions/perfect-fit/everic-vial-solutions): Les flacons EVERIC® de SCHOTT Pharma proposent une conception flexible et modulaire, conciliant les exigences des fabricants et des utilisateurs pour des performances optimisées. - [Conception optimisée du nid de seringues en polymère | SCHOTT Pharma](https://www.schott-pharma.com/fr/solutions/fill-and-finish/optimized-polymer-syringe-nest-design): Le nouveau système de nid et de cuve de SCHOTT Pharma est le premier au monde à accueillir 160 seringues en polymère, réduisant le temps de cycle et les coûts, tout en augmentant l’efficacité de vos lignes de remplissage et de finition à grande vitesse. - [Intégration de cartriQ® pour les injections SC à grand volume | SCHOTT Pharma](https://www.schott-pharma.com/fr/solutions/safe-and-easy-administration/large-volume-injections-biologics/cartriq-integration-sterile-large-volume): L’intégration de cartriQ® assure une administration SC sûre et stable des produits biologiques de grand volume, facilitant ainsi une administration de médicaments à domicile, conviviale pour le patient. - [Produits biologiques à grand volume | SCHOTT Pharma](https://www.schott-pharma.com/fr/solutions/safe-and-easy-administration/large-volume-injections-biologics): SCHOTT Pharma propose une gamme de solutions d’emballage primaire pour les injecteurs à stylo, les auto-injecteurs, les systèmes d’administration portés sur le corps et les pompes à perfusion. - [Conservation du Vaccin ARNm à Basse Température ](https://www.schott-pharma.com/fr/solutions/perfect-fit/conservation-du-vaccin-arnm): Conservation du vaccin ARNm pour résoudre les problèmes techniques tels que le mouvement du piston ou la stérilité de l'ARNm à basse température - [Traitement de l'obésité | SCHOTT Pharma ](https://www.schott-pharma.com/fr/solutions/safe-and-easy-administration/traitement-obesite): Nos solutions d'emballage et d'administration de médicaments SCHOTT Pharma pour les traitements de l'obésité par GLP-1. En savoir plus ! - [Solutions de tests fonctionnels USP <382> | SCHOTT Pharma](https://www.schott-pharma.com/fr/solutions/perfect-fit/usp-382): Tests rigoureux selon USP <382> pour les systèmes entièrement assemblés et remplis de médicaments, allant de la vérification de l’intégrité de l’emballage et des contrôles CCI à l’analyse de la fragmentation - [Préparation de la soumission de médicaments | SCHOTT Pharma](https://www.schott-pharma.com/fr/solutions/perfect-fit/preparation-soumission-medicament): Préparation de la soumission de médicaments : tests complets d’emballages pour une conformité totale et la sécurité des patients. Contactez-nous ! - [Lixiviation pour Faibles Volumes | SCHOTT Pharma ](https://www.schott-pharma.com/fr/solutions/perfect-fit/lixiviation-faible-volumes): Découvrez comment SCHOTT Pharma Services peut vous aider à réduire le risque de lixiviation pour vos médicaments fragiles à faible volume. - [Conservation des médicaments biotech | SCHOTT Pharma](https://www.schott-pharma.com/fr/solutions/perfect-fit/conservation-medicaments-biotech): Conservation des médicaments biotech. Découvrez les sept principaux défis liés à l'interaction entre le médicament et le conteneur pour les biotechnologies ! - [Traitement du diabète | SCHOTT Pharma ](https://www.schott-pharma.com/fr/solutions/safe-and-easy-administration/traitement-du-diabete): Nos solutions de conditionnement et d’administration de médicaments optimisées pour le traitement du diabète à base de GLP-1. En savoir plus ! - [Solutions d'Emballage Pharmaceutique | SCHOTT Pharma ](https://www.schott-pharma.com/fr/solutions): Solutions d'emballage pharmaceutique des médicaments, qui aident les entreprises pharmaceutiques, biotechnologiques & les CDMO dans leurs activités. ## Expertises | La page Expertise pharmaceutique de SCHOTT Pharma met en avant sa connaissance approfondie de l’industrie en matière de confinement des médicaments, de systèmes d’administration, de soutien réglementaire et d’optimisation de la fabrication, offrant des informations, des meilleures pratiques et des conseils d’experts pour aider les partenaires à relever des défis complexes dans les secteurs pharmaceutique et biotechnologique. - [Glossaire | SCHOTT Pharma ](https://www.schott-pharma.com/fr/pharma-expertise/centre-de-connaissances/glossaire): Le glossaire de SCHOTT Pharma comprend les mots-clés, les acronymes et la terminologie pharmaceutique les plus importants des l'emballage pharmaceutique. - [Expertise Pharmaceutique | SCHOTT Pharma](https://www.schott-pharma.com/fr/pharma-expertise): Expertise pharmaceutique à la disposition des entreprises et des particuliers pour des solutions de stockage et d'administration de médicaments. ## SCHOTT Pharma Pharmaversity® | La page SCHOTT Pharmaversity de SCHOTT Pharma met en avant des offres éducatives, des programmes de formation et des expertises pour les professionnels de l’industrie pharmaceutique et biotechnologique, conçus pour développer les compétences, approfondir les connaissances du secteur et soutenir les meilleures pratiques en matière d’emballage et de délivrance de médicaments. - [Pharmaversité® | Formation pharmaceutique](https://www.schott-pharma.com/fr/pharma-expertise/schott-pharmaversity): Pour obtenir des informations précieuses sur les sujets de l’industrie, explorez la Pharmaversité® afin d’élargir votre formation pharmaceutique avec l’aide d’experts en verre et en polymères. ## Blogs SCHOTT Pharma - [Intégrité de la fermeture des contenants (CCI) | SCHOTT Pharma](https://www.schott-pharma.com/fr/pharma-expertise/centre-de-connaissances/blog/container-closure-integrity): Découvrez comment la combinaison idéale de flacon, de bouchon et de scellage assure une intégrité optimale de la fermeture du récipient, prévient le pop-up/pop-off et améliore l’efficacité des opérations de remplissage et de finition. - [Innovations et Développement des Dispositifs Médicaux | SCHOTT Pharma](https://www.schott-pharma.com/fr/pharma-expertise/centre-de-connaissances/blog/conception-flexible-dispositifs-medicaux): Tom van Ginneken de SCHOTT Pharma parle des avantages du polymère comme solution parfaite pour les conteneurs COC personnalisés. - [Avantages clés des conteneurs d’emballage primaire intelligents | SCHOTT Pharma](https://www.schott-pharma.com/fr/pharma-expertise/centre-de-connaissances/blog/advantages-smart-primary-packaging): Les conteneurs intelligents de SCHOTT Pharma sont marqués au laser avec un code unique afin d’assurer une traçabilité optimale tout au long du processus de remplissage et de finition. - [Qu’est-ce que le test d’intégrité de fermeture de conteneur | SCHOTT Pharma](https://www.schott-pharma.com/fr/pharma-expertise/centre-de-connaissances/blog/what-is-container-closure-integrity-testing): Il est essentiel de garantir l’intégrité des fermetures de conteneur ainsi que celle du conteneur lui-même afin de maintenir une barrière stérile contre les contaminants potentiels et d’éliminer le risque de fuite. Cet article présente un aperçu des tests d’intégrité des fermetures de conteneurs (CCIT) et explique pourquoi ils sont essentiels. - [Biosimilaires et génériques | SCHOTT Pharma](https://www.schott-pharma.com/fr/pharma-expertise/centre-de-connaissances/blog/biosimilars-generics): Principales tendances de l'industrie et avantages liés au choix du bon emballage primaire dans un paysage pharmaceutique en évolution constante - [SCHOTT Pharma redéfinit le secteur des soins de santé](https://www.schott-pharma.com/fr/pharma-expertise/centre-de-connaissances/blog/redefining-healthcare-the-power-of-large-volume-sterile-cartridges): Redéfinir les soins de santé grâce à des cartouches stériles de grand volume, facilitant l’administration sous-cutanée des médicaments de manière plus simple et économique, ainsi que l’auto-administration à domicile. - [Diversité et inclusion chez SCHOTT Pharma](https://www.schott-pharma.com/fr/pharma-expertise/centre-de-connaissances/blog/diversity-and-inclusion-at-schott-pharma): La diversité et l’inclusion chez SCHOTT Pharma constituent la clé du succès de l’entreprise et l’élan des équipes engagées. - [Médicaments falsifiés | SCHOTT Pharma](https://www.schott-pharma.com/fr/pharma-expertise/centre-de-connaissances/blog/counterfeit-drugs-protecting-patients): SCHOTT Pharma place la santé des patients au premier plan avec les ampoules AC ! Découvrez comment protéger les patients contre les médicaments falsifiés. - [Systèmes d’inspection visuelle | Schott Pharma](https://www.schott-pharma.com/fr/pharma-expertise/centre-de-connaissances/blog/container-quality-automated-visual-inspection-systems): Amélioration de la qualité des contenants pharmaceutiques grâce aux systèmes d’inspection visuelle automatisés - [Conception de produits pharmaceutiques : sûre pour les patients, durable pour la planète I SCHOTT Pharma](https://www.schott-pharma.com/fr/pharma-expertise/centre-de-connaissances/blog/pharmaceutical-product-design): Découvrez comment SCHOTT Pharma intègre l’écoconception pour développer des produits pharmaceutiques assurant la sécurité des patients et promouvant la durabilité environnementale. Découvrez notre engagement envers la neutralité climatique d’ici 2030. - [Comment sélectionner les meilleures ampoules pour votre ligne de remplissage | SCHOTT Pharma](https://www.schott-pharma.com/fr/pharma-expertise/centre-de-connaissances/blog/how-to-choose-the-best-ampoules-for-your-filling-line): Découvrez comment choisir les meilleures ampoules pour votre ligne de remplissage. Comprenez les différentes formes d’ampoules et leur compatibilité avec les divers types de machines Fill-and-Finish. - [Meilleur système de rupture d’ampoule | SCHOTT Pharma](https://www.schott-pharma.com/fr/pharma-expertise/centre-de-connaissances/blog/systemes-de-cassure-d-ampoules): Lisez l’article de blog de Schott Pharma et découvrez comment sélectionner le système de rupture optimal pour votre ampoule. - [Pourquoi les essais cliniques échouent | SCHOTT Pharma](https://www.schott-pharma.com/fr/pharma-expertise/centre-de-connaissances/blog/why-clinical-trials-fail): Les pièges courants et les principaux défis des essais cliniques, ainsi que la manière dont des choix d’emballage appropriés peuvent atténuer les risques et améliorer les taux de réussite. - [Le flacon en tant que plateforme | SCHOTT Pharma](https://www.schott-pharma.com/fr/pharma-expertise/centre-de-connaissances/blog/drug-development-efficiency-vial-as-platform): Comment les solutions d’emballage pré-testées, telles que le flacon en tant que plateforme, améliorent l’efficacité du développement de médicaments et renforcent la sécurité de la production - [Flacons à encliqueter | SCHOTT Pharma](https://www.schott-pharma.com/fr/pharma-expertise/centre-de-connaissances/blog/snap-on-vials): SCHOTT Pharma fabrique des flacons encliquetables en tubes de verre FIOLAX® de haute qualité, assurant une compatibilité optimale avec divers composants dans les applications pharmaceutiques. - [Comment les conteneurs RTU accélèrent la mise sur le marché ? | SCHOTT Pharma](https://www.schott-pharma.com/fr/pharma-expertise/centre-de-connaissances/blog/comment-rtu-packaging-accelere-le-delai-de-mise-sur-le-marche): Découvrez comment les conteneurs RTU accélèrent la mise sur le marché et augmentent le flux de trésorerie, tout en maintenant une qualité supérieure. - [Normes Pharmaceutiques pour le Verre | SCHOTT Pharma ](https://www.schott-pharma.com/fr/pharma-expertise/centre-de-connaissances/blog/repenser-les-normes-pharmaceutiques-pour-les-stratégies-de-test-dédiées-au-verre): La pharmacopée américaine vise à créer une flexibilité supplémentaire pour les exigences en matière d'emballage et de stockage. En savoir plus ! - [Comment les ampoules sont devenues l'emballage préféré ? | SCHOTT Pharma](https://www.schott-pharma.com/fr/pharma-expertise/centre-de-connaissances/blog/comment-ampoules-devenues-emballage-primaire-le-plus-populaire-au-monde-medicaments): SCHOTT Pharma montre comment les ampoules sont passés de récipients pour le sang au IIIe siècle à l’emballage préféré pour les médicaments. - [Comment optimiser le remplissage et la finition avec l'emballage RTU I SCHOTT Pharma](https://www.schott-pharma.com/fr/pharma-expertise/centre-de-connaissances/blog/comment-optimiser-processus-fill-and-finish-avec-solutions-stockage-medicaments-steriles): Comment l'emballage RTU optimise les processus Fill-and-Finish, garantissant la sécurité des patients, accélérant les délais de mise sur le marché. - [Qu’est-ce qu’un flacon et comment choisir le bon | SCHOTT Pharma](https://www.schott-pharma.com/fr/pharma-expertise/centre-de-connaissances/blog/qu-est-ce-qu-une-fiole): Qu’est-ce qu’un flacon ? En savoir plus sur les composants, les types et les applications pharmaceutiques d’un flacon, ainsi que sur la façon de choisir le bon flacon - [Recyclage en boucle fermée | Emballage pharmaceutique](https://www.schott-pharma.com/fr/pharma-expertise/centre-de-connaissances/blog/closed-loop-recycling-initiative): Découvrez comment le recyclage en boucle fermée dans les emballages de transport pharmaceutique peut réduire la demande de plastique vierge. - [Vers des dispositifs d’injection à zéro émission nette | SCHOTT Pharma](https://www.schott-pharma.com/fr/pharma-expertise/centre-de-connaissances/blog/designing-a-pathway-towards-net-zero-injection-devices): Chez SCHOTT Pharma, nous sommes convaincus que les produits à zéro émission nette exigent une collaboration intersectorielle solide. - [Réduire le Coût Total de Possession avec l'Emballage RTU | SCHOTT Pharma](https://www.schott-pharma.com/fr/pharma-expertise/centre-de-connaissances/blog/reduire-cout-total-proprietaire-emballage-rtu): Découvrez comment les flacons en verre RTU comme adaptiQ de SCHOTT Pharma réduisent le coût total de possession, améliorent la stabilité des médicaments. - [5 étapes pour la réduction des particules dans les emballages RTU I SCHOTT Pharmaceutique](https://www.schott-pharma.com/fr/pharma-expertise/centre-de-connaissances/blog/5-etapes-pour-reduire-les-particules-dans-emballage-rtu): Réduire la contamination par les particules d'emballages RTU. De l'approvisionnement en matériaux propres aux laboratoires de particules avancés. - [Des solutions d’emballage primaire innovantes pour Bayer | SCHOTT Pharma](https://www.schott-pharma.com/fr/pharma-expertise/centre-de-connaissances/blog/des-solutions-demballage-primaire-innovantes-pour-bayer): Ce partenariat stratégique avec SCHOTT Pharma permet à Bayer de commercialiser des médicaments biotechnologiques de manière plus sûre et plus rapide grâce à des solutions d’emballage primaire innovantes. - [Comment Utiliser une Seringue Pré-remplie | SCHOTT Pharma ](https://www.schott-pharma.com/fr/pharma-expertise/centre-de-connaissances/blog/utilisation-seringue-verre-pre-remplie): Les seringues pré-remplies en verre (PFS) permettent d'administrer des médicaments injectables en une seule étape. En savoir plus ! - [Les Emballages de Médicaments à ARNm | SCHOTT Pharma ](https://www.schott-pharma.com/fr/pharma-expertise/centre-de-connaissances/blog/emballages-primaires-pharmaceutiques-arnm-medicaments): Découvrez comment les médicaments à ARNm influencent l'emballage primaire des produits pharmaceutiques, car le besoin de ces contenants augmente de jour en jour. - [Validation du Stérilité dans les Emballages RTU I SCHOTT Pharma](https://www.schott-pharma.com/fr/pharma-expertise/centre-de-connaissances/blog/validation-sterilite-rtu): En savoir plus sur la validation de la stérilisation dans les emballages RTU et la quantification de la stérilité avec le Sterility Assurance Level. - [Méthodes de Stérilisation Pharmaceutique : Conteneurs RTU | SCHOTT Pharma](https://www.schott-pharma.com/fr/pharma-expertise/centre-de-connaissances/blog/sterilite-emballages-rtu): Pour atteindre les niveaux de stérilité obligatoires, différentes méthodes de stérilisation sont appliquées dans des conteneurs d'emballage RTU. - [Comment les Contenants de Médicaments améliorent la Stabilité ? ](https://www.schott-pharma.com/fr/pharma-expertise/centre-de-connaissances/blog/stabilite-des-medicaments): Divers emballages pharmaceutiques de différentes qualités de verre protègent les produits biologiques et améliorent la stabilité des médicaments. - [Les Tests des Extractibles Expliqués I SCHOTT Pharma](https://www.schott-pharma.com/fr/pharma-expertise/centre-de-connaissances/blog/test-des-extractibles): Le tests des extractibles est utilisé pour analyser les matériaux potentiellement nocifs. Découvrez le rôle des tests d'extractibilité dans l'industrie pharma. - [Le Conteneur Idéal | Seringues pour Vaccins ARNm ](https://www.schott-pharma.com/fr/pharma-expertise/centre-de-connaissances/blog/seringues-pour-vaccins-arnm): Seringues pour vaccin ARNm pourraient être le conteneur idéal pour remplacer les flacons multidoses et prolonger la durée de conservation des vaccins. - [Résoudre les défis de la biotechnologie en matière de conditionnement des médicaments grâce aux flacons | SCHOTT Pharma](https://www.schott-pharma.com/fr/pharma-expertise/centre-de-connaissances/blog/résoudre-les-défis-de-confinement-des-médicaments-biotechnologiques): La croissance du nombre de formulations pharmaceutiques représente un défi pour le remplissage et la manipulation des flacons en verre pharmaceutique, mais SCHOTT EVERIC® répond à cette demande. - [SCHOTT Pharma Blog | Base de Connaissance Pharmaceutique ](https://www.schott-pharma.com/fr/pharma-expertise/centre-de-connaissances/blog): Le blog de SCHOTT Pharma est votre référence pour les tendances pharmaceutiques et les nouveaux produits et services. En savoir plus! ## SCHOTT Pharma Academy/Événements/Certificats | Les ressources d’expertise pharmaceutique de SCHOTT Pharma incluent des programmes éducatifs, des événements et des formations via la Pharmaversity Academy, ainsi qu’un accès à des certificats et à des informations sectorielles, permettant aux partenaires pharmaceutiques et biotechnologiques d’approfondir leurs connaissances, leurs compétences et leur maîtrise réglementaire. - [Certificats | SCHOTT Pharma](https://www.schott-pharma.com/fr/pharma-expertise/centre-de-connaissances/certificats): Téléchargez les derniers certificats de SCHOTT Pharma. Découvrez les détails et accédez aux fichiers PDF. ## SCHOTT Pharma À propos de nous | La page À propos de SCHOTT Pharma met en avant la mission, les valeurs et l’histoire de l’entreprise, en soulignant son rôle dans le confinement et l’administration des médicaments, son engagement envers la qualité et l’innovation, sa présence mondiale, ainsi que son soutien aux partenaires pharmaceutiques et biotechnologiques pour améliorer les résultats des soins de santé. - [SCHOTT Pharma Philosophie | La Santé Humaine Compte ](https://www.schott-pharma.com/fr/a-propos/parce-que-la-sante-humaine-est-importante): Avec vous - nos clients et nos partenaires - nous visons la meilleure expérience possible pour les patients. Parce que la santé humaine est importante ! - [À Propos – SCHOTT Pharma ](https://www.schott-pharma.com/fr/a-propos): Leader mondial des entreprises pharma, nous concevons des solutions pour que les médicaments soient sûrs et faciles à utiliser pour tous. ## Communiqués de presse de SCHOTT Pharma | La page Actualités et Médias de SCHOTT Pharma présente les derniers communiqués de presse, mises à jour de l’entreprise, résultats financiers, événements et annonces du secteur concernant les innovations, expansions, partenariats et performances, afin de tenir les parties prenantes de l’industrie pharmaceutique et biotechnologique informées des évolutions. - [Foires et Événements | SCHOTT Pharma](https://www.schott-pharma.com/fr/actualites-et-medias/foires-et-evenements): L'ensemble des événements spécialisés, des salons et des conférences présentés par SCHOTT Pharma. - [Dossier de Presse | SCHOTT Pharma](https://www.schott-pharma.com/fr/actualites-et-medias/kits-medias): La gamme complète des dossiers de presse de SCHOTT Pharma, de notre rôle dans la lutte contre le COVID-19. - [Formulaire Actualités et Médias | SCHOTT Pharma ](https://www.schott-pharma.com/fr/actualites-et-medias/demande): Contactez notre équipe SCHOTT Pharma Actualités et Médias - [Actualités et Médias Contacts | SCHOTT Pharma](https://www.schott-pharma.com/fr/actualites-et-medias/contacts): Coordonnées de l'équipe Actualités et médias de SCHOTT Pharma - [Communiqués de presse | SCHOTT Pharma](https://www.schott-pharma.com/fr/actualites-et-medias/communiques-medias): Les dernières publications médiatiques de SCHOTT Pharma - [SCHOTT annonce une année couronnée de succès pour sa division pharmaceutique | SCHOTT](https://www.schott-pharma.com/fr/actualites-et-medias/communiques-medias/2022/schott-signale-une-annee-reussie-pour-lunite-commerciale-pharmaceutique): COMMUNIQUÉ DE PRESSE : L’unité commerciale pharmaceutique de SCHOTT a connu une année 2021 très fructueuse et vise à s’appuyer sur ce succès - [Actualités et Médias | SCHOTT Pharma ](https://www.schott-pharma.com/fr/actualites-et-medias): Les dernières nouvelles et les communiqués de presse du fabricant international de verres spéciaux. ## Durabilité de SCHOTT Pharma | La page Développement durable de SCHOTT Pharma présente les initiatives de responsabilité environnementale et sociale de l’entreprise, y compris les objectifs en matière d’action climatique, d’efficacité des ressources, de chaînes d’approvisionnement éthiques et d’engagement communautaire, afin de soutenir des soins de santé durables et un impact à long terme. - [Produits durables I SCHOTT Pharma](https://www.schott-pharma.com/fr/a-propos/durabilite/produits-durables): SCHOTT Pharma s’engage à réduire l’impact environnemental grâce à la conception durable des produits, à l’optimisation de la chaîne d’approvisionnement et aux partenariats. Nos efforts se concentrent sur les matériaux écologiques et la gestion du cycle de vie, contribuant ainsi aux solutions au changement climatique. - [Conformité | SCHOTT Pharma](https://www.schott-pharma.com/fr/a-propos/durabilite/compliance): Tout ce que vous devez savoir sur les politiques de conformité de SCHOTT Pharma, y compris son Code de conduite, ses pratiques commerciales éthiques, sa responsabilité sociale et sa gouvernance d’entreprise. - [Développement durable | SCHOTT Pharma](https://www.schott-pharma.com/fr/a-propos/durabilite): Découvrez comment SCHOTT Pharma renforce la durabilité sur l’ensemble de sa chaîne de valeur grâce à des pratiques commerciales responsables, à des actions en faveur du climat, à des initiatives de circularité et à une utilisation efficace des ressources. ## SCHOTT Pharma Autres Pages - [Newsletter | SCHOTT Pharma](https://www.schott-pharma.com/fr/newsletter): Restez informé des dernières nouvelles et tendances avec la newsletter SCHOTT Pharma. Inscrivez-vous maintenant ! - [SCHOTT Pharma AG & Co. KGaA](https://www.schott-pharma.com/fr/mentions-legales): Vous trouverez ici nos mentions légales avec les informations légales de SCHOTT Pharma. - [Conditions Générales | SCHOTT Pharma ](https://www.schott-pharma.com/fr/conditions-generales): Consultez les conditions générales de SCHOTT Pharma. Téléchargez les PDFs pour en savoir plus ! - [Politique de Protection des Données | SCHOTT Pharma ](https://www.schott-pharma.com/fr/politique-de-protection-des-donnees): Pour en savoir plus sur la politique de protection des données y compris qui contrôle vos données personnelles et vos droits concernant la protection de vos données. - [Politique de Protection des Données Évents | SCHOTT Pharma](https://www.schott-pharma.com/fr/politique-de-protection-des-donnees-events): Traitement de vos données personnelles par SCHOTT Pharma pour l'organisation d'événements. - [Avis de Non-Responsabilité et Informations Légales | SCHOTT Pharma](https://www.schott-pharma.com/fr/avis-de-non-responsabilite): Informations légales pour l'utilisation du site web de SCHOTT Pharma.